{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "bfcd542f",
   "metadata": {},
   "source": [
    "# Introductions"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3d7e91d5",
   "metadata": {},
   "source": [
    "<p style='text-align: justify;'>Hypertension has been known as one of the leading preventable risk factor for cardiovascular disease and responsible for approximately 50% of cardiovascular morbidity and mortality worldwide (1). In addition to being a major risk factor for cardiovascular disease, it was also found to be a risk factor for renal and cerebrovascular diseases (2). The associated risks of being diagnosed with hypertension was due to arterial wall modifications (during ageing), and the increased exposure to unhealthy lifestyle, such as unhealthy diets and lack of physical activities. This means that the adult population were at higher risks to suffer with hypertension, where those that were diagnosed with the disease falls in majority to the category of primary (essential) hypertension while a few hypertensive patients have secondary hypertension. To add context to the differences of the types of hypertension, primary hypertension is characterized as high blood pressure without an identifiable cause while secondary hypertension is associated by known disease or condition (3). Moreover, in a general sense, hypertension is characterized with chronic elevation of blood pressure, which in the long run would cause organ damage and eventually lead to a cascade of systematic problems in the body. Therefore, as a general practice, the blood pressure level of 140/90mm Hg became an indicator where treatment of hypertension should begin to prevent chronic complications (3).\n",
    "\n",
    "<p style='text-align: justify;'>For blood pressure regulation under physiological conditions, the Renin-Angiotensin Aldesteron system (RAAS) functions to regulate blood pressure and hydro-electrolytic balance. The RAAS system works by cleavage of the susbtrate Angeiotensinogen (AGT) into Angiotensin-I by the enzyme Renin, and then further cleaved by Angiotensin-Converting Enzyme (ACE) into Angiotensin-II, which was the key player in the system. With this biological knowledge of the RAAS sytem and its key functionality in the regulation of blood pressure, therapeutic drugs that functions as inhibitors of the enzymes that participate in the RAAS system, for instance, Renin inhibitors, ACE inhibitors, Angeiotensin-II type 1 receptor antagonists, and mineralocorticoid receptor antagonists, in turn would help regulate the disregulated RAAS system and treat/prevent the event of hypertesion in high-risk patients (4).\n",
    "\n",
    "\n",
    "<p style='text-align: justify;'>In the field of genetics and genomics, the Framingham Heart Study had recorded blood pressure data for three generations and with the absence of environmental factors, it was shown that children whose parents and grandparents diagnosed with hypertension had an increased risk of having the condition (6). In addition, a monogenic hypertension research had found that 12 genes (CYP11B1, CYP11B2, WNK1, WNK4, KLHL3, CUL3, SCNN1B, SCNN1G, CYP17A1, HSD11B2, NR3C2 and KCNJ5) in which 8 of these genes were involved in Mendelian syndromes causing Hypertension. Furthermore, 5 out of the 12 monogenic hypertension genes had upregulated expressions mutation while the remaining genes had downregulation expression mutation that led the reduction of inhibitory effects on blood pressure. Moreover, the 12 genes in the study belonged to two groups of pathways, such as the renal sodium handling pathway and steroid hormone metabolism pathway (1). Another case control study of monogenic forms of hypertension, such that genes were identified to determine the key mechanisms in the pathophysiology aspect of hypertension, especially those involved in the RAAS, catecholamine/adrenergic system, renal kinin system, epithelial sodium channel, adducin, and including those involved in lipoprotein metabolism, hormone receptors, and growth factors. The list of genes found in this review include AGT variants, adregenic receptors (ADRA1B and ADRB2), dopamine D1 receptor (DRD1), AGTR1, REN, ACE, glucocorticoid-remediable aldosteronism (GRA), 11-β-hydroxylase (CYP11B1), aldosterone synthase (CYP11B2), epithelial sodium channel three subunits (SCNN1A, SCNN1B and SCNN1G) (6). \n",
    "\n",
    "Comments: Will be adding more as semester progresses..."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "643186f8",
   "metadata": {},
   "source": [
    "## References\n",
    "1. Ehret, G. B., & Caulfield, M. J. (2013). Genes for blood pressure: an opportunity to understand hypertension. European heart journal, 34(13), 951–961. https://doi.org/10.1093/eurheartj/ehs455.\n",
    "2. Aliouche, H. (2023, January 16). The genetics of hypertension. News Medical Life Sciences. https://www.news-medical.net/health/The-Genetics-of-Hypertension.aspx \n",
    "3. Hegde S, Ahmed I, Aeddula NR. Secondary Hypertension. [Updated 2023 Jan 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK544305/\n",
    "4. Information from KEGG Pathway, ID:hsa04614 (Acessed 2023 Jun 05). Minoru Kanehisa and others, KEGG for representation and analysis of molecular networks involving diseases and drugs, Nucleic Acids Research, Volume 38, Issue suppl_1, 1 January 2010, Pages D355–D360, https://doi.org/10.1093/nar/gkp896\n",
    "5. Foëx, P., & Sear, J. W. (2004). Hypertension: pathophysiology and treatment. Continuing Education in Anaesthesia Critical Care & Pain, 4(3), 71–75. doi:10.1093/bjaceaccp/mkh020\n",
    "6. Adua, E. Decoding the mechanism of hypertension through multiomics profiling. J Hum Hypertens 37, 253–264 (2023). https://doi.org/10.1038/s41371-022-00769-8 \n",
    "7. Amberger JS, Bocchini CA, Schiettecatte FJM, Scott AF, Hamosh A. OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders. Nucleic Acids Res. 2015 Jan;43(Database issue):D789-98. doi: 10.1093/nar/gku1205. PMID: 25428349."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9f029bd3",
   "metadata": {},
   "source": [
    "# Project Task"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "703455b0",
   "metadata": {},
   "source": [
    "Purpose: To obtain and compile data for the gene targets/biomarkers associated with Hypertension.\n",
    "   - Each line of the data file would contain key information about the gene/biomarkers for Hypertensive drugs.\n",
    "     - The list of headers of data file:\n",
    "       - Gene, Mutation_Remark, System/Pathway_info, Drug_Combination, Actionability Rank, Drug name, Primary_Outcome_Measure, Primary or Secondary Hypertension?, Cell location, and Drug Class."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cbb5a15d",
   "metadata": {},
   "source": [
    "# Tools for Gathering Information"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5d13e617",
   "metadata": {},
   "source": [
    "- KEGG Pathway/Drug/Disease\n",
    "- ClinVar\n",
    "- Online Mendelian Inheritance in Man (OMIM) Database Analysis\n",
    "- ClinicalTrial.Gov"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e394c0de",
   "metadata": {},
   "source": [
    "# Methodology Overview with Use of Genomic Tools and Resources\n",
    "<p style='text-align: justify;'>The first step was to utilize the KEGG Disease, Pathways, and Drugs Database to obtain pathways, genes, and drugs associated with either primary/secondary hypertension diseases and also provide a big overview of the disease pathway networks. Afterwards, potential gene targets/biomarkers for the disease hypertension were acquired through the search of clinical variants in-connect with hypertension through the use of the NCBI ClinVar database and then data of genetic disorders connected to the disease were also retrieved from the NCBI Online Mendelian Inheritance in Man (OMIM) database. Finally, the suspected gene targers/biomarkers for either primary/secondary hypertensions would be searched through the ClinicalTrial.Gov webpage to obtain clinical drug trial informations, which would then populate the results table as instructed in the project prompt."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8bc2d93a",
   "metadata": {},
   "source": [
    "# Part 1: Search Diseases/Pathways/Anti-hypertensive Drugs/Brite Associated with Hypertension"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fc6e4d05",
   "metadata": {},
   "source": [
    "### KEGG Disease Database"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "c70822e8",
   "metadata": {},
   "outputs": [],
   "source": [
    "# First create a KEGG Object\n",
    "from bioservices import * # create the session\n",
    "k = KEGG(verbose=False) # object created"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "08da9ec2",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ds:H00603\tHypertension exacerbated in pregnancy\n",
      "ds:H01619\tPrimary pulmonary hypertension\n",
      "ds:H01621\tPulmonary arterial hypertension\n",
      "ds:H01622\tChronic thromboembolic pulmonary hypertension\n",
      "ds:H01633\tHigh blood pressure; Hypertension\n",
      "ds:H01686\tIdiopathic portal hypertension; Non-cirrhotic portal fibrosis; Banti syndrome\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Here we will search in KEGG Disease database\n",
    "k.dbinfo('disease')\n",
    "\n",
    "# We use the object's find method and pass in parameters disease and Hypertension.\n",
    "K_result = k.find('disease','Hypertension')  # Locate Hypertension under Disease Database\n",
    "print(K_result)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "69913fe1",
   "metadata": {},
   "source": [
    "### Retrieve the Information about these KEGG Disease Database IDs associated with Hypertension"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "6f4744d0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ENTRY       H00603                      Disease\n",
      "NAME        Hypertension exacerbated in pregnancy\n",
      "DESCRIPTION \"Hypertension exacerbated by pregnancy\" is a syndrome similar to Apparent mineralocorticoid excess (AME) with autosomal dominant early-onset hypertension. The affected individuals have a gain of function mutation in the human mineralocorticoid receptor (MR), resulting in constitutively stimulated Na reabsorption. Hypertension is present in nonpregnant patients and may be severe, but the characteristic feature is marked worsening during pregnancy. The proposed explanation is that the mutation renders the receptor sensitive to nonmineralocorticoid steroids such as progesterone, the level of which rises 100-fold during pregnancy.\n",
      "CATEGORY    Cardiovascular disease\n",
      "BRITE       Human diseases in ICD-11 classification [BR:br08403]\n",
      "             11 Diseases of the circulatory system\n",
      "              Hypertensive diseases\n",
      "               BA04  Secondary hypertension\n",
      "                H00603  Hypertension exacerbated in pregnancy\n",
      "PATHWAY     hsa04960  Aldosterone-regulated sodium reabsorption\n",
      "GENE        NR3C2 [HSA:4306] [KO:K08555]\n",
      "DBLINKS     ICD-11: BA04\n",
      "            ICD-10: I15.8\n",
      "            OMIM: 605115\n",
      "REFERENCE   PMID:17647025\n",
      "  AUTHORS   Vehaskari VM\n",
      "  TITLE     Heritable forms of hypertension.\n",
      "  JOURNAL   Pediatr Nephrol 24:1929-37 (2009)\n",
      "            DOI:10.1007/s00467-007-0537-8\n",
      "REFERENCE   PMID:17262198\n",
      "  AUTHORS   Rosskopf D, Schurks M, Rimmbach C, Schafers R\n",
      "  TITLE     Genetics of arterial hypertension and hypotension.\n",
      "  JOURNAL   Naunyn Schmiedebergs Arch Pharmacol 374:429-69 (2007)\n",
      "            DOI:10.1007/s00210-007-0133-2\n",
      "REFERENCE   PMID:12538613\n",
      "  AUTHORS   Rafestin-Oblin ME, Souque A, Bocchi B, Pinon G, Fagart J, Vandewalle A\n",
      "  TITLE     The severe form of hypertension caused by the activating S810L mutation in the mineralocorticoid receptor is cortisone related.\n",
      "  JOURNAL   Endocrinology 144:528-33 (2003)\n",
      "            DOI:10.1210/en.2002-220708\n",
      "///\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# use the 'get' method to retrieve the annotations of the input term.\n",
    "holder1 = k.get('H00603') # Hypertension exacerbated in pregnancy\n",
    "print(holder1)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0276b60a",
   "metadata": {},
   "source": [
    "Note: For ID:H00603, gene found: NR3C2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "574653ef",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ENTRY       H01619                      Disease\n",
      "NAME        Primary pulmonary hypertension\n",
      "DESCRIPTION Primary pulmonary hypertension (PPH) is a progressive disease characterised by raised pulmonary vascular resistance, which results in diminished right-heart function due to increased right ventricular afterload. PPH occurs most commonly in young and middle-aged women; mean survival from onset of symptoms is 2-3 years. Mutations in the type II bone morphogenetic protein (BMP) receptor (BMPR)-II are now considered to be the genetic basis for familial PPH and ~30% of cases of sporadic PPH. BMPs are members of the transforming growth factor beta superfamily and affect intracellular signalling via Smads and mitogen-activated protein kinases. It has been shown that missense mutations of cysteine residues in the extracellular or kinase domain of BMPR2 result in intracellular localisation of the mutated receptor and negligible Smad signalling.\n",
      "CATEGORY    Cardiovascular disease\n",
      "BRITE       Human diseases in ICD-11 classification [BR:br08403]\n",
      "             11 Diseases of the circulatory system\n",
      "              Pulmonary heart disease or diseases of pulmonary circulation\n",
      "               BB01  Pulmonary hypertension\n",
      "                H01619  Primary pulmonary hypertension\n",
      "            Pathway-based classification of diseases [BR:br08402]\n",
      "             Signal transduction\n",
      "              nt06507  TGFB signaling\n",
      "               H01619  Primary pulmonary hypertension\n",
      "PATHWAY     hsa04350  TGF-beta signaling pathway\n",
      "NETWORK     nt06507(H01619) TGFB signaling\n",
      "GENE        (PPH1) BMPR2 [HSA:659] [KO:K04671]\n",
      "            (PPH2) SMAD9 [HSA:4093] [KO:K16791]\n",
      "            (PPH3) CAV1 [HSA:857] [KO:K06278]\n",
      "            (PPH4) KCNK3 [HSA:3777] [KO:K04914]\n",
      "DRUG        Nitric oxide [DR:D00074]\n",
      "DBLINKS     ICD-11: BB01\n",
      "            ICD-10: I27.0\n",
      "            MeSH: D065627\n",
      "            OMIM: 178600 615342 615343 615344\n",
      "REFERENCE   PMID:9729004\n",
      "  AUTHORS   Gaine SP, Rubin LJ\n",
      "  TITLE     Primary pulmonary hypertension.\n",
      "  JOURNAL   Lancet 352:719-25 (1998)\n",
      "            DOI:10.1016/S0140-6736(98)02111-4\n",
      "REFERENCE   PMID:12737878 (PPH1)\n",
      "  AUTHORS   Runo JR, Loyd JE\n",
      "  TITLE     Primary pulmonary hypertension.\n",
      "  JOURNAL   Lancet 361:1533-44 (2003)\n",
      "            DOI:10.1016/S0140-6736(03)13167-4\n",
      "REFERENCE   PMID:15005857\n",
      "  AUTHORS   Rudarakanchana N, Morrell NW\n",
      "  TITLE     Primary pulmonary hypertension: molecular basis and potential for therapy.\n",
      "  JOURNAL   Expert Rev Mol Med 6:1-15 (2004)\n",
      "            DOI:10.1017/S1462399404007483\n",
      "REFERENCE   PMID:12503718\n",
      "  AUTHORS   Eddahibi S, Morrell N, d'Ortho MP, Naeije R, Adnot S\n",
      "  TITLE     Pathobiology of pulmonary arterial hypertension.\n",
      "  JOURNAL   Eur Respir J 20:1559-72 (2002)\n",
      "            DOI:10.1183/09031936.02.00081302\n",
      "REFERENCE   PMID:19211612 (PPH2)\n",
      "  AUTHORS   Shintani M, Yagi H, Nakayama T, Saji T, Matsuoka R\n",
      "  TITLE     A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension.\n",
      "  JOURNAL   J Med Genet 46:331-7 (2009)\n",
      "            DOI:10.1136/jmg.2008.062703\n",
      "REFERENCE   PMID:22474227 (PPH3)\n",
      "  AUTHORS   Austin ED, Ma L, LeDuc C, Berman Rosenzweig E, Borczuk A, Phillips JA 3rd, Palomero T, Sumazin P, Kim HR, Talati MH, West J, Loyd JE, Chung WK\n",
      "  TITLE     Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension.\n",
      "  JOURNAL   Circ Cardiovasc Genet 5:336-43 (2012)\n",
      "            DOI:10.1161/CIRCGENETICS.111.961888\n",
      "REFERENCE   PMID:23883380 (PPH4)\n",
      "  AUTHORS   Ma L, Roman-Campos D, Austin ED, Eyries M, Sampson KS, Soubrier F, Germain M, Tregouet DA, Borczuk A, Rosenzweig EB, Girerd B, Montani D, Humbert M, Loyd JE, Kass RS, Chung WK\n",
      "  TITLE     A novel channelopathy in pulmonary arterial hypertension.\n",
      "  JOURNAL   N Engl J Med 369:351-361 (2013)\n",
      "            DOI:10.1056/NEJMoa1211097\n",
      "///\n",
      "\n"
     ]
    }
   ],
   "source": [
    "holder2 = k.get('H01619') # Primary pulmonary hypertension\n",
    "print(holder2)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4b627109",
   "metadata": {},
   "source": [
    "For ID: H01619, Gene found: BMPR2, SMAD9, CAV1, KCNK3"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "271f8a2c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ENTRY       H01621                      Disease\n",
      "NAME        Pulmonary arterial hypertension\n",
      "DESCRIPTION Pulmonary arterial hypertension (PAH) is a progressive disorder in which endothelial dysfunction and vascular remodeling obstruct small pulmonary arteries, resulting in increased pulmonary vascular resistance and pulmonary pressures. This leads to reduced cardiac output, right heart failure, and ultimately death. PAH is divided into disease subgroups that include heritable (HPAH, formerly familial PAH), idiopathic (IPAH), and PAH associated with a variety of other systemic diseases or drug/toxin exposures. It has been discovered that altered BMPR2 signaling is the major heritable risk factor for development of PAH, via rare variants (mutations) in the BMPR2 gene (coding for a type II receptor member of the transforming growth factor [TGF]-beta family). Pathogenic mutations in the type I receptor ACVRL1 and, at a significantly lower frequency, the type III receptor endoglin in multiple kindreds cause PAH associated with hereditary hemorrhagic telangiectasia (HHT). Together, these observations support a prominent role for TGF-beta family members in the development of PAH.\n",
      "CATEGORY    Cardiovascular disease\n",
      "BRITE       Human diseases in ICD-11 classification [BR:br08403]\n",
      "             11 Diseases of the circulatory system\n",
      "              Pulmonary heart disease or diseases of pulmonary circulation\n",
      "               BB01  Pulmonary hypertension\n",
      "                H01621  Pulmonary arterial hypertension\n",
      "PATHWAY     hsa04350  TGF-beta signaling pathway\n",
      "GENE        (PPH1) BMPR2 [HSA:659] [KO:K04671]\n",
      "            (PPH2) SMAD9 [HSA:4093] [KO:K16791]\n",
      "            (PPH3) CAV1 [HSA:857] [KO:K06278]\n",
      "            (PPH4) KCNK3 [HSA:3777] [KO:K04914]\n",
      "            (PPH5) ATP13A3 [HSA:79572] [KO:K14951]\n",
      "            (HHT2) ACVRL1 [HSA:94] [KO:K13594]\n",
      "            (PVOD2) EIF2AK4 [HSA:440275] [KO:K16196]\n",
      "DRUG        Epoprostenol [DR:D00106]\n",
      "            Epoprostenol sodium [DR:D01337]\n",
      "            Iloprost [DR:D02721]\n",
      "            Treprostinil [DR:D06213]\n",
      "            Treprostinil diolamine [DR:D10430]\n",
      "            Selexipag [DR:D09994]\n",
      "            Bosentan [DR:D01227]\n",
      "            Ambrisentan [DR:D07077]\n",
      "            Macitentan [DR:D10135]\n",
      "            Riociguat [DR:D09572]\n",
      "            Sildenafil [DR:D08514]\n",
      "            Sildenafil citrate [DR:D02229]\n",
      "            Tadalafil [DR:D02008]\n",
      "            Nitric oxide [DR:D00074]\n",
      "DBLINKS     ICD-11: BB01.0\n",
      "            ICD-10: I27\n",
      "            MeSH: D065627\n",
      "            OMIM: 178600 615342 615343 615344 265400 600376 234810\n",
      "REFERENCE   PMID:24951762\n",
      "  AUTHORS   Lai YC, Potoka KC, Champion HC, Mora AL, Gladwin MT\n",
      "  TITLE     Pulmonary arterial hypertension: the clinical syndrome.\n",
      "  JOURNAL   Circ Res 115:115-30 (2014)\n",
      "            DOI:10.1161/CIRCRESAHA.115.301146\n",
      "REFERENCE   PMID:24355637\n",
      "  AUTHORS   Soubrier F, Chung WK, Machado R, Grunig E, Aldred M, Geraci M, Loyd JE, Elliott CG, Trembath RC, Newman JH, Humbert M\n",
      "  TITLE     Genetics and genomics of pulmonary arterial hypertension.\n",
      "  JOURNAL   J Am Coll Cardiol 62:D13-21 (2013)\n",
      "            DOI:10.1016/j.jacc.2013.10.035\n",
      "REFERENCE   PMID:24951767\n",
      "  AUTHORS   Austin ED, Loyd JE\n",
      "  TITLE     The genetics of pulmonary arterial hypertension.\n",
      "  JOURNAL   Circ Res 115:189-202 (2014)\n",
      "            DOI:10.1161/CIRCRESAHA.115.303404\n",
      "REFERENCE   PMID:10973254 (BMPR2)\n",
      "  AUTHORS   Lane KB, Machado RD, Pauciulo MW, Thomson JR, Phillips JA 3rd, Loyd JE, Nichols WC, Trembath RC\n",
      "  TITLE     Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension.\n",
      "  JOURNAL   Nat Genet 26:81-4 (2000)\n",
      "            DOI:10.1038/79226\n",
      "REFERENCE   PMID:19211612 (SMAD9)\n",
      "  AUTHORS   Shintani M, Yagi H, Nakayama T, Saji T, Matsuoka R\n",
      "  TITLE     A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension.\n",
      "  JOURNAL   J Med Genet 46:331-7 (2009)\n",
      "            DOI:10.1136/jmg.2008.062703\n",
      "REFERENCE   PMID:22474227 (CAV1)\n",
      "  AUTHORS   Austin ED, Ma L, LeDuc C, Berman Rosenzweig E, Borczuk A, Phillips JA 3rd, Palomero T, Sumazin P, Kim HR, Talati MH, West J, Loyd JE, Chung WK\n",
      "  TITLE     Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension.\n",
      "  JOURNAL   Circ Cardiovasc Genet 5:336-43 (2012)\n",
      "            DOI:10.1161/CIRCGENETICS.111.961888\n",
      "REFERENCE   PMID:23883380 (KCNK3)\n",
      "  AUTHORS   Ma L, Roman-Campos D, Austin ED, Eyries M, Sampson KS, Soubrier F, Germain M, Tregouet DA, Borczuk A, Rosenzweig EB, Girerd B, Montani D, Humbert M, Loyd JE, Kass RS, Chung WK\n",
      "  TITLE     A novel channelopathy in pulmonary arterial hypertension.\n",
      "  JOURNAL   N Engl J Med 369:351-361 (2013)\n",
      "            DOI:10.1056/NEJMoa1211097\n",
      "REFERENCE   PMID:30679663 (ATP13A3)\n",
      "  AUTHORS   Barozzi C, Galletti M, Tomasi L, De Fanti S, Palazzini M, Manes A, Sazzini M, Galie N\n",
      "  TITLE     A Combined Targeted and Whole Exome Sequencing Approach Identified Novel Candidate Genes Involved in Heritable Pulmonary Arterial Hypertension.\n",
      "  JOURNAL   Sci Rep 9:753 (2019)\n",
      "            DOI:10.1038/s41598-018-37277-0\n",
      "REFERENCE   PMID:11484689 (ACVRL1)\n",
      "  AUTHORS   Trembath RC, Thomson JR, Machado RD, Morgan NV, Atkinson C, Winship I, Simonneau G, Galie N, Loyd JE, Humbert M, Nichols WC, Morrell NW, Berg J, Manes A, McGaughran J, Pauciulo M, Wheeler L\n",
      "  TITLE     Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.\n",
      "  JOURNAL   N Engl J Med 345:325-34 (2001)\n",
      "            DOI:10.1056/NEJM200108023450503\n",
      "REFERENCE   PMID:24292273 (EIF2AK4)\n",
      "  AUTHORS   Eyries M, Montani D, Girerd B, Perret C, Leroy A, Lonjou C, Chelghoum N, Coulet F, Bonnet D, Dorfmuller P, Fadel E, Sitbon O, Simonneau G, Tregouet DA, Humbert M, Soubrier F\n",
      "  TITLE     EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension.\n",
      "  JOURNAL   Nat Genet 46:65-9 (2014)\n",
      "            DOI:10.1038/ng.2844\n",
      "///\n",
      "\n"
     ]
    }
   ],
   "source": [
    "holder3 = k.get('H01621') # Pulmonary arterial hypertension\n",
    "print(holder3)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "dde6f5b9",
   "metadata": {},
   "source": [
    "For ID:H01621, Gene found: BMPR2, SMAD9, CAV1, KCNK3, ATP13A3, ACVRL1, EIF2AK4"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "6b26a85c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ENTRY       H01622                      Disease\n",
      "NAME        Chronic thromboembolic pulmonary hypertension\n",
      "DESCRIPTION Chronic thromboembolic pulmonary hypertension (CTEPH) is classified as group 4 pulmonary hypertension (PH) by the World Health Organization. It is a rare, but underdiagnosed, complication of acute pulmonary embolism (PE) resulting from occlusion of large pulmonary arteries with a fibrothrombotic material and in many cases, the development of a distal vessel arteriopathy that closely mimics pulmonary arterial hypertension. While the pathogenesis of CTEPH is not entirely understood, the primary pathophysiology appears to be related to an initial thrombotic event followed by both inadequate thrombus resolution and secondary arteriopathy. Several risk factors for development of CTEPH have been found, including the size of the initial PE, splenectomy, chronic inflammatory conditions, and indwelling catheters and cardiac pacemaker leads. There is however an increased incidence of elevated factor VIII levels in CTEPH, and this finding persists after treatment. However, none of these findings explain the development of CTEPH in the majority of patients affected by this disease.\n",
      "CATEGORY    Cardiovascular disease\n",
      "BRITE       Human diseases in ICD-11 classification [BR:br08403]\n",
      "             11 Diseases of the circulatory system\n",
      "              Pulmonary heart disease or diseases of pulmonary circulation\n",
      "               BB01  Pulmonary hypertension\n",
      "                H01622  Chronic thromboembolic pulmonary hypertension\n",
      "DRUG        Riociguat [DR:D09572]\n",
      "DBLINKS     ICD-11: BB01.3\n",
      "            ICD-10: I27.2\n",
      "REFERENCE   PMID:26739298\n",
      "  AUTHORS   Poch DS, Auger WR\n",
      "  TITLE     Chronic thromboembolic pulmonary hypertension: detection, medical and surgical treatment approach, and current outcomes.\n",
      "  JOURNAL   Heart Fail Rev 21:309-22 (2016)\n",
      "            DOI:10.1007/s10741-015-9518-3\n",
      "REFERENCE   PMID:26585271\n",
      "  AUTHORS   O'Connell C, Montani D, Savale L, Sitbon O, Parent F, Seferian A, Bulifon S, Fadel E, Mercier O, Mussot S, Fabre D, Dartevelle P, Humbert M, Simonneau G, Jais X\n",
      "  TITLE     Chronic thromboembolic pulmonary hypertension.\n",
      "  JOURNAL   Presse Med 44:e409-16 (2015)\n",
      "            DOI:10.1016/j.lpm.2015.10.010\n",
      "REFERENCE   PMID:27345156\n",
      "  AUTHORS   Robbins IM, Pugh ME, Hemnes AR\n",
      "  TITLE     Update on chronic thromboembolic pulmonary hypertension.\n",
      "  JOURNAL   Trends Cardiovasc Med 27:29-37 (2017)\n",
      "            DOI:10.1016/j.tcm.2016.05.010\n",
      "REFERENCE   PMID:26099554\n",
      "  AUTHORS   Witkin AS, Channick RN\n",
      "  TITLE     Chronic Thromboembolic Pulmonary Hypertension: the End Result of Pulmonary Embolism.\n",
      "  JOURNAL   Curr Cardiol Rep 17:63 (2015)\n",
      "            DOI:10.1007/s11886-015-0621-9\n",
      "///\n",
      "\n"
     ]
    }
   ],
   "source": [
    "holder4 = k.get('H01622') # Chronic thromboembolic pulmonary hypertension\n",
    "print(holder4) "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1dd5acd5",
   "metadata": {},
   "source": [
    "For ID:H01622, Gene found: None"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "d3d0f889",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ENTRY       H01633                      Disease\n",
      "NAME        High blood pressure;\n",
      "            Hypertension\n",
      "DESCRIPTION High blood pressure (hypertension) is the most frequent classic cardiovascular risk factor and accounts for a large proportion of cardiovascular mortality, the main cause of death worldwide. Hypertension is generally classified as primary (essential) or secondary. Essential hypertension (EH) is the most common diagnosis in this disease, suggesting that a monocausal etiology has not been identified. However, a number of risk factors associated with EH have also been identified such as age, sex, demographic, environmental, genetic, and vascular factors. Secondary hypertension generally has an earlier age at onset, no family history, and a clear cause such as a renal or endocrine disorder, or an iatrogenic trigger, such as use of oral contraceptives. Blood pressure is a heritable trait; an estimated 30% of variance in blood pressure relates to genetic factors. Understanding of the genetic architecture of traits has progressed in rare mendelian hypertensive phenotypes, such as Gordon's syndrome.\n",
      "CATEGORY    Cardiovascular disease\n",
      "BRITE       Human diseases in ICD-11 classification [BR:br08403]\n",
      "             11 Diseases of the circulatory system\n",
      "              Hypertensive diseases\n",
      "               BA00  Essential hypertension\n",
      "                H01633  High blood pressure\n",
      "PATHWAY     hsa04925  Aldosterone synthesis and secretion\n",
      "            hsa04960  Aldosterone-regulated sodium reabsorption\n",
      "GENE        CYP11B2 [HSA:1585] [KO:K07433]\n",
      "            CYP11B1 [HSA:1584] [KO:K00497]\n",
      "            HSD11B2 [HSA:3291] [KO:K00071]\n",
      "            NR3C2 [HSA:4306] [KO:K08555]\n",
      "            SCNN1B [HSA:6338] [KO:K04825]\n",
      "            SCNN1G [HSA:6340] [KO:K04827]\n",
      "DRUG        Methyldopa [DR:D00405]\n",
      "            Clonidine hydrochloride [DR:D00604]\n",
      "            Guanfacine hydrochloride [DR:D00606]\n",
      "            Mecamylamine hydrochloride [DR:D00611]\n",
      "            Prazosin hydrochloride [DR:D00609]\n",
      "            Doxazosin mesylate [DR:D00608]\n",
      "            Hydralazine hydrochloride [DR:D01302]\n",
      "            Minoxidil [DR:D00418]\n",
      "            Methyldopa and hydrochlorothiazide [DR:D10267]\n",
      "            Clonidine and chlorthalidone [DR:D10591]\n",
      "            Hydrochlorothiazide [DR:D00340]\n",
      "            Chlorothiazide [DR:D00519]\n",
      "            Methyclothiazide [DR:D00656]\n",
      "            Chlorthalidone [DR:D00272]\n",
      "            Indapamide [DR:D00345]\n",
      "            Furosemide [DR:D00331]\n",
      "            Torsemide [DR:D00382]\n",
      "            Spironolactone [DR:D00443]\n",
      "            Eplerenone [DR:D01115]\n",
      "            Hydrochlorothiazide and triamterene [DR:D10269]\n",
      "            Spironolactone and hydrochlorothiazide [DR:D10270]\n",
      "            Amiloride hydrochloride and hydrochlorothiazide [DR:D10271]\n",
      "            Phenoxybenzamine hydrochloride [DR:D00507]\n",
      "            Diltiazem hydrochloride [DR:D00616]\n",
      "            Pindolol [DR:D00513]\n",
      "            Propranolol hydrochloride [DR:D00483]\n",
      "            Nadolol [DR:D00432]\n",
      "            Metoprolol tartrate [DR:D00601]\n",
      "            Metoprolol succinate [DR:D00635]\n",
      "            Atenolol [DR:D00235]\n",
      "            Acebutolol hydrochloride [DR:D00597]\n",
      "            Betaxolol hydrochloride [DR:D00598]\n",
      "            Bisoprolol fumarate [DR:D00634]\n",
      "            Esmolol hydrochloride [DR:D00644]\n",
      "            Nebivolol hydrochloride [DR:D06622]\n",
      "            Labetalol hydrochloride [DR:D00600]\n",
      "            Carvedilol [DR:D00255]\n",
      "            Carvedilol phosphate [DR:D03415]\n",
      "            Propranolol hydrochloride and hydrochlorothiazide [DR:D10274]\n",
      "            Nadolol and bendroflumethiazide [DR:D10272]\n",
      "            Metoprolol and hydrochlorothiazide [DR:D10273]\n",
      "            Bisoprolol fumarate and hydrochlorothiazide [DR:D10275]\n",
      "            Atenolol and chlorthalidone [DR:D10592]\n",
      "            Amlodipine besylate [DR:D00615]\n",
      "            Amlodipine benzoate [DR:D11881]\n",
      "            Felodipine [DR:D00319]\n",
      "            Isradipine [DR:D00349]\n",
      "            Nicardipine hydrochloride [DR:D00617]\n",
      "            Nifedipine [DR:D00437]\n",
      "            Nisoldipine [DR:D00618]\n",
      "            Clevidipine [DR:D08892]\n",
      "            Levamlodipine maleate [DR:D11723]\n",
      "            Amlodipine and celecoxib [DR:D11705]\n",
      "            Verapamil hydrochloride [DR:D00619]\n",
      "            Captopril [DR:D00251]\n",
      "            Enalapril maleate [DR:D00621]\n",
      "            Lisinopril [DR:D00362]\n",
      "            Perindopril erbumine [DR:D00624]\n",
      "            Ramipril [DR:D00421]\n",
      "            Quinapril hydrochloride [DR:D00459]\n",
      "            Benazepril hydrochloride [DR:D00620]\n",
      "            Fosinopril sodium [DR:D00622]\n",
      "            Trandolapril [DR:D00383]\n",
      "            Moexipril hydrochloride [DR:D00623]\n",
      "            Captopril and hydrochlorothiazide [DR:D10276]\n",
      "            Enalapril maleate and hydrochlorothiazide [DR:D10277]\n",
      "            Hydrochlorothiazide and lisinopril [DR:D10268]\n",
      "            Quinapril hydrochloride and hydrochlorothiazide [DR:D10278]\n",
      "            Benazepril hydrochloride and hydrochlorothiazide [DR:D10279]\n",
      "            Fosinopril and hydrochlorothiazide [DR:D10280]\n",
      "            Moexipril hydrochloride and hydrochlorothiazide [DR:D10281]\n",
      "            Perindopril and amlodipine [DR:D11581]\n",
      "            Trandolapril and verapamil hydrochloride [DR:D10282]\n",
      "            Amlodipine and benazepril [DR:D11069]\n",
      "            Losartan potassium [DR:D00357]\n",
      "            Eprosartan mesylate [DR:D02082]\n",
      "            Valsartan [DR:D00400]\n",
      "            Irbesartan [DR:D00523]\n",
      "            Candesartan cilexetil [DR:D00626]\n",
      "            Telmisartan [DR:D00627]\n",
      "            Olmesartan medoxomil [DR:D01204]\n",
      "            Azilsartan medoxomil [DR:D08067]\n",
      "            Azilsartan kamedoxomil [DR:D08865]\n",
      "            Losartan potassium and hydrochlorothiazide [DR:D07895]\n",
      "            Eprosartan mesylate and hydrochlorothiazide [DR:D10283]\n",
      "            Valsartan and hydrochlorothiazide [DR:D09197]\n",
      "            Irbesartan and hydrochlorothiazide [DR:D10249]\n",
      "            Candesartan cilexetil and hydrochlorothiazide [DR:D09196]\n",
      "            Telmisartan and hydrochlorothiazide [DR:D09219]\n",
      "            Olmesartan medoxomil and hydrochlorothiazide [DR:D10284]\n",
      "            Azilsartan medoxomil and chlorthalidone [DR:D10589]\n",
      "            Valsartan and amlodipine besilate [DR:D09745]\n",
      "            Amlodipine besylate and olmesartan medoxomil [DR:D10285]\n",
      "            Telmisartan and amlodipine besilate [DR:D09743]\n",
      "            Amlodipine, valsartan and hydrochlorothiazide [DR:D10286]\n",
      "            Olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide [DR:D10288]\n",
      "            Nebivolol and valsartan [DR:D11388]\n",
      "            Aliskiren fumarate [DR:D06412]\n",
      "            Aliskiren hemifumarate and hydrochlorothiazide [DR:D10289]\n",
      "            Amlodipine besilate and atorvastatin calcium [DR:D08488]\n",
      "            Terazosin hydrochloride anhydrous [DR:D11585]\n",
      "            Enalaprilat [DR:D03769]\n",
      "            Methyldopate hydrochloride [DR:D04997]\n",
      "DBLINKS     ICD-11: BA00\n",
      "            ICD-10: I10\n",
      "            MeSH: D006973\n",
      "REFERENCE\n",
      "  AUTHORS   Foex P, Sear JW.\n",
      "  TITLE     Hypertension: pathophysiology and treatment.\n",
      "  JOURNAL   Continuing Education in Anaesthesia, Critical Care & Pain 4:71-75 (2004)\n",
      "            DOI:10.1093/bjaceaccp/mkh020\n",
      "REFERENCE   PMID:25832858\n",
      "  AUTHORS   Poulter NR, Prabhakaran D, Caulfield M\n",
      "  TITLE     Hypertension.\n",
      "  JOURNAL   Lancet 386:801-12 (2015)\n",
      "            DOI:10.1016/S0140-6736(14)61468-9\n",
      "REFERENCE   PMID:27028574\n",
      "  AUTHORS   Singh M, Singh AK, Pandey P, Chandra S, Singh KA, Gambhir IS\n",
      "  TITLE     Molecular genetics of essential hypertension.\n",
      "  JOURNAL   Clin Exp Hypertens 38:268-77 (2016)\n",
      "            DOI:10.3109/10641963.2015.1116543\n",
      "REFERENCE   PMID:23303660\n",
      "  AUTHORS   Ehret GB, Caulfield MJ\n",
      "  TITLE     Genes for blood pressure: an opportunity to understand hypertension.\n",
      "  JOURNAL   Eur Heart J 34:951-61 (2013)\n",
      "            DOI:10.1093/eurheartj/ehs455\n",
      "///\n",
      "\n"
     ]
    }
   ],
   "source": [
    "holder5 = k.get('H01633') # High blood pressure; Hypertension\n",
    "print(holder5)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fb27b314",
   "metadata": {},
   "source": [
    "For ID:H01633, Gene found: CYP11B2, CYP11B1, HSD11B2, NR3C2, SCNN1B, SCNN1G"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "356384d5",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ENTRY       H01686                      Disease\n",
      "NAME        Idiopathic portal hypertension;\n",
      "            Non-cirrhotic portal fibrosis;\n",
      "            Banti syndrome\n",
      "DESCRIPTION Idiopathic portal hypertension (IPH) is a disorder generally classified as a noncirrhotic portal hypertension of unknown etiology, and is clinically characterized by portal hypertension, splenomegaly, and pancytopenia. The principal pathologic changes of IPH are devastation of the intrahepatic terminal portal radicles with considerable portal fibrosis and secondary atrophy of the liver parenchyma that follows portal thrombosis. The incidence varies considerably with the country. In contrast to its high prevalence in India, IPH is comparatively a rare disorder in Western countries. Middle-aged women are more prone to IPH in Japan. IPH usually suggests a benign prognosis, but sometimes is complicated with severe hemorrhage due to ruptured esophageal varices, or massive splenomegaly. It is mainly managed by supportive treatment such as endoscopic, radiological and/or surgical management for esophageal varices and/or splenomegaly. The definite etiology of IPH is still uncertain, but there are several theories on the potential pathogenesis of IPH. These theories include immunological disorders, infections, and genetic variants.\n",
      "CATEGORY    Digestive system disease\n",
      "BRITE       Human diseases in ICD-11 classification [BR:br08403]\n",
      "             13 Diseases of the digestive system\n",
      "              Diseases of liver\n",
      "               DB98  Vascular disorders of the liver\n",
      "                H01686  Idiopathic portal hypertension\n",
      "COMMENT     Japanese study groups usually use the term of \"IPH\", whereas Indian researchers prefer to use the term non-cirrhotic portal fibrosis for the name of this disorder. Groups in Western countries have proposed terms such as nodular regenerative hyperplasia (NRH), hepatoportal sclerosis, or Idiopathic noncirrhotic portal hypertension.\n",
      "DBLINKS     ICD-11: DB98.70\n",
      "            ICD-10: K76.6\n",
      "            MeSH: C537903\n",
      "REFERENCE   PMID:25343110\n",
      "  AUTHORS   Tanaka T, Sugawara Y, Kokudo N\n",
      "  TITLE     The current clinical aspects of idiopathic portal hypertension.\n",
      "  JOURNAL   Intractable Rare Dis Res 2:94-7 (2013)\n",
      "            DOI:10.5582/irdr.2013.v2.3.94\n",
      "REFERENCE   PMID:11928079\n",
      "  AUTHORS   Okudaira M, Ohbu M, Okuda K\n",
      "  TITLE     Idiopathic portal hypertension and its pathology.\n",
      "  JOURNAL   Semin Liver Dis 22:59-72 (2002)\n",
      "            DOI:10.1055/s-2002-23207\n",
      "///\n",
      "\n"
     ]
    }
   ],
   "source": [
    "holder6 = k.get('H01686') # Idiopathic portal hypertension; Non-cirrhotic portal fibrosis; Banti syndrome\n",
    "print(holder6)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8dfc33cd",
   "metadata": {},
   "source": [
    "For ID:H01686, Gene found: None"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "16a683dd",
   "metadata": {},
   "source": [
    "### Checkpoint_1: Potential Gene Targets/Biomarkers retrieved from KEGG Disease Database: \n",
    "- NR3C2, BMPR2, SMAD9, CAV1, KCNK3, ATP13A3, ACVRL1, CYP11B2, CYP11B1, HSD11B2, SCNN1B, SCNN1G"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d13c21dd",
   "metadata": {},
   "source": [
    "### KEGG Pathway Database Associated with Hypertension"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "62213108",
   "metadata": {},
   "source": [
    "#### The searches above had the associated pathways, which were then listed in the following: \n",
    "        1. hsa04960  Aldosterone-regulated sodium reabsorption\n",
    "        2. hsa04350  TGF-beta signaling pathway\n",
    "        3. hsa04925  Aldosterone synthesis and secretion\n",
    "        4. hsa04614  Renin-angiotensin system (From Literature Review)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2b81a04a",
   "metadata": {},
   "source": [
    "#### Get the actual pathway diagram using the 'get' method"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "9a5a38b9",
   "metadata": {},
   "outputs": [],
   "source": [
    "from Bio.KEGG.REST import *\n",
    "from Bio.KEGG.KGML import KGML_parser\n",
    "from Bio.Graphics.KGML_vis import KGMLCanvas\n",
    "from Bio.Graphics.ColorSpiral import ColorSpiral\n",
    "\n",
    "from IPython.display import Image, HTML"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "6faefa16",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<IPython.core.display.Image object>"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Next get the pathway diagram of the Aldosterone-regulated sodium reabsorption\n",
    "Image(kegg_get(\"hsa04960\",\"image\").read())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "df85eb3a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Pathway: Aldosterone-regulated sodium reabsorption\n",
      "KEGG ID: path:hsa04960\n",
      "Image file: https://www.kegg.jp/kegg/pathway/hsa/hsa04960.png\n",
      "Organism: hsa\n",
      "Entries: 33\n",
      "Entry types:\n",
      "\tgene: 19\n",
      "\tcompound: 10\n",
      "\tmap: 4\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# To generate an image link of the pathway above\n",
    "pathway1 = KGML_parser.read(kegg_get(\"hsa04960\", \"kgml\"))\n",
    "print(pathway1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "122164fa",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<IPython.core.display.Image object>"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Next get the pathway diagram of the TGF-beta signaling pathway\n",
    "Image(kegg_get(\"hsa04350\",\"image\").read())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "acd93b3d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Pathway: TGF-beta signaling pathway\n",
      "KEGG ID: path:hsa04350\n",
      "Image file: https://www.kegg.jp/kegg/pathway/hsa/hsa04350.png\n",
      "Organism: hsa\n",
      "Entries: 103\n",
      "Entry types:\n",
      "\tgene: 84\n",
      "\tgroup: 13\n",
      "\tcompound: 1\n",
      "\tmap: 5\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# To generate an image link of the pathway above\n",
    "pathway2 = KGML_parser.read(kegg_get(\"hsa04350\", \"kgml\"))\n",
    "print(pathway2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "fdc72e6a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<IPython.core.display.Image object>"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Next get the pathway diagram of the Aldosterone synthesis and secretion\n",
    "Image(kegg_get(\"hsa04925\",\"image\").read())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "f6b0a4d9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Pathway: Aldosterone synthesis and secretion\n",
      "KEGG ID: path:hsa04925\n",
      "Image file: https://www.kegg.jp/kegg/pathway/hsa/hsa04925.png\n",
      "Organism: hsa\n",
      "Entries: 78\n",
      "Entry types:\n",
      "\tgene: 41\n",
      "\tgroup: 1\n",
      "\tcompound: 28\n",
      "\tmap: 8\n",
      "\n"
     ]
    }
   ],
   "source": [
    " # To generate an image link of the pathway above\n",
    "pathway3 = KGML_parser.read(kegg_get(\"hsa04925\", \"kgml\"))\n",
    "print(pathway3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "cad540b2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<IPython.core.display.Image object>"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "Image(kegg_get(\"hsa04614\",\"image\").read()) # Renin-angiotensin system (From Literature Review)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "19d22010",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Pathway: Renin-angiotensin system\n",
      "KEGG ID: path:hsa04614\n",
      "Image file: https://www.kegg.jp/kegg/pathway/hsa/hsa04614.png\n",
      "Organism: hsa\n",
      "Entries: 45\n",
      "Entry types:\n",
      "\tgene: 29\n",
      "\tcompound: 11\n",
      "\tmap: 5\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# To generate an image link of the pathway above # # Renin-angiotensin system\n",
    "pathway4 = KGML_parser.read(kegg_get(\"hsa04614\", \"kgml\"))\n",
    "print(pathway4)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "94bd9f39",
   "metadata": {},
   "source": [
    "### KEGG Drug Database Associated with the term, Hypertension"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "88d7f85a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Now find drugs related to Hypertension\n",
    "k = KEGG()\n",
    "# k.dbinfo(\"drug\")\n",
    "print(k.find(\"drug\",\"hypertension\"))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "9918b4c8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Entry</th>\n",
       "      <th>Name</th>\n",
       "      <th>Name(TN)</th>\n",
       "      <th>Disease</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>D00074</td>\n",
       "      <td>Nitric oxide (JAN/USAN)</td>\n",
       "      <td>INOmax (TN)</td>\n",
       "      <td>Pulmonary hypertension [DS:H01619 H01621]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>D00106</td>\n",
       "      <td>Epoprostenol (USAN/INN)</td>\n",
       "      <td>Epoprostenol (TN)</td>\n",
       "      <td>Pulmonary arterial hypertension [DS:H01621]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NaN</td>\n",
       "      <td>Prostaglandin I2</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NaN</td>\n",
       "      <td>Prostacyclin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>D00235</td>\n",
       "      <td>Atenolol (JP18/USP/INN)</td>\n",
       "      <td>Tenormin (TN)</td>\n",
       "      <td>Hypertension [DS:H01633]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Angina pectoris due to coronary atherosclerosi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Myocardial Infarction [DS:H01730]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>D00251</td>\n",
       "      <td>Captopril (JP18/USP/INN)</td>\n",
       "      <td>Apopril (TN)</td>\n",
       "      <td>Hypertension [DS:H01633]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Capoten (TN)</td>\n",
       "      <td>Diabetic Nephropathy [DS:H01456]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>D00255</td>\n",
       "      <td>Carvedilol (JP18/USP/INN)</td>\n",
       "      <td>Artist (TN)</td>\n",
       "      <td>Hypertension [DS:H01633]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Coreg (TN)</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>D00272</td>\n",
       "      <td>Chlorthalidone (USP)</td>\n",
       "      <td>Hygroton (TN)</td>\n",
       "      <td>Hypertension [DS:H01633]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>NaN</td>\n",
       "      <td>Chlortalidone (JAN/INN)</td>\n",
       "      <td>Thalitone (TN)</td>\n",
       "      <td>Nephrotic syndrome [DS:H01657]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>D00319</td>\n",
       "      <td>Felodipine (JP18/USP/INN)</td>\n",
       "      <td>Plendil (TN)</td>\n",
       "      <td>Hypertension [DS:H01633]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>D00331</td>\n",
       "      <td>Furosemide (JP18/USP/INN)</td>\n",
       "      <td>Lasix (TN)</td>\n",
       "      <td>Hypertension [DS:H01633]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>NaN</td>\n",
       "      <td>Frusemide</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>D00340</td>\n",
       "      <td>Hydrochlorothiazide (JP18/USP/INN)</td>\n",
       "      <td>Esidrix (TN)</td>\n",
       "      <td>Hypertension [DS:H01633]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Microzide (TN)</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>D00345</td>\n",
       "      <td>Indapamide (JP18/USP)</td>\n",
       "      <td>Lozol (TN)</td>\n",
       "      <td>Hypertension [DS:H01633]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Natrix (TN)</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     Entry                                Name           Name(TN)  \\\n",
       "0   D00074             Nitric oxide (JAN/USAN)        INOmax (TN)   \n",
       "1   D00106             Epoprostenol (USAN/INN)  Epoprostenol (TN)   \n",
       "2      NaN                    Prostaglandin I2                NaN   \n",
       "3      NaN                        Prostacyclin                NaN   \n",
       "4   D00235             Atenolol (JP18/USP/INN)      Tenormin (TN)   \n",
       "5      NaN                                 NaN                NaN   \n",
       "6      NaN                                 NaN                NaN   \n",
       "7   D00251            Captopril (JP18/USP/INN)       Apopril (TN)   \n",
       "8      NaN                                 NaN       Capoten (TN)   \n",
       "9   D00255           Carvedilol (JP18/USP/INN)        Artist (TN)   \n",
       "10     NaN                                 NaN         Coreg (TN)   \n",
       "11  D00272                Chlorthalidone (USP)      Hygroton (TN)   \n",
       "12     NaN             Chlortalidone (JAN/INN)     Thalitone (TN)   \n",
       "13  D00319           Felodipine (JP18/USP/INN)       Plendil (TN)   \n",
       "14  D00331           Furosemide (JP18/USP/INN)         Lasix (TN)   \n",
       "15     NaN                           Frusemide                NaN   \n",
       "16  D00340  Hydrochlorothiazide (JP18/USP/INN)       Esidrix (TN)   \n",
       "17     NaN                                 NaN     Microzide (TN)   \n",
       "18  D00345               Indapamide (JP18/USP)         Lozol (TN)   \n",
       "19     NaN                                 NaN        Natrix (TN)   \n",
       "\n",
       "                                              Disease  \n",
       "0           Pulmonary hypertension [DS:H01619 H01621]  \n",
       "1         Pulmonary arterial hypertension [DS:H01621]  \n",
       "2                                                 NaN  \n",
       "3                                                 NaN  \n",
       "4                            Hypertension [DS:H01633]  \n",
       "5   Angina pectoris due to coronary atherosclerosi...  \n",
       "6             Acute Myocardial Infarction [DS:H01730]  \n",
       "7                            Hypertension [DS:H01633]  \n",
       "8                    Diabetic Nephropathy [DS:H01456]  \n",
       "9                            Hypertension [DS:H01633]  \n",
       "10                                                NaN  \n",
       "11                           Hypertension [DS:H01633]  \n",
       "12                     Nephrotic syndrome [DS:H01657]  \n",
       "13                           Hypertension [DS:H01633]  \n",
       "14                           Hypertension [DS:H01633]  \n",
       "15                                                NaN  \n",
       "16                           Hypertension [DS:H01633]  \n",
       "17                                                NaN  \n",
       "18                           Hypertension [DS:H01633]  \n",
       "19                                                NaN  "
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Again the command line run above did not work, \n",
    "# and as an alternative, the search would be manually done through the KEGG webpage \n",
    "# and manually retrieve the output results\n",
    "\n",
    "import pandas as pd\n",
    "df_KEGG_DRG = pd.read_csv(\"/Users/trini/OneDrive/Documents/New York University/Guided Studies/KEGG_Drug_Search_Hypertension.csv\")\n",
    "df_KEGG_DRG.head(20)  # Show only the first 10 of the table"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f4716727",
   "metadata": {},
   "source": [
    "Note: The cells that have 'NaN' are not true, it is actually broken merge of a whole entry. Ex: Entry #1 to 3 are one whole \"D00106\" entry"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "21721158",
   "metadata": {},
   "source": [
    "### KEGG Brite Hierarchy of the term 'Hypertension' in Homo sapiens"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "5d826b67",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+H\tDisease\n",
      "!\n",
      "A01 Certain infectious or parasitic diseases\n",
      "B  Gastroenteritis or colitis of infectious origin\n",
      "C    Bacterial intestinal infections\n",
      "D      1A00  Cholera\n",
      "E        H00110  Cholera\n",
      "D      1A01  Intestinal infection due to other Vibrio\n",
      "E        H00307  Vibrio parahaemolyticus infection\n",
      "E        H00308  Vibrio vulnificus infection\n",
      "D      1A02  Intestinal infections due to Shigella\n",
      "E        H00299  Shigellosis\n",
      "D      1A03  Intestinal infections due to Escherichia coli\n",
      "E        H00278  Enteropathogenic Escherichia coli (EPEC) infection\n",
      "E        H00280  Enterotoxigenic Escherichia coli (ETEC) infection\n",
      "E        H01311  Enteroinvasive Escherichia coli (EIEC) infection\n",
      "E        H00277  Enterohemorrhagic Escherichia coli (EHEC) infection\n",
      "E        H01312  Enteroaggregative Escherichia coli (EAEC) infection\n",
      "D      1A04  Intestinal infections due to Clostridioides difficile\n",
      "E        H00338  Pseudomembranous colitis\n",
      "D      1A05  Intestinal infections due to Yersinia enterocolitica\n",
      "E        H00298  Yersiniosis\n",
      "D      1A06  Gastroenteritis due to Campylobacter\n",
      "E        H00321  Campylobacter infection\n",
      "D      1A07  Typhoid fever\n",
      "E        H00111  Typhoid fever\n",
      "D      1A08  Paratyphoid fever\n",
      "E        H00112  Paratyphoid fever\n",
      "D      1A09  Infections due to other Salmonella\n",
      "E        H00113  Salmonellosis\n",
      "D      1A0Y  Other specified bacterial intestinal infections\n",
      "E        H01454  Colonic spirochetosis\n",
      "D      1A0Z  Bacterial intestinal infections, unspecified\n",
      "C    Bacterial foodborne intoxications\n",
      "D      1A10  Foodborne staphylococcal intoxication\n",
      "E        H01175  Staphylococcal infection\n",
      "D      1A11  Botulism\n",
      "E        H00339  Botulism\n",
      "D      1A12  Foodborne Clostridium perfringens intoxication\n",
      "E        H00335  Foodborne Clostridium perfringens intoxication\n",
      "D      1A13  Foodborne Bacillus cereus intoxication\n",
      "E        H00329  Foodborne Bacillus cereus intoxication\n",
      "D      1A1Y  Other specified bacterial foodborne intoxications\n",
      "E        H00300  Enterobacter infection\n",
      "D      1A1Z  Bacterial foodborne intoxications, unspecified\n",
      "C    Viral intestinal infections\n",
      "D      1A20  Enteritis due to Adenovirus\n",
      "D      1A21  Gastroenteritis due to Astrovirus\n",
      "D      1A22  Gastroenteritis due to Rotavirus\n",
      "E        H00975  Rotaviral enteritis\n",
      "D      1A23  Enteritis due to Norovirus\n",
      "E        H01323  Enteritis due to Norovirus\n",
      "D      1A24  Intestinal infections due to Cytomegalovirus\n",
      "D      1A2Y  Other specified viral intestinal infections\n",
      "D      1A2Z  Viral intestinal infections, unspecified\n",
      "E        H01430  Viral gastroenteritis\n",
      "C    Protozoal intestinal infections\n",
      "D      1A30  Infections due to Balantidium coli\n",
      "E        H01087  Balantidiasis\n",
      "D      1A31  Giardiasis\n",
      "E        H00362  Giardiasis\n",
      "D      1A32  Cryptosporidiosis\n",
      "E        H00356  Cryptosporidiosis\n",
      "D      1A33  Cystoisosporiasis\n",
      "E        H02372  Cystoisosporiasis\n",
      "D      1A34  Sarcocystosis\n",
      "E        H02373  Sarcocystosis\n",
      "D      1A35  Blastocystosis\n",
      "E        H02374  Blastocystosis\n",
      "D      1A36  Amoebiasis\n",
      "E        H00360  Amoebiasis\n",
      "D      1A3Y  Other specified protozoal intestinal infections\n",
      "E        H01089  Dientamoebiasis\n",
      "D      1A3Z  Protozoal intestinal infections, unspecified\n",
      "C    1A40  Gastroenteritis or colitis without specification of infectious agent\n",
      "B  Predominantly sexually transmitted infections\n",
      "C    Syphilis\n",
      "D      1A60  Congenital syphilis\n",
      "E        H00354  Syphilis\n",
      "D      1A61  Early syphilis\n",
      "E        H00354  Syphilis\n",
      "D      1A62  Late syphilis\n",
      "E        H00354  Syphilis\n",
      "D      1A63  Latent syphilis, unspecified as early or late\n",
      "D      1A6Z  Syphilis, unspecified\n",
      "C    Gonococcal infection\n",
      "D      1A70  Gonococcal genitourinary infection\n",
      "E        H00315  Gonococcal infection\n",
      "D      1A71  Gonococcal pelviperitonitis\n",
      "E        H00315  Gonococcal infection\n",
      "D      1A72  Gonococcal infection of other sites\n",
      "E        H00315  Gonococcal infection\n",
      "D      1A73  Disseminated gonococcal infection\n",
      "D      1A7Z  Gonococcal infection, unspecified\n",
      "C    Sexually transmissible infections due to chlamydia\n",
      "D      1A80  Chlamydial lymphogranuloma\n",
      "E        H00348  Lymphogranuloma venereum\n",
      "D      1A81  Non-ulcerative sexually transmitted chlamydial infection\n",
      "E        H00347  Chlamydia infection\n",
      "D      1A8Y  Other specified sexually transmissible infections due to chlamydia\n",
      "D      1A8Z  Sexually transmissible infections due to chlamydia, unspecified\n",
      "C    1A90  Chancroid\n",
      "D      H00305  Chancroid\n",
      "C    1A91  Granuloma inguinale\n",
      "D      H01415  Donovanosis\n",
      "C    1A92  Trichomoniasis\n",
      "D      H00812  Trichomoniasis\n",
      "C    1A93  Sexually transmissible infestations\n",
      "C    1A94  Anogenital herpes simplex infection\n",
      "D      H00365  Herpes simplex virus infection\n",
      "C    1A95  Anogenital warts\n",
      "D      H01418  Condyloma acuminatum\n",
      "C    1A9Y  Other specified predominantly sexually transmitted infections\n",
      "D      H00388  Non-chlamydial non-gonococcal urethritis\n",
      "C    1A9Z  Predominantly sexually transmitted infections, unspecified\n",
      "B  Mycobacterial diseases\n",
      "C    Tuberculosis\n",
      "D      1B10  Tuberculosis of the respiratory system\n",
      "E        H00342  Tuberculosis\n",
      "D      1B11  Tuberculosis of the nervous system\n",
      "E        H00342  Tuberculosis\n",
      "D      1B12  Tuberculosis of other systems and organs\n",
      "E        H00342  Tuberculosis\n",
      "D      1B13  Miliary tuberculosis\n",
      "D      1B14  Latent tuberculosis\n",
      "D      1B1Y  Other specified tuberculosis\n",
      "D      1B1Z  Tuberculosis, unspecified\n",
      "C    1B20  Leprosy\n",
      "D      H00344  Leprosy\n",
      "D      H01473  Erythema nodosum leprosum\n",
      "C    1B21  Infections due to non-tuberculous mycobacteria\n",
      "D      H01458  Nontuberculous mycobacterial infection\n",
      "D      H01462  Rapidly growing mycobacteria infection\n",
      "D      H02029  Mycobacterium avium complex (MAC) pulmonary disease\n",
      "D      H01042  Buruli ulcer\n",
      "C    1B2Y  Other specified mycobacterial diseases\n",
      "C    1B2Z  Mycobacterial diseases, unspecified\n",
      "D      H01021  Rhodococcus equi infection\n",
      "D      H01049  Gordonia bronchialis infection\n",
      "D      H01050  Tsukamurella infection\n",
      "B  Certain staphylococcal or streptococcal diseases\n",
      "C    Acute rheumatic fever\n",
      "D      1B40  Acute rheumatic fever without mention of heart involvement\n",
      "D      1B41  Acute rheumatic fever with heart involvement\n",
      "D      1B42  Rheumatic chorea\n",
      "E        H01924  Sydenham chorea\n",
      "C    1B50  Scarlet fever\n",
      "D      H01515  Scarlet fever\n",
      "C    1B51  Streptococcal pharyngitis\n",
      "D      H00333  Streptococcal infection\n",
      "D      H01424  Group A streptococcal pharyngitis\n",
      "C    1B53  Meningitis due to Streptococcus\n",
      "D      H00333  Streptococcal infection\n",
      "D      H01406  Streptococcus suis infection\n",
      "C    1B54  Meningitis due to Staphylococcus\n",
      "C    1B5Y  Other specified staphylococcal or streptococcal diseases\n",
      "C    1B5Z  Staphylococcal or streptococcal diseases, unspecified\n",
      "B  Pyogenic bacterial infections of the skin or subcutaneous tissues\n",
      "C    1B70  Bacterial cellulitis, erysipelas or lymphangitis\n",
      "D      H01517  Erysipelas\n",
      "C    1B71  Necrotising fasciitis\n",
      "D      H01455  Necrotizing fasciitis\n",
      "C    1B72  Impetigo\n",
      "C    1B73  Ecthyma\n",
      "C    1B74  Superficial bacterial folliculitis\n",
      "C    1B75  Deep bacterial folliculitis or pyogenic abscess of the skin\n",
      "C    1B7Y  Other specified pyogenic bacterial infection of skin and subcutaneous tissue\n",
      "D      H01407  Capnocytophaga ochracea infection\n",
      "B  Certain zoonotic bacterial diseases\n",
      "C    1B90  Rat-bite fevers\n",
      "D      H01314  Rat-bite fever\n",
      "C    1B91  Leptospirosis\n",
      "D      H00355  Leptospirosis\n",
      "C    1B92  Glanders\n",
      "D      H00316  Glanders\n",
      "C    1B93  Plague\n",
      "D      H00297  Plague\n",
      "C    1B94  Tularaemia\n",
      "D      H00312  Tularemia\n",
      "C    1B95  Brucellosis\n",
      "D      H00325  Brucellosis\n",
      "C    1B96  Erysipeloid\n",
      "D      H01315  Erysipeloid\n",
      "C    1B97  Anthrax\n",
      "D      H00328  Anthrax\n",
      "C    1B98  Cat-scratch disease\n",
      "D      H00326  Bartonellosis\n",
      "C    1B99  Pasteurellosis\n",
      "D      H00306  Pasteurellosis\n",
      "C    1B9A  Extraintestinal yersiniosis\n",
      "D      H00298  Yersiniosis\n",
      "C    1B9Z  Unspecified zoonotic bacterial disease\n",
      "B  Other bacterial diseases\n",
      "C    1C10  Actinomycosis\n",
      "D      H01325  Actinomycosis\n",
      "C    1C11  Bartonellosis\n",
      "D      H00326  Bartonellosis\n",
      "D      H00327  Trench fever\n",
      "C    1C12  Whooping cough\n",
      "D      H00319  Pertussis\n",
      "C    1C13  Tetanus\n",
      "D      H00337  Tetanus\n",
      "C    1C14  Obstetrical tetanus\n",
      "C    1C15  Tetanus neonatorum\n",
      "C    1C16  Gas gangrene\n",
      "D      H00336  Gas gangrene\n",
      "C    1C17  Diphtheria\n",
      "D      H00343  Diphtheria\n",
      "D      H01051  Corynebacterium ulcerans infection\n",
      "C    1C18  Brazilian purpuric fever\n",
      "D      H01330  Brazilian purpuric fever\n",
      "C    1C19  Legionellosis\n",
      "D      H00311  Legionellosis\n",
      "C    1C1A  Listeriosis\n",
      "D      H00332  Listeriosis\n",
      "C    1C1B  Nocardiosis\n",
      "D      H00345  Nocardiosis\n",
      "C    1C1C  Meningococcal disease\n",
      "D      H00314  Meningococcal infection\n",
      "C    1C1D  Yaws\n",
      "D      H01318  Yaws\n",
      "C    1C1E  Pinta\n",
      "D      H01530  Pinta\n",
      "C    1C1F  Endemic non-venereal syphilis\n",
      "D      H01531  Bejel\n",
      "C    1C1G  Lyme borreliosis\n",
      "D      H00353  Lyme borreliosis\n",
      "C    1C1H  Necrotising ulcerative gingivitis\n",
      "D      H01440  Acute necrotizing ulcerative gingivitis\n",
      "C    1C1J  Relapsing fever\n",
      "D      H00427  Relapsing fever\n",
      "C    Other diseases due to chlamydiae\n",
      "D      1C20  Chlamydial conjunctivitis\n",
      "D      1C21  Chlamydial peritonitis\n",
      "D      1C22  Infections due to Chlamydia psittaci\n",
      "E        H00350  Psittacosis\n",
      "D      1C23  Trachoma\n",
      "E        H00349  Trachoma\n",
      "D      1C2Y  Other specified diseases due to chlamydiae\n",
      "D      1C2Z  Diseases due to chlamydiae, unspecified\n",
      "C    Rickettsioses\n",
      "D      1C30  Typhus fever\n",
      "E        H00322  Epidemic typhus\n",
      "E        H00324  Scrub typhus\n",
      "D      1C31  Spotted fever\n",
      "E        H00323  Spotted fever\n",
      "D      1C32  Rickettsialpox\n",
      "E        H02379  Rickettsialpox\n",
      "D      1C33  Q fever\n",
      "E        H00310  Q fever\n",
      "D      1C3Y  Other specified rickettsioses\n",
      "E        H01140  Sennetsu neorickettsiosis\n",
      "D      1C3Z  Rickettsioses, unspecified\n",
      "C    1C40  Campylobacteriosis\n",
      "D      H00321  Campylobacter infection\n",
      "C    1C41  Bacterial infection of unspecified site\n",
      "D      H00302  Citrobacter infection\n",
      "D      H00303  Serratia infection\n",
      "D      H01441  Pseudomonas aeruginosa infection\n",
      "C    1C42  Melioidosis\n",
      "D      H00317  Melioidosis\n",
      "C    1C43  Actinomycetoma\n",
      "D      H01451  Actinomycetoma\n",
      "C    1C44  Non-pyogenic bacterial infections of the skin\n",
      "C    1C45  Toxic shock syndrome\n",
      "D      H01426  Invasive streptococcal disease\n",
      "C    1C4Y  Other specified bacterial diseases\n",
      "D      H01335  Photorhabdus asymbiotica infection\n",
      "D      H01343  Pantoea ananatis infection\n",
      "D      H01446  Propionibacterium acnes infection\n",
      "C    1C4Z  Unspecified bacterial disease\n",
      "B  Human immunodeficiency virus disease\n",
      "C    1C60  Human immunodeficiency virus disease associated with tuberculosis\n",
      "C    1C61  Human immunodeficiency virus disease associated with malaria\n",
      "C    1C62  Human immunodeficiency virus disease without mention of tuberculosis or malaria\n",
      "D      H01563  HIV infection\n",
      "B  Viral infections of the central nervous system\n",
      "C    1C80  Viral encephalitis not elsewhere classified\n",
      "D      H02511  Jamestown Canyon encephalitis\n",
      "D      H02512  Cache Valley virus infection\n",
      "D      H02536  Infection-induced acute encephalopathy\n",
      "C    1C81  Acute poliomyelitis\n",
      "D      H00376  Acute poliomyelitis\n",
      "C    1C82  Rabies\n",
      "D      H00377  Rabies\n",
      "D      H00378  Lyssavirus infection\n",
      "C    1C83  Western equine encephalitis\n",
      "D      H01534  Western equine encephalitis\n",
      "C    1C84  Eastern equine encephalitis\n",
      "D      H01535  Eastern equine encephalitis\n",
      "C    1C85  Japanese encephalitis\n",
      "D      H01533  Japanese encephalitis\n",
      "C    1C86  St Louis encephalitis\n",
      "D      H02166  Saint Louis encephalitis\n",
      "C    1C87  Rocio viral encephalitis\n",
      "D      H02171  Rocio viral encephalitis\n",
      "C    1C88  Murray Valley encephalitis\n",
      "D      H01536  Murray Valley encephalitis\n",
      "C    1C89  Far Eastern tick-borne encephalitis\n",
      "D      H00380  Tick-borne viral encephalitis\n",
      "C    1C8A  Central European tick-borne encephalitis\n",
      "D      H00380  Tick-borne viral encephalitis\n",
      "C    1C8B  California encephalitis\n",
      "C    1C8C  Venezuelan equine encephalitis\n",
      "D      H01547  Venezuelan equine encephalitis\n",
      "C    1C8D  La Crosse encephalitis\n",
      "D      H01537  La Crosse encephalitis\n",
      "C    1C8E  Viral meningitis not elsewhere classified\n",
      "D      H00393  Enterovirus infection\n",
      "C    1C8F  Lymphocytic choriomeningitis\n",
      "D      H01324  Lymphocytic choriomeningitis\n",
      "C    1C8Y  Other specified viral infections of the central nervous system\n",
      "C    1C8Z  Viral infections of the central nervous system, unspecified\n",
      "D      H00379  Mosquito-borne viral encephalitis\n",
      "B  Non-viral and unspecified infections of the central nervous system\n",
      "C    1D00  Infectious encephalitis not elsewhere classified\n",
      "D      H01417  Acute encephalitis\n",
      "C    1D01  Infectious meningitis not elsewhere classified\n",
      "D      H00304  Haemophilus influenzae infection\n",
      "D      H01313  Escherichia coli meningitis\n",
      "D      H01429  Aseptic meningitis\n",
      "C    1D02  Infectious myelitis not elsewhere classified\n",
      "C    1D03  Infectious abscess of the central nervous system\n",
      "C    1D04  Infectious granulomas of the central nervous system\n",
      "C    1D05  Infectious cysts of the central nervous system\n",
      "C    1D0Y  Other specified non-viral and unspecified infections of the central nervous system\n",
      "C    1D0Z  Non-viral and unspecified infections of the central nervous system, unspecified\n",
      "B  Dengue\n",
      "C    1D20  Dengue without warning signs\n",
      "D      H00381  Dengue\n",
      "C    1D21  Dengue with warning signs\n",
      "D      H00381  Dengue\n",
      "C    1D22  Severe dengue\n",
      "D      H00381  Dengue\n",
      "C    1D2Z  Dengue fever, unspecified\n",
      "D      H00381  Dengue\n",
      "B  Certain arthropod-borne viral fevers\n",
      "C    1D40  Chikungunya virus disease\n",
      "D      H01540  Chikungunya fever\n",
      "C    1D41  Colorado tick fever\n",
      "D      H02165  Colorado tick fever\n",
      "C    1D42  O'nyong-nyong fever\n",
      "D      H01545  O'nyong-nyong fever\n",
      "C    1D43  Oropouche virus disease\n",
      "D      H02163  Oropouche fever\n",
      "C    1D44  Rift Valley fever\n",
      "D      H01549  Rift Valley fever\n",
      "C    1D45  Sandfly fever\n",
      "D      H02164  Sandfly fever\n",
      "C    1D46  West Nile virus infection\n",
      "D      H01548  West Nile fever\n",
      "C    1D47  Yellow fever\n",
      "D      H00384  Yellow fever\n",
      "C    1D48  Zika virus disease\n",
      "D      H01553  Zika fever\n",
      "C    1D49  Crimean-Congo haemorrhagic fever\n",
      "D      H00284  Crimean-Congo hemorrhagic fever\n",
      "C    1D4A  Omsk haemorrhagic fever\n",
      "D      H00416  Omsk hemorrhagic fever\n",
      "C    1D4B  Kyasanur Forest disease\n",
      "D      H01322  Kyasanur Forest disease\n",
      "C    1D4C  Alkhurma haemorrhagic fever\n",
      "D      H01560  Alkhumra hemorrhagic fever\n",
      "C    1D4D  Ross River disease\n",
      "D      H00397  Ross River fever\n",
      "C    1D4E  Severe fever with thrombocytopenia syndrome\n",
      "D      H01416  Severe fever with thrombocytopenia syndrome\n",
      "C    1D4Y  Other specified arthropod-borne viral fevers\n",
      "D      H00385  South American hemorrhagic fever\n",
      "D      H01546  Mayaro fever\n",
      "D      H01550  Bunyamwera fever\n",
      "D      H02509  Vesicular stomatitis fever\n",
      "C    1D4Z  Arthropod-borne viral fever, virus unspecified\n",
      "D      H00382  Mosquito-borne viral fever\n",
      "D      H00383  Arthropod-borne viral fever\n",
      "B  Certain zoonotic viral diseases\n",
      "C    1D60  Filovirus disease\n",
      "D      H00283  Ebola disease\n",
      "D      H00405  Marburg disease\n",
      "C    1D61  Arenavirus disease\n",
      "D      H02173  Arenaviral hemorrhagic fever\n",
      "D      H01541  Argentine hemorrhagic fever\n",
      "D      H01542  Bolivian hemorrhagic fever\n",
      "D      H00386  Lassa fever\n",
      "D      H01543  Venezuelan hemorrhagic fever\n",
      "D      H01544  Brazilian hemorrhagic fever\n",
      "C    1D62  Hantavirus disease\n",
      "D      H00389  Hemorrhagic fever with renal syndrome\n",
      "D      H00390  Hantavirus pulmonary syndrome\n",
      "C    1D63  Henipavirus encephalitis\n",
      "D      H00391  Henipavirus infection\n",
      "D      H01538  Hendra virus infection\n",
      "D      H01539  Nipah virus infection\n",
      "C    1D64  Middle East respiratory syndrome\n",
      "D      H01419  Middle East respiratory syndrome\n",
      "C    1D65  Severe acute respiratory syndrome\n",
      "D      H00402  Severe acute respiratory syndrome\n",
      "C    1D6Y  Other specified zoonotic viral diseases\n",
      "C    1D6Z  Zoonotic viral disease, virus unspecified\n",
      "B  Certain other viral diseases\n",
      "C    1D80  Mumps\n",
      "D      H00396  Mumps\n",
      "C    1D81  Infectious mononucleosis\n",
      "D      H00367  Infectious mononucleosis\n",
      "C    1D82  Cytomegaloviral disease\n",
      "D      H00368  Cytomegalovirus infection\n",
      "C    1D83  Epidemic myalgia\n",
      "D      H00393  Enterovirus infection\n",
      "D      H02413  Epidemic myalgia\n",
      "C    1D84  Viral conjunctivitis\n",
      "D      H01320  Epidemic keratoconjunctivitis\n",
      "D      H00393  Enterovirus infection\n",
      "D      H01421  Acute hemorrhagic conjunctivitis\n",
      "D      H01420  Pharyngoconjunctival fever\n",
      "C    1D85  Viral carditis\n",
      "C    1D86  Viral haemorrhagic fever, not elsewhere classified\n",
      "C    Viral infection of unspecified site\n",
      "D      1D90  Adenovirus infection of unspecified site\n",
      "E        H00371  Adenovirus infection\n",
      "D      1D91  Enterovirus infection of unspecified site\n",
      "E        H00393  Enterovirus infection\n",
      "D      1D92  Coronavirus infection, unspecified site\n",
      "D      1D93  Parvovirus infection of unspecified site\n",
      "D      1D9Y  Other viral infections of unspecified site\n",
      "D      1D9Z  Unspecified viral infection of unspecified site\n",
      "C    1E1Y  Other specified viral diseases\n",
      "C    1E1Z  Unspecified viral disease\n",
      "B  Influenza\n",
      "C    1E30  Influenza due to identified seasonal influenza virus\n",
      "D      H00398  Influenza\n",
      "C    1E31  Influenza due to identified zoonotic or pandemic influenza virus\n",
      "D      H00399  Avian influenza\n",
      "C    1E32  Influenza, virus not identified\n",
      "B  Viral hepatitis\n",
      "C    1E50  Acute viral hepatitis\n",
      "D      H02162  Viral hepatitis\n",
      "D      H00411  Hepatitis A\n",
      "D      H00412  Hepatitis B\n",
      "D      H00413  Hepatitis C\n",
      "D      H00414  Hepatitis D\n",
      "D      H00415  Hepatitis E\n",
      "C    1E51  Chronic viral hepatitis\n",
      "D      H02162  Viral hepatitis\n",
      "D      H00412  Hepatitis B\n",
      "D      H00413  Hepatitis C\n",
      "D      H00414  Hepatitis D\n",
      "D      H00415  Hepatitis E\n",
      "C    1E5Z  Viral hepatitis, unspecified\n",
      "B  Viral infections characterised by skin or mucous membrane lesions\n",
      "C    Infections due to poxvirus\n",
      "D      1E70  Smallpox\n",
      "E        H00372  Smallpox\n",
      "D      1E71  Monkeypox\n",
      "E        H00373  Mpox (Monkeypox)\n",
      "D      1E72  Cowpox\n",
      "E        H02351  Cowpox\n",
      "D      1E73  Vaccinia\n",
      "E        H02352  Vaccinia\n",
      "D      1E74  Buffalopox\n",
      "D      1E75  Orf\n",
      "E        H02354  Orf\n",
      "D      1E76  Molluscum contagiosum\n",
      "E        H01052  Molluscum contagiosum\n",
      "D      1E7Y  Other specified infections due to poxvirus\n",
      "D      1E7Z  Infections due to poxvirus, unspecified\n",
      "C    Human papillomavirus infection of skin or mucous membrane\n",
      "D      1E80  Common warts\n",
      "D      1E81  Plane warts\n",
      "D      1E82  Warts of lips or oral cavity\n",
      "D      1E83  Wart virus proliferation in immune-deficient states\n",
      "E        H00842  Epidermodysplasia verruciformis\n",
      "D      1E8Z  Viral warts, not elsewhere classified\n",
      "E        H00374  Viral wart\n",
      "C    Varicella zoster virus infections\n",
      "D      1E90  Varicella\n",
      "E        H00366  Varicella\n",
      "D      1E91  Zoster\n",
      "E        H00366  Varicella\n",
      "E        H01624  Postherpetic neuralgia\n",
      "C    1F00  Herpes simplex infections\n",
      "D      H00365  Herpes simplex virus infection\n",
      "D      H00387  B virus infection\n",
      "C    1F01  Roseola infantum\n",
      "D      H00369  Exanthema subitum\n",
      "C    1F02  Rubella\n",
      "D      H00395  Rubella\n",
      "C    1F03  Measles\n",
      "D      H00394  Measles\n",
      "C    1F04  Erythema infectiosum\n",
      "D      H00404  Erythema infectiosum\n",
      "C    1F05  Picornavirus infections presenting in the skin or mucous membranes\n",
      "D      H00393  Enterovirus infection\n",
      "D      H01327  Herpangina\n",
      "D      H01326  Hand, foot and mouth disease\n",
      "C    1F0Y  Other specified viral infections characterised by skin or mucous membrane lesions\n",
      "C    1F0Z  Viral infections characterised by skin or mucous membrane lesions, unspecified\n",
      "B  Mycoses\n",
      "C    1F20  Aspergillosis\n",
      "D      H01328  Aspergillosis\n",
      "C    1F21  Basidiobolomycosis\n",
      "D      H01503  Zygomycosis\n",
      "D      H02032  Entomophthoramycosis\n",
      "C    1F22  Blastomycosis\n",
      "D      H01501  Blastomycosis\n",
      "C    1F23  Candidosis\n",
      "D      H00363  Candidiasis\n",
      "D      H01109  Chronic mucocutaneous candidiasis\n",
      "C    1F24  Chromoblastomycosis\n",
      "D      H01520  Chromomycosis\n",
      "C    1F25  Coccidioidomycosis\n",
      "D      H01319  Coccidioidomycosis\n",
      "C    1F26  Conidiobolomycosis\n",
      "D      H01503  Zygomycosis\n",
      "D      H02032  Entomophthoramycosis\n",
      "C    1F27  Cryptococcosis\n",
      "D      H00364  Cryptococcosis\n",
      "C    1F28  Dermatophytosis\n",
      "D      H01316  Dermatophytosis\n",
      "C    1F29  Eumycetoma\n",
      "D      H02385  Eumycetoma\n",
      "C    1F2A  Histoplasmosis\n",
      "D      H01062  Histoplasmosis\n",
      "C    1F2B  Lobomycosis\n",
      "D      H01518  Lobomycosis\n",
      "C    1F2C  Mucormycosis\n",
      "D      H01503  Zygomycosis\n",
      "D      H02033  Mucormycosis\n",
      "C    1F2D  Non-dermatophyte superficial dermatomycoses\n",
      "D      H01334  Tinea versicolor\n",
      "D      H02428  Trichosporonosis\n",
      "C    1F2E  Paracoccidioidomycosis\n",
      "D      H01329  Paracoccidioidomycosis\n",
      "C    1F2F  Phaeohyphomycosis\n",
      "D      H02386  Phaeohyphomycosis\n",
      "C    1F2G  Pneumocystosis\n",
      "D      H01521  Pneumocystis pneumonia\n",
      "C    1F2H  Scedosporiosis\n",
      "D      H02392  Scedosporiosis\n",
      "C    1F2J  Sporotrichosis\n",
      "D      H01499  Sporotrichosis\n",
      "C    1F2K  Talaromycosis\n",
      "D      H02393  Talaromycosis\n",
      "C    1F2L  Emmonsiosis\n",
      "C    1F2Y  Other specified mycoses\n",
      "C    1F2Z  Mycoses, unspecified\n",
      "B  Parasitic diseases\n",
      "C    Malaria\n",
      "D      1F40  Malaria due to Plasmodium falciparum\n",
      "E        H00361  Malaria\n",
      "D      1F41  Malaria due to Plasmodium vivax\n",
      "E        H00361  Malaria\n",
      "D      1F42  Malaria due to Plasmodium malariae\n",
      "E        H00361  Malaria\n",
      "D      1F43  Malaria due to Plasmodium ovale\n",
      "E        H00361  Malaria\n",
      "D      1F44  Other parasitologically confirmed malaria\n",
      "D      1F45  Malaria without parasitological confirmation\n",
      "D      1F4Z  Malaria, unspecified\n",
      "C    Nonintestinal protozoal diseases\n",
      "D      1F50  Acanthamoebiasis\n",
      "E        H02401  Acanthamoebiasis\n",
      "D      1F51  African trypanosomiasis\n",
      "E        H00357  African trypanosomiasis\n",
      "D      1F52  Babesiosis\n",
      "E        H01060  Babesiosis\n",
      "D      1F53  Chagas disease\n",
      "E        H00358  Chagas disease\n",
      "D      1F54  Leishmaniasis\n",
      "E        H00359  Leishmaniasis\n",
      "D      1F55  Naegleriasis\n",
      "E        H02399  Primary amoebic meningoencephalitis (PAM)\n",
      "D      1F56  Rhinosporidiosis\n",
      "E        H02400  Rhinosporidiosis\n",
      "D      1F57  Toxoplasmosis\n",
      "E        H00435  Toxoplasmosis\n",
      "D      1F58  Microsporidiosis\n",
      "E        H01336  Encephalitozoon infection\n",
      "D      1F5Z  Unspecified protozoal disease\n",
      "C    Helminthiases\n",
      "D      Diseases due to nematodes\n",
      "E        1F60  Angiostrongyliasis\n",
      "F          H02403  Angiostrongyliasis\n",
      "E        1F61  Anisakiasis\n",
      "F          H01058  Anisakiasis\n",
      "E        1F62  Ascariasis\n",
      "F          H01090  Ascariasis\n",
      "E        1F63  Capillariasis\n",
      "F          H02404  Capillariasis\n",
      "E        1F64  Dracunculiasis\n",
      "F          H01044  Dracunculiasis\n",
      "E        1F65  Enterobiasis\n",
      "F          H01091  Enterobiasis\n",
      "E        1F66  Filariasis\n",
      "F          H02028  Filariasis\n",
      "F          H01104  Loiasis\n",
      "F          H01061  Mansonelliasis\n",
      "F          H01086  Lymphatic filariasis\n",
      "E        1F67  Gnathostomiasis\n",
      "F          H01057  Gnathostomiasis\n",
      "E        1F68  Hookworm diseases\n",
      "F          H01092  Hookworm disease\n",
      "E        1F69  Oesophagostomiasis\n",
      "F          H02405  Oesophagostomiasis\n",
      "E        1F6A  Onchocerciasis\n",
      "F          H01043  Onchocerciasis\n",
      "E        1F6B  Strongyloidiasis\n",
      "F          H01100  Strongyloidiasis\n",
      "E        1F6C  Syngamosis\n",
      "F          H02406  Syngamosis\n",
      "E        1F6D  Toxocariasis\n",
      "F          H01056  Toxocariasis\n",
      "E        1F6E  Trichinosis\n",
      "F          H01099  Trichinosis\n",
      "E        1F6F  Trichostrongyliasis\n",
      "F          H02407  Trichostrongyliasis\n",
      "E        1F6G  Trichuriasis\n",
      "F          H01046  Trichuriasis\n",
      "E        1F6H  Uncinariosis\n",
      "E        1F6Y  Other specified diseases due to nematodes\n",
      "F          H01137  Baylisascariasis\n",
      "E        1F6Z  Diseases due to nematodes, unspecified\n",
      "D      Diseases due to cestodes\n",
      "E        1F70  Cysticercosis\n",
      "F          H01047  Cysticercosis\n",
      "E        1F71  Diphyllobothriasis\n",
      "F          H01085  Diphyllobothriasis\n",
      "E        1F72  Dipylidiasis\n",
      "F          H02408  Dipylidiasis\n",
      "E        1F73  Echinococcosis\n",
      "F          H01153  Human echinococcosis\n",
      "E        1F74  Hymenolepiasis\n",
      "F          H01138  Hymenolepiasis\n",
      "E        1F75  Sparganosis\n",
      "F          H01014  Sparganosis\n",
      "E        1F76  Taeniasis\n",
      "F          H01152  Taenia saginata infection\n",
      "E        1F7Y  Other specified diseases due to cestodes\n",
      "E        1F7Z  Diseases due to cestodes, unspecified\n",
      "D      Diseases due to trematodes\n",
      "E        1F80  Clonorchiasis\n",
      "F          H01610  Clonorchiasis\n",
      "E        1F81  Dicrocoeliasis\n",
      "F          H02409  Dicrocoeliasis\n",
      "E        1F82  Fascioliasis\n",
      "F          H01048  Liver fluke disease\n",
      "E        1F83  Fasciolopsiasis\n",
      "E        1F84  Opisthorchiasis\n",
      "F          H01628  Opisthorchiasis\n",
      "E        1F85  Paragonimiasis\n",
      "F          H01093  Paragonimiasis\n",
      "E        1F86  Schistosomiasis\n",
      "F          H01045  Schistosomiasis\n",
      "E        1F8Y  Other specified diseases due to trematodes\n",
      "F          H01617  Foodborne trematodiasis\n",
      "E        1F8Z  Diseases due to trematodes, unspecified\n",
      "D      1F90  Other and unspecified infestation by parasitic worms\n",
      "D      1F91  Diphyllobothriasis and sparganosis\n",
      "D      1F9Z  Helminthiases, unspecified\n",
      "E        H01055  Giant kidney worm infection\n",
      "C    Infestations by ectoparasites\n",
      "D      1G00  Pediculosis\n",
      "E        H01054  Pediculosis\n",
      "D      1G01  Myiasis\n",
      "E        H01178  Myiasis\n",
      "D      1G02  External hirudiniasis\n",
      "D      1G03  Pthiriasis\n",
      "E        H02423  Phthiriasis\n",
      "D      1G04  Scabies\n",
      "E        H01519  Scabies\n",
      "D      1G05  Tungiasis\n",
      "E        H01179  Tungiasis\n",
      "D      1G06  Cimicosis\n",
      "E        H02416  Cimicosis\n",
      "D      1G07  Infestation by mites\n",
      "D      1G0Y  Infestation by other specified ectoparasite\n",
      "D      1G0Z  Infestation by unknown or unspecified ectoparasite\n",
      "E        H01098  Pentastomiasis\n",
      "C    1G2Y  Other specified parasitic diseases\n",
      "C    1G2Z  Unspecified parasitic diseases\n",
      "B  Sepsis\n",
      "C    1G40  Sepsis without septic shock\n",
      "C    1G41  Sepsis with septic shock\n",
      "B  1G60  Certain other disorders of infectious origin\n",
      "B  Sequelae of infectious diseases\n",
      "C    1G80  Sequelae of tuberculosis\n",
      "C    1G81  Sequelae of trachoma\n",
      "C    1G82  Sequelae of leprosy\n",
      "C    1G83  Sequelae of poliomyelitis\n",
      "C    1G84  Sequelae of viral encephalitis\n",
      "C    1G85  Sequelae of diphtheria\n",
      "C    1G8Y  Sequelae of other specified infectious diseases\n",
      "B  1H0Z  Infection, unspecified\n",
      "A02 Neoplasms\n",
      "B  Neoplasms of brain or central nervous system\n",
      "C    2A00  Primary neoplasms of brain\n",
      "D      H00042  Glioma\n",
      "D      H01692  Subependymal giant cell astrocytoma\n",
      "D      H01667  Medulloblastoma\n",
      "D      H01007  Choroid plexus papilloma\n",
      "C    2A01  Primary neoplasms of meninges\n",
      "D      H01556  Meningioma\n",
      "C    2A02  Primary neoplasm of spinal cord, cranial nerves or remaining parts of central nervous system\n",
      "D      H00043  Neuroblastoma\n",
      "C    2A0Z  Other and unspecified neoplasms of brain or central nervous system\n",
      "B  Neoplasms of haematopoietic or lymphoid tissues\n",
      "C    Myeloproliferative neoplasms\n",
      "D      2A20  Non mast cell myeloproliferative neoplasms\n",
      "E        H00004  Chronic myeloid leukemia\n",
      "E        H01605  Myelofibrosis\n",
      "E        H01590  Chronic eosinophilic leukemia\n",
      "E        H01599  Hypereosinophilic syndrome\n",
      "E        H00012  Polycythemia vera\n",
      "D      2A21  Mastocytosis\n",
      "E        H01511  Mast-cell leukemia\n",
      "D      2A22  Other and unspecified myeloproliferative neoplasms\n",
      "C    Myelodysplastic syndromes\n",
      "D      2A30  Refractory anaemia\n",
      "D      2A31  Refractory neutropaenia\n",
      "D      2A32  Refractory thrombocytopenia\n",
      "D      2A33  Refractory anaemia with ring sideroblasts\n",
      "D      2A34  Refractory cytopenia with multi-lineage dysplasia\n",
      "D      2A35  Refractory anaemia with excess of blasts\n",
      "D      2A36  Myelodysplastic syndrome with isolated del(5q)\n",
      "E        H01481  Myelodysplastic syndrome\n",
      "E        H01484  5q- syndrome\n",
      "D      2A37  Myelodysplastic syndrome, unclassifiable\n",
      "E        H01481  Myelodysplastic syndrome\n",
      "D      2A38  Refractory cytopenia of childhood\n",
      "D      2A3Y  Other specified myelodysplastic syndromes\n",
      "D      2A3Z  Myelodysplastic syndromes, unspecified\n",
      "E        H01481  Myelodysplastic syndrome\n",
      "C    Myelodysplastic and myeloproliferative neoplasms\n",
      "D      2A40  Chronic myelomonocytic leukaemia\n",
      "E        H02411  Chronic myelomonocytic leukemia\n",
      "D      2A41  Atypical chronic myeloid leukaemia, BCR-ABL1negative\n",
      "E        H02412  Atypical chronic myeloid leukemia\n",
      "D      2A42  Juvenile myelomonocytic leukaemia\n",
      "E        H02541  Juvenile myelomonocytic leukemia\n",
      "D      2A43  Refractory anaemia with ring sideroblasts associated with marked thrombocytosis\n",
      "D      2A44  Myeloproliferative and myelodysplastic disease, unclassifiable\n",
      "D      2A4Y  Other specified myelodysplastic and myeloproliferative neoplasms\n",
      "D      2A4Z  Myelodysplastic and myeloproliferative neoplasms, unspecified\n",
      "E        H02410  Myelodysplastic/myeloproliferative neoplasms\n",
      "C    Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1\n",
      "D      2A50  Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement\n",
      "D      2A51  Myeloid neoplasm associated with PDGFRB rearrangement\n",
      "D      2A52  Myeloid or lymphoid neoplasms with FGFR1 abnormalities\n",
      "D      2A5Z  Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1, unspecified\n",
      "C    2A60  Acute myeloid leukaemias and related precursor neoplasms\n",
      "D      H00003  Acute myeloid leukemia\n",
      "D      H02542  Acute promyelocytic leukemia\n",
      "C    2A61  Acute leukaemias of ambiguous lineage\n",
      "C    Precursor lymphoid neoplasms\n",
      "D      2A70  Precursor B-lymphoblastic neoplasms\n",
      "E        H00001  B-cell acute lymphoblastic leukemia\n",
      "D      2A71  Precursor T-lymphoblastic neoplasms\n",
      "E        H00002  T-cell acute lymphoblastic leukemia\n",
      "D      2A7Z  Precursor lymphoid neoplasms, unspecified\n",
      "C    Mature B-cell neoplasms\n",
      "D      2A80  Follicular lymphoma\n",
      "E        H01613  Follicular lymphoma\n",
      "D      2A81  Diffuse large B-cell lymphomas\n",
      "E        H02424  Primary central nervous system lymphoma\n",
      "E        H02434  Diffuse large B-cell lymphoma, not otherwise specified\n",
      "D      2A82  Mature B-cell neoplasm with leukaemic behaviour\n",
      "E        H00005  Chronic lymphocytic leukemia\n",
      "E        H00006  Hairy cell leukemia\n",
      "D      2A83  Plasma cell neoplasms\n",
      "E        H00010  Multiple myeloma\n",
      "E        H01461  Crow-Fukase syndrome\n",
      "D      2A84  Heavy chain diseases or malignant immunoproliferative diseases\n",
      "D      2A85  Other specified mature B-cell neoplasms or lymphoma\n",
      "E        H00011  Lymphoplasmacytic lymphoma\n",
      "E        H01464  Mantle cell lymphoma\n",
      "E        H00008  Burkitt lymphoma\n",
      "D      2A86  B-cell lymphoma, mixed features\n",
      "D      2A8Z  Mature B-cell neoplasms, unspecified\n",
      "C    Mature T-cell or NK-cell neoplasms\n",
      "D      2A90  Mature T-cell lymphoma, specified types, nodal or systemic\n",
      "E        H01892  Peripheral T cell lymphoma\n",
      "E        H00009  Adult T-cell leukemia\n",
      "E        H01601  Anaplastic large-cell lymphoma\n",
      "D      Mature T-cell or NK-cell lymphomas and lymphoproliferative disorders, primary cutaneous specified types\n",
      "E        2B00  Subcutaneous panniculitis-like T-cell lymphoma\n",
      "E        2B01  Mycosis fungoides\n",
      "F          H01463  Mycosis fungoides\n",
      "E        2B02  Sézary syndrome\n",
      "E        2B03  Primary cutaneous CD-30 positive T-cell lymphoproliferative disorders\n",
      "E        2B0Y  Other specified primary cutaneous mature T-cell or NK-cell lymphomas and lymphoproliferative disorders\n",
      "E        2B0Z  Primary cutaneous T-cell lymphoma of undetermined or unspecified type\n",
      "D      2B2Y  Other specified mature T-cell or NK-cell neoplasms\n",
      "D      2B2Z  Mature T-cell or NK-cell neoplasms, unspecified\n",
      "C    2B30  Hodgkin lymphoma\n",
      "D      H00007  Hodgkin lymphoma\n",
      "C    2B31  Histiocytic or dendritic cell neoplasms\n",
      "D      H01512  Langerhans cell histiocytosis\n",
      "D      H02425  Erdheim-Chester disease\n",
      "C    2B32  Immunodeficiency-associated lymphoproliferative disorders\n",
      "C    2B33  Malignant haematopoietic neoplasms without further specification\n",
      "D      H02418  Non-Hodgkin lymphoma\n",
      "C    2B3Z  Neoplasms of haematopoietic or lymphoid tissues, unspecified\n",
      "B  Malignant neoplasms, except primary neoplasms of lymphoid, haematopoietic, central nervous system or related tissues\n",
      "C    Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues\n",
      "D      Malignant mesenchymal neoplasms\n",
      "E        2B50  Chondrosarcoma, primary site\n",
      "F          H00053  Extraskeletal myxoid chondrosarcoma\n",
      "E        2B51  Osteosarcoma, primary site\n",
      "F          H00036  Osteosarcoma\n",
      "F          H01470  Giant cell tumor of bone\n",
      "F          H00881  Li-Fraumeni syndrome\n",
      "E        2B52  Ewing sarcoma, primary site\n",
      "F          H00035  Ewing sarcoma\n",
      "E        2B53  Fibroblastic or myofibroblastic tumour, primary site\n",
      "E        2B54  Unclassified pleomorphic sarcoma, primary site\n",
      "E        2B55  Rhabdomyosarcoma, primary site\n",
      "F          H00037  Rhabdomyosarcoma\n",
      "F          H02427  Soft tissue sarcomas\n",
      "E        2B56  Angiosarcoma, primary site\n",
      "F          H01666  Angiosarcoma\n",
      "F          H01557  Hepatic angiosarcoma\n",
      "E        2B57  Kaposi sarcoma, primary site\n",
      "F          H00041  Kaposi sarcoma\n",
      "E        2B58  Leiomyosarcoma, primary site\n",
      "E        2B59  Liposarcoma, primary site\n",
      "F          H00049  Myxoid liposarcoma\n",
      "E        2B5A  Synovial sarcoma, primary site\n",
      "F          H00050  Synovial sarcoma\n",
      "F          H02427  Soft tissue sarcomas\n",
      "E        2B5B  Gastrointestinal stromal tumour, primary site\n",
      "F          H01591  Gastrotintestinal stromal tumor\n",
      "E        2B5C  Endometrial stromal sarcoma, primary site\n",
      "E        2B5D  Malignant mixed epithelial mesenchymal tumour, primary site\n",
      "E        2B5E  Malignant nerve sheath tumour of peripheral nerves or autonomic nervous system, primary site\n",
      "E        2B5F  Sarcoma, not elsewhere classified, primary site\n",
      "E        2B5G  Myosarcoma of uterus, part not specified\n",
      "E        2B5H  Well differentiated lipomatous tumour, primary site\n",
      "E        2B5J  Malignant miscellaneous tumours of bone or articular cartilage of other or unspecified sites\n",
      "E        2B5K  Unspecified malignant soft tissue tumours or sarcomas of bone or articular cartilage of other or unspecified sites\n",
      "F          H00051  Alveolar soft part sarcoma\n",
      "F          H00052  Clear cell sarcoma of soft tissue\n",
      "F          H01985  Desmoplastic small round cell tumor\n",
      "E        2B5Y  Other specified malignant mesenchymal neoplasms\n",
      "E        2B5Z  Malignant mesenchymal neoplasm of unspecified type\n",
      "D      Malignant neoplasms of lip, oral cavity or pharynx\n",
      "E        2B60  Malignant neoplasms of lip\n",
      "F          H00016  Oral cancer\n",
      "E        2B61  Malignant neoplasms of base of tongue\n",
      "F          H00016  Oral cancer\n",
      "E        2B62  Malignant neoplasms of other or unspecified parts of tongue\n",
      "F          H00016  Oral cancer\n",
      "E        2B63  Malignant neoplasms of gum\n",
      "F          H00016  Oral cancer\n",
      "E        2B64  Malignant neoplasms of floor of mouth\n",
      "F          H00016  Oral cancer\n",
      "E        2B65  Malignant neoplasms of palate\n",
      "F          H00016  Oral cancer\n",
      "E        2B66  Malignant neoplasms of other or unspecified parts of mouth\n",
      "F          H00016  Oral cancer\n",
      "E        2B67  Malignant neoplasms of parotid gland\n",
      "E        2B68  Malignant neoplasms of submandibular or sublingual glands\n",
      "F          H01508  Salivary gland cancer\n",
      "F          H02420  Head and neck cancer\n",
      "E        2B69  Malignant neoplasms of tonsil\n",
      "F          H01509  Tonsillar cancer\n",
      "F          H02420  Head and neck cancer\n",
      "E        2B6A  Malignant neoplasms of oropharynx\n",
      "F          H01559  Oropharyngeal cancer\n",
      "F          H02420  Head and neck cancer\n",
      "E        2B6B  Malignant neoplasms of nasopharynx\n",
      "F          H00054  Nasopharyngeal cancer\n",
      "E        2B6C  Malignant neoplasms of piriform sinus\n",
      "E        2B6D  Malignant neoplasms of hypopharynx\n",
      "E        2B6E  Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx\n",
      "F          H02420  Head and neck cancer\n",
      "E        2B6Y  Other specified malignant neoplasms of lip, oral cavity or pharynx\n",
      "E        2B6Z  Malignant neoplasms of lip, oral cavity or pharynx, unspecified\n",
      "D      Malignant neoplasms of digestive organs\n",
      "E        2B70  Malignant neoplasms of oesophagus\n",
      "F          H00017  Esophageal cancer\n",
      "E        2B71  Malignant neoplasms of oesophagogastric junction\n",
      "E        2B72  Malignant neoplasms of stomach\n",
      "F          H00018  Gastric cancer\n",
      "E        Malignant neoplasms of intestine\n",
      "F          2B80  Malignant neoplasms of small intestine\n",
      "G            H00034  Carcinoid\n",
      "F          2B81  Malignant neoplasms of appendix\n",
      "F          Malignant neoplasms of large intestine\n",
      "G            2B90  Malignant neoplasms of colon\n",
      "H              H00020  Colorectal cancer\n",
      "H              H02565  Hereditary nonpolyposis colorectal cancer\n",
      "H              H02568  Polymerase proofreading-associated polyposis\n",
      "G            2B91  Malignant neoplasms of rectosigmoid junction\n",
      "H              H00020  Colorectal cancer\n",
      "G            2B92  Malignant neoplasms of rectum\n",
      "H              H00020  Colorectal cancer\n",
      "G            2B93  Malignant neoplasms of large intestine, site unspecified\n",
      "G            2B9Y  Other specified malignant neoplasms of large intestine\n",
      "H              H00876  Mismatch repair deficiency\n",
      "F          2C00  Malignant neoplasms of anus or anal canal\n",
      "G            H00044  Cancer of the anal canal\n",
      "F          2C0Y  Other specified malignant neoplasms of intestine\n",
      "F          2C0Z  Malignant neoplasms of intestine, unspecified\n",
      "E        2C10  Malignant neoplasm of pancreas\n",
      "F          H00019  Pancreatic cancer\n",
      "F          H00045  Pancreatic neuroendocrine tumor\n",
      "E        2C11  Malignant neoplasms of other or ill-defined digestive organs\n",
      "E        2C12  Malignant neoplasms of liver or intrahepatic bile ducts\n",
      "F          H00048  Hepatocellular carcinoma\n",
      "F          H02302  Hepatoblastoma\n",
      "F          H00046  Cholangiocarcinoma\n",
      "E        2C13  Malignant neoplasms of gallbladder\n",
      "F          H00047  Gallbladder cancer\n",
      "E        2C14  Malignant neoplasms of proximal biliary tract, cystic duct\n",
      "E        2C15  Malignant neoplasms of biliary tract, distal bile duct\n",
      "E        2C16  Malignant neoplasms of ampulla of Vater\n",
      "E        2C17  Malignant neoplasms of other or unspecified parts of biliary tract\n",
      "E        2C18  Malignant neoplasms of perihilar bile duct\n",
      "E        2C1Z  Malignant neoplasms of digestive organs, unspecified\n",
      "D      Malignant neoplasms of middle ear, respiratory or intrathoracic organs\n",
      "E        2C20  Malignant neoplasms of nasal cavity\n",
      "F          H00043  Neuroblastoma\n",
      "E        2C21  Malignant neoplasms of middle ear\n",
      "E        2C22  Malignant neoplasms of accessory sinuses\n",
      "E        2C23  Malignant neoplasms of larynx\n",
      "F          H00055  Laryngeal cancer\n",
      "F          H02420  Head and neck cancer\n",
      "E        2C24  Malignant neoplasms of trachea\n",
      "E        2C25  Malignant neoplasms of bronchus or lung\n",
      "F          H00014  Non-small cell lung cancer\n",
      "F          H00013  Small cell lung cancer\n",
      "E        2C26  Malignant neoplasms of the pleura\n",
      "F          H00015  Malignant pleural mesothelioma\n",
      "E        2C27  Malignant neoplasms of thymus\n",
      "E        2C28  Malignant neoplasms of heart, mediastinum or non-mesothelioma of pleura\n",
      "E        2C29  Malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs\n",
      "E        2C2Y  Other specified malignant neoplasms of middle ear, respiratory or intrathoracic organs\n",
      "E        2C2Z  Malignant neoplasms of middle ear, respiratory or intrathoracic organs, unspecified\n",
      "D      Malignant neoplasms of skin\n",
      "E        2C30  Melanoma of skin\n",
      "F          H00038  Melanoma\n",
      "E        2C31  Squamous cell carcinoma of skin\n",
      "F          H00040  Squamous cell carcinoma\n",
      "F          H02566  Muir-Torre syndrome\n",
      "E        2C32  Basal cell carcinoma of skin\n",
      "F          H00039  Basal cell carcinoma\n",
      "E        2C33  Adnexal carcinoma of skin\n",
      "E        2C34  Cutaneous neuroendocrine carcinoma\n",
      "F          H01555  Merkel cell carcinoma\n",
      "E        2C35  Cutaneous sarcoma\n",
      "E        2C3Y  Other specified malignant neoplasms of skin\n",
      "E        2C3Z  Malignant neoplasm of skin of unknown or unspecified type\n",
      "D      Malignant neoplasms of peripheral nerves or autonomic nervous system\n",
      "E        2C40  Malignant neuroepitheliomatous neoplasms of peripheral nerves or autonomic nervous system\n",
      "E        2C41  Malignant perineurioma\n",
      "E        2C4Y  Other specified malignant neoplasms of peripheral nerves and autonomic nervous system\n",
      "E        2C4Z  Malignant neoplasms of peripheral nerves or autonomic nervous system, unspecified\n",
      "D      Malignant neoplasms of retroperitoneum, peritoneum or omentum\n",
      "E        2C50  Malignant neoplasms of retroperitoneum\n",
      "E        2C51  Malignant neoplasms of peritoneum\n",
      "F          H01665  Primary peritoneal carcinoma\n",
      "E        2C52  Malignant neoplasms of omentum\n",
      "E        2C53  Malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum\n",
      "E        2C5Y  Other specified malignant neoplasms of retroperitoneum, peritoneum or omentum\n",
      "E        2C5Z  Malignant neoplasms of retroperitoneum, peritoneum or omentum, unspecified\n",
      "D      Malignant neoplasms of breast\n",
      "E        2C60  Carcinoma of breast, specialised type\n",
      "E        2C61  Invasive carcinoma of breast\n",
      "F          H00031  Breast cancer\n",
      "E        2C62  Inflammatory carcinoma of breast\n",
      "E        2C63  Malignant phyllodes tumour of breast\n",
      "E        2C64  Solid papillary carcinoma of breast with evidence of invasion\n",
      "E        2C65  Hereditary breast and ovarian cancer syndrome\n",
      "F          H02531  Familial breast-ovarian cancer\n",
      "E        2C6Y  Other specified malignant neoplasms of breast\n",
      "E        2C6Z  Malignant neoplasms of breast, unspecified\n",
      "D      Malignant neoplasms of female genital organs\n",
      "E        2C70  Malignant neoplasms of vulva\n",
      "F          H00029  Vulvar cancer\n",
      "E        2C71  Malignant neoplasms of vagina\n",
      "E        2C72  Malignant neoplasms of uterine ligament, parametrium, or uterine adnexa\n",
      "E        2C73  Malignant neoplasms of ovary\n",
      "F          H00027  Ovarian cancer\n",
      "E        2C74  Malignant neoplasms of fallopian tube\n",
      "F          H01554  Fallopian tube cancer\n",
      "E        2C75  Malignant neoplasms of placenta\n",
      "F          H00028  Choriocarcinoma\n",
      "E        2C76  Malignant neoplasms of corpus uteri\n",
      "F          H00026  Endometrial cancer\n",
      "E        2C77  Malignant neoplasms of cervix uteri\n",
      "F          H00030  Cervical cancer\n",
      "E        2C78  Malignant neoplasms of uterus, part not specified\n",
      "E        2C79  Malignant neoplasm involving overlapping sites of female genital organs\n",
      "E        2C7Y  Other specified malignant neoplasms of female genital organs\n",
      "E        2C7Z  Malignant neoplasms of female genital organs, unspecified\n",
      "D      Malignant neoplasms of male genital organs\n",
      "E        2C80  Malignant neoplasms of testis\n",
      "F          H00023  Testicular cancer\n",
      "E        2C81  Malignant neoplasms of penis\n",
      "F          H00025  Penile cancer\n",
      "E        2C82  Malignant neoplasms of prostate\n",
      "F          H00024  Prostate cancer\n",
      "F          H02530  Hereditary prostate cancer\n",
      "E        2C83  Malignant neoplasms of scrotum\n",
      "E        2C84  Malignant neoplasms of other specified male genital organs\n",
      "E        2C8Z  Malignant neoplasms of male genital organs, unspecified\n",
      "D      Malignant neoplasms of urinary tract\n",
      "E        2C90  Malignant neoplasms of kidney, except renal pelvis\n",
      "F          H00021  Renal cell carcinoma\n",
      "F          H02301  Nephroblastoma\n",
      "E        2C91  Malignant neoplasms of renal pelvis\n",
      "E        2C92  Malignant neoplasms of ureter\n",
      "E        2C93  Malignant neoplasms of urethra or paraurethral gland\n",
      "E        2C94  Malignant neoplasms of bladder\n",
      "F          H00022  Bladder cancer\n",
      "E        2C95  Malignant neoplasm involving overlapping sites of urinary organs\n",
      "E        2C9Y  Other specified malignant neoplasms of urinary tract\n",
      "E        2C9Z  Malignant neoplasms of urinary tract, unspecified\n",
      "D      Malignant neoplasms of eye or ocular adnexa\n",
      "E        2D00  Malignant neoplasm of conjunctiva\n",
      "E        2D01  Malignant neoplasm of cornea\n",
      "E        2D02  Malignant neoplasm of retina\n",
      "F          H01513  Retinoblastoma\n",
      "E        2D03  Malignant neoplasm of lacrimal apparatus\n",
      "E        2D04  Malignant neoplasm of orbit\n",
      "E        2D05  Malignant neoplasm of choroid\n",
      "E        2D06  Malignant neoplasm of ciliary body\n",
      "E        2D07  Malignant neoplasm of iris\n",
      "E        2D0Y  Other specified malignant neoplasms of eye and ocular adnexa\n",
      "E        2D0Z  Malignant neoplasms of eye or ocular adnexa, unspecified\n",
      "D      Malignant neoplasms of endocrine glands\n",
      "E        2D10  Malignant neoplasms of thyroid gland\n",
      "F          H00032  Thyroid cancer\n",
      "F          H01592  Medullary thyroid cancer\n",
      "E        2D11  Malignant neoplasms of adrenal gland\n",
      "F          H00033  Adrenal carcinoma\n",
      "E        2D12  Malignant neoplasms of other endocrine glands or related structures\n",
      "F          H01510  Malignant paraganglioma\n",
      "E        2D1Z  Malignant neoplasms of endocrine glands, unspecified\n",
      "D      2D3Y  Other specified malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues\n",
      "D      2D3Z  Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues, unspecified\n",
      "C    Malignant neoplasms of ill-defined or unspecified primary sites\n",
      "D      2D40  Adenocarcinoma of unspecified site\n",
      "D      2D41  Unspecified carcinoma of unspecified site\n",
      "D      2D42  Malignant neoplasms of ill-defined sites\n",
      "D      2D43  Malignant neoplasms of independent, multiple primary sites\n",
      "D      2D4Y  Other specified malignant neoplasms of unspecified primary sites\n",
      "D      2D4Z  Unspecified malignant neoplasms of unspecified sites\n",
      "C    Malignant neoplasm metastases\n",
      "D      2D50  Malignant neoplasm metastasis in brain\n",
      "D      2D51  Malignant neoplasm metastasis in meninges\n",
      "D      2D52  Malignant neoplasm metastasis in spinal cord, cranial nerves or remaining parts of central nervous system\n",
      "D      Malignant neoplasm metastasis in lymph nodes\n",
      "E        2D60  Malignant neoplasm metastasis in lymph node of a single region\n",
      "F          H02610  Head and neck squamous cell carcinoma\n",
      "E        2D61  Malignant neoplasm metastases in lymph nodes of multiple regions\n",
      "E        2D6Z  Metastatic malignant neoplasm to unspecified lymph node\n",
      "D      Malignant neoplasm metastasis in thoracic or respiratory organs\n",
      "E        2D70  Malignant neoplasm metastasis in lung\n",
      "E        2D71  Malignant neoplasm metastasis in mediastinum\n",
      "E        2D72  Malignant neoplasm metastasis in pleura\n",
      "E        2D73  Malignant neoplasm metastasis in upper respiratory tract organs\n",
      "E        2D7Y  Malignant neoplasm metastasis in other specified thoracic organs\n",
      "E        2D7Z  Malignant neoplasm metastasis in thoracic or respiratory organs, unspecified\n",
      "D      Malignant neoplasm metastasis in digestive system\n",
      "E        2D80  Malignant neoplasm metastasis in liver or intrahepatic bile duct\n",
      "E        2D81  Malignant neoplasm metastasis in pancreas\n",
      "E        2D82  Malignant neoplasm metastasis in extrahepatic bile ducts\n",
      "E        2D83  Malignant neoplasm metastasis in ampulla of Vater\n",
      "E        2D84  Malignant neoplasm metastasis in the small intestine\n",
      "E        2D85  Malignant neoplasm metastasis in large intestine\n",
      "E        2D86  Malignant neoplasm metastasis in anus\n",
      "E        2D8Y  Malignant neoplasm metastasis in other specified digestive system organ\n",
      "E        2D8Z  Malignant neoplasm metastasis in unspecified digestive system organ\n",
      "D      Malignant neoplasm metastasis in retroperitoneum or peritoneum\n",
      "E        2D90  Malignant neoplasm metastasis in retroperitoneum\n",
      "E        2D91  Malignant neoplasm metastasis in peritoneum\n",
      "D      Malignant neoplasm metastasis in other sites\n",
      "E        2E00  Malignant neoplasm metastasis in kidney or renal pelvis\n",
      "E        2E01  Malignant neoplasm metastasis in bladder\n",
      "E        2E02  Malignant neoplasm metastasis in other or unspecified urinary system organs\n",
      "E        2E03  Malignant neoplasm metastasis in bone or bone marrow\n",
      "E        2E04  Malignant neoplasm metastasis in soft tissue\n",
      "E        2E05  Malignant neoplasm metastasis in female reproductive system\n",
      "E        2E06  Malignant neoplasm metastasis in male genital organs\n",
      "E        2E07  Malignant neoplasm metastasis in adrenal gland\n",
      "E        2E08  Metastatic malignant neoplasm involving skin\n",
      "E        2E09  Malignant neoplasm metastasis in peripheral nervous system\n",
      "E        2E0Y  Malignant neoplasm metastasis in other specified sites\n",
      "D      2E2Z  Malignant neoplasm metastasis, unspecified\n",
      "B  In situ neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues\n",
      "C    2E60  Carcinoma in situ of oral cavity, oesophagus or stomach\n",
      "C    2E61  Carcinoma in situ of other or unspecified digestive organs\n",
      "C    2E62  Carcinoma in situ of middle ear or respiratory system\n",
      "C    2E63  Melanoma in situ neoplasms\n",
      "C    2E64  Carcinoma in situ of skin\n",
      "C    2E65  Carcinoma in situ of breast\n",
      "C    2E66  Carcinoma in situ of cervix uteri\n",
      "C    2E67  Carcinoma in situ of other or unspecified genital organs\n",
      "C    2E68  Carcinoma in situ of bladder\n",
      "C    2E69  Carcinoma in situ of other or unspecified urinary organs\n",
      "C    2E6A  Carcinoma in situ of the eye or ocular adnexa\n",
      "C    2E6B  Carcinoma in situ of thyroid and other endocrine glands\n",
      "D      H01558  Parathyroid carcinoma\n",
      "C    2E6Y  Carcinoma in situ of other specified site\n",
      "C    2E6Z  Carcinoma in situ of unspecified site\n",
      "B  Benign neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues\n",
      "C    Benign mesenchymal neoplasms\n",
      "D      2E80  Benign lipomatous neoplasm\n",
      "D      2E81  Benign vascular neoplasms\n",
      "E        H01471  Lymphangioma\n",
      "E        H01735  Lymphangiomatosis\n",
      "E        H01482  Infantile hemangioma\n",
      "E        H01875  Infantile hepatic hemangioma\n",
      "D      2E82  Benign chondrogenic tumours\n",
      "D      2E83  Benign osteogenic tumours\n",
      "D      2E84  Benign fibrogenic or myofibrogenic tumour\n",
      "D      2E85  Benign fibrohistiocytic tumour\n",
      "D      2E86  Benign smooth muscle or skeletal muscle tumour\n",
      "E        H01640  Uterine leiomyoma\n",
      "D      2E87  Benign gastrointestinal stromal tumour\n",
      "D      2E88  Benign endometrial stromal nodule\n",
      "D      2E89  Benign mesenchymal tumours of uncertain differentiation\n",
      "D      2E8A  Other mixed or unspecified benign mesenchymal tumours\n",
      "D      2E8Y  Other specified benign mesenchymal neoplasm\n",
      "D      2E8Z  Benign mesenchymal neoplasms, unspecified\n",
      "E        H00804  Multiple cutaneous and uterine leiomyomata\n",
      "C    Benign non-mesenchymal neoplasms\n",
      "D      2E90  Benign neoplasm of lip, oral cavity or pharynx\n",
      "D      2E91  Benign neoplasm of major salivary glands\n",
      "D      2E92  Benign neoplasm of digestive organs\n",
      "E        H02538  Paraganglioma\n",
      "E        H01025  Familial adenomatous polyposis\n",
      "E        H00539  PTEN hamartoma tumor syndrome\n",
      "E        H01023  Juvenile polyposis syndrome\n",
      "E        H01024  Hereditary mixed polyposis syndrome\n",
      "D      Benign neoplasm of respiratory or intrathoracic organs\n",
      "E        2F00  Benign neoplasm of middle ear or respiratory system\n",
      "E        2F01  Benign neoplasm of intrathoracic organs\n",
      "E        2F0Y  Benign neoplasms of other specified respiratory and intrathoracic organs\n",
      "E        2F0Z  Benign neoplasms of unspecified respiratory and intrathoracic organs\n",
      "D      2F10  Benign neoplasm of mesothelial tissue\n",
      "D      Benign cutaneous neoplasms\n",
      "E        2F20  Benign cutaneous melanocytic neoplasms\n",
      "E        2F21  Benign keratinocytic acanthomas\n",
      "E        2F22  Benign neoplasms of epidermal appendages\n",
      "F          H00827  Brooke-Spiegler syndrome\n",
      "F          H00828  Familial cylindromatosis\n",
      "F          H00829  Multiple familial trichoepithelioma\n",
      "F          H00947  Pilomatricoma\n",
      "E        2F23  Benign dermal fibrous or fibrohistiocytic neoplasms\n",
      "F          H01910  Infantile myofibromatosis\n",
      "E        2F24  Benign cutaneous neoplasms of neural or nerve sheath origin\n",
      "E        2F25  Cherry angioma\n",
      "E        2F26  Lobular capillary haemangioma\n",
      "E        2F2Y  Other specified benign cutaneous neoplasms\n",
      "E        2F2Z  Benign cutaneous neoplasm of unspecified type\n",
      "D      2F30  Benign neoplasm of breast\n",
      "D      2F31  Benign non-mesenchymal neoplasms of uterus\n",
      "D      2F32  Benign neoplasm of ovary\n",
      "D      2F33  Benign neoplasm of other or unspecified female genital organs\n",
      "D      2F34  Benign neoplasm of male genital organs\n",
      "D      2F35  Benign neoplasm of urinary organs\n",
      "E        H01691  Renal angiomyolipoma\n",
      "D      2F36  Benign neoplasm of eye or ocular adnexa\n",
      "E        H01149  Ring dermoid of cornea\n",
      "D      2F37  Benign neoplasm of endocrine glands\n",
      "E        H01102  Pituitary adenomas\n",
      "D      2F3Y  Benign non-mesenchymal neoplasms of other specified site\n",
      "D      2F3Z  Benign non-mesenchymal neoplasms of unspecified site\n",
      "C    2F5Y  Other specified benign neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues\n",
      "C    2F5Z  Benign neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues, unspecified\n",
      "B  Neoplasms of uncertain behaviour, except of lymphoid, haematopoietic, central nervous system or related tissues\n",
      "C    2F70  Neoplasms of uncertain behaviour of oral cavity or digestive organs\n",
      "C    2F71  Neoplasms of uncertain behaviour of middle ear, respiratory or intrathoracic organs\n",
      "C    2F72  Neoplasms of uncertain behaviour of skin\n",
      "C    2F73  Neoplasms of uncertain behaviour of retroperitoneum\n",
      "C    2F74  Neoplasms of uncertain behaviour of peritoneum\n",
      "C    2F75  Neoplasms of uncertain behaviour of breast\n",
      "C    2F76  Neoplasms of uncertain behaviour of female genital organs\n",
      "C    2F77  Neoplasms of uncertain behaviour of male genital organs\n",
      "C    2F78  Neoplasms of uncertain behaviour of urinary organs\n",
      "C    2F79  Neoplasms of uncertain behaviour of eye or ocular adnexa\n",
      "C    2F7A  Neoplasms of uncertain behaviour of endocrine glands\n",
      "D      H00247  Multiple endocrine neoplasia syndrome\n",
      "C    2F7B  Neoplasms of uncertain behaviour of bone or articular cartilage\n",
      "C    2F7C  Neoplasms of uncertain behaviour of connective or other soft tissue\n",
      "C    2F7Y  Neoplasms of uncertain behaviour of other specified site\n",
      "D      H02624  Tumor predisposition syndrome\n",
      "C    2F7Z  Neoplasms of uncertain behaviour of unspecified site\n",
      "B  Neoplasms of unknown behaviour, except of lymphoid, haematopoietic, central nervous system or related tissues\n",
      "C    2F90  Neoplasms of unknown behaviour of oral cavity or digestive organs\n",
      "C    2F91  Neoplasms of unknown behaviour of middle ear, respiratory or intrathoracic organs\n",
      "C    2F92  Neoplasms of unknown behaviour of skin\n",
      "C    2F93  Neoplasms of unknown behaviour of retroperitoneum\n",
      "C    2F94  Neoplasms of unknown behaviour of peritoneum\n",
      "C    2F95  Neoplasms of unknown behaviour of breast\n",
      "C    2F96  Neoplasms of unknown behaviour of female genital organs\n",
      "C    2F97  Neoplasms of unknown behaviour of male genital organs\n",
      "C    2F98  Neoplasms of unknown behaviour of urinary organs\n",
      "C    2F99  Neoplasms of unknown behaviour of eye or ocular adnexa\n",
      "C    2F9A  Neoplasms of unknown behaviour of endocrine glands\n",
      "C    2F9B  Neoplasms of unknown behaviour of bone or articular cartilage\n",
      "C    2F9C  Neoplasms of unknown behaviour of connective or other soft tissue\n",
      "C    2F9Y  Neoplasms of unknown behaviour of other specified site\n",
      "C    2F9Z  Neoplasms of unknown behaviour of unspecified site\n",
      "A03 Diseases of the blood or blood-forming organs\n",
      "B  Anaemias or other erythrocyte disorders\n",
      "C    Nutritional or metabolic anaemias\n",
      "D      3A00  Iron deficiency anaemia\n",
      "E        H01145  Atransferrinemia\n",
      "E        H01196  Hypochromic microcytic anemia\n",
      "E        H01278  Iron-refractory iron deficiency anemia\n",
      "E        H02206  Aceruloplasminemia\n",
      "D      3A01  Megaloblastic anaemia due to vitamin B12 deficiency\n",
      "E        H01277  Vitamin B12 deficiency anaemia\n",
      "E        H01190  Transcobalamin II deficiency\n",
      "D      3A02  Folate deficiency anaemia\n",
      "E        H01197  Dihydrofolate reductase deficiency\n",
      "E        H01262  Formiminotransferase deficiency\n",
      "D      3A03  Other nutritional or metabolic anaemias\n",
      "E        H00198  Orotic aciduria\n",
      "C    Haemolytic anaemias\n",
      "D      Congenital haemolytic anaemia\n",
      "E        3A10  Hereditary haemolytic anaemia\n",
      "F          H00668  Anemia due to disorders of glutathione metabolism\n",
      "F          H00231  Hereditary elliptocytosis\n",
      "F          H01125  Hereditary pyropoikilocytosis\n",
      "F          H02001  Familial pseudohyperkalemia\n",
      "F          H00230  Hereditary spherocytosis\n",
      "F          H00232  Hereditary stomatocytosis\n",
      "F          H00664  Anemia due to disorders of glycolytic enzymes\n",
      "F          H00674  Anemia due to disorders of nucleotide metabolism\n",
      "F          H00832  Core neuroacanthocytosis syndromes\n",
      "F          H01214  Rh-null hemolytic anemia (RHN)\n",
      "F          H01432  Choreoacanthocytosis\n",
      "F          H01434  Atypical hemolytic uremic syndrome\n",
      "F          H01720  Southeast Asian ovalocytosis\n",
      "F          H01978  Dehydrated hereditary stomatocytosis\n",
      "F          H01979  Overhydrated hereditary stomatocytosis\n",
      "F          H02002  Cryohydrocytosis\n",
      "E        3A1Y  Other specified congenital haemolytic anaemia\n",
      "D      Acquired haemolytic anaemia\n",
      "E        3A20  Acquired haemolytic anaemia, immune\n",
      "F          H01585  Autoimmune hemolytic anemia\n",
      "E        3A21  Acquired haemolytic anaemia, non-immune\n",
      "F          H01053  Paroxysmal nocturnal hemoglobinuria\n",
      "E        3A2Z  Acquired haemolytic anaemia, unspecified\n",
      "D      3A4Z  Haemolytic anaemias, unspecified\n",
      "C    3A50  Thalassaemias\n",
      "D      H00228  Thalassemia\n",
      "C    3A51  Sickle cell disorders or other haemoglobinopathies\n",
      "D      H00229  Sickle cell anemia\n",
      "C    Pure red cell aplasia\n",
      "D      3A60  Congenital pure red cell aplasia\n",
      "E        H00237  Diamond-Blackfan anemia\n",
      "D      3A61  Acquired pure red cell aplasia\n",
      "E        H01586  Acquired pure red cell aplasia\n",
      "D      3A6Z  Pure red cell aplasia, unspecified\n",
      "C    3A70  Aplastic anaemia\n",
      "D      H01132  Aplastic anemia\n",
      "D      H00238  Fanconi anemia\n",
      "D      H00439  Shwachman-Diamond syndrome\n",
      "D      H00507  Dyskeratosis congenita\n",
      "D      H00788  Hoyeraal-Hreidarsson syndrome\n",
      "D      H00921  Revesz syndrome\n",
      "D      H02524  Ataxia-pancytopenia syndrome\n",
      "D      H02529  Bone marrow failure syndrome\n",
      "D      H02569  Pulmonary fibrosis and/or bone marrow failure, telomere-related\n",
      "D      H02608  Autoinflammatory-pancytopenia syndrome\n",
      "C    3A71  Anaemia due to chronic disease\n",
      "D      H01642  Renal anemia\n",
      "C    3A72  Sideroblastic anaemia\n",
      "D      H00982  Sideroblastic anemia\n",
      "D      H00898  Myopathy with lactic acidosis and sideroblastic anaemia\n",
      "C    3A73  Congenital dyserythropoietic anaemia\n",
      "D      H00917  Congenital dyserythropoietic anemia\n",
      "C    Polycythaemia\n",
      "D      3A80  Congenital polycythaemia\n",
      "E        H00236  Congenital polycythemia\n",
      "D      3A81  Acquired polycythaemia\n",
      "D      3A8Z  Polycythaemia, unspecified\n",
      "C    3A90  Anaemia due to acute disease\n",
      "C    3A91  Congenital methaemoglobinaemia\n",
      "D      H00235  Methemoglobinemia\n",
      "C    3A92  Hereditary methaemoglobinaemia\n",
      "D      H00235  Methemoglobinemia\n",
      "C    3A93  Acquired methaemoglobinaemia\n",
      "C    3A94  Acute posthaemorrhagic anaemia\n",
      "C    3A9Y  Other specified anaemias or erythrocyte disorders\n",
      "C    3A9Z  Anaemias or other erythrocyte disorders, unspecified\n",
      "B  Coagulation defects, purpura or other haemorrhagic or related conditions\n",
      "C    Coagulation defects\n",
      "D      Congenital or constitutional haemorrhagic condition\n",
      "E        3B10  Hereditary factor VIII deficiency\n",
      "F          H00219  Hemophilia\n",
      "E        3B11  Hereditary factor IX deficiency\n",
      "F          H00219  Hemophilia\n",
      "E        3B12  Von Willebrand disease\n",
      "F          H00219  Hemophilia\n",
      "F          H02092  von Willebrand disease\n",
      "E        3B13  Haemophilia C\n",
      "F          H00938  Factor XI deficiency\n",
      "E        3B14  Other inherited coagulation factor deficiency with bleeding tendency\n",
      "F          H01254  Congenital prothrombin deficiency\n",
      "F          H00222  Afibrinogenemia\n",
      "F          H02257  Factor X deficiency\n",
      "F          H00995  Combined deficiency of vitamin K-dependent clotting factors\n",
      "F          H02256  Factor VII deficiency\n",
      "F          H00220  Factor V deficiency\n",
      "F          H00221  Combined deficiency of factors V and VIII\n",
      "F          H00945  Factor XIII deficiency\n",
      "E        3B15  Inherited coagulation factor deficiency without bleeding tendency\n",
      "F          H00941  Factor XII deficiency\n",
      "F          H01078  Fletcher factor deficiency\n",
      "E        3B1Z  Congenital or constitutional haemorrhagic condition, unspecified\n",
      "D      Haemorrhagic diseases due to acquired coagulation factor defects\n",
      "E        3B20  Disseminated intravascular coagulation\n",
      "F          H01587  Disseminated intravascular coagulation\n",
      "E        3B21  Haemorrhagic disorder due to circulating anticoagulants and coagulation factors\n",
      "F          H01759  Autoimmune acquired factor XIII (F13) deficiency\n",
      "E        3B22  Acquired haemophilia\n",
      "E        3B2Y  Other specified haemorrhagic diseases due to acquired coagulation factor defects\n",
      "D      3B4Z  Coagulation defects, unspecified\n",
      "C    Fibrinolytic defects\n",
      "D      3B50  Inherited fibrinolytic defects\n",
      "E        H00983  Alpha-2-plasmin inhibitor (a2-PI) deficiency\n",
      "E        H01106  Plasminogen activator inhibitor type 1 deficiency\n",
      "E        H01206  Plasminogen deficiency\n",
      "D      3B51  Acquired fibrinolytic defects\n",
      "C    3B60  Non-thrombocytopenic purpura\n",
      "C    3B61  Thrombophilia\n",
      "D      H00223  Inherited thrombophilia\n",
      "D      H01381  Antithrombin III deficiency\n",
      "C    3B62  Qualitative platelet defects\n",
      "D      H01235  Bleeding disorder platelet-type\n",
      "D      H02097  Gray platelet syndrome\n",
      "D      H00224  Bernard-Soulier syndrome\n",
      "D      H00226  Glanzmann thrombasthenia\n",
      "D      H01523  Wiskott-Aldrich syndrome\n",
      "D      H01162  Scott syndrome\n",
      "D      H02093  Platelet-type von Willebrand disease\n",
      "D      H02259  Stormorken syndrome\n",
      "C    3B63  Thrombocytosis\n",
      "D      H01612  Essential thrombocythemia\n",
      "C    3B64  Thrombocytopenia\n",
      "D      H00978  Thrombocytopenia (THC)\n",
      "D      H00227  Congenital amegakaryocytic thrombocytopenia\n",
      "D      H00233  MYH9-related disease\n",
      "D      H00578  Epstein syndrome\n",
      "D      H00867  Radioulnar synostosis with amegakaryocytic thrombocytopenia\n",
      "D      H01740  Macrothrombocytopenia\n",
      "D      H01847  Thrombocytopenia-absent radius syndrome\n",
      "D      H02052  Sebastian syndrome\n",
      "D      H02053  Fechtner syndrome\n",
      "D      H01240  Immune thrombocytopenia\n",
      "D      H00225  Thrombotic thrombocytopenic purpura\n",
      "C    3B65  Thrombotic microangiopathy, not elsewhere classified\n",
      "C    3B6Y  Other specified coagulation defects, purpura or other haemorrhagic or related conditions\n",
      "C    3B6Z  Coagulation defects, purpura or other haemorrhagic or related conditions, unspecified\n",
      "B  Diseases of spleen\n",
      "C    3B80  Congenital disorders of spleen\n",
      "C    3B81  Acquired disorders of spleen\n",
      "C    3B8Z  Diseases of spleen, unspecified\n",
      "B  3C0Y  Other specified diseases of the blood or blood-forming organs\n",
      "B  3C0Z  Diseases of the blood or blood-forming organs, unspecified\n",
      "A04 Diseases of the immune system\n",
      "B  Primary immunodeficiencies\n",
      "C    4A00  Primary immunodeficiencies due to disorders of innate immunity\n",
      "D      H01725  Primary immunodeficiency disease\n",
      "D      H02525  Disorders of innate immunity\n",
      "D      H02620  Autoinflammation with episodic fever and lymphadenopathy\n",
      "D      H00098  Chronic granulomatous disease\n",
      "D      H01094  Eosinophil peroxidase deficiency\n",
      "D      H02024  Neutrophil specific granule deficiency\n",
      "D      H02025  Myeloperoxidase deficiency\n",
      "D      H00104  Alternative complement pathway component defects\n",
      "D      H00102  Classic complement pathway component defects\n",
      "D      H00103  Late complement pathway defects\n",
      "D      H01006  Hereditary angioedema\n",
      "D      H00105  Mannose-binding lectin pathway component defects\n",
      "D      H00106  Complement regulatory protein defects\n",
      "D      H01136  Carboxypeptidase N deficiency\n",
      "D      H00089  IFN-gamma/IL-12 axis\n",
      "D      H00096  Defects of toll-like receptor signaling\n",
      "D      H00721  Pyogenic bacterial infections, recurrent, due to MYD88 deficiency\n",
      "D      H00090  NK cell defects\n",
      "D      H00097  WHIM syndrome\n",
      "D      H01117  Chronic recurrent multifocal osteomyelitis\n",
      "C    4A01  Primary immunodeficiencies due to disorders of adaptive immunity\n",
      "D      H01725  Primary immunodeficiency disease\n",
      "D      H02526  Disorders of adaptive immunity\n",
      "D      H00085  Agammaglobulinemias\n",
      "D      H02308  Immunodeficiency-centromeric instability-facial anomalies syndrome\n",
      "D      H00086  Hyper IgM syndromes, autosomal recessive type\n",
      "D      H00088  Common variable immunodeficiency\n",
      "D      H00093  Combined immunodeficiency\n",
      "D      H00091  T-B+Severe combined immunodeficiency\n",
      "D      H00092  T-B-Severe combined immunodeficiency\n",
      "D      H01128  Reticular dysgenesis\n",
      "D      H01244  T+B+Severe combined immunodeficiencies (SCIDs)\n",
      "D      H02309  Adenosine deaminase deficiency\n",
      "D      H02554  Omenn syndrome\n",
      "D      H00984  Bare lymphocyte syndrome type1\n",
      "D      H00985  Bare lymphocyte syndrome type2\n",
      "D      H00087  Other humoral immunodeficiencies\n",
      "D      H00924  Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation\n",
      "D      H01181  T-cell immunodeficiency congenital alopecia and nail dystrophy\n",
      "D      H01387  Activated PI3K-delta syndrome\n",
      "D      H02015  LIG4 syndrome\n",
      "D      H02133  Vici syndrome\n",
      "D      H02585  Roifman-Chitayat syndrome\n",
      "D      H01971  IPEX syndrome\n",
      "D      H00108  Autoimmune lymphoproliferative syndromes\n",
      "D      H01969  X-linked lymphoproliferative syndrome\n",
      "D      H01970  Lymphoproliferative syndrome\n",
      "D      H00109  Familial hemophagocytic lymphohistiocytosis\n",
      "D      H02491  Immunoskeletal dysplasia with neurodevelopmental abnormalities\n",
      "D      H02574  BILU syndrome\n",
      "D      H00064  Ataxia telangiectasia\n",
      "D      H00094  Immunodeficiency associated with DNA repair defects\n",
      "D      H00962  RIDDLE syndrome\n",
      "D      H01344  Nijmegen breakage syndrome\n",
      "D      H01346  Bloom syndrome\n",
      "D      H02014  Ataxia-telangiectasia-like syndrome\n",
      "D      H00580  Schimke immunoosseous dysplasia\n",
      "D      H01264  Hepatic venoocclusive disease with immunodeficiency\n",
      "D      H01968  Hyper-IgE syndrome\n",
      "C    4A0Y  Other specified primary immunodeficiencies\n",
      "D      H01245  Immunodeficiency without anhidrotic ectodermal dysplasia\n",
      "C    4A0Z  Primary immunodeficiencies, unspecified\n",
      "B  4A20  Acquired immunodeficiencies\n",
      "C    H00406  Acquired immunodeficiency syndrome (AIDS)\n",
      "B  Nonorgan specific systemic autoimmune disorders\n",
      "C    4A40  Lupus erythematosus\n",
      "D      H00080  Systemic lupus erythematosus\n",
      "D      H01500  Lupus nephritis\n",
      "C    4A41  Idiopathic inflammatory myopathy\n",
      "D      H01604  Polymyositis and dermatomyositis\n",
      "D      H01229  Inclusion body myopathy 3\n",
      "D      H01505  Inclusion body myositis\n",
      "D      H02031  Inclusion body myopathy with Paget disease of bone and frontotemporal dementia\n",
      "C    4A42  Systemic sclerosis\n",
      "D      H01492  Systemic sclerosis\n",
      "C    4A43  Overlap or undifferentiated nonorgan specific systemic autoimmune disease\n",
      "D      H01761  Immunoglobulin G4-related disease\n",
      "D      H01502  Sjogren syndrome\n",
      "D      H01710  Mixed connective tissue disease\n",
      "D      H01693  Eosinophilic fasciitis\n",
      "D      H01133  Reynolds syndrome\n",
      "D      H01232  Syndromic multisystem autoimmune disease\n",
      "D      H02540  Infantile-onset multisystem autoimmune disease\n",
      "C    4A44  Vasculitis\n",
      "D      H01698  Giant cell arteritis\n",
      "D      H01382  Polyarteritis nodosa\n",
      "D      H01718  Kawasaki disease\n",
      "D      H01625  Buerger disease\n",
      "D      H01584  IgA vasculitis\n",
      "D      H01767  Henoch-Schonlein purpura nephritis\n",
      "D      H01658  Microscopic polyangiitis\n",
      "D      H01655  Granulomatosis with polyangiitis\n",
      "D      H01468  Eosinophilic granulomatosis with polyangiitis\n",
      "D      H01465  Large-vessel vasculitis\n",
      "C    4A45  Antiphospholipid syndrome\n",
      "D      H01697  Antiphospholipid syndrome\n",
      "C    4A4Y  Other specified nonorgan specific systemic autoimmune disorders\n",
      "D      H02537  Autoinflammation, immune dysregulation, and eosinophilia\n",
      "D      H02621  X-linked systemic autoinflammatory disease\n",
      "C    4A4Z  Nonorgan specific systemic autoimmune disorders, unspecified\n",
      "B  Autoinflammatory disorders\n",
      "C    4A60  Monogenic autoinflammatory syndromes\n",
      "D      H02588  NLRP1-associated autoinflammation with arthritis and dyskeratosis\n",
      "D      H02589  Periodic fever, immunodeficiency, and thrombocytopenia syndrome\n",
      "D      H02591  Interleukin-18 binding protein deficiency\n",
      "D      H02592  Familial Behcet-like autoinflammatory syndrome\n",
      "D      H02593  Chronic mucocutaneous ulceration\n",
      "D      H02599  Inherited autoinflammatory disease\n",
      "D      H00288  Familial Mediterranean fever\n",
      "D      H00282  Cryopyrin associated periodic syndrome\n",
      "D      H02159  Familial cold autoinflammatory syndrome\n",
      "D      H02555  Muckle-Wells syndrome\n",
      "D      H02556  CINCA syndrome\n",
      "D      H00912  Tumor necrosis factor receptor-associated periodic syndrome\n",
      "D      H00285  Blau syndrome\n",
      "D      H00287  Pyogenic sterile arthritis, pyoderma gangrenosum, and acne syndrome\n",
      "D      H01743  Autoinflammation and PLCG2-associated antibody deficiency and immune dysregulation\n",
      "D      H01744  Polyglucosan body myopathy\n",
      "D      H02414  Autoinflammation, panniculitis, and dermatosis syndrome\n",
      "D      H02467  Neonatal inflammatory skin and bowel disease\n",
      "D      H02532  Proteasome-associated autoinflammatory syndrome\n",
      "D      H02561  Familial autoinflammatory syndrome with or without immunodeficiency\n",
      "C    4A61  SAPHO syndrome\n",
      "C    4A62  Behçet disease\n",
      "D      H01476  Behcet disease\n",
      "C    4A6Y  Other specified autoinflammatory disorders\n",
      "D      H01748  NLRC4 inflammasomopathy\n",
      "C    4A6Z  Autoinflammatory disorders, unspecified\n",
      "B  Allergic or hypersensitivity conditions\n",
      "C    4A80  Allergic or hypersensitivity disorders involving the respiratory tract\n",
      "C    4A81  Allergic or hypersensitivity disorders involving the eye\n",
      "C    4A82  Allergic or hypersensitivity disorders involving skin or mucous membranes\n",
      "C    4A83  Allergic or hypersensitivity disorders involving the gastrointestinal tract\n",
      "D      H01782  Eosinophilic gastrointestinal disorder\n",
      "C    4A84  Anaphylaxis\n",
      "D      H01359  Anaphylaxis\n",
      "C    4A85  Complex allergic or hypersensitivity conditions\n",
      "C    4A8Y  Allergic or hypersensitivity conditions of other specified type\n",
      "C    4A8Z  Allergic or hypersensitivity conditions of unspecified type\n",
      "B  Immune system disorders involving white cell lineages\n",
      "C    4B00  Disorders of neutrophil number\n",
      "D      H00100  Neutropenic disorders\n",
      "D      H00939  Darsun syndrome\n",
      "D      H01218  P14 deficiency\n",
      "C    4B01  Disorders of neutrophil function\n",
      "C    4B02  Eosinopenia\n",
      "C    4B03  Eosinophilia\n",
      "C    4B04  Disorders with decreased monocyte counts\n",
      "C    4B05  Disorders with increased monocyte counts\n",
      "C    4B06  Acquired lymphopenia\n",
      "C    4B07  Acquired lymphocytosis\n",
      "C    4B0Y  Other specified immune system disorders involving white cell lineages\n",
      "D      H00234  Pelger-Huet anomaly\n",
      "D      H02051  May-Hegglin anomaly\n",
      "C    4B0Z  Immune system disorders involving white cell lineages, unspecified\n",
      "B  Certain disorders involving the immune system\n",
      "C    4B20  Sarcoidosis\n",
      "D      H01309  Sarcoidosis, early-onset\n",
      "C    4B21  Polyclonal hypergammaglobulinaemia\n",
      "C    4B22  Cryoglobulinaemia\n",
      "C    4B23  Immune reconstitution inflammatory syndrome\n",
      "C    4B24  Graft-versus-host disease\n",
      "D      H00084  Graft-versus-host disease\n",
      "C    4B2Y  Other specified disorders involving the immune system\n",
      "D      H01479  Castleman disease\n",
      "B  4B40  Diseases of thymus\n",
      "B  4B4Y  Other specified diseases of the immune system\n",
      "B  4B4Z  Diseases of the immune system, unspecified\n",
      "A05 Endocrine, nutritional or metabolic diseases\n",
      "B  Endocrine diseases\n",
      "C    Disorders of the thyroid gland or thyroid hormones system\n",
      "D      5A00  Hypothyroidism\n",
      "E        H01186  Abnormal thyroid hormone metabolism\n",
      "E        H00251  Thyroid dyshormonogenesis\n",
      "E        H00249  Thyroid hormone resistance syndrome\n",
      "E        H00250  Congenital nongoitrous hypothyroidism (CHNG)\n",
      "E        H00650  Allan-Herndon-Dudley syndrome\n",
      "E        H01040  Bamforth-Lazarus syndrome\n",
      "D      5A01  Nontoxic goitre\n",
      "D      5A02  Thyrotoxicosis\n",
      "E        H01269  Congenital hyperthyroidism\n",
      "E        H01645  Hyperthyroidism\n",
      "E        H00082  Graves disease\n",
      "E        H02402  Thyroid eye disease\n",
      "D      5A03  Thyroiditis\n",
      "E        H01647  Subacute thyroiditis\n",
      "E        H00081  Hashimoto thyroiditis\n",
      "D      5A04  Hypersecretion of calcitonin\n",
      "D      5A05  Generalised resistance to thyroid hormone\n",
      "D      5A06  Sick-euthyroid syndrome\n",
      "D      5A0Y  Other specified disorders of the thyroid gland or thyroid hormones system\n",
      "D      5A0Z  Disorders of the thyroid gland or thyroid hormones system, unspecified\n",
      "C    Diabetes mellitus\n",
      "D      5A10  Type 1 diabetes mellitus\n",
      "E        H00408  Type 1 diabetes mellitus\n",
      "E        H01224  Ketosis-prone diabetes mellitus\n",
      "D      5A11  Type 2 diabetes mellitus\n",
      "E        H00409  Type 2 diabetes mellitus\n",
      "D      5A12  Malnutrition-related diabetes mellitus\n",
      "D      5A13  Diabetes mellitus, other specified type\n",
      "E        H00410  Maturity onset diabetes of the young (MODY)\n",
      "E        H01228  Insulin-resistant diabetes mellitus with acanthosis nigricans\n",
      "E        H00766  Wolcott-Rallison syndrome\n",
      "D      5A14  Diabetes mellitus, type unspecified\n",
      "D      Acute complications of diabetes mellitus\n",
      "E        5A20  Diabetic hyperosmolar hyperglycaemic state\n",
      "E        5A21  Hypoglycaemia in the context of diabetes mellitus\n",
      "E        5A22  Diabetic acidosis\n",
      "E        5A23  Diabetic coma\n",
      "E        5A24  Uncontrolled or unstable diabetes mellitus\n",
      "E        5A2Y  Other specified acute complications of diabetes mellitus\n",
      "C    Other disorders of glucose regulation or pancreatic internal secretion\n",
      "D      5A40  Intermediate hyperglycaemia\n",
      "D      5A41  Hypoglycaemia without associated diabetes\n",
      "E        H01909  Hypoinsulinemic hypoglycemia with hemihypertrophy\n",
      "D      5A42  Increased secretion of glucagon\n",
      "D      5A43  Abnormal secretion of gastrin\n",
      "E        H01522  Zollinger-Ellison syndrome\n",
      "D      5A44  Insulin-resistance syndromes\n",
      "E        H00419  Congenital generalized lipodystrophy\n",
      "E        H00420  Familial partial lipodystrophy\n",
      "E        H00719  Leprechaunism\n",
      "E        H00942  Rabson-Mendenhall syndrome\n",
      "E        H01474  Acquired generalized lipodystrophy\n",
      "E        H02384  Abdominal obesity-metabolic syndrome\n",
      "D      5A45  Persistent hyperinsulinaemic hypoglycaemia of infancy\n",
      "E        H01267  Familial hyperinsulinemic hypoglycemia\n",
      "D      5A4Y  Other specified disorders of glucose regulation or pancreatic internal secretion\n",
      "D      5A4Z  Disorders of glucose regulation or pancreatic internal secretion, unspecified\n",
      "C    Disorders of the parathyroids or parathyroid hormone system\n",
      "D      5A50  Hypoparathyroidism\n",
      "E        H01862  Hypoparathyroidism\n",
      "E        H00244  Pseudohypoparathyroidism\n",
      "D      5A51  Hyperparathyroidism\n",
      "E        H00246  Primary hyperparathyroidism\n",
      "E        H01669  Secondary hyperparathyroidism\n",
      "E        H02026  Familial hypocalciuric hypercalcemia\n",
      "E        H02030  Neonatal hyperparathyroidism\n",
      "D      5A5Y  Other specified disorders of the parathyroids or parathyroid hormone system\n",
      "D      5A5Z  Disorders of the parathyroids or parathyroid hormone system, unspecified\n",
      "C    Disorders of the pituitary hormone system\n",
      "D      5A60  Hyperfunction of pituitary gland\n",
      "E        H01683  Disorders of antidiuretic hormone (ADH) secretion\n",
      "E        H01483  Acromegaly\n",
      "E        H01618  Pituitary gigantism\n",
      "E        H01864  Excessive secretion of growth hormone\n",
      "E        H01388  Hyperprolactinemia\n",
      "E        H01682  Syndrome of inappropriate antidiuretic hormone secretion\n",
      "E        H01294  Nephrogenic syndrome of inappropriate antidiuresis\n",
      "E        H00937  Precocious puberty\n",
      "E        H02018  Central precocious puberty\n",
      "E        H01701  Pituitary TSH hypersecretion\n",
      "D      5A61  Hypofunction or certain other specified disorders of pituitary gland\n",
      "E        H01683  Disorders of antidiuretic hormone (ADH) secretion\n",
      "E        H00254  Growth hormone deficiency\n",
      "E        H00931  Growth hormone insensitivity with immunodeficiency\n",
      "E        H01253  Isolated follicle-stimulating hormone deficiency\n",
      "E        H01274  Growth delay due to insulin-like growth factor I resistance\n",
      "E        H01700  Hypopituitarism\n",
      "E        H01907  Acid-labile subunit deficiency\n",
      "E        H01973  Fertile eunuch syndrome\n",
      "E        H02035  Isolated growth hormone deficiency\n",
      "E        H02036  Combined pituitary hormone deficiency\n",
      "E        H02037  Laron syndrome\n",
      "E        H02038  X-linked panhypopituitarism\n",
      "E        H02039  Kowarski syndrome\n",
      "E        H02040  Insulin-like growth factor I deficiency\n",
      "E        H01011  Adrenocorticotropic hormone deficiency\n",
      "E        H00255  Hypogonadotropic hypogonadism\n",
      "E        H01860  Abnormal pituitary gonadotropin secretion\n",
      "E        H01699  Isolated TSH deficiency\n",
      "E        H02034  Central hypothyroidism and testicular enlargement\n",
      "E        H00253  Neurohypophyseal diabetes insipidus\n",
      "E        H00854  Wolfram syndrome\n",
      "E        H00682  Woodhouse-Sakati syndrome\n",
      "D      5A6Z  Disorders of the pituitary hormone system, unspecified\n",
      "C    Disorders of the adrenal glands or adrenal hormone system\n",
      "D      5A70  Cushing syndrome\n",
      "E        H01431  Cushing syndrome\n",
      "E        H00260  Pigmented micronodular adrenocortical disease\n",
      "E        H01820  Carney complex\n",
      "E        H02049  Bilateral macronodular adrenal hyperplasia\n",
      "D      5A71  Adrenogenital disorders\n",
      "E        H01702  Glucocorticoid resistance syndrome\n",
      "E        H00216  Congenital adrenal hyperplasia\n",
      "E        H02315  Disordered steroidogenesis due to cytochrome P450 oxidoreductase\n",
      "E        H01111  Cortisone reductase deficiency\n",
      "D      5A72  Hyperaldosteronism\n",
      "E        H00602  Glucocorticoid-remediable aldosteronism (GRA)\n",
      "E        H01603  Primary aldosteronism\n",
      "E        H00259  Apparent mineralocorticoid excess syndrome\n",
      "D      5A73  Hypoaldosteronism\n",
      "E        H00258  Aldosterone synthase deficiency\n",
      "D      5A74  Adrenocortical insufficiency\n",
      "E        H01598  Addison disease\n",
      "E        H00177  Neonatal adrenoleukodystrophy\n",
      "E        H00256  Familial glucocorticoid deficiency\n",
      "E        H00257  Achalasia Addisonianism Alacrima syndrome\n",
      "E        H02314  Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete\n",
      "E        H02316  Adrenal insufficiency, NR5A1 related\n",
      "E        H02319  IMAGE syndrome\n",
      "D      5A75  Adrenomedullary hyperfunction\n",
      "D      5A76  Certain specified disorders of adrenal gland\n",
      "E        H01163  Corticosteroid-binding globulin (CBG) deficiency\n",
      "D      5A7Z  Disorders of the adrenal glands or adrenal hormone system, unspecified\n",
      "C    Disorders of the gonadal hormone system\n",
      "D      5A80  Ovarian dysfunction\n",
      "E        H01739  Polycystic ovary syndrome\n",
      "D      5A81  Testicular dysfunction or testosterone-related disorders\n",
      "E        H02019  Familial male-limited precocious puberty\n",
      "E        H02027  Male hypogonadism\n",
      "D      5A8Z  Disorders of the gonadal hormone system, unspecified\n",
      "C    Certain disorders of puberty\n",
      "D      5A90  Disorder of puberty due to oestrogen resistance\n",
      "E        H02061  Estrogen resistance syndrome\n",
      "D      5A91  Delayed puberty\n",
      "D      5A92  Peripheral precocious puberty\n",
      "E        H00794  Aromatase excess syndrome\n",
      "E        H00937  Precocious puberty\n",
      "D      5A9Y  Other disorders of puberty\n",
      "E        H02020  Aromatase deficiency\n",
      "D      5A9Z  Disorders of puberty, unspecified\n",
      "C    Polyglandular dysfunction\n",
      "D      5B00  Autoimmune polyendocrinopathy\n",
      "E        H01972  Autoimmune polyendocrinopathy syndrome type 1\n",
      "D      5B01  Polyglandular hyperfunction\n",
      "D      5B0Y  Other specified polyglandular dysfunction\n",
      "D      5B0Z  Polyglandular dysfunction, unspecified\n",
      "C    Endocrine disorders, not elsewhere classified\n",
      "D      5B10  Carcinoid syndrome\n",
      "D      5B11  Short stature, not elsewhere classified\n",
      "D      5B12  Constitutional tall stature\n",
      "D      5B1Y  Other specified endocrine disorders, not elsewhere classified\n",
      "C    5B3Y  Other specified endocrine diseases\n",
      "C    5B3Z  Endocrine diseases, unspecified\n",
      "B  Nutritional disorders\n",
      "C    Undernutrition\n",
      "D      5B50  Underweight in infants, children or adolescents\n",
      "D      5B51  Wasting in infants, children or adolescents\n",
      "D      5B52  Acute malnutrition in infants, children or adolescents\n",
      "D      5B53  Stunting in infants, children or adolescents\n",
      "D      5B54  Underweight in adults\n",
      "D      5B55  Vitamin A deficiency\n",
      "E        H01266  Hypercarotenemia and vitamin A deficiency\n",
      "D      5B56  Vitamin C deficiency\n",
      "E        H01580  Vitamin C deficiency\n",
      "D      5B57  Vitamin D deficiency\n",
      "E        H01143  Vitamin D-dependent rickets\n",
      "D      5B58  Vitamin E deficiency\n",
      "E        H00981  Ataxia with isolated vitamin E deficiency (AVED)\n",
      "D      5B59  Vitamin K deficiency\n",
      "D      5B5A  Vitamin B1 deficiency\n",
      "E        H01566  Beriberi\n",
      "E        H01565  Wernicke encephalopathy\n",
      "D      5B5B  Vitamin B2 deficiency\n",
      "E        H02544  Riboflavin deficiency\n",
      "D      5B5C  Vitamin B3 deficiency\n",
      "E        H01582  Pellagra\n",
      "D      5B5D  Vitamin B6 deficiency\n",
      "D      5B5E  Folate deficiency\n",
      "D      5B5F  Vitamin B12 deficiency\n",
      "D      5B5G  Biotin deficiency\n",
      "D      5B5H  Pantothenic acid deficiency\n",
      "D      5B5J  Choline deficiency\n",
      "D      5B5K  Mineral deficiencies\n",
      "E        H01925  Transient neonatal zinc deficiency\n",
      "D      Sequelae of malnutrition or certain specified nutritional deficiencies\n",
      "E        5B60  Sequelae of protein-energy malnutrition\n",
      "E        5B61  Sequelae of vitamin A deficiency\n",
      "E        5B62  Sequelae of vitamin C deficiency\n",
      "E        5B63  Sequelae of rickets\n",
      "E        5B6Y  Other specified sequelae of malnutrition or certain specified nutritional deficiencies\n",
      "E        5B6Z  Sequelae of malnutrition or certain specified nutritional deficiencies, unspecified\n",
      "D      5B70  Essential fatty acid deficiency\n",
      "D      5B71  Protein deficiency\n",
      "D      5B7Y  Other specified undernutrition\n",
      "D      5B7Z  Unspecified undernutrition\n",
      "C    Overweight, obesity or specific nutrient excesses\n",
      "D      Overweight or obesity\n",
      "E        5B80  Overweight or localised adiposity\n",
      "E        5B81  Obesity\n",
      "F          H02059  Leptin deficiency\n",
      "F          H02060  Leptin receptor deficiency\n",
      "F          H02105  Prohormone convertase 1/3 deficiency\n",
      "F          H02106  Genetic obesity\n",
      "F          H02235  Morbid obesity and spermatogenic failure\n",
      "D      Certain specified nutrient excesses\n",
      "E        5B90  Vitamin excesses\n",
      "F          H01266  Hypercarotenemia and vitamin A deficiency\n",
      "E        5B91  Mineral excesses\n",
      "E        5B9Y  Other specified nutrient excesses\n",
      "E        5B9Z  Certain specified nutrient excesses, unspecified\n",
      "D      5C1Y  Other specified overweight, obesity or specific nutrient excesses\n",
      "D      5C1Z  Overweight, obesity or specific nutrient excesses, unspecified\n",
      "C    5C3Y  Other specified nutritional disorders\n",
      "C    5C3Z  Nutritional disorders, unspecified\n",
      "B  Metabolic disorders\n",
      "C    Inborn errors of metabolism\n",
      "D      5C50  Inborn errors of amino acid or other organic acid metabolism\n",
      "E        H00167  Phenylketonuria\n",
      "E        H02419  Glycine encephalopathy with normal serum glycine\n",
      "E        H00163  Alkaptonuria\n",
      "E        H00165  Tyrosinemia\n",
      "E        H00171  Histidinemia\n",
      "E        H01233  Urocanase deficiency\n",
      "E        H01583  Hydroxykynureninuria\n",
      "E        H02545  Hypertryptophanemia\n",
      "E        H00188  Hyperlysinemia\n",
      "E        H01242  Saccharopinuria\n",
      "E        H02644  Alpha-aminoadipic and alpha-ketoadipic aciduria\n",
      "E        H02313  5-Oxoprolinase deficiency\n",
      "E        H01079  3-Phosphoglycerate dehydrogenase (3-PGDH) deficiency\n",
      "E        H01082  Phosphoserine aminotransferase deficiency\n",
      "E        H02116  Phosphoserine phosphatase deficiency\n",
      "E        H01003  Dimethylglycine dehydrogenase deficiency\n",
      "E        H00191  Nonketotic hyperglycinemia\n",
      "E        H02380  D-glyceric aciduria\n",
      "E        H00190  Hyperprolinemia\n",
      "E        H00187  Ornithine transcarbamylase deficiency\n",
      "E        H00189  Ornithinaemia\n",
      "E        H01398  Primary hyperammonemia (Urea cycle disorders)\n",
      "E        H01400  Secondary hyperammonemia\n",
      "E        H01028  Argininosuccinic aciduria\n",
      "E        H00164  Carbamoyl phosphate synthetase I deficiency\n",
      "E        H00186  Hyperargininemia\n",
      "E        H00185  Citrullinemia\n",
      "E        H01032  N-acetylglutamate synthase deficiency\n",
      "E        H01268  Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome\n",
      "E        H00182  Cystathioninuria\n",
      "E        H00183  Homocystinuria\n",
      "E        H00184  Hypermethioninemia\n",
      "E        H01237  Sulfite oxidase deficiency\n",
      "E        H01285  Methylcobalamin deficiency type G\n",
      "E        H02311  Molybdenum cofactor deficiency\n",
      "E        H02485  Extraoral halitosis due to MTO deficiency\n",
      "E        H00172  Maple syrup urine disease\n",
      "E        H01076  Beta-ketothiolase deficiency\n",
      "E        H01279  Isobutyryl-CoA dehydrogenase deficiency\n",
      "E        H02136  Branched-chain ketoacid dehydrogenase kinase deficiency\n",
      "E        H02285  Methylmalonate semialdehyde dehydrogenase deficiency\n",
      "E        H02546  Hypervalinemia and hyperleucine-isoleucinemia\n",
      "E        H01349  Methacrylic aciduria\n",
      "E        H00173  Isovaleric acidemia\n",
      "E        H00174  Methylmalonic aciduria\n",
      "E        H00175  Propionic acidemia\n",
      "E        H00180  Holocarboxylase synthetase deficiency\n",
      "E        H00181  3-Methylcrotonylglycinuria\n",
      "E        H00375  SBCAD deficiency\n",
      "E        H00754  3-Methylglutaconic aciduria\n",
      "E        H01182  Biotinidase deficiency\n",
      "E        H02221  Methylmalonic aciduria and homocystinuria\n",
      "E        H02222  Methylmalonic acidemia and hyperhomocysteinemia, cblX type\n",
      "E        H00074  Canavan disease\n",
      "E        H00178  Glutaric acidemia\n",
      "E        H00835  Succinic semialdehyde dehydrogenase deficiency\n",
      "E        H01146  Aminoacylase 1 deficiency\n",
      "E        H01225  D-2-hydroxyglutaric aciduria\n",
      "E        H01280  L-2-hydroxyglutaric aciduria\n",
      "E        H01283  Malonyl-CoA decarboxylase deficiency\n",
      "E        H02304  Combined D-2- and L-2-hydroxyglutaric aciduria\n",
      "E        H02109  Combined malonic and methylmalonic aciduria\n",
      "E        H01119  Prolidase deficiency\n",
      "E        H01234  Trimethylaminuria\n",
      "E        H00923  Congenital systemic glutamine deficiency\n",
      "E        H01386  Asparagine synthetase deficiency\n",
      "E        H02312  Glutathione synthetase deficiency\n",
      "D      5C51  Inborn errors of carbohydrate metabolism\n",
      "E        H01065  Pentosuria\n",
      "E        H01135  Ribose 5-phosphate isomerase deficiency\n",
      "E        H01189  Transaldolase deficiency\n",
      "E        H02439  Short stature, developmental delay, congenital heart defect\n",
      "E        H02013  Glycerol kinase deficiency\n",
      "E        H00117  Primary hyperoxaluria\n",
      "E        H00069  Glycogen storage disease\n",
      "E        H00150  Danon disease\n",
      "E        H01375  Glucose 6-phosphate dehydrogenase deficiency\n",
      "E        H01760  Hepatic glycogen storage disease\n",
      "E        H01762  Muscle glycogen storage disease\n",
      "E        H01939  Glycogen storage disease type I\n",
      "E        H01940  Glycogen storage disease type II\n",
      "E        H01941  Glycogen storage disease type III\n",
      "E        H01942  Glycogen storage disease type IV\n",
      "E        H01943  Glycogen storage disease type V\n",
      "E        H01944  Glycogen storage disease type VI\n",
      "E        H01945  Glycogen storage disease type VII\n",
      "E        H01946  Glycogen storage disease type XI\n",
      "E        H01947  Fanconi-Bickel syndrome\n",
      "E        H01948  Glycogen storage disease type IX\n",
      "E        H01949  Glycogen storage disease type 0b\n",
      "E        H01950  Glycogen storage disease type 0a\n",
      "E        H01951  Glycogen storage disease type X\n",
      "E        H01952  Glycogen storage disease type XII\n",
      "E        H01953  Glycogen storage disease type XIII\n",
      "E        H01954  Glycogen storage disease type XIV\n",
      "E        H01955  Glycogen storage disease type XV\n",
      "E        H01956  Glycogen storage disease of heart\n",
      "E        H00070  Galactosemia\n",
      "E        H02008  Galactose-1P uridylyltransferase deficiency\n",
      "E        H02009  Galactokinase deficiency\n",
      "E        H02010  Galactose epimerase deficiency\n",
      "E        H00071  Hereditary fructose intolerance\n",
      "E        H00114  Fructose-1,6-bisphosphatase deficiency\n",
      "E        H02567  Sorbitol dehydrogenase deficiency with peripheral neuropathy\n",
      "D      5C52  Inborn errors of lipid metabolism\n",
      "E        H01589  Systemic primary carnitine deficiency\n",
      "E        H01981  Carnitine palmitoyltransferase I deficiency\n",
      "E        H01982  Carnitine palmitoyltransferase II deficiency\n",
      "E        H01983  Carnitine-acylcarnitine translocase deficiency\n",
      "E        H02596  Disorders of carnitine transport and the carnitine cycle\n",
      "E        H00392  VLCAD deficiency\n",
      "E        H00488  MCAD deficiency\n",
      "E        H00489  LCHAD deficiency\n",
      "E        H00525  Disorders of mitochondrial fatty-acid oxidation\n",
      "E        H00925  2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency\n",
      "E        H01352  Mitochondrial trifunctional protein deficiency\n",
      "E        H01364  3-Hydroxyacyl-CoA dehydrogenase deficiency\n",
      "E        H01929  2,4-Dienoyl-CoA reductase deficiency\n",
      "E        H01980  SCAD deficiency\n",
      "E        H02085  Acyl-CoA dehydrogenase 9 deficiency\n",
      "E        H00179  3-Hydroxy-3-methylglutaryl-CoA lyase deficiency\n",
      "E        H01121  Succinyl CoA:3-oxoacid CoA transferase (SCOT) deficiency\n",
      "E        H01123  HMG-CoA synthase deficiency\n",
      "E        H00162  Sjogren-Larsson syndrome\n",
      "E        H02284  Leukotriene C4 synthase deficiency\n",
      "E        H00161  Smith-Lemli-Opitz syndrome\n",
      "E        H00206  Mevalonate kinase deficiency\n",
      "E        H00617  Desmosterolosis\n",
      "E        H01281  Lathosterolosis\n",
      "E        H00151  Cerebrotendinous xanthomatosis\n",
      "E        H00624  Progressive familial intrahepatic cholestasis\n",
      "E        H00628  Congenital bile acid synthesis defect\n",
      "E        H02099  Alpha-methylacyl-CoA racemase deficiency\n",
      "E        H00152  Sitosterolemia\n",
      "E        H00736  Dorfman-Chanarin syndrome\n",
      "E        H01297  Neutral lipid storage disease with myopathy\n",
      "E        H00654  Barth syndrome\n",
      "E        H02527  Lipid storage myopathy due to FLAD1 deficiency\n",
      "D      5C53  Inborn errors of energy metabolism\n",
      "E        H01427  Mitochondrial disease\n",
      "E        H01096  Pyruvate kinase deficiency\n",
      "E        H00072  Pyruvate dehydrogenase complex deficiency\n",
      "E        H01996  Pyruvate dehydrogenase phosphatase deficiency\n",
      "E        H01997  Pyruvate dehydrogenase E1-alpha deficiency\n",
      "E        H01998  Pyruvate dehydrogenase E1-beta deficiency\n",
      "E        H01999  Pyruvate dehydrogenase E2 deficiency\n",
      "E        H02000  Dihydrolipoamide dehydrogenase deficiency\n",
      "E        H02003  Pyruvate dehydrogenase E3-binding protein deficiency\n",
      "E        H00073  Pyruvate carboxylase deficiency\n",
      "E        H02197  Mitochondrial pyruvate carrier deficiency\n",
      "E        H02438  Hyperglycinemia, lactic acidosis, and seizures\n",
      "E        H02520  Phosphoenolpyruvate carboxykinase deficiency\n",
      "E        H01022  Diseases of the tricarboxylic acid cycle\n",
      "E        H02004  Fumarase deficiency\n",
      "E        H02006  Alpha-ketoglutarate dehydrogenase complex deficiency\n",
      "E        H02113  Infantile cerebellar-retinal degeneration\n",
      "E        H02562  Yoon-Bellen neurodevelopmental syndrome\n",
      "E        H00469  Mitochondrial DNA depletion syndrome\n",
      "E        H01389  Alpers syndrome\n",
      "E        H01390  Mitochondrial neurogastrointestinal encephalomyopathy\n",
      "E        H01384  Mitochondrial recessive ataxia syndrome\n",
      "E        H00999  Coenzyme Q10 deficiency\n",
      "E        H00871  Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation\n",
      "E        H01367  Infantile liver failure\n",
      "E        H01354  Leigh syndrome\n",
      "E        H01369  ATP synthase deficiency\n",
      "E        H00473  Mitochondrial complex I deficiency\n",
      "E        H00891  Combined oxidative phosphorylation deficiency\n",
      "E        H00920  Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis\n",
      "E        H01201  Jensen syndrome\n",
      "E        H01368  Cytochrome c oxidase (COX) deficiency\n",
      "E        H01894  Multiple mitochondrial dysfunctions syndrome\n",
      "E        H02005  Mitochondrial complex II deficiency\n",
      "E        H02007  GRACILE syndrome\n",
      "E        H02086  Mitochondrial complex III deficiency\n",
      "E        H01305  Global cerebral hypomyelination\n",
      "E        H01348  Mitochondrial phosphate carrier deficiency\n",
      "E        H00834  Guanidinoacetate methyltransferase deficiency\n",
      "E        H00849  Cerebral creatine deficiency syndrome\n",
      "E        H02181  Idiopathic hyperCKemia\n",
      "E        H02196  X-linked creatine deficiency syndrome\n",
      "E        H01248  Erythrocyte lactate transporter defect\n",
      "E        H01900  Encephalopathy due to defective mitochondrial and peroxisomal fission\n",
      "E        H02518  Neonatal severe encephalopathy with lactic acidosis and brain abnormalities\n",
      "E        H02643  Lipoyltransferase 1 deficiency\n",
      "D      5C54  Inborn errors of glycosylation or other specified protein modification\n",
      "E        H01486  Multiple congenital anomalies-hypotonia-seizures syndrome\n",
      "E        H01487  CHIME syndrome\n",
      "E        H00118  Congenital disorders of glycosylation type I\n",
      "E        H00119  Congenital disorders of glycosylation type II\n",
      "E        H01188  Tn syndrome\n",
      "E        H01193  Familial tumoral calcinosis\n",
      "E        H00996  Amish infantile epilepsy syndrome\n",
      "E        H01127  PIGM-congenital disorder of glycosylation\n",
      "E        H01489  Inherited glycosylphosphatidylinositol deficiencies\n",
      "E        H02451  Congenital disorder of glycosylation with defective fucosylation\n",
      "D      5C55  Inborn errors of purine, pyrimidine or nucleotide metabolism\n",
      "E        H00192  Xanthinuria\n",
      "E        H00194  Lesch-Nyhan syndrome\n",
      "E        H00195  Adenine phosphoribosyltransferase deficiency\n",
      "E        H00196  Phosphoribosylpyrophosphate synthetase superactivity\n",
      "E        H00197  Adenylosuccinate lyase deficiency\n",
      "E        H00964  Thiopurine S-methyltransferase deficiency (TPMT deficiency)\n",
      "E        H00966  AICA-ribosiduria\n",
      "E        H02011  Familial juvenile hyperuricemic nephropathy\n",
      "E        H02237  AMP deaminase deficiency\n",
      "E        H00193  Dihydropyrimidine dehydrogenase deficiency\n",
      "E        H00199  Dihydropyrimidinase deficiency\n",
      "E        H00200  Beta-ureidopropionase deficiency\n",
      "E        H00290  Aicardi-Goutieres syndrome\n",
      "E        H00878  Cystic leukoencephalopathy without megalencephaly\n",
      "E        H02433  Hypomyelination with brainstem and spinal cord involvement and leg spasticity\n",
      "D      5C56  Lysosomal diseases\n",
      "E        H01425  Lysosomal storage disease\n",
      "E        H00423  Sphingolipidosis\n",
      "E        H00124  GM2 gangliosidoses\n",
      "E        H00281  GM1 gangliosidosis\n",
      "E        H00426  Gangliosidosis\n",
      "E        H02016  Tay-Sachs disease\n",
      "E        H02017  Sandhoff disease\n",
      "E        H00125  Fabry disease\n",
      "E        H00127  Metachromatic leukodystrophy\n",
      "E        H00272  Multiple sulfatase deficiency\n",
      "E        H00126  Gaucher disease\n",
      "E        H00136  Niemann-Pick disease type C\n",
      "E        H00137  Niemann-Pick disease type A/B\n",
      "E        H00138  Farber lipogranulomatosis\n",
      "E        H00148  Lysosomal acid lipase deficiency\n",
      "E        H00424  Defects in the degradation of sphingomyelin\n",
      "E        H01239  Combined SAP deficiency\n",
      "E        H02468  Early childhood-onset progressive leukodystrophy\n",
      "E        H00149  Neuronal ceroid lipofuscinosis\n",
      "E        H02275  Batten disease\n",
      "E        H02276  Kufs disease\n",
      "E        H02277  Santavuori-Haltia disease\n",
      "E        H02278  Jansky-Bielschowsky disease\n",
      "E        H02279  Cathepsin D deficiency\n",
      "E        H00422  Glycoproteinoses\n",
      "E        H00143  Mucolipidosis II\n",
      "E        H00144  Mucolipidosis IV\n",
      "E        H02130  Mucolipidosis III\n",
      "E        H00139  alpha-Mannosidosis\n",
      "E        H00140  beta-Mannosidosis\n",
      "E        H00141  Fucosidosis\n",
      "E        H00142  Sialidosis\n",
      "E        H00145  Aspartylglucosaminuria\n",
      "E        H00146  Alpha-N-acetylgalactosaminidase deficiency\n",
      "E        H00276  Galactosialidosis\n",
      "E        H00421  Mucopolysaccharidosis\n",
      "E        H00128  Mucopolysaccharidosis type I\n",
      "E        H00129  Mucopolysaccharidosis type II\n",
      "E        H00123  Mucopolysaccharidosis type IV\n",
      "E        H00131  Mucopolysaccharidosis type VI\n",
      "E        H00130  Mucopolysaccharidosis type III\n",
      "E        H00132  Mucopolysaccharidosis type VII\n",
      "E        H00133  Mucopolysaccharidosis type IX\n",
      "E        H02205  Mucopolysaccharidosis-plus syndrome\n",
      "E        H00147  Sialuria\n",
      "E        H00273  Pycnodysostosis\n",
      "E        H00274  Papillon-Lefevre syndrome\n",
      "E        H00425  Lysosomal cysteine protease deficiencies\n",
      "E        H02128  Defects in lysosomal trafficking\n",
      "D      5C57  Peroxisomal diseases\n",
      "E        H00177  Neonatal adrenoleukodystrophy\n",
      "E        H00205  Peroxisome biogenesis disorder\n",
      "E        H00207  Rhizomelic chondrodysplasia punctata\n",
      "E        H01342  Zellweger syndrome\n",
      "E        H02100  Peroxisomal fatty acyl-CoA reductase 1 disorder\n",
      "E        H00075  Refsum disease\n",
      "E        H00176  Adrenoleukodystrophy\n",
      "E        H00407  Peroxisomal beta-oxidation enzyme deficiency\n",
      "E        H00874  Leukoencephalopathy with dystonia and motor neuropathy\n",
      "E        H02096  Peroxisomal acyl-CoA oxidase deficiency\n",
      "E        H02098  D-bifunctional protein deficiency\n",
      "E        H02099  Alpha-methylacyl-CoA racemase deficiency\n",
      "E        H00203  Acatalasemia\n",
      "D      5C58  Inborn errors of porphyrin or heme metabolism\n",
      "E        H02025  Myeloperoxidase deficiency\n",
      "E        H00208  Hyperbilirubinemia\n",
      "E        H02054  Crigler-Najjar syndrome\n",
      "E        H02055  Gilbert syndrome\n",
      "E        H02056  Dubin-Johnson syndrome\n",
      "E        H00624  Progressive familial intrahepatic cholestasis\n",
      "E        H02192  Benign recurrent intrahepatic cholestasis\n",
      "E        H00950  Arthrogryposis, renal dysfunction, and cholestasis\n",
      "E        H01936  Hyperbiliverdinemia\n",
      "E        H02057  Rotor syndrome\n",
      "E        H01763  Porphyria\n",
      "E        H00202  Hepatic porphyria\n",
      "E        H00201  Erythropoietic porphyria\n",
      "D      5C59  Inborn errors of neurotransmitter metabolism\n",
      "E        H01005  Dopamine beta-hydroxylase deficiency\n",
      "E        H01161  Aromatic L-amino acid decarboxylase deficiency\n",
      "E        H02597  Sepiapterin reductase deficiency\n",
      "E        H00548  Brunner syndrome\n",
      "E        H01257  GABA-transaminase deficiency\n",
      "E        H02432  Butyrylcholinesterase deficiency\n",
      "D      5C5A  Alpha-1-antitrypsin deficiency\n",
      "E        H01103  Alpha-1-antitrypsin deficiency\n",
      "D      5C5Y  Other specified inborn errors of metabolism\n",
      "E        H00967  Adiponectin deficiency\n",
      "E        H01567  Thiamine pyrophosphokinase deficiency\n",
      "E        H02441  HUPRA syndrome\n",
      "D      5C5Z  Inborn errors of metabolism, unspecified\n",
      "C    Disorders of metabolite absorption or transport\n",
      "D      5C60  Disorders of amino acid absorption or transport\n",
      "E        H00692  Lowe syndrome\n",
      "E        H00275  Cystinosis\n",
      "E        H00901  Cystinuria\n",
      "E        H00843  Hartnup disorder\n",
      "E        H00899  Lysinuric protein intolerance\n",
      "E        H00905  Iminoglycinuria\n",
      "E        H00911  Dicarboxylic aminoaciduria\n",
      "E        H01304  Hyperglycinuria\n",
      "D      5C61  Disorders of carbohydrate absorption or transport\n",
      "E        H00115  Congenital sucrase-isomaltase deficiency\n",
      "E        H02090  Trehalase deficiency\n",
      "E        H00836  GLUT1 deficiency syndrome\n",
      "E        H01126  Familial renal glucosuria\n",
      "E        H02575  Lactose intolerance, adult type\n",
      "E        H00116  Congenital lactase deficiency\n",
      "E        H01261  Congenital glucose-galactose malabsorption\n",
      "D      5C62  Disorders of lipid absorption or transport\n",
      "E        H02330  Pancreatic lipase deficiency\n",
      "D      5C63  Disorders of vitamin or non-protein cofactor absorption or transport\n",
      "E        H01252  Hereditary folate malabsorption\n",
      "E        H01262  Formiminotransferase deficiency\n",
      "E        H01295  Neurodegeneration due to cerebral folate transport deficiency\n",
      "E        H00214  Hypophosphatemic rickets\n",
      "E        H02139  Autosomal recessive hypophosphatemic rickets\n",
      "E        H02141  Autosomal dominant hypophosphatemic rickets\n",
      "E        H02142  X-linked recessive hypophosphatemic rickets\n",
      "E        H02143  X-linked dominant hypophosphatemic rickets\n",
      "E        H01124  Pyridoxamine-5'-phosphate oxidase (PNPO) deficiency\n",
      "E        H01183  Thiamine-responsive megaloblastic anemia\n",
      "E        H01231  Biotin-responsive basal ganglia disease\n",
      "D      5C64  Disorders of mineral absorption or transport\n",
      "E        H00210  Wilson disease\n",
      "E        H00209  Menkes syndrome\n",
      "E        H00833  Neurodegeneration with brain iron accumulation\n",
      "E        H02207  Kufor-Rakeb syndrome\n",
      "E        H02208  Pantothenate kinase-associated neurodegeneration\n",
      "E        H02209  HARP syndrome\n",
      "E        H00211  Hemochromatosis\n",
      "E        H00212  Acrodermatitis enteropathica\n",
      "E        H02550  Birk-Landau-Perez syndrome\n",
      "E        H00213  Hypophosphatasia\n",
      "E        H01113  Acid phosphatase deficiency\n",
      "E        H02138  Hereditary hypophophatemic rickets with hypercalciuria\n",
      "E        H00240  Gitelman syndrome\n",
      "E        H01210  Hypomagnesemia\n",
      "E        H00245  Calcium sensing receptor (CASR) related disease\n",
      "E        H01371  Hypercalcemia infantile\n",
      "E        H01938  Hypermanganesemia with dystonia\n",
      "D      5C6Y  Other specified disorders of metabolite absorption or transport\n",
      "D      5C6Z  Disorders of metabolite absorption or transport, unspecified\n",
      "C    Disorders of fluid, electrolyte or acid-base balance\n",
      "D      5C70  Volume depletion\n",
      "D      5C71  Hyperosmolality or hypernatraemia\n",
      "D      5C72  Hypo-osmolality or hyponatraemia\n",
      "D      5C73  Acidosis\n",
      "D      5C74  Alkalosis\n",
      "D      5C75  Mixed disorder of acid-base balance\n",
      "D      5C76  Hyperkalaemia\n",
      "D      5C77  Hypokalaemia\n",
      "D      5C78  Fluid overload\n",
      "D      5C7Y  Other specified disorders of fluid, electrolyte or acid-base balance\n",
      "D      5C7Z  Disorders of fluid, electrolyte or acid-base balance, unspecified\n",
      "C    Disorders of lipoprotein metabolism or certain specified lipidaemias\n",
      "D      5C80  Hyperlipoproteinaemia\n",
      "E        H01101  Combined lipase deficiency\n",
      "E        H01635  Hyperlipidemia\n",
      "E        H00155  Familial hypercholesterolemia\n",
      "E        H01383  Hyperlipoproteinemia type IIa\n",
      "E        H01918  Familial autosomal recessive hypercholesterolemia\n",
      "E        H00154  Hyperlipoproteinemia, type I\n",
      "E        H00157  Hyperlipoproteinemia, type V\n",
      "E        H01637  Hypertriglyceridemia\n",
      "E        H01784  Primary hyperchylomicronemia\n",
      "E        H00153  Familial combined hyperlipidemia\n",
      "E        H00156  Hyperlipoproteinemia, type III\n",
      "E        H01199  Hyperalphalipoproteinemia\n",
      "E        H01108  CD36 deficiency\n",
      "E        H02329  Hepatic lipase deficiency\n",
      "D      5C81  Hypolipoproteinaemia\n",
      "E        H00159  Tangier disease\n",
      "E        H00930  Hypoalphalipoproteinemia\n",
      "E        H00160  Abetalipoproteinemia\n",
      "E        H00927  Chylomicron retention disease\n",
      "E        H01270  Familial hypobetalipoproteinemia\n",
      "E        H00158  Lecithin:cholesterol acyltransferase deficiency\n",
      "D      5C8Y  Other specified disorders of lipoprotein metabolism or lipidaemias\n",
      "D      5C8Z  Unspecified disorders of lipoprotein metabolism or lipidaemias\n",
      "C    5C90  Metabolic or transporter liver disease\n",
      "C    Other metabolic disorders\n",
      "D      5D00  Amyloidosis\n",
      "E        H01185  Cerebral amyloid angiopathy\n",
      "E        H01217  Primary localized cutaneous amyloidosis\n",
      "E        H02499  AL amyloidosis\n",
      "E        H00845  Familial amyloidosis\n",
      "E        H02484  X-linked reticulate pigmentary disorder with systemic manifestations\n",
      "E        H02322  Amyloidosis, Finnish type\n",
      "D      5D01  Tumour lysis syndrome\n",
      "D      5D0Y  Other specified metabolic disorders\n",
      "C    5D2Z  Metabolic disorders, unspecified\n",
      "B  Postprocedural endocrine or metabolic disorders\n",
      "C    5D40  Postprocedural hypothyroidism\n",
      "C    5D41  Postprocedural hypoinsulinaemia\n",
      "C    5D42  Postprocedural hypoparathyroidism\n",
      "C    5D43  Postprocedural hypopituitarism\n",
      "C    5D44  Postprocedural ovarian failure\n",
      "C    5D45  Postprocedural testicular hypofunction\n",
      "C    5D46  Postprocedural adrenocortical hypofunction\n",
      "A06 Mental, behavioural or neurodevelopmental disorders\n",
      "B  Neurodevelopmental disorders\n",
      "C    6A00  Disorders of intellectual development\n",
      "D      H00480  X-linked intellectual developmental disorder\n",
      "D      H00658  X-linked syndromic intellectual developmental disorder\n",
      "D      H00768  Autosomal recessive intellectual developmental disorder\n",
      "D      H00773  Autosomal dominant intellectual developmental disorder\n",
      "D      H01306  FRA12A mental retardation\n",
      "D      H01911  Syndromic autosomal recessive mental retardation\n",
      "D      H02463  Syndromic intellectual developmental disorder\n",
      "C    6A01  Developmental speech or language disorders\n",
      "D      H00902  Speech-language disorder 1\n",
      "C    6A02  Autism spectrum disorder\n",
      "D      H02111  Autism\n",
      "D      H01882  Asperger syndrome\n",
      "D      H02371  Intellectual developmental disorder with autism and speech delay\n",
      "D      H02507  Pilarowski-Bjornsson syndrome\n",
      "C    6A03  Developmental learning disorder\n",
      "C    6A04  Developmental motor coordination disorder\n",
      "C    6A05  Attention deficit hyperactivity disorder\n",
      "D      H01895  Attention deficit hyperactivity disorder (ADHD)\n",
      "C    6A06  Stereotyped movement disorder\n",
      "C    6A0Y  Other specified neurodevelopmental disorders\n",
      "D      H02387  Snijders Blok-Fisher syndrome\n",
      "D      H02490  Gabriele-de Vries syndrome\n",
      "D      H02510  Jaberi-Elahi syndrome\n",
      "D      H02521  Diets-Jongmans syndrome\n",
      "D      H02571  Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities\n",
      "C    6A0Z  Neurodevelopmental disorders, unspecified\n",
      "B  Schizophrenia or other primary psychotic disorders\n",
      "C    6A20  Schizophrenia\n",
      "D      H01649  Schizophrenia\n",
      "C    6A21  Schizoaffective disorder\n",
      "C    6A22  Schizotypal disorder\n",
      "C    6A23  Acute and transient psychotic disorder\n",
      "C    6A24  Delusional disorder\n",
      "C    6A25  Symptomatic manifestations of primary psychotic disorders\n",
      "C    6A2Y  Other specified primary psychotic disorder\n",
      "C    6A2Z  Schizophrenia or other primary psychotic disorders, unspecified\n",
      "B  Catatonia\n",
      "C    6A40  Catatonia associated with another mental disorder\n",
      "C    6A41  Catatonia induced by substances or medications\n",
      "C    6A4Z  Catatonia, unspecified\n",
      "B  Mood disorders\n",
      "C    Bipolar or related disorders\n",
      "D      6A60  Bipolar type I disorder\n",
      "E        H01653  Bipolar disorder\n",
      "D      6A61  Bipolar type II disorder\n",
      "E        H01653  Bipolar disorder\n",
      "D      6A62  Cyclothymic disorder\n",
      "D      6A6Y  Other specified bipolar or related disorders\n",
      "D      6A6Z  Bipolar or related disorders, unspecified\n",
      "C    Depressive disorders\n",
      "D      6A70  Single episode depressive disorder\n",
      "E        H01646  Major depressive disorder\n",
      "D      6A71  Recurrent depressive disorder\n",
      "E        H01646  Major depressive disorder\n",
      "D      6A72  Dysthymic disorder\n",
      "D      6A73  Mixed depressive and anxiety disorder\n",
      "D      6A7Y  Other specified depressive disorders\n",
      "D      6A7Z  Depressive disorders, unspecified\n",
      "C    6A80  Symptomatic and course presentations for mood episodes in mood disorders\n",
      "C    6A8Y  Other specified mood disorders\n",
      "C    6A8Z  Mood disorders, unspecified\n",
      "B  Anxiety or fear-related disorders\n",
      "C    6B00  Generalised anxiety disorder\n",
      "D      H01662  Generalized anxiety disorder\n",
      "C    6B01  Panic disorder\n",
      "D      H01664  Panic disorder\n",
      "C    6B02  Agoraphobia\n",
      "C    6B03  Specific phobia\n",
      "C    6B04  Social anxiety disorder\n",
      "D      H01670  Social anxiety disorder\n",
      "C    6B05  Separation anxiety disorder\n",
      "C    6B06  Selective mutism\n",
      "C    6B0Y  Other specified anxiety or fear-related disorders\n",
      "C    6B0Z  Anxiety or fear-related disorders, unspecified\n",
      "B  Obsessive-compulsive or related disorders\n",
      "C    6B20  Obsessive-compulsive disorder\n",
      "D      H01450  Obsessive-compulsive disorder\n",
      "C    6B21  Body dysmorphic disorder\n",
      "D      H01447  Body dysmorphic disorder\n",
      "C    6B22  Olfactory reference disorder\n",
      "C    6B23  Hypochondriasis\n",
      "C    6B24  Hoarding disorder\n",
      "D      H01448  Hoarding disorder\n",
      "C    6B25  Body-focused repetitive behaviour disorders\n",
      "D      H00864  Trichotillomania\n",
      "D      H01449  Excoriation disorder\n",
      "C    6B2Y  Other specified obsessive-compulsive or related disorders\n",
      "C    6B2Z  Obsessive-compulsive or related disorders, unspecified\n",
      "D      H01453  Obsessive-Compulsive and Related Disorder\n",
      "B  Disorders specifically associated with stress\n",
      "C    6B40  Post traumatic stress disorder\n",
      "C    6B41  Complex post traumatic stress disorder\n",
      "C    6B42  Prolonged grief disorder\n",
      "C    6B43  Adjustment disorder\n",
      "C    6B44  Reactive attachment disorder\n",
      "C    6B45  Disinhibited social engagement disorder\n",
      "C    6B4Y  Other specified disorders specifically associated with stress\n",
      "C    6B4Z  Disorders specifically associated with stress, unspecified\n",
      "B  Dissociative disorders\n",
      "C    6B60  Dissociative neurological symptom disorder\n",
      "C    6B61  Dissociative amnesia\n",
      "C    6B62  Trance disorder\n",
      "C    6B63  Possession trance disorder\n",
      "C    6B64  Dissociative identity disorder\n",
      "C    6B65  Partial dissociative identity disorder\n",
      "C    6B66  Depersonalization-derealization disorder\n",
      "C    6B6Y  Other specified dissociative disorders\n",
      "C    6B6Z  Dissociative disorders, unspecified\n",
      "B  Feeding or eating disorders\n",
      "C    6B80  Anorexia Nervosa\n",
      "C    6B81  Bulimia Nervosa\n",
      "C    6B82  Binge eating disorder\n",
      "C    6B83  Avoidant-restrictive food intake disorder\n",
      "C    6B84  Pica\n",
      "C    6B85  Rumination-regurgitation disorder\n",
      "C    6B8Y  Other specified feeding or eating disorders\n",
      "D      H01703  Eating Disorders\n",
      "C    6B8Z  Feeding or eating disorders, unspecified\n",
      "B  Elimination disorders\n",
      "C    6C00  Enuresis\n",
      "C    6C01  Encopresis\n",
      "C    6C0Z  Elimination disorders, unspecified\n",
      "B  Disorders of bodily distress or bodily experience\n",
      "C    6C20  Bodily distress disorder\n",
      "C    6C21  Body integrity dysphoria\n",
      "C    6C2Y  Other specified disorders of bodily distress or bodily experience\n",
      "C    6C2Z  Disorders of bodily distress or bodily experience, unspecified\n",
      "B  Disorders due to substance use or addictive behaviours\n",
      "C    Disorders due to substance use\n",
      "D      6C40  Disorders due to use of alcohol\n",
      "E        H01611  Alcohol dependence\n",
      "E        H01071  Acute alcohol sensitivity\n",
      "D      6C41  Disorders due to use of cannabis\n",
      "D      6C42  Disorders due to use of synthetic cannabinoids\n",
      "D      6C43  Disorders due to use of opioids\n",
      "D      6C44  Disorders due to use of sedatives, hypnotics or anxiolytics\n",
      "D      6C45  Disorders due to use of cocaine\n",
      "D      6C46  Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone\n",
      "D      6C47  Disorders due to use of synthetic cathinones\n",
      "D      6C48  Disorders due to use of caffeine\n",
      "D      6C49  Disorders due to use of hallucinogens\n",
      "D      6C4A  Disorders due to use of nicotine\n",
      "D      6C4B  Disorders due to use of volatile inhalants\n",
      "D      6C4C  Disorders due to use of MDMA or related drugs, including MDA\n",
      "D      6C4D  Disorders due to use of dissociative drugs including ketamine and phencyclidine [PCP]\n",
      "D      6C4E  Disorders due to use of other specified psychoactive substances, including medications\n",
      "D      6C4F  Disorders due to use of multiple specified psychoactive substances, including medications\n",
      "D      6C4G  Disorders due to use of unknown or unspecified psychoactive substances\n",
      "D      6C4H  Disorders due to use of non-psychoactive substances\n",
      "D      6C4Y  Other specified disorders due to substance use\n",
      "D      6C4Z  Disorders due to substance use, unspecified\n",
      "C    Disorders due to addictive behaviours\n",
      "D      6C50  Gambling disorder\n",
      "D      6C51  Gaming disorder\n",
      "D      6C5Y  Other specified disorders due to addictive behaviours\n",
      "D      6C5Z  Disorders due to addictive behaviours, unspecified\n",
      "B  Impulse control disorders\n",
      "C    6C70  Pyromania\n",
      "C    6C71  Kleptomania\n",
      "C    6C72  Compulsive sexual behaviour disorder\n",
      "C    6C73  Intermittent explosive disorder\n",
      "C    6C7Y  Other specified impulse control disorders\n",
      "C    6C7Z  Impulse control disorders, unspecified\n",
      "B  Disruptive behaviour or dissocial disorders\n",
      "C    6C90  Oppositional defiant disorder\n",
      "C    6C91  Conduct-dissocial disorder\n",
      "C    6C9Y  Other specified disruptive behaviour or dissocial disorders\n",
      "C    6C9Z  Disruptive behaviour or dissocial disorders, unspecified\n",
      "B  Personality disorders and related traits\n",
      "C    6D10  Personality disorder\n",
      "C    6D11  Prominent personality traits or patterns\n",
      "B  Paraphilic disorders\n",
      "C    6D30  Exhibitionistic disorder\n",
      "C    6D31  Voyeuristic disorder\n",
      "C    6D32  Pedophilic disorder\n",
      "C    6D33  Coercive sexual sadism disorder\n",
      "C    6D34  Frotteuristic disorder\n",
      "C    6D35  Other paraphilic disorder involving non-consenting individuals\n",
      "C    6D36  Paraphilic disorder involving solitary behaviour or consenting individuals\n",
      "C    6D3Z  Paraphilic disorders, unspecified\n",
      "B  Factitious disorders\n",
      "C    6D50  Factitious disorder imposed on self\n",
      "C    6D51  Factitious disorder imposed on another\n",
      "C    6D5Z  Factitious disorders, unspecified\n",
      "B  Neurocognitive disorders\n",
      "C    6D70  Delirium\n",
      "C    6D71  Mild neurocognitive disorder\n",
      "C    6D72  Amnestic disorder\n",
      "C    Dementia\n",
      "D      6D80  Dementia due to Alzheimer disease\n",
      "D      6D81  Dementia due to cerebrovascular disease\n",
      "D      6D82  Dementia due to Lewy body disease\n",
      "D      6D83  Frontotemporal dementia\n",
      "D      6D84  Dementia due to psychoactive substances including medications\n",
      "D      6D85  Dementia due to diseases classified elsewhere\n",
      "D      6D86  Behavioural or psychological disturbances in dementia\n",
      "D      6D8Y  Dementia, other specified cause\n",
      "D      6D8Z  Dementia, unknown or unspecified cause\n",
      "C    6E0Y  Other specified neurocognitive disorders\n",
      "C    6E0Z  Neurocognitive disorders, unspecified\n",
      "B  Mental or behavioural disorders associated with pregnancy, childbirth or the puerperium\n",
      "C    6E20  Mental or behavioural disorders associated with pregnancy, childbirth or the puerperium, without psychotic symptoms\n",
      "C    6E21  Mental or behavioural disorders associated with pregnancy, childbirth or the puerperium, with psychotic symptoms\n",
      "C    6E2Z  Mental or behavioural disorders associated with pregnancy, childbirth or the puerperium, unspecified\n",
      "B  6E40  Psychological or behavioural factors affecting disorders or diseases classified elsewhere\n",
      "B  Secondary mental or behavioural syndromes associated with disorders or diseases classified elsewhere\n",
      "C    6E60  Secondary neurodevelopmental syndrome\n",
      "C    6E61  Secondary psychotic syndrome\n",
      "C    6E62  Secondary mood syndrome\n",
      "C    6E63  Secondary anxiety syndrome\n",
      "C    6E64  Secondary obsessive-compulsive or related syndrome\n",
      "C    6E65  Secondary dissociative syndrome\n",
      "C    6E66  Secondary impulse control syndrome\n",
      "C    6E67  Secondary neurocognitive syndrome\n",
      "C    6E68  Secondary personality change\n",
      "C    6E69  Secondary catatonia syndrome\n",
      "C    6E6Y  Other specified secondary mental or behavioural syndrome\n",
      "C    6E6Z  Secondary mental or behavioural syndrome, unspecified\n",
      "B  6E8Y  Other specified mental, behavioural or neurodevelopmental disorders\n",
      "B  6E8Z  Mental, behavioural or neurodevelopmental disorders, unspecified\n",
      "A07 Sleep-wake disorders\n",
      "B  Insomnia disorders\n",
      "C    7A00  Chronic insomnia\n",
      "D      H01609  Insomnia\n",
      "C    7A01  Short-term insomnia\n",
      "D      H01609  Insomnia\n",
      "C    7A0Z  Insomnia disorders, unspecified\n",
      "B  Hypersomnolence disorders\n",
      "C    7A20  Narcolepsy\n",
      "D      H01293  Narcolepsy\n",
      "C    7A21  Idiopathic hypersomnia\n",
      "C    7A22  Kleine-Levin syndrome\n",
      "C    7A23  Hypersomnia due to a medical condition\n",
      "C    7A24  Hypersomnia due to a medication or substance\n",
      "C    7A25  Hypersomnia associated with a mental disorder\n",
      "C    7A26  Insufficient sleep syndrome\n",
      "C    7A2Y  Other specified hypersomnolence disorders\n",
      "C    7A2Z  Hypersomnolence disorders, unspecified\n",
      "B  Sleep-related breathing disorders\n",
      "C    7A40  Central sleep apnoeas\n",
      "C    7A41  Obstructive sleep apnoea\n",
      "C    7A42  Sleep-related hypoventilation or hypoxemia disorders\n",
      "D      H01727  Primary alveolar hypoventilation syndrome\n",
      "D      H01729  Premature ventricular complexes\n",
      "D      H01715  Obesity hypoventilation syndrome\n",
      "D      H00916  Congenital central hypoventilation syndrome\n",
      "C    7A4Y  Other specified sleep-related breathing disorders\n",
      "C    7A4Z  Sleep-related breathing disorders, unspecified\n",
      "B  Circadian rhythm sleep-wake disorders\n",
      "C    7A60  Delayed sleep-wake phase disorder\n",
      "D      H00689  Delayed sleep phase syndrome\n",
      "C    7A61  Advanced sleep-wake phase disorder\n",
      "D      H00688  Familial advanced sleep phase syndrome\n",
      "C    7A62  Irregular sleep-wake rhythm disorder\n",
      "C    7A63  Non-24 hour sleep-wake rhythm disorder\n",
      "C    7A64  Circadian rhythm sleep-wake disorder, shift work type\n",
      "C    7A65  Circadian rhythm sleep-wake disorder, jet lag type\n",
      "C    7A6Z  Circadian rhythm sleep-wake disorders, unspecified\n",
      "B  Sleep-related movement disorders\n",
      "C    7A80  Restless legs syndrome\n",
      "D      H01597  Restless legs syndrome\n",
      "C    7A81  Periodic limb movement disorder\n",
      "C    7A82  Sleep-related leg cramps\n",
      "C    7A83  Sleep-related bruxism\n",
      "C    7A84  Sleep-related rhythmic movement disorder\n",
      "C    7A85  Benign sleep myoclonus of infancy\n",
      "C    7A86  Propriospinal myoclonus at sleep onset\n",
      "C    7A87  Sleep-related movement disorder due to a medical condition\n",
      "C    7A88  Sleep-related movement disorder due to a medication or substance\n",
      "C    7A8Y  Other specified sleep-related movement disorders\n",
      "C    7A8Z  Sleep-related movement disorders, unspecified\n",
      "B  Parasomnia disorders\n",
      "C    7B00  Disorders of arousal from non-REM sleep\n",
      "C    7B01  Parasomnias related to REM sleep\n",
      "C    7B02  Other parasomnias\n",
      "C    7B0Y  Other specified parasomnia disorders\n",
      "C    7B0Z  Parasomnia disorders, unspecified\n",
      "B  7B2Y  Other specified sleep-wake disorders\n",
      "B  7B2Z  Sleep-wake disorders, unspecified\n",
      "A08 Diseases of the nervous system\n",
      "B  Movement disorders\n",
      "C    8A00  Parkinsonism\n",
      "D      H01600  Parkinsonian syndrome\n",
      "D      H00057  Parkinson disease\n",
      "D      H00077  Progressive supranuclear palsy\n",
      "D      H00879  Perry syndrome\n",
      "D      H01574  Familial idiopathic basal ganglia calcification\n",
      "C    8A01  Choreiform disorders\n",
      "D      H00860  Benign hereditary chorea\n",
      "D      H00059  Huntington disease\n",
      "D      H01243  Huntington disease-like syndrome\n",
      "D      H00060  Dentatorubropallidoluysian atrophy (DRPLA)\n",
      "D      H00655  McLeod syndrome\n",
      "D      H00832  Core neuroacanthocytosis syndromes\n",
      "D      H01779  Neuroferritinopathy\n",
      "D      H02367  Chorea, childhood-onset, with psychomotor retardation\n",
      "C    8A02  Dystonic disorders\n",
      "D      H00831  Primary dystonia\n",
      "D      H01255  Juvenile-onset dystonia\n",
      "D      H01608  Cervical dystonia\n",
      "D      H02557  Dopa-responsive dystonia\n",
      "D      H00989  Mohr-Tranebjaerg syndrome\n",
      "C    8A03  Ataxic disorders\n",
      "D      H01616  Spinocerebellar degeneration\n",
      "D      H00067  Friedreich ataxia\n",
      "D      H00749  Episodic ataxias\n",
      "D      H00063  Spinocerebellar ataxia (SCA)\n",
      "D      H01478  Machado-Joseph disease\n",
      "D      H01891  Autosomal recessive spinocerebellar ataxias\n",
      "D      H02573  Autosomal recessive spinocerebellar ataxias with axonal neuropathy\n",
      "D      H00848  Ataxia with ocular apraxia\n",
      "D      H01036  Posterior column ataxia with retinitis pigmentosa\n",
      "D      H01038  Cerebellar ataxia cayman type\n",
      "D      H01170  Autosomal recessive spastic ataxia of Charlevoix-Saguenay\n",
      "D      H01204  Cerebellar ataxia, mental retardation (MR), and dysequilibrium syndrome (CAMRQ)\n",
      "D      H01432  Choreoacanthocytosis\n",
      "D      H02101  Autosomal dominant sensory ataxia\n",
      "D      H02140  Boucher-Neuhauser syndrome\n",
      "D      H02144  Gordon Holmes syndrome\n",
      "D      H02273  Nonprogressive cerebellar ataxia with mental retardation\n",
      "D      H02552  Ataxia, intention tremor, and hypotonia syndrome\n",
      "C    8A04  Disorders associated with tremor\n",
      "D      H01577  Essential tremor\n",
      "C    8A05  Tic disorders\n",
      "D      H00862  Tourette syndrome\n",
      "C    8A06  Myoclonic disorders\n",
      "C    8A07  Certain specified movement disorder\n",
      "D      H01287  Congenital mirror movements\n",
      "D      H01528  Neuroleptic malignant syndrome\n",
      "C    8A0Y  Other specified movement disorders\n",
      "D      H01570  Autosomal dominant striatal degeneration\n",
      "C    8A0Z  Movement disorders, unspecified\n",
      "B  Disorders with neurocognitive impairment as a major feature\n",
      "C    8A20  Alzheimer disease\n",
      "D      H00056  Alzheimer disease\n",
      "C    8A21  Progressive focal atrophies\n",
      "C    8A22  Lewy body disease\n",
      "D      H00066  Lewy body dementia (LBD)\n",
      "C    8A23  Frontotemporal lobar degeneration\n",
      "D      H00078  Frontotemporal lobar degeneration\n",
      "C    8A2Y  Other specified disorders with neurocognitive impairment as a major feature\n",
      "D      H00290  Aicardi-Goutieres syndrome\n",
      "C    8A2Z  Disorders with neurocognitive impairment as a major feature, unspecified\n",
      "B  Multiple sclerosis or other white matter disorders\n",
      "C    8A40  Multiple sclerosis\n",
      "D      H01490  Multiple sclerosis\n",
      "C    8A41  Isolated demyelinating syndromes of the central nervous system\n",
      "C    8A42  Acute disseminated encephalomyelitis\n",
      "C    8A43  Neuromyelitis optica\n",
      "D      H01491  Neuromyelitis optica\n",
      "C    8A44  Leukodystrophies\n",
      "D      H02598  Progressive leukoencephalopathy\n",
      "D      H00176  Adrenoleukodystrophy\n",
      "D      H00065  Alexander disease\n",
      "D      H00438  Nasu-Hakola disease\n",
      "D      H00679  Hypomyelinating leukodystrophy\n",
      "D      H00869  Leukoencephalopathy with vanishing white matter\n",
      "D      H00875  Megaloencephalic leukoencephalopathy with subcortical cysts\n",
      "D      H01230  Adult-onset autosomal dominant leukodystrophy\n",
      "D      H01807  Hereditary diffuse leukoencephalopathy with spheroids\n",
      "D      H02200  Leukoencephalopathy, progressive, with ovarian failure\n",
      "D      H02377  Leukodystrophy and acquired microcephaly with or without dystonia\n",
      "D      H00135  Krabbe disease\n",
      "C    8A45  Secondary white matter disorders\n",
      "D      H01724  HTLV1-associated myelopathy\n",
      "D      H01696  Subacute sclerosing panencephalitis\n",
      "D      H00370  Progressive multifocal leukoencephalopathy\n",
      "C    8A46  Central demyelination of corpus callosum\n",
      "C    8A4Y  Other specified multiple sclerosis or other white matter disorders\n",
      "D      H02457  Developmental delay, leukoencephalopathy, and neurologic decompensation\n",
      "C    8A4Z  Multiple sclerosis or other white matter disorders, unspecified\n",
      "B  Epilepsy or seizures\n",
      "C    8A60  Epilepsy due to structural or metabolic conditions or diseases\n",
      "D      H01826  Mesial temporal lobe epilepsy with hippocampal sclerosis\n",
      "C    8A61  Genetic or presumed genetic syndromes primarily expressed as epilepsy\n",
      "D      H00577  Symptomatic generalized epilepsies\n",
      "D      H00808  Idiopathic generalized epilepsies\n",
      "D      H01247  Pyridoxine-dependent epilepsy\n",
      "D      H01819  Early myoclonic encephalopathy\n",
      "D      H02250  Early-onset vitamin B6-dependent epilepsy\n",
      "D      H00806  Benign familial neonatal seizure\n",
      "D      H01818  Dravet syndrome\n",
      "D      H01815  Malignant migrating partial seizures in infancy\n",
      "D      H01775  PCDH19-related epilepsy syndrome\n",
      "D      H02212  Familial infantile myoclonic epilepsy\n",
      "D      H02215  Childhood absence epilepsy\n",
      "D      H01823  Myoclonic-astatic epilepsy\n",
      "D      H01822  Epilepsy with myoclonic absence\n",
      "D      H01258  Generalized epilepsy and paroxysmal dyskinesia\n",
      "D      H02361  Myoclonic-atonic epilepsy\n",
      "D      H02564  Generalized epilepsy with febrile seizures plus\n",
      "D      H02217  Juvenile myoclonic epilepsy\n",
      "D      H02216  Juvenile absence epilepsy\n",
      "D      H02213  Familial adult myoclonic epilepsy\n",
      "D      H00809  Familial epilepsy temporal lobe (ETL)\n",
      "D      H00810  Progressive myoclonic epilepsy\n",
      "D      H01212  Familial encephalopathy with neuroserpin inclusion bodies\n",
      "D      H01994  Lafora disease\n",
      "D      H01995  Unverricht-Lundborg disease\n",
      "D      H00807  Nocturnal frontal lobe epilepsy\n",
      "D      H00836  GLUT1 deficiency syndrome\n",
      "D      H02214  Familial focal epilepsy with variable foci\n",
      "C    8A62  Epileptic encephalopathies\n",
      "D      H01460  West syndrome\n",
      "D      H01813  Lennox-Gastaut syndrome\n",
      "D      H01514  Landau-Kleffner syndrome\n",
      "D      H00606  Early infantile epileptic encephalopathy\n",
      "D      H01808  Hemiconvulsion-hemiplegia-epilepsy syndrome\n",
      "D      H01812  Rasmussen encephalitis\n",
      "D      H01827  Rolandic epilepsy, mental retardation, and speech dyspraxia\n",
      "D      H01829  Acute encephalitis with refractory repetitive partial seizures\n",
      "D      H02150  Infantile or early childhood epileptic encephalopathy\n",
      "D      H02360  Epileptic encephalopathy, childhood-onset\n",
      "D      H02472  Early-onset progressive encephalopathy\n",
      "C    8A63  Seizure due to acute causes\n",
      "D      H00783  Febrile seizures\n",
      "C    8A64  Single seizure due to remote causes\n",
      "C    8A65  Single unprovoked seizure\n",
      "C    8A66  Status epilepticus\n",
      "C    8A67  Acute repetitive seizures\n",
      "C    8A68  Types of seizures\n",
      "C    8A6Y  Other specified epilepsy or seizures\n",
      "C    8A6Z  Epilepsy or seizures, unspecified\n",
      "B  Headache disorders\n",
      "C    8A80  Migraine\n",
      "D      H00775  Hemiplegic migraine\n",
      "D      H02362  Benign familial infantile seizure\n",
      "C    8A81  Tension-type headache\n",
      "C    8A82  Trigeminal autonomic cephalalgias\n",
      "D      H01588  Cluster headache\n",
      "C    8A83  Other primary headache disorder\n",
      "C    8A84  Secondary headache\n",
      "C    8A85  Painful cranial neuropathies or other facial pains\n",
      "C    8A8Y  Other specified headache disorders\n",
      "C    8A8Z  Headache disorders, unspecified\n",
      "B  Cerebrovascular diseases\n",
      "C    Intracranial haemorrhage\n",
      "D      8B00  Intracerebral haemorrhage\n",
      "D      8B01  Subarachnoid haemorrhage\n",
      "D      8B02  Nontraumatic subdural haemorrhage\n",
      "D      8B03  Nontraumatic epidural haemorrhage\n",
      "D      8B0Z  Intracranial haemorrhage, unspecified\n",
      "C    Cerebral ischaemia\n",
      "D      8B10  Transient ischaemic attack\n",
      "D      8B11  Cerebral ischaemic stroke\n",
      "D      8B1Y  Other specified cerebral ischaemia\n",
      "D      8B1Z  Cerebral ischaemia, unspecified\n",
      "C    8B20  Stroke not known if ischaemic or haemorrhagic\n",
      "C    8B21  Cerebrovascular disease with no acute cerebral symptom\n",
      "C    8B22  Certain specified cerebrovascular diseases\n",
      "D      H01184  Familial dementia\n",
      "D      H00534  Cerebral cavernous malformation\n",
      "D      H01396  Moyamoya disease\n",
      "D      H00536  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL)\n",
      "D      H01757  Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy\n",
      "D      H00877  Brain small vessel disease\n",
      "C    8B23  Cerebrovascular abnormalities\n",
      "C    8B24  Hypoxic-ischaemic encephalopathy\n",
      "C    8B25  Late effects of cerebrovascular disease\n",
      "C    8B26  Vascular syndromes of brain in cerebrovascular diseases\n",
      "D      H01120  Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome\n",
      "C    8B2Z  Cerebrovascular diseases, unspecified\n",
      "B  Spinal cord disorders excluding trauma\n",
      "C    8B40  Cauda equina syndrome\n",
      "C    8B41  Myelitis\n",
      "D      H01863  Atopic myelitis\n",
      "C    8B42  Myelopathy\n",
      "C    8B43  Non-compressive vascular myelopathies\n",
      "C    8B44  Degenerative myelopathic disorders\n",
      "D      H00266  Hereditary spastic paraplegia\n",
      "D      H01351  Spastic ataxia\n",
      "D      H02114  Spastic paraplegia, optic atrophy, and neuropathy\n",
      "D      H02293  Spastic paraplegia-psychomotor retardation-seizures syndrome\n",
      "D      H02178  MASA syndrome\n",
      "D      H01172  Infantile-onset ascending hereditary spastic paralysis\n",
      "C    8B4Y  Other specified spinal cord disorders excluding trauma\n",
      "C    8B4Z  Spinal cord disorders excluding trauma, unspecified\n",
      "B  Motor neuron diseases or related disorders\n",
      "C    8B60  Motor neuron disease\n",
      "D      H00058  Amyotrophic lateral sclerosis (ALS)\n",
      "D      H00970  Juvenile primary lateral sclerosis\n",
      "D      H02342  Frontotemporal dementia and amyotrophic lateral sclerosis\n",
      "D      H00841  Infantile progressive bulbar palsy\n",
      "C    8B61  Spinal muscular atrophy\n",
      "D      H00455  Spinal muscular atrophy\n",
      "D      H00062  Spinal and bulbar muscular atrophy (SBMA)\n",
      "D      H00524  Scapuloperoneal spinal muscular atrophy\n",
      "D      H00856  Distal hereditary motor neuropathies\n",
      "D      H02238  Spinal muscular atrophy with congenital bone fractures\n",
      "C    8B62  Post polio progressive muscular atrophy\n",
      "C    8B6Y  Other specified motor neuron diseases or related disorders\n",
      "C    8B6Z  Motor neuron diseases or related disorders, unspecified\n",
      "B  Disorders of nerve root, plexus or peripheral nerves\n",
      "C    Disorders of cranial nerves\n",
      "D      8B80  Disorders of olfactory nerve\n",
      "D      8B81  Disorders of vestibulocochlear nerve\n",
      "D      8B82  Disorders of trigeminal nerve\n",
      "D      8B83  Disorders of spinal accessory nerve\n",
      "D      8B84  Disorders of hypoglossal nerve\n",
      "D      8B85  Disorders of multiple cranial nerves\n",
      "D      8B86  Disorders of vagus nerve\n",
      "D      8B87  Disorders of glossopharyngeal nerve\n",
      "D      8B88  Disorders of facial nerve\n",
      "D      8B8Y  Other specified disorders of cranial nerves\n",
      "E        H02594  Congenital facial palsy with ptosis and velopharyngeal dysfunction\n",
      "D      8B8Z  Disorders of cranial nerves, unspecified\n",
      "C    Nerve root or plexus disorders\n",
      "D      8B90  Nerve root and plexus compressions\n",
      "D      8B91  Brachial plexus disorders\n",
      "D      8B92  Lumbosacral plexus disorders\n",
      "D      8B93  Radiculopathy\n",
      "D      8B94  Diabetic radiculoplexoneuropathy\n",
      "D      8B95  Secondary brachial plexus lesion due to certain specified disorders\n",
      "D      8B9Y  Other specified nerve root or plexus disorders\n",
      "D      8B9Z  Nerve root or plexus disorders, unspecified\n",
      "C    Polyneuropathy\n",
      "D      8C00  Idiopathic progressive neuropathy\n",
      "D      8C01  Inflammatory polyneuropathy\n",
      "E        H01436  Guillain-Barre syndrome\n",
      "E        H01689  Fisher syndrome\n",
      "E        H01842  Bickerstaff brainstem encephalitis\n",
      "E        H01527  Chronic inflammatory demyelinating polyradiculoneuropathy\n",
      "D      8C03  Other secondary polyneuropathy\n",
      "E        H01459  Diabetic neuropathy\n",
      "E        H02559  Microvascular complications of diabetes\n",
      "D      8C0Y  Other specified polyneuropathy\n",
      "D      8C0Z  Polyneuropathy, unspecified\n",
      "C    Mononeuropathy\n",
      "D      8C10  Mononeuropathies of upper limb\n",
      "E        H00798  Familial carpal tunnel syndrome\n",
      "D      8C11  Mononeuropathies of lower limb\n",
      "D      8C12  Certain specified mononeuropathies\n",
      "D      8C1Y  Mononeuropathy of other specified site\n",
      "D      8C1Z  Mononeuropathy of unspecified site\n",
      "C    Hereditary neuropathy\n",
      "D      8C20  Hereditary motor and sensory neuropathy\n",
      "E        H00264  Charcot-Marie-Tooth disease\n",
      "E        H02357  Congenital hypomyelinating neuropathy\n",
      "E        H01131  Hereditary neuralgic amyotrophy\n",
      "E        H01155  Roussy-Levy syndrome\n",
      "E        H01296  Hereditary neuropathy with liability to pressure palsies\n",
      "E        H02344  Cowchock syndrome\n",
      "E        H02345  Autosomal recessive peripheral neuropathy (PNRIID)\n",
      "E        H02359  Dejerine-Sottas disease\n",
      "E        H02649  Autosomal dominant slowed nerve conduction velocity\n",
      "D      8C21  Hereditary sensory or autonomic neuropathy\n",
      "E        H00265  Hereditary sensory and autonomic neuropathy\n",
      "E        H02580  Hereditary sensory neuropathy with spastic paraplegia\n",
      "E        H01987  Familial dysautonomia\n",
      "E        H01836  Congenital pain insensitivity with anhidrosis\n",
      "E        H00774  Congenital insensitivity to pain\n",
      "E        H00935  Cold-induced sweating syndrome\n",
      "D      8C2Y  Other specified hereditary neuropathy\n",
      "E        H01259  Giant axonal neuropathy\n",
      "D      8C2Z  Hereditary neuropathy, unspecified\n",
      "C    8C4Y  Other specified disorders of nerve root, plexus or peripheral nerves\n",
      "C    8C4Z  Disorders of nerve root, plexus or peripheral nerves, unspecified\n",
      "B  Diseases of neuromuscular junction or muscle\n",
      "C    Myasthenia gravis or certain specified neuromuscular junction disorders\n",
      "D      8C60  Myasthenia gravis\n",
      "E        H01594  Myasthenia gravis\n",
      "D      8C61  Congenital myasthenic syndromes\n",
      "E        H00770  Congenital myasthenic syndrome\n",
      "D      8C62  Lambert-Eaton syndrome\n",
      "E        H01596  Lambert-Eaton myasthenic syndrome\n",
      "D      8C6Y  Other specified myasthenia gravis and neuromuscular junction disorders\n",
      "D      8C6Z  Unspecified myasthenia gravis or neuromuscular junction disorders\n",
      "C    Primary disorders of muscles\n",
      "D      8C70  Muscular dystrophy\n",
      "E        H00562  Dystrophinopathies\n",
      "E        H01964  Becker muscular dystrophy\n",
      "E        H01963  Duchenne muscular dystrophy\n",
      "E        H00563  Emery-Dreifuss muscular dystrophy\n",
      "E        H00591  Facioscapulohumeral muscular dystrophy\n",
      "E        H00565  Sarcoglycanopathies\n",
      "E        H00593  Limb-girdle muscular dystrophy\n",
      "E        H00567  Limb-girdle muscular dystrophy 1C\n",
      "E        H00592  Calpainopathy\n",
      "E        H01959  Muscular dystrophy-dystroglycanopathy type C\n",
      "E        H01962  Congenital muscular dystrophy type 1D\n",
      "E        H01974  Limb-girdle muscular dystrophy 2B\n",
      "E        H00656  Scapuloperoneal myopathy\n",
      "E        H00120  Muscular dystrophy-dystroglycanopathy type A\n",
      "E        H00590  Congenital muscular dystrophies (CMD/MDC)\n",
      "E        H01284  Marinesco-Sjogren syndrome\n",
      "E        H01340  Bethlem myopathy\n",
      "E        H01341  Collagen VI myopathy\n",
      "E        H01778  Ullrich disease\n",
      "E        H01957  Fukuyama congenital muscular dystrophy\n",
      "E        H01958  Merosin-deficient congenital muscular dystrophy\n",
      "E        H01960  Muscular dystrophy-dystroglycanopathy type B\n",
      "E        H01961  Congenital muscular dystrophy type 1C\n",
      "E        H02307  Muscular dystrophy-dystroglycanopathy\n",
      "E        H00697  X-linked myopathy with postural muscle atrophy\n",
      "D      8C71  Myotonic disorders\n",
      "E        H00568  Myotonic dystrophy\n",
      "E        H01777  Schwartz-Jampel syndrome\n",
      "E        H00705  Myotonia congenita\n",
      "E        H00744  Potassium-aggravated myotonia\n",
      "E        H01804  Isaacs syndrome\n",
      "E        H02390  Autosomal recessive neuromyotonia and axonal neuropathy\n",
      "E        H01780  Non-dystrophic myotonia\n",
      "E        H02179  Rippling muscle disease\n",
      "D      8C72  Congenital myopathies\n",
      "E        H01810  Congenital myopathy\n",
      "E        H00698  Nemaline myopathy\n",
      "E        H00702  Cap myopathy\n",
      "E        H00700  Centronuclear myopathy\n",
      "E        H00699  Central core disease\n",
      "E        H00703  Myosin storage myopathy\n",
      "E        H01291  Spheroid body myopathy\n",
      "E        H01310  Multi-minicore disease\n",
      "E        H01338  Myosclerosis\n",
      "E        H00701  Congenital fiber type disproportion\n",
      "E        H00657  Reducing body myopathy\n",
      "E        H01781  Autophagic vacuolar myopathy\n",
      "E        H02084  Native American myopathy\n",
      "E        H02258  Tubular aggregate myopathy\n",
      "E        H02320  Vacuolar myopathy with CASQ1 aggregates\n",
      "E        H02321  Early-onset myopathy, areflexia, respiratory distress, and dysphagia\n",
      "D      8C73  Mitochondrial myopathies\n",
      "E        H01363  NARP syndrome\n",
      "E        H00068  Leber hereditary optic atrophy\n",
      "E        H01200  Fatal infantile cardioencephalomyopathy\n",
      "E        H01347  MELAS syndrome\n",
      "E        H01356  Myoclonic Epilepsy and Ragged-Red Fiber Disease\n",
      "E        H01365  Leber hereditary optic neuropathy and dystonia\n",
      "E        H02201  Mitochondrial myopathy with lactic acidosis\n",
      "E        H02447  Myopathy with extrapyramidal signs\n",
      "E        H02448  Harel-Yoon syndrome\n",
      "D      8C74  Periodic paralyses or disorders of muscle membrane excitability\n",
      "E        H00743  Paramyotonia congenita\n",
      "E        H00215  Periodic paralysis\n",
      "E        H00746  Hypokalemic periodic paralysis\n",
      "E        H00745  Hyperkalemic periodic paralysis\n",
      "E        H00747  Thyrotoxic hypokalemic periodic paralysis\n",
      "E        H00748  Andersen-Tawil syndrome\n",
      "D      8C75  Distal myopathies\n",
      "E        H00566  Distal myopathy with anterior tibial onset\n",
      "E        H00594  Distal myopathy\n",
      "E        H00596  Nonaka myopathy (NM)\n",
      "E        H01965  Miyoshi muscular dystrophy\n",
      "E        H01975  Welander distal myopathy\n",
      "E        H01976  Tibial muscular dystrophy\n",
      "E        H01977  Laing distal myopathy\n",
      "E        H02182  Distal myopathy, Tateyama type\n",
      "E        H02586  Distal myopathy with rimmed vacuoles\n",
      "D      8C76  Myofibrillar myopathy\n",
      "E        H00595  Myofibrillar myopathies\n",
      "D      8C77  Ocular myopathy\n",
      "D      8C78  Malignant hyperthermia or hyperpyrexia\n",
      "E        H02646  Malignant hyperthermia\n",
      "D      8C7Y  Other specified primary disorders of muscles\n",
      "E        H01129  Brody myopathy\n",
      "D      8C7Z  Primary disorders of muscles, unspecified\n",
      "C    Secondary myopathies\n",
      "D      8C80  Drug-induced myopathy\n",
      "D      8C81  Autoimmune myopathy\n",
      "D      8C82  Myopathy in certain specified infectious or parasitic disease\n",
      "D      8C83  Myopathy in certain specified endocrine disease\n",
      "D      8C84  Secondary rhabdomyolysis\n",
      "D      8C8Y  Other specified secondary myopathies\n",
      "D      8C8Z  Secondary myopathies, unspecified\n",
      "C    8D0Y  Other specified diseases of neuromuscular junction or muscle\n",
      "C    8D0Z  Diseases of neuromuscular junction or muscle, unspecified\n",
      "B  Cerebral palsy\n",
      "C    8D20  Spastic cerebral palsy\n",
      "D      H01097  Spastic quadriplegic cerebral palsy\n",
      "C    8D21  Dyskinetic cerebral palsy\n",
      "C    8D22  Ataxic cerebral palsy\n",
      "C    8D23  Worster-Drought syndrome\n",
      "D      H01837  Congenital suprabulbar paresis\n",
      "C    8D2Y  Other specified cerebral palsy\n",
      "C    8D2Z  Cerebral palsy, unspecified\n",
      "B  Nutritional or toxic disorders of the nervous system\n",
      "C    8D40  Neurological disorders due to nutrient deficiency\n",
      "C    8D41  Neurological disorders due to an excess of micro or macro nutrients\n",
      "C    8D42  Neurological disorders due to overweight or obesity in adults or children\n",
      "C    8D43  Neurological disorders due to toxicity\n",
      "D      H01578  Subacute myelo-optico-neuropathy (SMON)\n",
      "C    8D44  Alcohol-related neurological disorders\n",
      "C    8D4Y  Other specified nutritional or toxic disorders of the nervous system\n",
      "C    8D4Z  Nutritional or toxic disorders of the nervous system, unspecified\n",
      "B  Disorders of cerebrospinal fluid pressure or flow\n",
      "C    8D60  Increased intracranial pressure\n",
      "C    8D61  Intracranial hypotension\n",
      "C    8D62  Cerebrospinal fluid rhinorrhoea\n",
      "C    8D63  Cerebrospinal fluid otorrhoea\n",
      "C    8D64  Hydrocephalus\n",
      "D      H01676  Normal pressure hydrocephalus\n",
      "C    8D65  Cerebrospinal fluid fistula\n",
      "C    8D66  Syringomyelia or syringobulbia\n",
      "D      H01675  Syringomyelia\n",
      "C    8D67  Intracranial arachnoid cyst\n",
      "C    8D68  Porencephalic cyst\n",
      "C    8D6Y  Other specified disorders of cerebrospinal fluid pressure or flow\n",
      "C    8D6Z  Disorders of cerebrospinal fluid pressure or flow, unspecified\n",
      "B  Disorders of autonomic nervous system\n",
      "C    8D80  Congenital malformations of the autonomic nervous system\n",
      "C    8D81  Inherited autonomic nervous system disorders\n",
      "C    8D82  Autoimmune disorders involving the autonomic nervous system\n",
      "C    8D83  Autonomic nervous system disorder due to infection\n",
      "C    8D84  Pure autonomic nervous system failure\n",
      "C    8D85  Autonomic nervous system disorder due to substances\n",
      "C    8D86  Autonomic nervous system hyperactivity\n",
      "C    8D87  Autonomic nervous system disorder due to certain specified neurodegenerative disorder\n",
      "D      H01614  Multiple system atrophy\n",
      "D      H01177  Infantile bilateral striatal necrosis\n",
      "C    8D88  Autonomic neuropathies\n",
      "C    8D89  Disorders of orthostatic tolerance\n",
      "D      H01031  Orthostatic intolerance\n",
      "C    8D8A  Focal or segmental autonomic disorders\n",
      "C    8D8B  Disorders affecting autonomic synaptic neurotransmission\n",
      "C    8D8C  Autonomic dysreflexia\n",
      "C    8D8D  Hypoglycaemia unawareness\n",
      "C    8D8Y  Other specified disorders of autonomic nervous system\n",
      "C    8D8Z  Disorders of autonomic nervous system, unspecified\n",
      "B  Human prion diseases\n",
      "C    8E00  Sporadic Creutzfeldt-Jakob Disease\n",
      "D      H00061  Prion disease\n",
      "C    8E01  Acquired prion disease\n",
      "D      H00061  Prion disease\n",
      "C    8E02  Genetic prion diseases\n",
      "D      H00061  Prion disease\n",
      "C    8E03  Variably protease sensitive prionopathy\n",
      "D      H00061  Prion disease\n",
      "C    8E0Y  Other specified human prion diseases\n",
      "D      H00061  Prion disease\n",
      "C    8E0Z  Human prion diseases, unspecified\n",
      "B  Disorders of consciousness\n",
      "C    8E20  Persistent vegetative state\n",
      "C    8E21  Permanent vegetative state\n",
      "C    8E22  Minimally conscious state\n",
      "C    8E2Y  Other specified disorders of consciousness\n",
      "C    8E2Z  Disorders of consciousness, unspecified\n",
      "B  Other disorders of the nervous system\n",
      "C    8E40  Disorders of the meninges excluding infection\n",
      "D      H01668  Neoplastic meningitis\n",
      "C    8E41  Pachymeningitis\n",
      "C    8E42  Superficial siderosis of the nervous system\n",
      "D      H01846  Superficial siderosis\n",
      "C    8E43  Pain disorders\n",
      "D      H01638  Neuropathic pain\n",
      "D      H00772  Paroxysmal extreme pain disorder\n",
      "D      H01391  Familial episodic pain syndrome\n",
      "C    8E44  Post anoxic brain damage\n",
      "C    8E45  Locked-in syndrome\n",
      "C    8E46  Reye syndrome\n",
      "C    8E47  Encephalopathy, not elsewhere classified\n",
      "D      H01841  Acute encephalopathy with biphasic seizures and late reduced diffusion\n",
      "D      H02261  PEBAT\n",
      "D      H02262  PEBEL\n",
      "C    8E48  Encephalitis, not elsewhere classified\n",
      "C    8E49  Postviral fatigue syndrome\n",
      "C    8E4A  Paraneoplastic or autoimmune disorders of the nervous system\n",
      "D      H01452  Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection\n",
      "C    8E4Y  Other specified disorders of the nervous system\n",
      "D      H02473  Leukoencephalopathy, brain calcifications, and cysts\n",
      "D      H02476  Childhood-onset neurodegeneration with brain atrophy\n",
      "D      H02489  Mild encephalopathy with reversible myelin vacuolization\n",
      "D      H02572  Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures\n",
      "B  Postprocedural disorders of the nervous system\n",
      "C    8E60  Post ventricular shunting leak\n",
      "C    8E61  Post radiation injury of the nervous system\n",
      "C    8E62  Postprocedural meningitis\n",
      "C    8E63  Post pump encephalopathy\n",
      "C    8E64  Multifocal cerebral infarctions\n",
      "C    8E66  Intracranial hypotension due to lumbar puncture\n",
      "B  8E7Y  Other specified diseases of the nervous system\n",
      "B  8E7Z  Diseases of the nervous system, unspecified\n",
      "A09 Diseases of the visual system\n",
      "B  Disorders of the ocular adnexa or orbit\n",
      "C    Disorders of eyelid or peri-ocular area\n",
      "D      9A00  Congenital malposition of eyelids\n",
      "D      9A01  Infectious disorders of eyelid\n",
      "E        H01644  Blepharitis\n",
      "D      9A02  Inflammatory disorders of eyelid\n",
      "E        H01644  Blepharitis\n",
      "D      9A03  Acquired malposition of eyelid\n",
      "D      9A04  Acquired disorders of eyelashes\n",
      "D      9A05  Movement disorders of eyelid\n",
      "D      9A06  Certain specified disorders of eyelid\n",
      "D      9A0Y  Other specified disorders of eyelid or peri-ocular area\n",
      "D      9A0Z  Disorders of eyelid or peri-ocular area, unspecified\n",
      "C    Disorders of lacrimal apparatus\n",
      "D      9A10  Disorders of lacrimal gland\n",
      "D      9A11  Disorders of lacrimal drainage system\n",
      "D      9A1Y  Other specified disorders of lacrimal apparatus\n",
      "D      9A1Z  Disorders of lacrimal apparatus, unspecified\n",
      "C    Disorders of orbit\n",
      "D      9A20  Displacement of eyeball\n",
      "D      9A21  Orbital infection\n",
      "D      9A22  Orbital inflammation\n",
      "D      9A23  Orbital cyst\n",
      "D      9A24  Bony deformity of orbit\n",
      "D      9A25  Soft tissue deformity of orbit\n",
      "D      9A26  Combined bony and soft tissue deformity of orbit\n",
      "D      9A2Y  Other specified disorders of orbit\n",
      "D      9A2Z  Disorders of orbit, unspecified\n",
      "C    9A4Y  Other specified disorders of the ocular adnexa or orbit\n",
      "C    9A4Z  Disorders of the ocular adnexa or orbit, unspecified\n",
      "B  Disorders of the eyeball anterior segment\n",
      "C    Disorders of conjunctiva\n",
      "D      9A60  Conjunctivitis\n",
      "E        H01366  Bacterial conjunctivitis\n",
      "D      9A61  Certain specified disorders of conjunctiva\n",
      "D      9A62  Mucous membrane pemphigoid with ocular involvement\n",
      "D      9A6Y  Other specified disorders of conjunctiva\n",
      "D      9A6Z  Disorders of conjunctiva, unspecified\n",
      "C    Disorders of the cornea\n",
      "D      9A70  Hereditary corneal dystrophies\n",
      "E        H00960  Fuchs corneal dystrophy\n",
      "E        H00963  Congenital hereditary endothelial dystrophy\n",
      "E        H00726  Meesmann corneal dystrophy\n",
      "E        H00951  Reis-Bucklers corneal dystrophy\n",
      "E        H00952  Thiel-Behnke dystrophies\n",
      "E        H00953  Gelatinous drop-like corneal dystrophy\n",
      "E        H00954  Macular corneal dystrophy\n",
      "E        H00955  Granular corneal dystrophies\n",
      "E        H00956  Lattice corneal dystrophies\n",
      "E        H00957  Fleck corneal dystrophy\n",
      "E        H00958  Congenital stromal corneal dystrophy\n",
      "E        H00959  Schnyder corneal dystrophy\n",
      "E        H01221  Epithelial basement membrane corneal dystrophy\n",
      "D      9A71  Infectious keratitis\n",
      "D      9A72  Traumatic keratitis\n",
      "D      9A73  Exposure keratitis\n",
      "D      9A74  Neurotrophic keratitis\n",
      "D      9A75  Autoimmune keratitis\n",
      "D      9A76  Corneal ulcer\n",
      "D      9A77  Corneal scars or opacities\n",
      "D      9A78  Certain specified disorders of cornea\n",
      "E        H00789  Keratoconus\n",
      "E        H02426  EDICT syndrome\n",
      "D      9A79  Keratoconjunctivitis sicca\n",
      "E        H01641  Dry eye disease\n",
      "D      9A7Y  Other specified disorders of the cornea\n",
      "E        H01273  Autosomal dominant keratitis\n",
      "D      9A7Z  Disorders of the cornea, unspecified\n",
      "C    Disorders of the anterior chamber\n",
      "D      9A80  Hyphaema\n",
      "D      9A81  Parasites in the anterior chamber of the eye\n",
      "D      9A82  Cyst in the anterior chamber of the eye\n",
      "D      9A83  Flat anterior chamber hypotony of eye\n",
      "D      9A8Y  Other specified disorders of the anterior chamber\n",
      "D      9A8Z  Disorders of the anterior chamber, unspecified\n",
      "C    Disorders of the anterior uvea\n",
      "D      9A90  Degeneration of iris or ciliary body\n",
      "D      9A91  Cyst of iris or ciliary body\n",
      "D      9A92  Persistent pupillary membranes\n",
      "D      9A93  Adhesions or disruptions of iris or ciliary body\n",
      "D      9A94  Certain specified disorders of iris or ciliary body\n",
      "D      9A96  Anterior uveitis\n",
      "D      9A9Y  Other specified disorders of the anterior uvea\n",
      "D      9A9Z  Disorders of the anterior uvea, unspecified\n",
      "C    Functional disorders of the pupil\n",
      "D      9B00  Disorders of the afferent pupillary system\n",
      "D      9B01  Disorders of the efferent pupillary system\n",
      "D      9B02  Light-near dissociations\n",
      "D      9B0Y  Other specified functional disorders of the pupil\n",
      "D      9B0Z  Functional disorders of the pupil, unspecified\n",
      "C    Disorders of lens\n",
      "D      9B10  Cataract\n",
      "E        H01202  Cataract\n",
      "E        H02204  Hereditary hyperferritinaemia-cataract syndrome\n",
      "D      9B11  Certain specified disorders of lens\n",
      "D      9B1Z  Disorders of lens, unspecified\n",
      "C    9B3Y  Other specified disorders of the eyeball anterior segment\n",
      "C    9B3Z  Disorders of the eyeball anterior segment, unspecified\n",
      "B  Disorders of the eyeball posterior segment\n",
      "C    Disorders of sclera\n",
      "D      9B50  Episcleritis\n",
      "D      9B51  Scleritis\n",
      "D      9B52  Scleral staphyloma\n",
      "D      9B5Y  Other specified disorders of sclera\n",
      "D      9B5Z  Disorders of sclera, unspecified\n",
      "C    Disorders of the choroid\n",
      "D      9B60  Choroidal degeneration\n",
      "D      9B61  Choroidal dystrophy\n",
      "E        H00732  Sorsby fundus dystrophy\n",
      "E        H01116  Choroideremia\n",
      "E        H01768  Central areolar choroidal dystrophy\n",
      "E        H01880  Autosomal recessive microcephaly and chorioretinopathy\n",
      "E        H02107  Bietti crystalline corneoretinal dystrophy\n",
      "D      9B62  Chorioretinal scars\n",
      "D      9B63  Choroidal haemorrhage or rupture\n",
      "D      9B64  Choroidal detachment\n",
      "D      9B65  Choroiditis\n",
      "D      9B66  Intermediate choroiditis\n",
      "D      9B6Y  Other specified disorders of the choroid\n",
      "D      9B6Z  Disorders of the choroid, unspecified\n",
      "C    Disorders of the retina\n",
      "D      9B70  Inherited retinal dystrophies\n",
      "E        H00481  Cone-rod dystrophy and cone dystrophy\n",
      "E        H00527  Retinitis pigmentosa\n",
      "E        H00814  Vitelliform macular dystrophy\n",
      "E        H00819  Stargardt disease\n",
      "E        H00825  Familial flecked retina syndrome\n",
      "E        H00837  Leber congenital amaurosis\n",
      "E        H00971  Achromatopsia\n",
      "E        H00974  Blue cone monochromacy\n",
      "E        H01009  Newfoundland rod-cone dystrophy\n",
      "E        H01130  Late-onset retinal degeneration\n",
      "E        H01770  Macular dystrophy\n",
      "E        H01890  Pattern dystrophies of the retinal pigment epithelium\n",
      "E        H02075  Enhanced S-cone syndrome\n",
      "E        H02077  Snowflake vitreoretinal degeneration\n",
      "E        H02078  Autosomal dominant vitreoretinochoroidopathy\n",
      "E        H02108  Basal laminar drusen\n",
      "E        H02110  Doyne honeycomb retinal dystrophy\n",
      "E        H02288  Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities\n",
      "E        H02289  Retinal dystrophy with or without extraocular anomalies\n",
      "E        H02290  Retinal dystrophy and iris coloboma with congenital cataract\n",
      "E        H02291  Retinal dystrophy, iris coloboma, and comedogenic acne syndrome\n",
      "E        H02341  Goldmann-Favre syndrome\n",
      "E        H02440  Fleck retina, familial benign\n",
      "D      9B71  Retinopathy\n",
      "E        H01457  Diabetic retinopathy\n",
      "E        H02559  Microvascular complications of diabetes\n",
      "D      9B72  Inflammatory diseases of the retina\n",
      "D      9B73  Retinal detachments or breaks\n",
      "E        H01766  Juvenile retinoschisis\n",
      "D      9B74  Retinal vascular occlusions\n",
      "D      9B75  Macular disorders\n",
      "E        H00821  Age-related macular degeneration\n",
      "E        H01480  Idiopathic macular hole\n",
      "E        H01010  Occult macular dystrophy\n",
      "E        H01651  Macular edema\n",
      "D      9B76  Degenerative high myopia\n",
      "D      9B77  Eales disease\n",
      "D      9B78  Certain specified retinal disorders\n",
      "E        H01000  Retinal vasculopathy with cerebral leukodystrophy\n",
      "E        H02251  Coats plus syndrome\n",
      "E        H01798  Autosomal dominant neovascular inflammatory vitreoretinopathy\n",
      "E        H01180  Sveinsson chorioretinal atrophy (SCRA)\n",
      "D      9B7Y  Other specified disorders of the retina\n",
      "E        H00690  Aland Island eye disease\n",
      "E        H01088  Pigmented paravenous chorioretinal atrophy\n",
      "E        H02469  Cone-rod synaptic disorder\n",
      "E        H02642  Retinal arterial macroaneurysm with supravalvular pulmonic stenosis\n",
      "D      9B7Z  Disorders of the retina, unspecified\n",
      "C    Disorders of the vitreous body\n",
      "D      9B80  Inherited vitreoretinal disorders\n",
      "E        H00805  Vitreoretinal degeneration\n",
      "E        H02073  Wagner syndrome\n",
      "D      9B81  Posterior vitreous detachment\n",
      "D      9B82  Vitreous prolapse\n",
      "D      9B83  Vitreous haemorrhage\n",
      "D      9B84  Vitreous opacities, membranes or strands\n",
      "D      9B8Y  Other specified disorders of the vitreous body\n",
      "D      9B8Z  Disorders of the vitreous body, unspecified\n",
      "C    9C0Y  Other specified disorders of the eyeball posterior segment\n",
      "C    9C0Z  Disorders of the eyeball posterior segment, unspecified\n",
      "B  Disorders of the eyeball affecting both anterior and posterior segments\n",
      "C    9C20  Panuveitis\n",
      "C    9C21  Endophthalmitis\n",
      "C    9C22  Eyeball deformity\n",
      "C    9C2Y  Other specified disorders of the eyeball affecting both anterior and posterior segments\n",
      "C    9C2Z  Disorders of the eyeball affecting both anterior and posterior segments, unspecified\n",
      "B  Disorders of the visual pathways or centres\n",
      "C    9C40  Disorder of the optic nerve\n",
      "D      H01719  Optic neuropathy\n",
      "D      H01717  Optic neuritis\n",
      "D      H00068  Leber hereditary optic atrophy\n",
      "D      H01020  Optic atrophy\n",
      "D      H01365  Leber hereditary optic neuropathy and dystonia\n",
      "D      H01378  Bosch-Boonstra optic atrophy syndrome\n",
      "C    9C41  Disorder of optic chiasm\n",
      "C    9C42  Disorder of post chiasmal visual pathways\n",
      "C    9C43  Disorder of visual cortex\n",
      "C    9C44  Disorder of higher visual centres\n",
      "C    9C4Y  Other specified disorders of the visual pathways or centres\n",
      "C    9C4Z  Disorders of the visual pathways or centres, unspecified\n",
      "B  Glaucoma or glaucoma suspect\n",
      "C    9C60  Glaucoma suspect\n",
      "C    9C61  Glaucoma\n",
      "D      H00612  Primary open angle glaucoma\n",
      "D      H01203  Primary congenital glaucoma\n",
      "C    9C6Y  Other specified glaucoma or glaucoma suspect\n",
      "C    9C6Z  Glaucoma or glaucoma suspect, unspecified\n",
      "B  Strabismus or ocular motility disorders\n",
      "C    9C80  Non paralytic strabismus\n",
      "C    9C81  Ocular motor nerve palsies\n",
      "C    9C82  Disorders of extraocular muscles\n",
      "D      H01118  Progressive external ophthalmoplegia\n",
      "D      H01355  Kearns-Sayre syndrome\n",
      "D      H01395  Autosomal recessive progressive external ophthalmoplegia\n",
      "D      H00704  Oculopharyngeal muscular dystrophy\n",
      "D      H02513  Oculopharyngodistal myopathy\n",
      "D      H00633  Duane retraction syndrome\n",
      "D      H00838  Congenital fibrosis of the extraocular muscles\n",
      "D      H02151  Hereditary congenital facial paresis\n",
      "C    9C83  Disorders of binocular movement\n",
      "D      H02450  Horizontal gaze palsy with progressive scoliosis\n",
      "C    9C84  Nystagmus\n",
      "D      H00776  Congenital motor nystagmus (CMN)\n",
      "C    9C85  Certain specified irregular eye movements\n",
      "C    9C8Y  Other specified strabismus or ocular motility disorders\n",
      "C    9C8Z  Strabismus or ocular motility disorders, unspecified\n",
      "B  Disorders of refraction or accommodation\n",
      "C    9D00  Disorders of refraction\n",
      "D      H02041  Myopia\n",
      "C    9D01  Disorders of accommodation\n",
      "C    9D0Y  Other specified disorders of refraction or accommodation\n",
      "C    9D0Z  Disorders of refraction or accommodation, unspecified\n",
      "B  Postprocedural disorders of eye or ocular adnexa\n",
      "C    9D20  Bullous aphakic keratopathy following cataract surgery\n",
      "C    9D21  Cataract lens fragments in eye following cataract surgery\n",
      "C    9D22  Chorioretinal scars after surgery for detachment\n",
      "C    9D23  Conjunctival blebitis after glaucoma surgery\n",
      "C    9D24  Complications with glaucoma drainage devices\n",
      "C    9D25  Glaucoma due to ocular surgery or laser\n",
      "B  Impairment of visual functions\n",
      "C    9D41  Impairment of visual field\n",
      "C    9D42  Patterns of visual field impairment\n",
      "C    9D43  Impairment of contrast vision\n",
      "C    9D44  Impairment of colour vision\n",
      "D      H00971  Achromatopsia\n",
      "D      H00976  Colorblindness\n",
      "C    9D45  Impairment of light sensitivity\n",
      "D      H00787  Congenital stationary night blindness\n",
      "C    9D46  Impairment of binocular functions\n",
      "C    Subjective visual experiences\n",
      "D      9D50  Visual discomfort\n",
      "D      9D51  Transient visual loss\n",
      "D      9D52  Hemifield losses\n",
      "D      9D53  Entoptic phenomena\n",
      "D      9D54  Visual illusions\n",
      "D      9D55  Nonorganic visual loss\n",
      "D      9D56  Visual release hallucinations\n",
      "D      9D5Y  Other specified subjective visual experiences\n",
      "D      9D5Z  Subjective visual experiences, unspecified\n",
      "C    9D7Y  Other specified impairment of visual functions\n",
      "D      H00973  Bradyopsia\n",
      "C    9D7Z  Impairment of visual functions, unspecified\n",
      "B  Vision impairment\n",
      "C    9D90  Vision impairment including blindness\n",
      "C    9D92  Specific vision dysfunctions\n",
      "C    9D93  Complex vision-related dysfunctions\n",
      "C    9D94  Impairment of presenting visual acuity\n",
      "C    9D95  Impairment of best corrected visual acuity\n",
      "C    9D96  Impairment of uncorrected visual acuity\n",
      "C    9D9Y  Other specified vision impairment\n",
      "C    9D9Z  Vision impairment, unspecified\n",
      "B  9E1Y  Other specified diseases of the visual system\n",
      "C    H00169  Ocular albinism\n",
      "B  9E1Z  Diseases of the visual system, unspecified\n",
      "A10 Diseases of the ear or mastoid process\n",
      "B  Diseases of external ear\n",
      "C    Infectious diseases of external ear\n",
      "D      AA00  Abscess of external ear\n",
      "D      AA01  Cellulitis of external ear\n",
      "D      AA02  Malignant otitis externa\n",
      "D      AA03  Otomycosis\n",
      "D      AA04  Perichondritis of external ear\n",
      "D      AA0Y  Other specified infectious diseases of external ear\n",
      "D      AA0Z  Infectious diseases of external ear, unspecified\n",
      "C    Otitis externa\n",
      "D      Noninfectious inflammation of external ear\n",
      "E        AA10  Seborrhoeic otitis externa\n",
      "E        AA11  Acute noninfectious otitis externa\n",
      "E        AA12  Chondrodermatitis nodularis\n",
      "E        AA13  Chronic otitis externa\n",
      "E        AA1Y  Other specified noninfectious inflammation of external ear\n",
      "E        AA1Z  Noninfectious inflammation of external ear, unspecified\n",
      "D      AA3Y  Other specified otitis externa\n",
      "D      AA3Z  Otitis externa, unspecified\n",
      "C    Noninflammatory disorders of the external ear\n",
      "D      AA40  Acquired deformity of external auditory canal\n",
      "D      AA41  Acquired deformity of pinna\n",
      "D      AA42  Impacted cerumen\n",
      "D      AA4Y  Other specified noninflammatory disorders of the external ear\n",
      "D      AA4Z  Noninflammatory disorders of the external ear, unspecified\n",
      "C    AA6Z  Diseases of external ear, unspecified\n",
      "B  Diseases of middle ear or mastoid\n",
      "C    Otitis media\n",
      "D      Nonsuppurative otitis media\n",
      "E        AA80  Acute serous or mucoid otitis media\n",
      "E        AA81  Acute nonserous nonsuppurative otitis media\n",
      "E        AA82  Chronic serous or mucoid otitis media\n",
      "E        AA83  Noninfected otitis media with effusion\n",
      "E        AA8Z  Nonsuppurative otitis media, unspecified\n",
      "D      Suppurative otitis media\n",
      "E        AA90  Acute suppurative otitis media\n",
      "E        AA91  Chronic suppurative otitis media\n",
      "E        AA9Y  Other specified suppurative otitis media\n",
      "E        AA9Z  Suppurative otitis media, unspecified\n",
      "D      AB00  Acute otitis media\n",
      "D      AB01  Chronic otitis media\n",
      "D      AB0Y  Other specified otitis media\n",
      "D      AB0Z  Otitis media, unspecified\n",
      "C    AB10  Disorders of Eustachian tube\n",
      "C    AB11  Mastoiditis or related conditions\n",
      "C    AB12  Cholesteatoma of middle ear\n",
      "C    AB13  Perforation of tympanic membrane\n",
      "C    AB14  Acute myringitis\n",
      "C    AB15  Chronic myringitis\n",
      "C    AB16  Tympanosclerosis\n",
      "C    AB17  Adhesive middle ear disease\n",
      "C    AB18  Discontinuity or dislocation of ear ossicles\n",
      "C    AB19  Acquired abnormalities of ear ossicles not related to discontinuity or dislocation\n",
      "C    AB1A  Polyp of middle ear\n",
      "C    AB1B  Middle ear cicatrix\n",
      "C    AB1Y  Other specified diseases of middle ear or mastoid\n",
      "C    AB1Z  Diseases of middle ear or mastoid, unspecified\n",
      "B  Diseases of inner ear\n",
      "C    AB30  Acute vestibular syndrome\n",
      "C    AB31  Episodic vestibular syndrome\n",
      "D      H01495  Meniere disease\n",
      "D      H01706  Delayed endolymphatic hydrops\n",
      "C    AB32  Chronic vestibular syndrome\n",
      "C    AB33  Otosclerosis\n",
      "C    AB34  Disorders of vestibular function\n",
      "C    AB35  Labyrinthine fistula\n",
      "C    AB36  Labyrinthine dysfunction\n",
      "C    AB37  Noise effects on inner ear\n",
      "C    AB3Y  Other specified diseases of inner ear\n",
      "C    AB3Z  Diseases of inner ear, unspecified\n",
      "B  Disorders with hearing impairment\n",
      "C    AB50  Congenital hearing impairment\n",
      "D      H00604  Deafness, autosomal dominant\n",
      "D      H00605  Deafness, autosomal recessive\n",
      "D      H01209  Deafness, X-linked\n",
      "D      H02336  Deafness, Y-linked\n",
      "D      H02636  Sinoatrial node dysfunction and deafness\n",
      "C    AB51  Acquired hearing impairment\n",
      "D      H01704  Sudden sensorineural hearing loss\n",
      "D      H01705  Bilateral sudden sensorineural hearing loss\n",
      "C    AB52  Deafness not otherwise specified\n",
      "C    AB53  Ototoxic hearing loss\n",
      "C    AB54  Presbycusis\n",
      "C    AB55  Sudden idiopathic hearing loss\n",
      "C    AB56  Hereditary hearing loss\n",
      "C    AB57  Auditory synaptopathy or neuropathy\n",
      "D      H02339  Auditory neuropathy\n",
      "C    AB5Y  Other specified disorders with hearing impairment\n",
      "C    AB5Z  Disorders with hearing impairment, unspecified\n",
      "B  Disorders of ear, not elsewhere classified\n",
      "C    AB70  Otalgia or effusion of ear\n",
      "C    AB71  Degenerative or vascular disorders of ear\n",
      "C    AB72  Disorders of acoustic nerve\n",
      "C    AB73  Atrophy ear\n",
      "C    AB7Y  Other specified disorders of ear, not elsewhere classified\n",
      "B  Postprocedural disorders of ear or mastoid process\n",
      "C    AB90  Recurrent cholesteatoma of postmastoidectomy cavity\n",
      "C    AB91  Mucosal cyst of postmastoidectomy cavity\n",
      "C    AB92  Granulation of postmastoidectomy cavity\n",
      "C    AB93  Chronic inflammation of postmastoidectomy cavity\n",
      "B  AC0Y  Other specified diseases of the ear or mastoid process\n",
      "B  AC0Z  Diseases of the ear or mastoid process, unspecified\n",
      "A11 Diseases of the circulatory system\n",
      "B  Hypertensive diseases\n",
      "C    BA00  Essential hypertension\n",
      "D      H01633  High blood pressure\n",
      "C    BA01  Hypertensive heart disease\n",
      "C    BA02  Hypertensive renal disease\n",
      "C    BA03  Hypertensive crisis\n",
      "C    BA04  Secondary hypertension\n",
      "D      H00242  Liddle syndrome\n",
      "D      H00603  Hypertension exacerbated in pregnancy\n",
      "B  Hypotension\n",
      "C    BA20  Idiopathic hypotension\n",
      "C    BA21  Orthostatic hypotension\n",
      "C    BA2Y  Other specified hypotension\n",
      "C    BA2Z  Hypotension, unspecified\n",
      "B  Ischaemic heart diseases\n",
      "C    Acute ischaemic heart disease\n",
      "D      BA40  Angina pectoris\n",
      "E        H01632  Angina pectoris\n",
      "D      BA41  Acute myocardial infarction\n",
      "E        H01730  Myocardial infarction\n",
      "D      BA42  Subsequent myocardial infarction\n",
      "D      BA43  Coronary thrombosis not resulting in myocardial infarction\n",
      "D      BA4Z  Acute ischaemic heart disease, unspecified\n",
      "C    Chronic ischaemic heart disease\n",
      "D      BA50  Old myocardial infarction\n",
      "D      BA51  Ischaemic cardiomyopathy\n",
      "D      BA52  Coronary atherosclerosis\n",
      "D      BA5Y  Other specified chronic ischaemic heart disease\n",
      "D      BA5Z  Chronic ischaemic heart disease, unspecified\n",
      "C    BA60  Certain current complications following acute myocardial infarction\n",
      "C    BA6Z  Ischaemic heart diseases, unspecified\n",
      "B  Diseases of coronary artery\n",
      "C    BA81  Coronary artery aneurysm\n",
      "C    BA82  Coronary artery dissection\n",
      "C    BA83  Coronary artery fistula, acquired\n",
      "C    BA84  Chronic total occlusion of coronary artery\n",
      "C    BA85  Coronary vasospastic disease\n",
      "C    BA86  Coronary microvascular disease\n",
      "C    BA8Y  Other specified diseases of coronary artery\n",
      "C    BA8Z  Diseases of coronary artery, unspecified\n",
      "D      H01742  Coronary artery disease\n",
      "B  Pulmonary heart disease or diseases of pulmonary circulation\n",
      "C    BB00  Pulmonary thromboembolism\n",
      "C    BB01  Pulmonary hypertension\n",
      "D      H01619  Primary pulmonary hypertension\n",
      "D      H01621  Pulmonary arterial hypertension\n",
      "D      H01866  Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis\n",
      "D      H01622  Chronic thromboembolic pulmonary hypertension\n",
      "C    BB02  Certain specified diseases of pulmonary vessels\n",
      "C    BB03  Acquired pulmonary venous abnormality\n",
      "C    BB0Y  Other specified pulmonary heart disease or diseases of pulmonary circulation\n",
      "C    BB0Z  Pulmonary heart disease or diseases of pulmonary circulation, unspecified\n",
      "B  Pericarditis\n",
      "C    BB20  Acute pericarditis\n",
      "C    BB21  Chronic rheumatic pericarditis\n",
      "C    BB22  Constrictive pericarditis\n",
      "C    BB23  Cardiac tamponade\n",
      "C    BB24  Haemopericardium\n",
      "C    BB25  Pericardial effusion\n",
      "C    BB2Y  Other specified pericarditis\n",
      "C    BB2Z  Pericarditis, unspecified\n",
      "B  Acute or subacute endocarditis\n",
      "C    BB40  Acute or subacute infectious endocarditis\n",
      "C    BB41  Myoendocarditis\n",
      "C    BB42  Periendocarditis\n",
      "C    BB4Y  Other specified acute or subacute endocarditis\n",
      "C    BB4Z  Acute or subacute endocarditis, unspecified\n",
      "B  Heart valve diseases\n",
      "C    Mitral valve disease\n",
      "D      BB60  Mitral valve stenosis\n",
      "D      BB61  Mitral valve insufficiency\n",
      "D      BB62  Mitral valve prolapse\n",
      "E        H01868  Mitral valve prolapse\n",
      "D      BB63  Mitral valve stenosis with insufficiency\n",
      "D      BB64  Mitral valvar abscess\n",
      "D      BB65  Mitral valve rupture\n",
      "D      BB6Y  Other specified mitral valve disease\n",
      "D      BB6Z  Mitral valve disease, unspecified\n",
      "C    Aortic valve disease\n",
      "D      BB70  Aortic valve stenosis\n",
      "D      BB71  Aortic valve insufficiency\n",
      "D      BB72  Aortic valve stenosis with insufficiency\n",
      "D      BB73  Aortic valvar abscess\n",
      "D      BB74  Aortic valvar prolapse\n",
      "D      BB7Y  Other specified aortic valve disease\n",
      "D      BB7Z  Aortic valve disease, unspecified\n",
      "C    Tricuspid valve disease\n",
      "D      BB80  Tricuspid valve stenosis\n",
      "D      BB81  Tricuspid valve insufficiency\n",
      "D      BB82  Tricuspid valve stenosis with insufficiency\n",
      "D      BB83  Tricuspid valvular abscess\n",
      "D      BB84  Tricuspid valve rupture\n",
      "D      BB8Y  Other specified tricuspid valve disease\n",
      "D      BB8Z  Tricuspid valve disease, unspecified\n",
      "C    Pulmonary valve disease\n",
      "D      BB90  Pulmonary valve stenosis\n",
      "D      BB91  Pulmonary valve insufficiency\n",
      "D      BB92  Pulmonary valve stenosis with insufficiency\n",
      "D      BB93  Pulmonary valvar abscess\n",
      "D      BB9Y  Other specified pulmonary valve disease\n",
      "D      BB9Z  Pulmonary valve disease, unspecified\n",
      "C    BC00  Multiple valve disease\n",
      "C    BC01  Prosthetic valve disease\n",
      "C    BC02  Acquired abnormality of congenitally malformed valve\n",
      "C    BC0Z  Heart valve diseases, unspecified\n",
      "D      H00334  Bacterial endocarditis\n",
      "B  BC20  Chronic rheumatic heart diseases, not elsewhere classified\n",
      "B  Diseases of the myocardium or cardiac chambers\n",
      "C    BC40  Acquired atrial abnormality\n",
      "C    BC41  Acquired ventricular abnormality\n",
      "C    BC42  Myocarditis\n",
      "D      H00295  Viral myocarditis\n",
      "C    BC43  Cardiomyopathy\n",
      "D      H00294  Dilated cardiomyopathy\n",
      "D      H00292  Hypertrophic cardiomyopathy\n",
      "D      H01219  Restrictive cardiomyopathy\n",
      "D      H00293  Arrhythmogenic right ventricular cardiomyopathy\n",
      "D      H00669  Naxos disease\n",
      "D      H02094  Carvajal syndrome\n",
      "D      H02498  Diabetic cardiomyopathy\n",
      "C    BC44  Noncompaction cardiomyopathy\n",
      "D      H01216  Left ventricular noncompaction\n",
      "C    BC45  Cardiomegaly\n",
      "C    BC46  Intracardiac thrombosis\n",
      "C    BC4Y  Other specified diseases of the myocardium or cardiac chambers\n",
      "C    BC4Z  Diseases of the myocardium or cardiac chambers, unspecified\n",
      "B  Cardiac arrhythmia\n",
      "C    BC60  Atrial premature depolarization\n",
      "C    BC61  Junctional premature depolarization\n",
      "C    BC62  Accessory pathway\n",
      "C    BC63  Conduction disorders\n",
      "D      H01263  Progressive cardiac conduction defect (PCCD)\n",
      "D      H02125  Cardiac conduction disease with or without dilated cardiomyopathy\n",
      "C    BC64  Sudden arrhythmic death syndrome\n",
      "C    BC65  Cardiac arrhythmia associated with genetic disorder\n",
      "D      H00720  Long QT syndrome\n",
      "D      H00748  Andersen-Tawil syndrome\n",
      "D      H02091  Jervell and Lange-Nielsen syndrome\n",
      "D      H00728  Brugada syndrome\n",
      "D      H00725  Short QT syndrome\n",
      "D      H00730  Familial idiopathic ventricular fibrillation\n",
      "D      H01019  Catecholaminergic polymorphic ventricular tachycardia\n",
      "D      H02122  Chronic atrial and intestinal dysrhythmia\n",
      "C    Ventricular rhythm disturbance\n",
      "D      BC70  Ventricular premature depolarization\n",
      "D      BC71  Ventricular tachyarrhythmia\n",
      "E        H02269  Familial ventricular tachycardia\n",
      "D      BC7Y  Other specified ventricular rhythm disturbance\n",
      "D      BC7Z  Ventricular rhythm disturbance, unspecified\n",
      "C    Supraventricular rhythm disturbance\n",
      "D      BC80  Supraventricular bradyarrhythmia\n",
      "E        H02636  Sinoatrial node dysfunction and deafness\n",
      "E        H00729  Sick sinus syndrome\n",
      "D      BC81  Supraventricular tachyarrhythmia\n",
      "E        H00731  Atrial fibrillation\n",
      "E        H01154  Wolff-Parkinson-White (WPW) syndrome\n",
      "D      BC8Y  Other specified supraventricular rhythm disturbance\n",
      "D      BC8Z  Supraventricular rhythm disturbance, unspecified\n",
      "C    BC90  Rhythm disturbance at level of atrioventricular junction\n",
      "C    BC91  Pacemaker or implantable cardioverter defibrillator battery at end of battery life\n",
      "C    BC9Y  Other specified cardiac arrhythmia\n",
      "C    BC9Z  Cardiac arrhythmia, unspecified\n",
      "B  Heart failure\n",
      "C    BD10  Congestive heart failure\n",
      "C    BD11  Left ventricular failure\n",
      "C    BD12  High output syndromes\n",
      "C    BD13  Right ventricular failure\n",
      "C    BD14  Biventricular failure\n",
      "C    BD1Y  Other specified heart failure\n",
      "D      H01631  Acute heart failure\n",
      "C    BD1Z  Heart failure, unspecified\n",
      "B  Diseases of arteries or arterioles\n",
      "C    BD30  Acute arterial occlusion\n",
      "C    Chronic arterial occlusive disease\n",
      "D      BD40  Atherosclerotic chronic arterial occlusive disease\n",
      "E        H01626  Arteriosclerosis obliterans\n",
      "E        H01629  Chronic arterial occlusive disease\n",
      "E        H02505  Atherosclerosis\n",
      "D      BD41  Non-atherosclerotic chronic arterial occlusive disease\n",
      "E        H01629  Chronic arterial occlusive disease\n",
      "D      BD42  Raynaud phenomenon\n",
      "E        H01620  Raynaud syndrome\n",
      "E        H01629  Chronic arterial occlusive disease\n",
      "D      BD4Y  Other specified chronic arterial occlusive disease\n",
      "D      BD4Z  Chronic arterial occlusive disease, unspecified\n",
      "C    BD50  Aortic aneurysm or dissection\n",
      "D      H00801  Familial thoracic aortic aneurysm and dissection\n",
      "C    BD51  Arterial aneurysm or dissection, excluding aorta\n",
      "C    BD52  Certain specified disorders of arteries or arterioles\n",
      "D      H00824  Calcification of joints and arteries\n",
      "D      H01002  Generalized arterial calcification of infancy\n",
      "C    BD53  Secondary disorders of arteries and arterioles\n",
      "C    BD54  Diabetic foot ulcer\n",
      "C    BD55  Asymptomatic stenosis of intracranial or extracranial artery\n",
      "C    BD56  Asymptomatic occlusion of intracranial or extracranial artery\n",
      "C    BD5Y  Other specified diseases of arteries or arterioles\n",
      "C    BD5Z  Diseases of arteries or arterioles, unspecified\n",
      "B  Diseases of veins\n",
      "C    BD70  Superficial thrombophlebitis\n",
      "C    BD71  Deep vein thrombosis\n",
      "D      H01723  Deep vein thrombosis\n",
      "C    BD72  Venous thromboembolism\n",
      "C    BD73  Acquired systemic vein abnormality\n",
      "C    BD74  Chronic peripheral venous insufficiency of lower extremities\n",
      "C    BD75  Venous varicosities of sites other than lower extremity\n",
      "C    BD7Y  Other specified diseases of veins\n",
      "C    BD7Z  Diseases of veins, unspecified\n",
      "B  Disorders of lymphatic vessels or lymph nodes\n",
      "C    BD90  Lymphadenitis\n",
      "D      H01397  Tick-borne lymphadenopathy\n",
      "C    BD91  Lymphangitis\n",
      "C    BD92  Lymphangiectasia\n",
      "C    BD93  Lymphoedema\n",
      "D      H00535  Lymphatic malformation\n",
      "D      H01017  Choanal atresia and lymphedema\n",
      "D      H02167  Lymphedema-distichiasis syndrome\n",
      "D      H02168  Hypotrichosis-lymphedema-telangiectasia syndrome\n",
      "D      H02169  Hennekam lymphangiectasia-lymphedema syndrome\n",
      "C    BD9Y  Other specified disorders of lymphatic vessels or lymph nodes\n",
      "C    BD9Z  Disorders of lymphatic vessels or lymph nodes, unspecified\n",
      "B  Postprocedural disorders of circulatory system\n",
      "C    BE10  Postcardiotomy syndrome\n",
      "C    BE11  Other functional disturbances following cardiac surgery\n",
      "C    BE12  Postprocedural valve disorders\n",
      "C    BE13  Postprocedural true or false aortic aneurysm\n",
      "C    BE14  Postprocedural disorder of circulatory system following repair of congenital heart or great vessel anomaly\n",
      "C    BE15  Postprocedural pulmonary arterial tree disorder\n",
      "C    BE16  Postprocedural pulmonary venous disorder\n",
      "C    BE17  Postprocedural residual or recurrent interatrial communication\n",
      "C    BE19  Postprocedural ventricular abnormality\n",
      "C    BE1A  Cardiac transplant associated coronary allograft vasculopathy\n",
      "C    BE1B  Lymphoedema due to surgery or radiotherapy\n",
      "C    BE1C  Inferior caval vein obstruction due to foreign body\n",
      "C    BE1D  Superior caval vein obstruction due to foreign body\n",
      "C    BE1E  Postprocedural right atrial complication\n",
      "C    BE1F  Postprocedural left atrial complication\n",
      "B  BE2Y  Other specified diseases of the circulatory system\n",
      "B  BE2Z  Diseases of the circulatory system, unspecified\n",
      "A12 Diseases of the respiratory system\n",
      "B  Upper respiratory tract disorders\n",
      "C    CA00  Acute nasopharyngitis\n",
      "D      H02442  Common cold\n",
      "C    CA01  Acute sinusitis\n",
      "C    CA02  Acute pharyngitis\n",
      "C    CA03  Acute tonsillitis\n",
      "C    CA04  Acute laryngopharyngitis\n",
      "C    CA05  Acute laryngitis or tracheitis\n",
      "C    CA06  Acute obstructive laryngitis or epiglottitis\n",
      "C    CA07  Acute upper respiratory infections of multiple and unspecified sites\n",
      "C    CA08  Vasomotor or allergic rhinitis\n",
      "D      H01360  Allergic rhinitis\n",
      "C    CA09  Chronic rhinitis, nasopharyngitis or pharyngitis\n",
      "C    CA0A  Chronic rhinosinusitis\n",
      "D      H01765  Eosinophilic sinusitis\n",
      "C    CA0B  Silent sinus syndrome\n",
      "C    CA0C  Cyst or mucocele of nose or nasal sinus\n",
      "C    CA0D  Deviated nasal septum\n",
      "C    CA0E  Hypertrophy of nasal turbinates\n",
      "C    CA0F  Chronic diseases of tonsils or adenoids\n",
      "C    CA0G  Chronic laryngitis or laryngotracheitis\n",
      "C    CA0H  Diseases of vocal cords or larynx, not elsewhere classified\n",
      "C    CA0J  Nasal polyp\n",
      "C    CA0K  Abscess of upper respiratory tract\n",
      "C    CA0Y  Other specified upper respiratory tract disorders\n",
      "C    CA0Z  Upper respiratory tract disorders, unspecified\n",
      "B  Certain lower respiratory tract diseases\n",
      "C    CA20  Bronchitis\n",
      "C    CA21  Emphysema\n",
      "C    CA22  Chronic obstructive pulmonary disease\n",
      "D      H01714  Chronic obstructive pulmonary disease (COPD)\n",
      "D      H01873  Obliterative bronchiolitis\n",
      "C    CA23  Asthma\n",
      "D      H00079  Asthma\n",
      "D      H01191  Asthma with nasal polyps and aspirin intolerance\n",
      "C    CA24  Bronchiectasis\n",
      "D      H00892  Bronchiectasis with or without elevated sweat chloride\n",
      "C    CA25  Cystic fibrosis\n",
      "D      H00218  Cystic fibrosis\n",
      "C    CA26  Chronic bronchiolitis\n",
      "D      H01873  Obliterative bronchiolitis\n",
      "D      H01713  Diffuse panbronchiolitis\n",
      "C    CA27  Tracheobronchitis\n",
      "C    CA2Y  Other specified lower respiratory tract disease\n",
      "C    CA2Z  Lower respiratory tract disease, unspecified\n",
      "B  Lung infections\n",
      "C    CA40  Pneumonia\n",
      "D      H00351  Chlamydial pneumonia\n",
      "D      H00304  Haemophilus influenzae infection\n",
      "D      H00301  Klebsiella infection\n",
      "D      H00341  Mycoplasma pneumonia\n",
      "D      H01441  Pseudomonas aeruginosa infection\n",
      "D      H00333  Streptococcal infection\n",
      "D      H01321  Pneumococcal disease\n",
      "D      H00401  Respiratory syncytial virus infection\n",
      "D      H00400  Parainfluenza infection\n",
      "D      H01063  Human metapneumovirus infection\n",
      "D      H01521  Pneumocystis pneumonia\n",
      "C    CA41  Acute bronchiolitis\n",
      "D      H00401  Respiratory syncytial virus infection\n",
      "C    CA42  Acute bronchitis\n",
      "D      H00341  Mycoplasma pneumonia\n",
      "D      H00401  Respiratory syncytial virus infection\n",
      "D      H00400  Parainfluenza infection\n",
      "D      H00304  Haemophilus influenzae infection\n",
      "C    CA43  Abscess of lung or mediastinum\n",
      "C    CA44  Pyothorax\n",
      "C    CA45  Respiratory infections, not elsewhere classified\n",
      "C    CA4Y  Other specified lung infections\n",
      "C    CA4Z  Lung infections, unspecified\n",
      "B  Lung diseases due to external agents\n",
      "C    CA60  Pneumoconiosis\n",
      "C    Pneumonitis\n",
      "D      CA70  Hypersensitivity pneumonitis due to organic dust\n",
      "E        H00346  Extrinsic allergic alveolitis\n",
      "E        H01411  Saccharomonospora viridis infection\n",
      "D      CA71  Pneumonitis due to solids and liquids\n",
      "D      CA72  Mendelson syndrome\n",
      "D      CA7Y  Other specified pneumonitis\n",
      "D      CA7Z  Pneumonitis, unspecified\n",
      "C    CA80  Airway disease due to specific organic dust\n",
      "C    CA81  Respiratory conditions due to inhalation of chemicals, gases, fumes or vapours\n",
      "C    CA82  Respiratory conditions due to other external agents\n",
      "C    CA8Y  Other specified lung diseases due to external agents\n",
      "C    CA8Z  Lung diseases due to external agents, unspecified\n",
      "B  Respiratory diseases principally affecting the lung interstitium\n",
      "C    CB00  Acute respiratory distress syndrome\n",
      "C    CB01  Pulmonary oedema\n",
      "C    CB02  Pulmonary eosinophilia\n",
      "C    CB03  Idiopathic interstitial pneumonitis\n",
      "D      H01716  Idiopathic interstitial pneumonias\n",
      "D      H01299  Idiopathic pulmonary fibrosis\n",
      "C    CB04  Primary interstitial lung diseases specific to infancy or childhood\n",
      "D      H00830  Alveolar capillary dysplasia with misalignment of pulmonary veins\n",
      "D      H00217  Pulmonary alveolar proteinosis\n",
      "D      H01122  Congenital pulmonary alveolar proteinosis\n",
      "D      H02124  Interstitial lung and liver disease\n",
      "D      H00913  Brain-lung-thyroid syndrome\n",
      "C    CB05  Interstitial lung diseases associated with systemic diseases\n",
      "D      H02466  Rajab interstitial lung disease with brain calcification\n",
      "C    CB06  Pulmonary alveolar microlithiasis\n",
      "D      H01298  Pulmonary alveolar microlithiasis\n",
      "C    CB07  Lymphangioleiomyomatosis\n",
      "D      H00896  Lymphangioleiomyomatosis\n",
      "C    CB0Y  Other specified respiratory diseases principally affecting the lung interstitium\n",
      "C    CB0Z  Respiratory diseases principally affecting the lung interstitium, unspecified\n",
      "B  Pleural, diaphragm or mediastinal disorders\n",
      "C    CB20  Pleural plaque\n",
      "C    CB21  Pneumothorax\n",
      "D      H01110  Pneumothorax\n",
      "C    CB22  Diseases of mediastinum, not elsewhere classified\n",
      "C    CB23  Disorders of diaphragm\n",
      "C    CB24  Chylous effusion\n",
      "C    CB25  Fibrothorax\n",
      "C    CB26  Haemothorax\n",
      "C    CB27  Pleural effusion\n",
      "C    CB2Y  Other specified pleural, diaphragm or mediastinal disorders\n",
      "C    CB2Z  Pleural, diaphragm or mediastinal disorders, unspecified\n",
      "B  CB40  Certain diseases of the respiratory system\n",
      "B  CB41  Respiratory failure\n",
      "B  Postprocedural disorders of the respiratory system\n",
      "C    CB60  Tracheostomy malfunction\n",
      "C    CB61  Chronic pulmonary insufficiency following surgery\n",
      "C    CB62  Postprocedural subglottic stenosis\n",
      "C    CB63  Postprocedural stenosis of the trachea\n",
      "C    CB64  Transfusion related acute lung injury\n",
      "B  CB7Z  Diseases of the respiratory system, unspecified\n",
      "A13 Diseases of the digestive system\n",
      "B  Diseases or disorders of orofacial complex\n",
      "C    DA00  Disorders of lips\n",
      "C    DA01  Disorders of oral mucosa\n",
      "D      H02648  Acantholytic blistering of the oral and laryngeal mucosa\n",
      "C    DA02  Miscellaneous specified disorders of lips or oral mucosa\n",
      "D      H00724  White sponge nevus\n",
      "C    DA03  Diseases of tongue\n",
      "C    DA04  Diseases of salivary glands\n",
      "C    DA05  Cysts of oral or facial-neck region\n",
      "C    DA06  Certain specified diseases of jaws\n",
      "C    DA07  Disorders of tooth development or eruption\n",
      "D      H00680  Primary failure of tooth eruption\n",
      "C    DA08  Diseases of hard tissues of teeth\n",
      "D      H01331  Dental caries\n",
      "C    DA09  Diseases of pulp or periapical tissues\n",
      "C    DA0A  Certain specified disorders of teeth or supporting structures\n",
      "C    DA0B  Gingival diseases\n",
      "C    DA0C  Periodontal disease\n",
      "D      H01408  Periodontal disease\n",
      "D      H02050  Prepubertal periodontitis\n",
      "D      H01317  Aggressive periodontitis\n",
      "C    DA0D  Certain specified disorders of gingiva or edentulous alveolar ridge\n",
      "D      H01250  Hereditary gingival fibromatosis\n",
      "C    DA0E  Dentofacial anomalies\n",
      "C    DA0F  Sensory disturbances affecting orofacial complex\n",
      "C    DA0Y  Other specified diseases or disorders of orofacial complex\n",
      "C    DA0Z  Diseases or disorders of orofacial complex, unspecified\n",
      "D      H01407  Capnocytophaga ochracea infection\n",
      "B  Diseases of oesophagus\n",
      "C    DA20  Acquired anatomical alterations of the oesophagus\n",
      "C    DA21  Motility disorders of oesophagus\n",
      "C    DA22  Gastro-oesophageal reflux disease\n",
      "D      H01602  Gastroesophageal reflux disease\n",
      "C    DA23  Columnar metaplastic epithelium of the oesophagus\n",
      "D      H01901  Barrett esophagus\n",
      "C    DA24  Oesophagitis\n",
      "D      H01361  Eosinophilic esophagitis\n",
      "C    DA25  Oesophageal ulcer\n",
      "C    DA26  Vascular disorders of the oesophagus\n",
      "C    DA2Y  Other specified diseases of oesophagus\n",
      "C    DA2Z  Diseases of oesophagus, unspecified\n",
      "B  Diseases of the stomach or the duodenum\n",
      "C    Diseases of stomach\n",
      "D      DA40  Acquired anatomical alterations of the stomach\n",
      "D      DA41  Gastroduodenal motor or secretory disorders\n",
      "D      DA42  Gastritis\n",
      "D      DA43  Vascular disorders of the stomach\n",
      "D      DA44  Gastric polyp\n",
      "D      DA4Y  Other specified diseases of stomach\n",
      "C    Diseases of duodenum\n",
      "D      DA50  Acquired anatomical alterations of the duodenum\n",
      "D      DA51  Duodenitis\n",
      "E        H00320  Helicobacter pylori infection\n",
      "D      DA52  Vascular disorders of the duodenum\n",
      "D      DA53  Duodenal polyp\n",
      "D      DA5Y  Other specified diseases of duodenum\n",
      "C    Ulcer of stomach or duodenum\n",
      "D      DA60  Gastric ulcer\n",
      "E        H01634  Peptic ulcer\n",
      "E        H00320  Helicobacter pylori infection\n",
      "E        H02504  Gastrointestinal ulceration, recurrent, with dysfunctional platelets\n",
      "D      DA61  Peptic ulcer, site unspecified\n",
      "E        H01634  Peptic ulcer\n",
      "D      DA62  Anastomotic ulcer\n",
      "E        H01634  Peptic ulcer\n",
      "E        H00320  Helicobacter pylori infection\n",
      "D      DA63  Duodenal ulcer\n",
      "E        H01634  Peptic ulcer\n",
      "E        H00320  Helicobacter pylori infection\n",
      "C    DA7Z  Diseases of the stomach or the duodenum, unspecified\n",
      "B  Diseases of small intestine\n",
      "C    DA90  Nonstructural developmental anomalies of small intestine\n",
      "D      H01805  Tricho-hepato-enteric syndrome\n",
      "D      H01276  Chronic idiopathic intestinal pseudo-obstruction\n",
      "D      H02553  Visceral myopathy\n",
      "C    DA91  Obstruction of small intestine\n",
      "C    DA92  Other acquired anatomical alterations of small intestine\n",
      "C    DA93  Motility disorders of small intestine\n",
      "C    DA94  Noninfectious enteritis or ulcer of small intestine\n",
      "D      H01853  Chronic nonspecific multiple ulcers of the small intestine\n",
      "C    DA95  Coeliac disease\n",
      "D      H02123  Celiac disease\n",
      "C    DA96  Intestinal malabsorption or protein-losing enteropathy\n",
      "D      H00352  Whipple disease\n",
      "D      H00988  Enterokinase deficiency\n",
      "D      H01016  Primary bile acid malabsorption\n",
      "D      H01935  Familial hypercholanemia\n",
      "C    DA97  Certain vascular disorders of small intestine\n",
      "C    DA98  Polyps of small intestine\n",
      "C    DA9Y  Other specified diseases of small intestine\n",
      "C    DA9Z  Diseases of small intestine, unspecified\n",
      "B  Diseases of appendix\n",
      "C    DB10  Appendicitis\n",
      "C    DB11  Certain specified diseases of appendix\n",
      "C    DB1Y  Other specified diseases of appendix\n",
      "C    DB1Z  Diseases of appendix, unspecified\n",
      "B  Diseases of large intestine\n",
      "C    DB30  Obstruction of large intestine\n",
      "C    DB31  Other acquired anatomical alterations of large intestine\n",
      "C    DB32  Motility disorders of large intestine\n",
      "D      H01871  Isolated hypoganglionosis\n",
      "C    DB33  Certain noninfectious colitis or proctitis\n",
      "C    DB34  Certain vascular disorders of large intestine\n",
      "C    DB35  Polyp of large intestine\n",
      "C    DB36  Certain infections of the large intestine\n",
      "C    DB3Y  Other specified diseases of large intestine\n",
      "C    DB3Z  Diseases of large intestine, unspecified\n",
      "B  Diseases of anal canal\n",
      "C    Acquired anatomical alterations of the anal canal\n",
      "D      DB50  Fissure or fistula of anal regions\n",
      "D      DB51  Stenosis of anal canal\n",
      "D      DB52  Ulcer of anus\n",
      "D      DB53  Anal prolapse\n",
      "D      DB5Y  Other specified acquired anatomical alterations of the anal canal\n",
      "D      DB5Z  Acquired anatomical alterations of the anal canal, unspecified\n",
      "C    Haemorrhoids or perianal venous conditions\n",
      "D      DB60  Haemorrhoids\n",
      "D      DB61  Perianal venous thrombosis\n",
      "D      DB62  Residual haemorrhoidal skin tags\n",
      "D      DB6Y  Other specified haemorrhoids or perianal venous conditions\n",
      "D      DB6Z  Haemorrhoids or perianal venous conditions, unspecified\n",
      "C    DB70  Infections of the anal region\n",
      "C    DB71  Anal polyp\n",
      "C    DB72  Certain specified diseases of anal canal\n",
      "C    DB7Y  Other specified diseases of anal canal\n",
      "C    DB7Z  Diseases of anal canal, unspecified\n",
      "B  Diseases of liver\n",
      "C    DB90  Infectious liver disease\n",
      "C    DB91  Acute or subacute hepatic failure\n",
      "D      H01712  Fulminant hepatic failure\n",
      "C    DB92  Non-alcoholic fatty liver disease\n",
      "D      H01333  Non-alcoholic fatty liver disease\n",
      "C    DB93  Hepatic fibrosis or cirrhosis\n",
      "D      H02194  North American Indian childhood cirrhosis\n",
      "D      H02225  Familial cirrhosis\n",
      "C    DB94  Alcoholic liver disease\n",
      "D      H02516  Alcoholic liver disease\n",
      "C    DB95  Drug-induced or toxic liver disease\n",
      "C    DB96  Autoimmune liver disease\n",
      "D      H01685  Autoimmune hepatitis\n",
      "D      H01467  Primary biliary cholangitis\n",
      "D      H01684  Primary sclerosing cholangitis\n",
      "D      H00742  Neonatal ichthyosis-sclerosing cholangitis (NISCH) syndrome\n",
      "C    DB97  Certain specified inflammatory liver diseases\n",
      "C    DB98  Vascular disorders of the liver\n",
      "D      H01687  Extrahepatic portal vein obstruction\n",
      "D      H01433  Budd-Chiari syndrome\n",
      "D      H01686  Idiopathic portal hypertension\n",
      "C    DB99  Certain specified diseases of liver\n",
      "D      H00545  Polycystic liver disease\n",
      "D      H01506  Hepatic encephalopathy\n",
      "C    DB9Z  Diseases of liver, unspecified\n",
      "B  Diseases of gallbladder or biliary tract\n",
      "C    DC10  Acquired anatomical alterations of gallbladder or bile ducts\n",
      "C    DC11  Cholelithiasis\n",
      "D      H01213  Gallbladder disease\n",
      "D      H01679  Intrahepatic lithiasis\n",
      "C    DC12  Cholecystitis\n",
      "D      H01213  Gallbladder disease\n",
      "C    DC13  Cholangitis\n",
      "C    DC14  Certain specified biliary diseases\n",
      "C    DC1Y  Other specified diseases of gallbladder or biliary tract\n",
      "C    DC1Z  Diseases of gallbladder or biliary tract, unspecified\n",
      "B  Diseases of pancreas\n",
      "C    DC30  Cystic diseases of the pancreas\n",
      "C    DC31  Acute pancreatitis\n",
      "D      H01681  Acute pancreatitis\n",
      "C    DC32  Chronic pancreatitis\n",
      "D      H01680  Chronic pancreatitis\n",
      "D      H00933  Hereditary pancreatitis\n",
      "D      H00932  Tropical calcific pancreatitis\n",
      "C    DC33  Autoimmune pancreatitis\n",
      "C    DC34  Obstructive pancreatitis\n",
      "C    DC35  Certain specified diseases of pancreas\n",
      "C    DC3Y  Other specified diseases of pancreas\n",
      "C    DC3Z  Diseases of pancreas, unspecified\n",
      "B  Diseases of peritoneum\n",
      "C    DC50  Peritonitis\n",
      "C    DC51  Certain specified disorders of peritoneum or retroperitoneum\n",
      "C    DC5Z  Diseases of peritoneum, unspecified\n",
      "B  Diverticular disease of intestine\n",
      "C    Diverticular disease of small intestine\n",
      "D      DC70  Diverticulitis of small intestine\n",
      "D      DC71  Diverticulosis of small intestine\n",
      "D      DC72  Diverticulum of small intestine\n",
      "C    Diverticular disease of large intestine\n",
      "D      DC80  Diverticulitis of large intestine\n",
      "D      DC81  Diverticulosis of large intestine\n",
      "D      DC82  Diverticulum of large intestine\n",
      "C    Diverticular disease of intestine of overlapping sites\n",
      "D      DC90  Diverticular disease of small and large intestine\n",
      "C    Diverticular disease of unspecified part of intestine\n",
      "D      DD00  Diverticulitis of unspecified part of intestine\n",
      "D      DD01  Diverticulosis of unspecified part of intestine\n",
      "D      DD02  Diverticulum of unspecified part of intestine\n",
      "C    DD1Z  Diverticular disease of intestine, unspecified\n",
      "B  Ischaemic vascular disorders of intestine\n",
      "C    DD30  Acute vascular disorders of intestine\n",
      "C    DD31  Chronic vascular disorders of intestine\n",
      "C    DD3Y  Other specified ischaemic vascular disorders of intestine\n",
      "C    DD3Z  Ischaemic vascular disorders of intestine, unspecified\n",
      "B  Hernias\n",
      "C    DD50  Non-abdominal wall hernia\n",
      "C    DD51  Inguinal hernia\n",
      "C    DD52  Femoral hernia\n",
      "C    DD53  Umbilical hernia\n",
      "C    DD54  Paraumbilical hernia\n",
      "C    DD55  Epigastric hernia\n",
      "C    DD56  Incisional hernia\n",
      "C    DD57  Parastomal hernia\n",
      "C    DD5Y  Other specified hernias\n",
      "C    DD5Z  Hernias, unspecified\n",
      "B  Inflammatory bowel diseases\n",
      "C    DD70  Crohn disease\n",
      "D      H00286  Crohn disease\n",
      "D      H01227  Inflammatory bowel disease (IBD)\n",
      "C    DD71  Ulcerative colitis\n",
      "D      H01227  Inflammatory bowel disease (IBD)\n",
      "D      H01466  Ulcerative colitis\n",
      "C    DD72  Indeterminate colitis\n",
      "D      H01227  Inflammatory bowel disease (IBD)\n",
      "C    DD7Y  Other specified inflammatory bowel diseases\n",
      "C    DD7Z  Inflammatory bowel diseases, unspecified\n",
      "B  Functional gastrointestinal disorders\n",
      "C    DD90  Functional oesophageal or gastroduodenal disorders\n",
      "C    DD91  Irritable bowel syndrome or certain specified functional bowel disorders\n",
      "D      H01615  Irritable bowel syndrome\n",
      "C    DD92  Functional anorectal disorders\n",
      "C    DD93  Functional digestive disorders of infants, toddlers or children\n",
      "C    DD94  Functional gallbladder disorder\n",
      "C    DD95  Functional sphincter of Oddi disorder\n",
      "C    DD9Y  Other specified functional gastrointestinal disorders\n",
      "C    DD9Z  Functional gastrointestinal disorders, unspecified\n",
      "B  Postprocedural disorders of digestive system\n",
      "C    DE10  Vomiting following gastrointestinal surgery\n",
      "C    DE11  Dumping syndrome\n",
      "C    DE12  Malfunction or complication of external stoma of digestive organs\n",
      "C    DE13  Postsurgical malabsorption, not elsewhere classified\n",
      "B  DE2Y  Other specified diseases of the digestive system\n",
      "B  DE2Z  Diseases of the digestive system, unspecified\n",
      "A14 Diseases of the skin\n",
      "B  Certain skin disorders attributable to infection or infestation\n",
      "C    Certain skin disorders attributable to viral infection\n",
      "D      Viral exanthems\n",
      "E        EA00  Viral exanthem due to unknown or unspecified agent\n",
      "E        EA0Y  Viral exanthem due to other specified virus\n",
      "D      Certain dermatoses with suspected viral aetiology\n",
      "E        EA10  Pityriasis rosea\n",
      "F          H01660  Pityriasis rosea\n",
      "E        EA11  Papular purpuric gloves and socks syndrome\n",
      "E        EA12  Infantile papular acrodermatitis\n",
      "D      Dermatoses from distant or systemic viral infection\n",
      "E        EA20  Necrolytic acral erythema\n",
      "D      EA3Z  Unspecified skin disorder attributable to viral infection\n",
      "C    Certain skin disorders attributable to bacterial infection\n",
      "D      Predominantly tropical or subtropical bacterial infections affecting skin\n",
      "E        EA40  Tropical phagedaenic ulcer\n",
      "D      EA50  Toxin-mediated cutaneous reactions to distant or systemic bacterial infection\n",
      "D      EA51  Skin complications of BCG immunisation\n",
      "D      EA5Y  Cutaneous involvement by other specified bacterial infection\n",
      "D      EA5Z  Cutaneous involvement by unspecified bacterial infection\n",
      "C    EA60  Certain skin disorders attributable to fungal infection\n",
      "C    EA6Y  Cutaneous involvement by other specified infection or infestation\n",
      "B  Inflammatory dermatoses\n",
      "C    Dermatitis and eczema\n",
      "D      EA80  Atopic eczema\n",
      "E        H01358  Atopic dermatitis\n",
      "D      EA81  Seborrhoeic dermatitis and related conditions\n",
      "E        H00795  Seborrhea-like dermatitis with psoriasiform element\n",
      "E        H01652  Seborrheic dermatitis\n",
      "D      EA82  Nummular dermatitis\n",
      "D      EA83  Lichen simplex or lichenification\n",
      "D      EA84  Asteatotic eczema\n",
      "D      EA85  Dermatitis or eczema of hands and feet\n",
      "D      EA86  Dermatitis and eczema of lower legs\n",
      "D      EA87  Dermatitis or eczema of anogenital region\n",
      "D      EA88  Miscellaneous specified eczematous dermatoses\n",
      "D      EA89  Generalised eczematous dermatitis of unspecified type\n",
      "D      EA8Y  Other specified eczematous dermatosis\n",
      "D      EA8Z  Dermatitis or eczema, unspecified\n",
      "C    Papulosquamous dermatoses\n",
      "D      EA90  Psoriasis\n",
      "E        H01656  Psoriasis\n",
      "E        H01663  Pustular psoriasis\n",
      "D      EA91  Lichen planus\n",
      "E        H01654  Lichen planus\n",
      "D      EA92  Lichenoid dermatoses\n",
      "D      EA93  Pityriasis lichenoides\n",
      "D      EA94  Pityriasis rubra pilaris\n",
      "E        H01659  Pityriasis rubra pilaris\n",
      "D      EA95  Small plaque parapsoriasis\n",
      "C    Urticaria, angioedema and other urticarial disorders\n",
      "D      EB00  Spontaneous urticaria\n",
      "D      EB01  Inducible urticaria and angioedema\n",
      "E        H01799  Vibratory urticaria\n",
      "D      EB02  Cholinergic urticaria and related conditions\n",
      "D      EB03  Syndromes with urticarial reactions or angioedema\n",
      "D      EB04  Idiopathic angioedema\n",
      "D      EB05  Urticaria of unspecified type\n",
      "D      EB0Y  Other specified urticarial disorders\n",
      "C    Inflammatory erythemas and other reactive inflammatory dermatoses\n",
      "D      EB10  Diffuse inflammatory erythemas\n",
      "D      EB11  Annular erythema\n",
      "D      EB12  Erythema multiforme\n",
      "E        H01695  Erythema multiforme\n",
      "D      EB13  Stevens-Johnson syndrome or toxic epidermal necrolysis\n",
      "E        H01694  Stevens-Johnson syndrome\n",
      "D      Neutrophilic dermatoses\n",
      "E        EB20  Acute febrile neutrophilic dermatosis\n",
      "F          H02590  Acute febrile neutrophilic dermatosis\n",
      "E        EB21  Pyoderma gangrenosum\n",
      "E        EB2Y  Other specified neutrophilic dermatoses\n",
      "D      EB30  Eosinophilic cellulitis\n",
      "D      EB31  Erythema nodosum\n",
      "E        H01473  Erythema nodosum leprosum\n",
      "C    Immunobullous diseases of the skin\n",
      "D      EB40  Pemphigus\n",
      "E        H01648  Pemphigus\n",
      "D      EB41  Pemphigoid\n",
      "E        H01650  Pemphigoid\n",
      "D      EB42  Linear IgA bullous dermatosis\n",
      "D      EB43  Epidermolysis bullosa acquisita\n",
      "D      EB44  Dermatitis herpetiformis\n",
      "E        H01362  Dermatitis herpetiformis\n",
      "D      EB4Y  Other specified immunobullous disorder\n",
      "C    Cutaneous lupus erythematosus\n",
      "D      EB50  Subacute cutaneous lupus erythematosus\n",
      "E        H01595  Cutaneous lupus erythematosus\n",
      "D      EB51  Chronic cutaneous lupus erythematosus\n",
      "E        H01595  Cutaneous lupus erythematosus\n",
      "D      EB5Z  Cutaneous lupus erythematosus of unspecified type\n",
      "C    Scarring or sclerosing inflammatory dermatoses\n",
      "D      EB60  Lichen sclerosus\n",
      "E        H01690  Lichen sclerosus et atrophicus\n",
      "D      EB61  Morphoea\n",
      "E        H01493  Localized Scleroderma\n",
      "C    EB7Y  Other specified inflammatory dermatoses\n",
      "B  Metabolic and nutritional disorders affecting the skin\n",
      "C    EB90  Dermatoses resulting from disturbed metabolic processes\n",
      "D      H01661  Xanthoma\n",
      "C    EB9Y  Other specified metabolic and nutritional disorders affecting the skin\n",
      "B  Genetic and developmental disorders affecting the skin\n",
      "C    Genetic syndromes affecting the skin\n",
      "D      EC10  Genetic syndromes with poikiloderma\n",
      "E        H00793  Poikiloderma with neutropenia\n",
      "E        H01906  Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis\n",
      "D      EC1Y  Other specified genetic syndromes affecting the skin\n",
      "C    EC20  Genetic disorders of keratinisation\n",
      "D      H01771  Congenital ichthyosis\n",
      "D      H00735  Ichthyosis vulgaris\n",
      "D      H00134  X-linked ichthyosis\n",
      "D      H00733  Harlequin ichthyosis\n",
      "D      H00734  Autosomal recessive congenital ichthyosis\n",
      "D      H00691  Bullous congenital ichthyosiform erythroderma (BCIE)\n",
      "D      H00693  Ichthyosis bullosa of Siemens\n",
      "D      H00707  Ichthyosis hystrix, Curth-Macklin type\n",
      "D      H02265  Annular epidermolytic ichthyosis\n",
      "D      H00710  Erythrokeratodermia variabilis\n",
      "D      H00738  Ichthyosis with confetti\n",
      "D      H00790  Keratosis linearis with ichthyosis congenita and sclerosing keratoderma\n",
      "D      H02449  Autosomal dominant lamellar ichthyosis\n",
      "D      H00737  Peeling skin syndrome\n",
      "D      H00715  Darier disease\n",
      "D      H00844  Familial benign chronic pemphigus\n",
      "D      H00716  Palmoplantar keratoderma with deafness\n",
      "D      H00274  Papillon-Lefevre syndrome\n",
      "D      H00695  Mal de Meleda\n",
      "D      H00714  Vohwinkel syndrome\n",
      "D      H00722  Epidermolytic palmoplantar keratoderma\n",
      "D      H00723  Non-epidermolytic palmoplantar keratoderma\n",
      "D      H02264  Palmoplantar keratoderma, Nagashima type\n",
      "D      H02266  Palmoplantar keratoderma, Bothnian type\n",
      "D      H02517  Olmsted syndrome\n",
      "D      H00717  Striate palmoplantar keratoderma\n",
      "D      H02263  Focal nonepidermolytic palmoplantar keratoderma\n",
      "D      H00755  Acrokeratosis verruciformis\n",
      "D      H01394  Cole disease\n",
      "C    EC21  Genetic defects of hair or hair growth\n",
      "D      H00667  Woolly hair\n",
      "D      H00670  Monilethrix\n",
      "D      H01796  Uncombable hair syndrome\n",
      "D      H00820  Bjornstad syndrome\n",
      "D      H00866  Trichothiodystrophy\n",
      "D      H00893  Skin fragility-woolly hair syndrome\n",
      "D      H00780  Atrichia with papular lesions\n",
      "D      H00784  Localized autosomal recessive hypotrichosis\n",
      "D      H00786  Hypotrichosis\n",
      "D      H00858  Marie-Unna hereditary hypotrichosis\n",
      "D      H00782  Hypotrichosis and recurrent skin vesicles\n",
      "C    EC22  Genetic defects of nails or nail growth\n",
      "D      H00683  Anonychia congenita\n",
      "D      H01307  Nonsyndromic congenital nail disorder\n",
      "C    EC23  Genetic disorders of skin pigmentation\n",
      "D      H00884  Familial progressive hyperpigmentation\n",
      "D      H00944  Dowling-Degos disease\n",
      "D      H02188  Watson syndrome\n",
      "D      H00166  Hermansky-Pudlak syndrome\n",
      "D      H00168  Oculocutaneous albinism\n",
      "D      H02021  Chediak-Higashi syndrome\n",
      "D      H00170  Piebaldism\n",
      "D      H00759  Waardenburg syndrome\n",
      "D      H00885  Hypomelanosis of Ito\n",
      "D      H01187  Tietz syndrome\n",
      "D      H02022  Griscelli syndrome\n",
      "D      H00880  Dyschromatosis symmetrica hereditaria\n",
      "D      H02350  Dyschromatosis universalis hereditaria\n",
      "C    Genetically-determined epidermolysis bullosa\n",
      "D      EC30  Epidermolysis bullosa simplex\n",
      "E        H00584  Epidermolysis bullosa simplex\n",
      "E        H00585  Epidermolysis bullosa, hemidesmosomal\n",
      "E        H00644  Ectodermal dysplasia/skin fragility syndrome\n",
      "D      EC31  Junctional epidermolysis bullosa\n",
      "E        H00586  Epidermolysis bullosa, junctional\n",
      "D      EC32  Dystrophic epidermolysis bullosa\n",
      "E        H00587  Epidermolysis bullosa, dystrophica\n",
      "E        H00763  Transient bullous dermolysis of the newborn\n",
      "D      EC33  Syndromic epidermolysis bullosa\n",
      "E        H00588  Kindler syndrome\n",
      "D      EC3Z  Epidermolysis bullosa\n",
      "E        H00813  Laryngo onycho cutaneous syndrome\n",
      "E        H01737  Epidermolysis bullosa\n",
      "C    Genetic disorders affecting dermal collagen, elastin or other matrix proteins\n",
      "D      EC40  Pseudoxanthoma elasticum\n",
      "E        H00560  Pseudoxanthoma elasticum\n",
      "D      EC4Y  Other specified genetic disorders affecting dermal matrix proteins\n",
      "C    Specified developmental anomalies affecting the skin\n",
      "D      EC50  Developmental anomalies of the umbilicus\n",
      "D      EC5Y  Other specified developmental anomalies affecting the skin\n",
      "C    EC7Y  Other specified genetic and developmental disorders affecting the skin\n",
      "B  Sensory and psychological disorders affecting the skin\n",
      "C    Disturbances of cutaneous sensation\n",
      "D      EC90  Pruritus\n",
      "D      EC91  Prurigo\n",
      "D      EC92  Mucocutaneous or cutaneous pain syndromes\n",
      "D      EC9Y  Other specified disturbances of cutaneous sensation\n",
      "C    Psychological or psychiatric conditions affecting the skin\n",
      "D      Self-inflicted skin disorders\n",
      "E        ED00  Artefactual skin disorder\n",
      "E        ED01  Simulated skin disease\n",
      "E        ED02  Painful bruising syndrome\n",
      "E        ED0Y  Other specified self-inflicted skin disorders\n",
      "D      ED2Y  Other specified psychological or psychiatric conditions affecting the skin\n",
      "C    Neurological conditions affecting the skin\n",
      "D      ED30  Neuropathic skin damage\n",
      "D      ED31  Burning feet syndrome\n",
      "D      ED3Y  Cutaneous involvement in other specified neurological condition\n",
      "B  Skin disorders involving specific cutaneous structures\n",
      "C    Disorders of the epidermis and epidermal appendages\n",
      "D      Disorders of epidermal keratinisation\n",
      "E        ED50  Ichthyoses\n",
      "E        ED51  Diffuse epidermal hyperkeratosis and acanthosis\n",
      "E        ED52  Porokeratoses\n",
      "F          H00791  Disseminated superficial actinic porokeratosis (DSAP)\n",
      "F          H01933  Porokeratosis\n",
      "E        ED53  Skin peeling\n",
      "E        ED54  Xerosis cutis or asteatosis\n",
      "E        ED55  Palmoplantar keratodermas\n",
      "F          H01673  Palmoplantar keratoderma\n",
      "F          H02318  Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal\n",
      "E        ED56  Keratosis pilaris\n",
      "F          H00750  Keratosis pilaris atrophicans\n",
      "E        ED5Y  Other specified disorders of epidermal keratinisation\n",
      "D      Disorders of skin colour\n",
      "E        ED60  Acquired hypermelanosis\n",
      "E        ED61  Acquired melanotic macules or lentigines\n",
      "E        ED62  Endogenous non-melanin pigmentation\n",
      "E        ED63  Acquired hypomelanotic disorders\n",
      "F          H01372  Vitiligo\n",
      "F          H01504  Vogt-Koyanagi-Harada syndrome\n",
      "E        ED64  Abnormal skin pigmentation\n",
      "E        ED6Y  Other specified disorders of skin pigmentation\n",
      "D      Disorders of hair\n",
      "E        ED70  Alopecia or hair loss\n",
      "F          H01158  Alopecia universalis\n",
      "E        ED71  Hypertrichosis\n",
      "E        ED72  Hirsutism and syndromes with hirsutism\n",
      "E        ED73  Acquired disorders of the hair shaft\n",
      "E        ED7Y  Other specified disorders of hair\n",
      "D      Disorders of the hair follicle\n",
      "E        Acne and related disorders\n",
      "F          ED80  Acne\n",
      "G            H01445  Acne vulgaris\n",
      "F          ED81  Acneform inflammatory disorders\n",
      "E        ED90  Rosacea and related disorders\n",
      "E        ED91  Disorders of the sebaceous gland\n",
      "E        ED92  Disorders involving the apocrine follicular unit\n",
      "F          H00681  Acne inversa\n",
      "E        ED9Y  Other specified disorders involving the hair follicle\n",
      "F          H00672  Pseudofolliculitis barbae\n",
      "D      Disorders of eccrine sweat glands or sweating\n",
      "E        EE00  Hyperhidrosis\n",
      "E        EE01  Hypohidrosis\n",
      "F          H01848  Acquired idiopathic generalized anhidrosis\n",
      "F          H02281  Isolated anhidrosis with normal sweat glands\n",
      "E        EE02  Miliaria\n",
      "E        EE0Y  Other specified disorders of eccrine sweat glands or sweating\n",
      "D      Disorders of the nail or perionychium\n",
      "E        EE10  Acquired deformities of the nail plate\n",
      "E        EE11  Acquired abnormalities of nail colour\n",
      "E        EE12  Infections of the nail or perionychium\n",
      "E        EE13  Certain disorders affecting the nails or perionychium\n",
      "E        EE1Y  Other specified disorders of the nail or perionychium\n",
      "E        EE1Z  Disorders of the nail or perionychium, unspecified\n",
      "D      Disorders of epidermal integrity\n",
      "E        EE20  Acute cutaneous distension syndrome\n",
      "E        EE21  Epidermal fragility\n",
      "C    Disorders of the dermis and subcutis\n",
      "D      Disorders of cutaneous connective tissue\n",
      "E        EE40  Atrophy or degeneration of dermal or subcutaneous connective tissue\n",
      "E        EE41  Abnormalities of dermal elastin\n",
      "F          H00557  Cutis laxa\n",
      "E        Poikiloderma\n",
      "F          EE50  Acquired poikiloderma\n",
      "E        Fibromatoses and keloids\n",
      "F          EE60  Keloid or hypertrophic scars\n",
      "F          EE61  Superficial fibromatoses\n",
      "F          EE6Y  Other specified fibromatous disorders of skin and soft tissue\n",
      "G            H00663  Restrictive dermopathy\n",
      "G            H01173  Stiff skin syndrome\n",
      "E        EE70  Perforating dermatoses\n",
      "E        EE7Y  Other specified disorders of cutaneous connective tissue\n",
      "D      Histiocytic-granulomatous disorders of the skin\n",
      "E        EE80  Necrobiotic granulomatous skin disorders\n",
      "E        EE81  Dermal dendrocyte, Class IIa histiocytoses\n",
      "E        EE8Y  Other specified histiocytic and granulomatous disorders of the skin\n",
      "D      Benign dermal lymphocytic or lymphoplasmacytic infiltrations or proliferations\n",
      "E        EE90  Benign lymphocytic infiltration of the skin\n",
      "E        EE91  Lymphocytoma cutis\n",
      "D      Disorders of subcutaneous fat\n",
      "E        EF00  Panniculitis\n",
      "E        EF01  Lipoatrophy or lipodystrophy\n",
      "F          H01475  Lipodystrophy\n",
      "E        EF02  Certain noninflammatory disorders of subcutaneous fat\n",
      "E        EF0Y  Other specified disorders of subcutaneous fat\n",
      "C    Disorders of cutaneous blood and lymphatic vessels\n",
      "D      Malformations involving cutaneous blood vessels\n",
      "E        EF20  Acquired malformations of cutaneous blood vessels\n",
      "E        EF2Z  Cutaneous vascular malformation, unspecified\n",
      "D      Purpura or bruising\n",
      "E        EF30  Purpura or bruising due to disorders of coagulation\n",
      "E        EF31  Traumatic purpura\n",
      "E        EF3Y  Other specified purpura\n",
      "E        EF3Z  Purpura of unspecified aetiology\n",
      "D      EF40  Vasculitis or capillaritis involving the skin\n",
      "D      Dermatoses attributable to hyperviscosity or microvascular occlusion\n",
      "E        EF50  Livedoid vasculopathy\n",
      "E        EF5Y  Other specified dermatoses attributable to hyperviscosity or microvascular occlusion\n",
      "D      Dermatoses resulting from vascular insufficiency\n",
      "E        EF60  Ischaemic ulceration of skin\n",
      "E        Dermatoses due to venous disease\n",
      "F          EF70  Lower limb venous eczema\n",
      "F          EF7Y  Other specified dermatoses due to venous disease\n",
      "F          EF7Z  Dermatoses due to venous disease, unspecified\n",
      "E        EF9Y  Other specified dermatoses resulting from vascular insufficiency\n",
      "D      Functional vascular disorders of the skin\n",
      "E        EG00  Vasodilatation of extremities\n",
      "F          H00771  Inherited erythromelalgia\n",
      "E        EG01  Vasoconstriction of extremities\n",
      "E        EG02  Flushing disorders\n",
      "B  Skin disorders involving certain specific body regions\n",
      "C    Skin disorders involving the head and neck\n",
      "D      EG30  Skin disorders localised to the scalp\n",
      "E        H01446  Propionibacterium acnes infection\n",
      "D      Disorders of the external ear involving the skin\n",
      "E        Inflammatory disorders of the external ear\n",
      "F          EG40  Contact dermatitis of external ear\n",
      "F          EG4Y  Other specified inflammatory disorder of external ear\n",
      "F          EG4Z  Inflammatory disorder of external ear, unspecified\n",
      "C    Skin disorders involving the genital and perianal regions\n",
      "D      Dermatoses of the anus, perianal area or perineum\n",
      "E        EG60  Anal pruritus\n",
      "E        EG61  Infections of the anus or perianal skin\n",
      "E        EG62  Inflammatory dermatoses of the perianal area\n",
      "E        EG63  Sacrococcygeal pilonidal disease\n",
      "D      EG7Y  Other specified skin disorders involving the genital and perianal regions\n",
      "C    EG9Y  Skin disorders involving other specific body regions\n",
      "C    EG9Z  Skin disorders involving certain specific body regions, unspecified\n",
      "B  Skin disorders associated with pregnancy, the neonatal period and infancy\n",
      "C    Skin disorders specific to the perinatal or neonatal period\n",
      "D      Neonatal skin infection\n",
      "E        EH10  Neonatal viral infections involving the skin\n",
      "E        EH11  Neonatal pyogenic skin infections\n",
      "E        EH12  Neonatal fungal infections involving the skin\n",
      "E        EH1Z  Neonatal skin infection, unspecified\n",
      "D      EH3Y  Other specified skin disorders specific to the perinatal or neonatal period\n",
      "C    EH40  Dermatoses of infancy\n",
      "B  Adverse cutaneous reactions to medication\n",
      "C    Drug eruptions\n",
      "D      EH60  Exanthematic drug eruption\n",
      "D      EH61  Drug-induced urticaria, angioedema and anaphylaxis\n",
      "D      EH62  Lichenoid drug eruption\n",
      "D      EH63  Stevens-Johnson syndrome and toxic epidermal necrolysis due to drug\n",
      "D      EH64  Drug-induced erythroderma\n",
      "D      EH65  DRESS syndrome\n",
      "D      EH66  Fixed drug eruption\n",
      "D      EH67  Acne or acneform reactions attributable to drugs\n",
      "D      EH6Y  Drug eruption of other specified type\n",
      "D      EH6Z  Drug eruption of unspecified type\n",
      "C    EH70  Pigmentary abnormalities of skin due to drug\n",
      "C    EH71  Dermatoses precipitated by drug therapy\n",
      "C    EH72  Drug-induced hair abnormalities\n",
      "C    EH73  Drug-induced nail abnormalities\n",
      "C    EH74  Drug-induced oral conditions\n",
      "C    EH75  Photosensitivity due to drug\n",
      "C    EH76  Dermatoses associated with specific classes of medication\n",
      "C    EH77  Localised adverse cutaneous reactions to administration of drug\n",
      "C    EH78  Adverse cutaneous reactions to herbal, homoeopathic or other alternative therapies\n",
      "C    EH7Y  Other specified adverse cutaneous reactions to medication\n",
      "C    EH7Z  Unspecified adverse cutaneous reactions to medication\n",
      "B  Skin disorders provoked by external factors\n",
      "C    EH90  Pressure ulceration\n",
      "C    EH92  Dermatoses provoked by friction or mechanical stress\n",
      "C    EH93  Dermatoses due to foreign bodies\n",
      "C    EH94  Scar of skin, not elsewhere classified\n",
      "C    Dermatoses provoked or exacerbated by exposure to cold\n",
      "D      EJ0Y  Other specified dermatoses provoked or exacerbated by exposure to cold\n",
      "C    Dermatoses provoked by heat or electricity\n",
      "D      EJ10  Erythema ab igne\n",
      "D      EJ1Y  Other specified dermatoses provoked by heat or electricity\n",
      "C    Dermatoses provoked by light or UV radiation\n",
      "D      Chronic effects of ultraviolet radiation on the skin\n",
      "E        EJ20  Photoaging of the skin\n",
      "E        EJ2Y  Other specified chronic effects of ultraviolet radiation on the skin\n",
      "D      EJ30  Autoimmune or other photodermatoses\n",
      "D      Acute effects of ultraviolet radiation on normal skin\n",
      "E        EJ40  Sunburn\n",
      "E        EJ41  Burn from exposure to artificial source of ultraviolet radiation\n",
      "E        EJ4Z  Acute effects of ultraviolet radiation on normal skin, unspecified\n",
      "D      EJ6Y  Other specified dermatoses provoked by light or UV radiation\n",
      "E        H02131  UV-sensitive syndrome\n",
      "C    Dermatoses due to ionizing radiation\n",
      "D      EJ71  Chronic effects of ionizing radiation on the skin\n",
      "D      EJ7Z  Dermatoses due to ionizing radiation, unspecified\n",
      "C    EK00  Allergic contact dermatitis\n",
      "D      H01357  Allergic contact dermatitis\n",
      "C    EK01  Photo-allergic contact dermatitis\n",
      "C    EK02  Irritant contact dermatitis\n",
      "C    EK10  Allergic contact urticaria\n",
      "C    EK11  Protein contact dermatitis\n",
      "C    EK12  Allergic contact sensitisation\n",
      "C    Phototoxic reactions to skin contact with photoactive agents\n",
      "D      EK20  Phototoxic reaction to fragrance or cosmetics\n",
      "D      EK2Y  Phototoxic reaction to skin contact with other specified photoactive agent\n",
      "D      EK2Z  Phototoxic dermatitis, unspecified\n",
      "C    EK50  Cutaneous reactions to venomous or noxious animals\n",
      "C    EK5Y  Other specified skin disorders provoked by external factors\n",
      "B  Benign proliferations, neoplasms and cysts of the skin\n",
      "C    EK70  Cutaneous cysts\n",
      "C    EK71  Skin tags or polyps\n",
      "B  Disorders of the skin of uncertain or unpredictable malignant potential\n",
      "C    EK90  Actinic keratosis and other discrete epidermal dysplasias\n",
      "D      H02429  Actinic keratosis\n",
      "C    EK91  Dermatoses which may presage cutaneous lymphoma\n",
      "C    EK92  Histiocytoses of uncertain malignant potential\n",
      "D      H01168  Sea-blue histiocyte disease\n",
      "B  Cutaneous markers of internal disorders\n",
      "C    Cutaneous markers of internal malignancy\n",
      "D      EL10  Paraneoplastic syndromes involving skin\n",
      "D      EL1Y  Other specified cutaneous markers of internal malignancy\n",
      "C    EL3Y  Other specified cutaneous markers of internal disorders\n",
      "B  Postprocedural disorders of the skin\n",
      "C    EL50  Unsatisfactory surgical scar of skin\n",
      "C    EL51  Cutaneous flap necrosis\n",
      "C    EL52  Myocutaneous flap necrosis\n",
      "C    EL53  Skin graft failure\n",
      "C    EL54  Composite graft failure\n",
      "C    Adverse cutaneous effects of therapeutic ionizing irradiation\n",
      "D      EL60  Acute radiodermatitis following radiotherapy\n",
      "D      EL61  Chronic radiodermatitis following radiotherapy\n",
      "D      EL63  Radionecrosis of skin due to therapeutic ionizing irradiation\n",
      "C    Complications of cutaneous cosmetic procedures\n",
      "D      EL73  Unsatisfactory outcome from cutaneous cosmetic surgical procedure\n",
      "C    EL80  Adverse cutaneous effects of diagnostic procedures\n",
      "B  EM0Y  Other specified diseases of the skin\n",
      "B  EM0Z  Skin disease of unspecified nature\n",
      "A15 Diseases of the musculoskeletal system or connective tissue\n",
      "B  Arthropathies\n",
      "C    Osteoarthritis\n",
      "D      FA00  Osteoarthritis of hip\n",
      "D      FA01  Osteoarthritis of knee\n",
      "D      FA02  Osteoarthritis of wrist or hand\n",
      "D      FA03  Osteoarthritis of other specified joint\n",
      "D      FA04  Oligoosteoarthritis\n",
      "D      FA05  Polyosteoarthritis\n",
      "D      FA0Z  Osteoarthritis, unspecified\n",
      "C    Infection related arthropathies\n",
      "D      FA10  Direct infections of joint\n",
      "E        H01442  Septic arthritis\n",
      "D      FA11  Reactive arthropathies\n",
      "D      FA12  Postinfectious arthropathies\n",
      "D      FA13  Infectious spondyloarthritis\n",
      "D      FA1Y  Other specified infection related arthropathies\n",
      "D      FA1Z  Infection related arthropathies, unspecified\n",
      "C    Inflammatory arthropathies\n",
      "D      FA20  Rheumatoid arthritis\n",
      "E        H00630  Rheumatoid arthritis\n",
      "D      FA21  Psoriatic arthritis\n",
      "D      FA22  Polymyalgia rheumatica\n",
      "E        H01606  Polymyalgia rheumatica\n",
      "D      FA23  Adult-onset Still disease\n",
      "E        H01516  Adult onset Still disease\n",
      "D      FA24  Juvenile idiopathic arthritis\n",
      "E        H01672  Juvenile idiopathic arthritis\n",
      "D      FA25  Gout\n",
      "E        H01532  Gout\n",
      "D      FA26  Certain specified crystal arthropathies\n",
      "E        H01236  Familial articular chondrocalcinosis\n",
      "D      FA27  Certain specified inflammatory arthropathies\n",
      "E        H01507  Seronegative arthritis\n",
      "D      FA2Z  Inflammatory arthropathies, unspecified\n",
      "C    Certain specified joint disorders or deformities of limbs\n",
      "D      FA30  Acquired deformities of fingers or toes\n",
      "D      FA31  Other acquired deformities of limbs\n",
      "D      FA32  Disorders of patella\n",
      "D      FA33  Internal derangement of knee\n",
      "D      FA34  Certain specified joint derangements\n",
      "D      FA35  Wear of articular bearing surface of joint prosthesis\n",
      "D      FA36  Effusion of joint\n",
      "D      FA37  Certain joint disorders, not elsewhere classified\n",
      "D      FA38  Arthropathy in diseases classified elsewhere\n",
      "D      FA3Z  Unspecified joint disorders and deformities of limbs\n",
      "C    FA5Y  Other specified arthropathies\n",
      "C    FA5Z  Arthropathies, unspecified\n",
      "B  Conditions associated with the spine\n",
      "C    Structural disorders of spine\n",
      "D      FA70  Spinal deformities\n",
      "D      FA71  Torticollis\n",
      "D      FA72  Disorders of vertebra\n",
      "E        H01708  Diffuse idiopathic skeletal hyperostosis\n",
      "D      FA7Y  Other specified structural disorders of spine\n",
      "D      FA7Z  Structural disorders of spine, unspecified\n",
      "C    Degenerative condition of spine\n",
      "D      FA80  Intervertebral disc degeneration\n",
      "E        H02539  Intervertebral disc disease\n",
      "D      FA81  Spondylolysis\n",
      "D      FA82  Spinal stenosis\n",
      "E        H01711  Spinal stenosis\n",
      "D      FA83  Ossification of spinal ligaments\n",
      "E        H00431  Ossification of the posterior longitudinal ligament of spine\n",
      "E        H01707  Ossified ligamentum flavum\n",
      "D      FA84  Spondylolisthesis\n",
      "D      FA85  Spinal endplate defects\n",
      "D      FA8Y  Other specified degenerative condition of spine\n",
      "D      FA8Z  Degenerative condition of spine, unspecified\n",
      "C    Inflammation of spine\n",
      "D      FA90  Infection of vertebra\n",
      "D      FA91  Infection of intervertebral disc\n",
      "D      FA92  Inflammatory spondyloarthritis\n",
      "E        H01674  Ankylosing spondylitis\n",
      "D      FA9Y  Other specified inflammation of spine\n",
      "D      FA9Z  Inflammation of spine, unspecified\n",
      "C    Spondylopathies\n",
      "D      FB00  Ankylosis of spinal joint\n",
      "D      FB0Y  Other specified spondylopathies\n",
      "D      FB0Z  Spondylopathies, unspecified\n",
      "C    FB10  Spinal instabilities\n",
      "C    FB1Y  Other specified conditions associated with the spine\n",
      "C    FB1Z  Conditions associated with the spine, unspecified\n",
      "B  Soft tissue disorders\n",
      "C    Disorders of muscles\n",
      "D      FB30  Infectious myositis\n",
      "D      FB31  Calcification or ossification of muscle\n",
      "E        H00441  Progressive osseous heteroplasia\n",
      "E        H00430  Fibrodysplasia ossificans progressiva\n",
      "D      FB32  Certain specified disorders of muscle\n",
      "E        H02452  Muscle hypertrophy\n",
      "D      FB33  Secondary disorders of muscle\n",
      "D      FB3Z  Disorders of muscles, unspecified\n",
      "C    Disorders of synovium or tendon\n",
      "D      FB40  Tenosynovitis\n",
      "D      FB41  Spontaneous rupture of synovium or tendon\n",
      "D      FB42  Certain specified disorders of synovium or tendon\n",
      "D      FB43  Secondary disorders of synovium or tendon\n",
      "D      FB4Y  Other specified disorders of synovium or tendon\n",
      "D      FB4Z  Disorders of synovium or tendon, unspecified\n",
      "C    Miscellaneous specified soft tissue disorders\n",
      "D      FB50  Bursitis\n",
      "D      FB51  Fibroblastic disorders\n",
      "D      FB52  Soft tissue disorders in diseases classified elsewhere\n",
      "D      FB53  Shoulder lesions\n",
      "D      FB54  Enthesopathies of lower limb\n",
      "D      FB55  Certain specified enthesopathies\n",
      "D      FB56  Specified soft tissue disorders, not elsewhere classified\n",
      "C    FB6Z  Soft tissue disorders, unspecified\n",
      "B  Osteopathies or chondropathies\n",
      "C    FB80  Certain specified disorders of bone density or structure\n",
      "D      H00501  Fibrous dysplasia, polyostotic\n",
      "D      H01774  Hyperostosis corticalis generalisata\n",
      "D      H02609  Craniodiaphyseal dysplasia\n",
      "C    FB81  Osteonecrosis\n",
      "D      H01709  Glucocorticoid-induced osteonecrosis\n",
      "C    FB82  Chondropathies\n",
      "D      H00448  Familial osteochondritis dissecans\n",
      "D      H01526  Legg-Calve-Perthes Disease\n",
      "D      H01529  Avascular necrosis of femoral head\n",
      "D      H01758  Relapsing polychondritis\n",
      "C    FB83  Low bone mass disorders\n",
      "D      H01593  Osteoporosis\n",
      "C    FB84  Osteomyelitis or osteitis\n",
      "C    FB85  Paget disease of bone\n",
      "D      H00437  Paget disease of bone\n",
      "C    FB86  Disorders associated with bone growth\n",
      "D      H00457  Primary hypertrophic osteoarthropathy\n",
      "D      H00472  Torg syndrome\n",
      "D      H00614  Hyaline fibromatosis syndrome\n",
      "D      H00623  Hajdu-Cheney syndrome\n",
      "D      H01865  Multicentric carpotarsal osteolysis syndrome\n",
      "D      H02042  Familial expansile osteolysis\n",
      "D      H02089  Winchester syndrome\n",
      "C    FB8Y  Other specified osteopathies or chondropathies\n",
      "C    FB8Z  Osteopathies or chondropathies, unspecified\n",
      "B  FC00  Certain specified acquired deformities of musculoskeletal system or connective tissue, not elsewhere classified\n",
      "B  FC01  Postprocedural disorders of the musculoskeletal system\n",
      "B  FC0Y  Other specified diseases of the musculoskeletal system or connective tissue\n",
      "B  FC0Z  Diseases of the musculoskeletal system or connective tissue, unspecified\n",
      "A16 Diseases of the genitourinary system\n",
      "B  Diseases of the female genital system\n",
      "C    Inflammatory disorders of the female genital tract\n",
      "D      GA00  Vulvitis\n",
      "D      GA01  Inflammatory disorders of the uterus, except cervix\n",
      "D      GA02  Vaginitis\n",
      "D      GA03  Diseases of Bartholin gland\n",
      "D      GA04  Cervicitis\n",
      "D      GA05  Female pelvic inflammatory diseases\n",
      "D      GA06  Pelvic peritoneal adhesions of unknown or combined origin\n",
      "D      GA07  Salpingitis and oophoritis\n",
      "D      GA0Z  Inflammatory disorders of the female genital tract, unspecified\n",
      "C    GA10  Endometriosis\n",
      "D      H01639  Endometriosis\n",
      "C    GA11  Adenomyosis\n",
      "C    Noninflammatory disorders of female genital tract\n",
      "D      GA12  Dyspareunia\n",
      "D      GA13  Acquired abnormalities of vulva or perineum\n",
      "D      GA14  Acquired abnormalities of vagina\n",
      "D      GA15  Acquired abnormalities of cervix uteri\n",
      "D      GA16  Acquired abnormalities of uterus, except cervix\n",
      "D      GA17  Acquired abnormalities of fallopian tube\n",
      "D      GA18  Acquired abnormalities of ovary\n",
      "D      GA19  Acquired abnormalities of broad ligament\n",
      "D      GA1Y  Other specified noninflammatory disorders of female genital tract\n",
      "D      GA1Z  Noninflammatory disorders of female genital tract, unspecified\n",
      "C    Abnormal uterine or vaginal bleeding\n",
      "D      GA20  Menstrual cycle bleeding disorders\n",
      "D      GA21  Nonmenstrual bleeding disorders\n",
      "D      GA22  Excessive menstruation with irregular cycle\n",
      "D      GA23  Anovulatory bleeding\n",
      "D      GA2Y  Other specified abnormal uterine or vaginal bleeding\n",
      "D      GA2Z  Abnormal uterine or vaginal bleeding, unspecified\n",
      "C    GA30  Menopausal or certain specified perimenopausal disorders\n",
      "D      H00627  Premature ovarian failure\n",
      "C    GA31  Female infertility\n",
      "D      H01897  Oocyte maturation defect\n",
      "D      H02335  Preimplantation embryonic lethality\n",
      "C    GA32  Complications associated with medically assisted reproduction\n",
      "D      H01039  Ovarian hyperstimulation syndrome\n",
      "C    GA33  Recurrent pregnancy loss\n",
      "C    GA34  Female pelvic pain associated with genital organs or menstrual cycle\n",
      "C    Dermatoses of female genitalia\n",
      "D      GA40  Inflammatory dermatoses of the vulva\n",
      "D      GA41  Ulcerative or erosive disorders of the vulva\n",
      "D      GA42  Sensory disturbance of the vulva\n",
      "D      GA43  Miscellaneous dermatoses of female genitalia\n",
      "D      GA4Y  Other specified dermatoses of female genitalia\n",
      "C    GA6Y  Other specified diseases of the female genital system\n",
      "C    GA6Z  Diseases of the female genital system, unspecified\n",
      "B  Diseases of the male genital system\n",
      "C    Dermatoses of male genitalia\n",
      "D      GA80  Ulcerative disorders of the penis or scrotum\n",
      "D      GA81  Miscellaneous dermatoses of male genitalia\n",
      "C    Diseases of prostate\n",
      "D      GA90  Hyperplasia of prostate\n",
      "D      GA91  Inflammatory and other diseases of prostate\n",
      "C    GB00  Hydrocele or spermatocele\n",
      "C    GB01  Torsion of testis, epididymis or appendices\n",
      "C    GB02  Orchitis or epididymitis\n",
      "C    GB03  Atrophy of testis\n",
      "C    GB04  Male infertility\n",
      "D      H00890  Azoospermia\n",
      "D      H01208  Globozoospermia\n",
      "D      H01282  Spermatogenic failure\n",
      "D      H02534  Y-linked spermatogenic failure\n",
      "C    GB05  Redundant prepuce, phimosis or paraphimosis\n",
      "C    GB06  Certain specified disorders of penis\n",
      "C    GB07  Inflammatory disorders of male genital organs, not elsewhere classified\n",
      "C    GB08  Vascular disorders of male genital organs\n",
      "C    GB0Y  Other specified diseases of the male genital system\n",
      "C    GB0Z  Diseases of the male genital system, unspecified\n",
      "B  Disorders of breast\n",
      "C    GB20  Benign breast disease\n",
      "C    GB21  Inflammatory disorders of breast\n",
      "C    GB22  Hypertrophy of breast\n",
      "C    GB23  Certain specified disorders of breast\n",
      "C    GB2Z  Disorders of breast, unspecified\n",
      "B  Diseases of the urinary system\n",
      "C    Glomerular diseases\n",
      "D      GB40  Nephritic syndrome\n",
      "E        H01688  Rapidly progressive glomerulonephritis\n",
      "D      GB41  Nephrotic syndrome\n",
      "E        H00576  Pierson syndrome\n",
      "E        H01657  Nephrotic syndrome\n",
      "E        H01722  Galloway-Mowat syndrome\n",
      "D      GB42  Persistent proteinuria or albuminuria\n",
      "D      GB4Y  Other specified glomerular diseases\n",
      "E        H00582  Benign familial hematuria\n",
      "D      GB4Z  Glomerular diseases, unspecified\n",
      "C    Renal tubulo-interstitial diseases\n",
      "D      GB50  Acute tubulo-interstitial nephritis\n",
      "D      GB51  Acute pyelonephritis\n",
      "D      GB52  Acute tubular necrosis\n",
      "D      GB53  Acute renal papillary necrosis\n",
      "D      GB54  Tubulo-interstitial nephritis, not specified as acute or chronic\n",
      "D      GB55  Chronic tubulo-interstitial nephritis\n",
      "E        H02577  Karyomegalic interstitial nephritis\n",
      "D      GB56  Obstructive or reflux nephropathy\n",
      "E        H01037  Vesicoureteral reflux\n",
      "D      GB57  Nephrocalcinosis\n",
      "D      GB58  Pyonephrosis\n",
      "D      GB59  Renal or perinephric abscess\n",
      "D      GB5Y  Other specified renal tubulo-interstitial diseases\n",
      "D      GB5Z  Renal tubulo-interstitial diseases, unspecified\n",
      "C    Kidney failure\n",
      "D      GB60  Acute kidney failure\n",
      "D      GB61  Chronic kidney disease\n",
      "E        H01456  Diabetic nephropathy\n",
      "E        H02559  Microvascular complications of diabetes\n",
      "D      GB6Z  Kidney failure, unspecified\n",
      "C    Urolithiasis\n",
      "D      GB70  Calculus of upper urinary tract\n",
      "E        H02145  Calcium oxalate nephrolithiasis\n",
      "E        H02626  Kalamiella piersonii infection\n",
      "D      GB71  Calculus of lower urinary tract\n",
      "D      GB7Z  Urolithiasis, unspecified\n",
      "C    Cystic or dysplastic kidney disease\n",
      "D      GB80  Nonfamilial nongenetic cystic kidney disease\n",
      "D      GB81  Autosomal dominant polycystic kidney disease\n",
      "E        H00542  Polycystic kidney disease\n",
      "D      GB82  Autosomal dominant tubulointerstitial disease\n",
      "E        H00541  Autosomal dominant tubulointerstitial kidney disease\n",
      "E        H02012  Medullary cystic kidney disease\n",
      "D      GB83  Nephronophthisis\n",
      "E        H00537  Nephronophthisis\n",
      "E        H00538  Senior-Loken syndrome\n",
      "D      GB8Y  Other specified cystic or dysplastic kidney disease\n",
      "E        H00542  Polycystic kidney disease\n",
      "D      GB8Z  Cystic or dysplastic kidney disease, unspecified\n",
      "C    GB90  Certain specified disorders of kidney or ureter\n",
      "D      H01198  Fanconi renotubular syndrome\n",
      "D      H00239  Bartter syndrome\n",
      "D      H00241  Combined proximal and distal renal tubular acidosis (RTA type 3)\n",
      "D      H00243  Hyperkalemic distal renal tubular acidosis (RTA type 4)\n",
      "D      H00428  Distal renal tubular acidosis (RTA type 1)\n",
      "D      H00429  Proximal renal tubular acidosis (RTA type 2)\n",
      "D      H02310  Renal tubular acidosis\n",
      "D      H00888  Nephrolithiasis/osteoporosis, hypophosphatemic\n",
      "D      H00252  Congenital nephrogenic diabetes insipidus\n",
      "D      H00694  Dent disease\n",
      "D      H00948  Renal hypouricemia\n",
      "D      H02147  X-linked recessive nephrolithiasis with renal failure\n",
      "D      H02148  Low molecular weight proteinuria with hypercalciuria and nephrocalcinosis\n",
      "D      H02149  X-linked hypercalciuric nephrolithiasis\n",
      "C    Certain specified diseases of urinary system\n",
      "D      GC00  Cystitis\n",
      "E        H01551  Interstitial cystitis\n",
      "D      GC01  Other disorders of bladder\n",
      "D      GC02  Urethritis and urethral syndrome\n",
      "D      GC03  Urethral stricture\n",
      "D      GC04  Fistula of the genitourinary tract\n",
      "D      GC05  Prolapsed urethral mucosa\n",
      "D      GC06  Urethral diverticulum\n",
      "D      GC07  Urethral caruncle\n",
      "D      GC08  Urinary tract infection, site not specified\n",
      "E        H01176  Uncomplicated urinary tract infection\n",
      "E        H00279  Uropathogenic Escherichia coli (UPEC) infection\n",
      "E        H01339  Asymptomatic bacteriuria\n",
      "D      GC0Y  Other diseases of urinary system\n",
      "C    GC2Z  Diseases of the urinary system, unspecified\n",
      "B  Other conditions of the genitourinary system\n",
      "C    Female pelvic floor dysfunction\n",
      "D      GC40  Pelvic organ prolapse\n",
      "D      GC41  Anorectal dysfunction associated with pelvic organ prolapse\n",
      "D      GC42  Sexual dysfunction associated with pelvic organ prolapse\n",
      "D      GC4Z  Female pelvic floor dysfunction, unspecified\n",
      "C    GC50  Functional bladder disorders, not otherwise specified\n",
      "C    GC51  Female Genital Mutilation\n",
      "B  Postprocedural disorders of genitourinary system\n",
      "C    GC70  Postoperative adhesions of vagina\n",
      "C    GC71  Prolapse of vaginal vault after hysterectomy\n",
      "C    GC72  Postprocedural urethral stricture\n",
      "C    GC73  Postprocedural pelvic peritoneal adhesions\n",
      "C    GC74  Malfunction or complication of external stoma of urinary tract\n",
      "C    GC75  Malfunction of the afferent segment of a continent urinary pouch\n",
      "C    GC76  Malfunction of the efferent segment of a continent urinary pouch\n",
      "C    GC77  Postprocedural nonmenstrual uterine bleeding\n",
      "C    GC78  Postprocedural acute female pelvic inflammatory disease\n",
      "C    GC79  Disorders of breast reduction\n",
      "C    GC7A  Disorders of breast augmentation\n",
      "C    GC7B  Postinterventional ischemia or infarction of kidney\n",
      "B  GC8Y  Other specified diseases of the genitourinary system\n",
      "B  GC8Z  Diseases of the genitourinary system, unspecified\n",
      "A17 Conditions related to sexual health\n",
      "B  Sexual dysfunctions\n",
      "C    HA00  Hypoactive sexual desire dysfunction\n",
      "C    HA01  Sexual arousal dysfunctions\n",
      "C    HA02  Orgasmic dysfunctions\n",
      "C    HA03  Ejaculatory dysfunctions\n",
      "C    HA0Y  Other specified sexual dysfunctions\n",
      "C    HA0Z  Sexual dysfunctions, unspecified\n",
      "B  Sexual pain disorders\n",
      "C    HA20  Sexual pain-penetration disorder\n",
      "C    HA2Y  Other specified sexual pain disorders\n",
      "C    HA2Z  Sexual pain disorders, unspecified\n",
      "B  HA40  Aetiological considerations in sexual dysfunctions and sexual pain disorders\n",
      "B  Gender incongruence\n",
      "C    HA60  Gender incongruence of adolescence or adulthood\n",
      "C    HA61  Gender incongruence of childhood\n",
      "C    HA6Z  Gender incongruence, unspecified\n",
      "B  HA8Y  Other specified conditions related to sexual health\n",
      "B  HA8Z  Conditions related to sexual health, unspecified\n",
      "A18 Pregnancy, childbirth or the puerperium\n",
      "B  Abortive outcome of pregnancy\n",
      "C    JA00  Abortion\n",
      "C    JA01  Ectopic pregnancy\n",
      "C    JA02  Molar pregnancy\n",
      "D      H00289  Recurrent hydatidiform moles\n",
      "C    JA03  Missed abortion\n",
      "C    JA04  Blighted ovum or nonhydatidiform mole\n",
      "C    JA05  Complications following abortion, ectopic or molar pregnancy\n",
      "C    JA0Z  Abortive outcome of pregnancy, unspecified\n",
      "B  Oedema, proteinuria, or hypertensive disorders in pregnancy, childbirth, or the puerperium\n",
      "C    JA20  Pre-existing hypertension complicating pregnancy, childbirth or the puerperium\n",
      "C    JA21  Pre-eclampsia superimposed on chronic hypertension\n",
      "C    JA22  Gestational oedema or proteinuria without hypertension\n",
      "C    JA23  Gestational hypertension\n",
      "C    JA24  Pre-eclampsia\n",
      "C    JA25  Eclampsia\n",
      "C    JA2Z  Oedema, proteinuria, or hypertensive disorders in pregnancy, childbirth, or the puerperium, unspecified\n",
      "B  Obstetric haemorrhage\n",
      "C    JA40  Haemorrhage in early pregnancy\n",
      "C    JA41  Antepartum haemorrhage\n",
      "C    JA42  Intrapartum haemorrhage\n",
      "C    JA43  Postpartum haemorrhage\n",
      "C    JA4Z  Obstetric haemorrhage, unspecified\n",
      "B  Certain specified maternal disorders predominantly related to pregnancy\n",
      "C    JA60  Excessive vomiting in pregnancy\n",
      "C    JA61  Venous complications in pregnancy\n",
      "C    JA62  Infections of genitourinary tract in pregnancy\n",
      "C    JA63  Diabetes mellitus in pregnancy\n",
      "C    JA64  Malnutrition in pregnancy\n",
      "C    JA65  Maternal care for other conditions predominantly related to pregnancy\n",
      "D      H02193  Intrahepatic cholestasis of pregnancy\n",
      "C    JA66  Clinical findings on antenatal screening of mother\n",
      "C    JA67  Complications of anaesthesia during pregnancy\n",
      "C    JA6Z  Maternal disorders predominantly related to pregnancy, unspecified\n",
      "B  Maternal care related to the fetus, amniotic cavity or possible delivery problems\n",
      "C    JA80  Maternal care related to multiple gestation\n",
      "C    JA81  Maternal care related to complications specific to multiple gestation\n",
      "C    JA82  Maternal care for known or suspected malpresentation of fetus\n",
      "C    JA83  Maternal care for known or suspected disproportion\n",
      "C    JA84  Maternal care for known or suspected abnormality of pelvic organs\n",
      "C    JA85  Maternal care for known or suspected fetal abnormality or damage\n",
      "C    JA86  Maternal care for other known or suspected fetal problems\n",
      "C    JA87  Maternal care related to polyhydramnios\n",
      "C    JA88  Maternal care related to certain specified disorders of amniotic fluid or membranes\n",
      "C    JA89  Maternal care related to premature rupture of membranes\n",
      "C    JA8A  Maternal care related to placental disorders\n",
      "C    JA8B  Maternal care related to placenta praevia or low lying placenta\n",
      "C    JA8C  Maternal care related to premature separation of placenta\n",
      "C    JA8D  Maternal care related to false labour\n",
      "C    JA8E  Maternal care related to prolonged pregnancy\n",
      "C    JA8Y  Maternal care related to other specified fetus, amniotic cavity or possible delivery problems\n",
      "C    JA8Z  Maternal care related to unspecified fetus, amniotic cavity or possible delivery problems\n",
      "B  Complications of labour or delivery\n",
      "C    JB00  Preterm labour or delivery\n",
      "C    JB01  Failed induction of labour\n",
      "C    JB02  Abnormalities of forces of labour\n",
      "C    JB03  Long labour\n",
      "C    JB04  Obstructed labour due to malposition or malpresentation of fetus\n",
      "C    JB05  Obstructed labour due to maternal pelvic abnormality\n",
      "C    JB06  Obstructed labour due to other causes\n",
      "C    JB07  Labour or delivery complicated by fetal distress\n",
      "C    JB08  Labour or delivery complicated by umbilical cord complications\n",
      "C    JB09  Perineal laceration during delivery\n",
      "C    JB0A  Certain specified obstetric trauma\n",
      "C    JB0B  Retained placenta or membranes, without haemorrhage\n",
      "C    JB0C  Complications of anaesthesia during labour or delivery\n",
      "C    JB0D  Certain specified complications of labour or delivery, not elsewhere classified\n",
      "C    JB0Y  Other specified complications of labour or delivery\n",
      "C    JB0Z  Complications of labour or delivery, unspecified\n",
      "B  Delivery\n",
      "C    JB20  Single spontaneous delivery\n",
      "C    JB21  Single delivery by forceps or vacuum extractor\n",
      "C    JB22  Single delivery by caesarean section\n",
      "C    JB23  Other assisted single delivery\n",
      "C    JB24  Multiple delivery\n",
      "C    JB2Z  Delivery, unspecified\n",
      "B  Complications predominantly related to the puerperium\n",
      "C    JB40  Infections in the puerperium\n",
      "C    JB41  Venous complications in the puerperium\n",
      "C    JB42  Obstetric embolism\n",
      "C    JB43  Complications of anaesthesia during the puerperium\n",
      "C    JB44  Certain specified complications of the puerperium\n",
      "C    JB45  Infections of breast associated with childbirth\n",
      "C    JB46  Certain specified disorders of breast or lactation associated with childbirth\n",
      "D      H01607  Galactorrhea\n",
      "C    JB4Z  Complications predominantly related to the puerperium, unspecified\n",
      "B  Certain obstetric conditions, not elsewhere classified\n",
      "C    JB60  Obstetric death of unspecified cause\n",
      "C    JB61  Death from any obstetric cause occurring more than 42 days but less than one year after delivery\n",
      "C    JB62  Death from sequelae of obstetric causes\n",
      "C    JB63  Maternal infectious diseases classifiable elsewhere but complicating pregnancy, childbirth or the puerperium\n",
      "C    JB64  Certain maternal diseases classifiable elsewhere but complicating pregnancy, childbirth or the puerperium\n",
      "C    JB65  Sequelae of complication of pregnancy, childbirth or the puerperium\n",
      "C    JB6Y  Other specified obstetric conditions, not elsewhere classified\n",
      "C    JB6Z  Unspecified obstetric condition\n",
      "A19 Certain conditions originating in the perinatal period\n",
      "B  Fetus or newborn affected by maternal factors or by complications of pregnancy, labour or delivery\n",
      "C    KA00  Fetus or newborn affected by maternal conditions that may be unrelated to present pregnancy\n",
      "C    KA01  Fetus or newborn affected by maternal complications of pregnancy\n",
      "C    KA02  Fetus or newborn affected by complications of placenta\n",
      "C    KA03  Fetus or newborn affected by complications of umbilical cord\n",
      "C    KA04  Fetus or newborn affected by other abnormalities of membranes\n",
      "C    KA05  Fetus or newborn affected by certain complications of labour or delivery\n",
      "C    KA06  Fetus or newborn affected by noxious influences transmitted via placenta or breast milk\n",
      "C    KA07  Neonatal dermatoses due to maternal antibodies\n",
      "C    KA0Z  Fetus or newborn affected by unspecified maternal factors or by complications of pregnancy, labour or delivery\n",
      "B  Disorders of newborn related to length of gestation or fetal growth\n",
      "C    KA20  Disorders of newborn related to slow fetal growth or fetal malnutrition\n",
      "C    KA21  Disorders of newborn related to short gestation or low birth weight, not elsewhere classified\n",
      "C    KA22  Disorders of newborn related to long gestation or high birth weight\n",
      "C    KA2Y  Other specified disorders of newborn related to length of gestation or fetal growth\n",
      "C    KA2Z  Disorders of newborn related to length of gestation or fetal growth, unspecified\n",
      "B  Birth injury\n",
      "C    KA40  Birth injury to central nervous system\n",
      "C    KA41  Birth injury to eye\n",
      "C    KA42  Birth injury to scalp\n",
      "C    KA43  Birth injury to skin or soft tissues\n",
      "C    KA44  Birth injury to peripheral nervous system\n",
      "C    KA45  Birth injury to skeleton\n",
      "C    KA46  Birth injury to other organs\n",
      "C    KA4Z  Birth injury, unspecified\n",
      "B  Infections of the fetus or newborn\n",
      "C    KA60  Sepsis of fetus or newborn\n",
      "C    KA61  Other bacterial infections of the fetus or newborn\n",
      "C    KA62  Viral infection in the fetus or newborn\n",
      "C    KA63  Fungal infection of fetus or newborn\n",
      "C    KA64  Parasitic diseases in the fetus or newborn\n",
      "C    KA65  Neonatal infections of certain specified sites\n",
      "C    KA6Y  Other specified infections of the fetus or newborn\n",
      "C    KA6Z  Infections of the fetus or newborn, unspecified\n",
      "B  Haemorrhagic or haematological disorders of fetus or newborn\n",
      "C    KA80  Fetal blood loss\n",
      "C    KA81  Umbilical haemorrhage of newborn\n",
      "C    KA82  Intracranial nontraumatic haemorrhage of fetus or newborn\n",
      "C    KA83  Certain specified neonatal haemorrhages\n",
      "C    KA84  Haemolytic disease of fetus or newborn\n",
      "C    KA85  Hydrops fetalis due to haemolytic disease\n",
      "C    KA86  Neonatal kernicterus\n",
      "C    KA87  Neonatal hyperbilirubinaemia\n",
      "D      H02152  Transient familial neonatal hyperbilirubinemia\n",
      "C    KA88  Disseminated intravascular coagulation of fetus or newborn\n",
      "C    KA89  Transient neonatal thrombocytopaenia\n",
      "C    KA8A  Polycythaemia neonatorum\n",
      "C    KA8B  Anaemia of prematurity\n",
      "C    KA8C  Congenital hypoplastic anaemia\n",
      "C    KA8D  Transient neonatal neutropaenia\n",
      "C    KA8E  Alloimmune neonatal neutropaenia\n",
      "C    KA8F  Neonatal vitamin K deficiency\n",
      "C    KA8Y  Other specified haemorrhagic or haematological disorders of fetus or newborn\n",
      "C    KA8Z  Haemorrhagic or haematological disorders of fetus or newborn, unspecified\n",
      "B  Neurological disorders specific to the perinatal or neonatal period\n",
      "C    KB00  Neonatal cerebral ischaemia\n",
      "C    KB01  Periventricular cysts of newborn\n",
      "C    KB02  Neonatal cerebral leukomalacia\n",
      "C    KB03  Neonatal encephalopathy\n",
      "D      H01211  MECP2-related severe neonatal encephalopathy\n",
      "C    KB04  Hypoxic ischaemic encephalopathy of newborn\n",
      "C    KB05  Neonatal hydrocephalus\n",
      "C    KB06  Neonatal seizures\n",
      "C    KB07  Compression of brain in neonate\n",
      "C    KB08  Disorders of muscle tone of newborn\n",
      "C    KB0Y  Other specified neurological disorders specific to the perinatal or neonatal period\n",
      "C    KB0Z  Neurological disorders specific to the perinatal or neonatal period, unspecified\n",
      "B  Respiratory disorders specific to the perinatal or neonatal period\n",
      "C    KB20  Intrauterine hypoxia\n",
      "C    KB21  Birth asphyxia\n",
      "C    KB22  Metabolic acidaemia in newborn\n",
      "C    KB23  Respiratory distress of newborn\n",
      "C    KB24  Congenital pneumonia\n",
      "C    KB25  Neonatal tracheitis\n",
      "C    KB26  Neonatal aspiration syndromes\n",
      "C    KB27  Pulmonary air leak or related conditions originating in the perinatal period\n",
      "C    KB28  Pulmonary haemorrhage originating in the perinatal period\n",
      "C    KB29  Chronic respiratory disease originating in the perinatal period\n",
      "C    KB2A  Apnoea of newborn\n",
      "C    KB2B  Primary atelectasis of newborn\n",
      "C    KB2C  Cyanotic attacks of newborn\n",
      "C    KB2D  Respiratory failure of newborn\n",
      "C    KB2E  Respiratory arrest of newborn\n",
      "C    KB2F  Congenital lung or lobar atelectasis\n",
      "C    KB2G  Tracheal haemorrhage of newborn due to airway trauma\n",
      "C    KB2H  Acquired vocal cord paralysis in newborn\n",
      "C    KB2J  Airway obstruction in the neonate due to airway abnormality\n",
      "C    KB2K  Pulmonary cysts in newborn\n",
      "C    KB2Y  Other specified respiratory disorders specific to the perinatal or neonatal period\n",
      "C    KB2Z  Respiratory disorders specific to the perinatal or neonatal period, unspecified\n",
      "B  Cardiovascular disorders present in the perinatal or neonatal period\n",
      "C    KB40  Neonatal cardiac failure\n",
      "C    KB41  Cardiac arrhythmias in the neonate\n",
      "C    KB42  Persistent pulmonary hypertension of the newborn\n",
      "C    KB44  Transient myocardial ischaemia of newborn\n",
      "C    KB45  Neonatal hypertension\n",
      "C    KB46  Neonatal hypotension\n",
      "C    KB47  Benign or innocent cardiac murmurs in newborn\n",
      "C    KB48  Patent arterial duct of prematurity\n",
      "C    KB4Y  Other specified cardiovascular disorders present in the perinatal or neonatal period\n",
      "C    KB4Z  Cardiovascular disorders present in the perinatal or neonatal period, unspecified\n",
      "B  Transitory endocrine or metabolic disorders specific to fetus or newborn\n",
      "C    KB60  Transitory disorders of carbohydrate metabolism specific to fetus or newborn\n",
      "D      H00513  Transient neonatal diabetes mellitus\n",
      "D      H00512  Permanent neonatal diabetes mellitus\n",
      "D      H01377  Mitchell-Riley syndrome\n",
      "C    KB61  Transitory neonatal disorders of calcium or magnesium metabolism\n",
      "C    KB62  Transitory neonatal disorders of thyroid function\n",
      "C    KB63  Certain specified transitory neonatal electrolyte or metabolic disturbances\n",
      "C    KB64  Transitory neonatal hypoparathyroidism\n",
      "C    KB6Z  Transitory endocrine or metabolic disorders specific to fetus or newborn, unspecified\n",
      "B  Digestive system disorders of fetus or newborn\n",
      "C    KB80  Gastro-oesophageal reflux disease in newborn\n",
      "C    KB81  Oesophagitis in newborn\n",
      "C    KB82  Prenatal gastric perforation\n",
      "C    KB83  Postnatal gastric perforation\n",
      "C    KB84  Postnatal isolated ileal perforation\n",
      "C    KB85  Prenatal intrauterine intestinal perforation\n",
      "C    KB86  Postnatal intestinal perforation\n",
      "C    KB87  Intestinal obstruction of newborn\n",
      "C    KB88  Necrotising enterocolitis of newborn\n",
      "C    KB89  Neonatal malabsorption syndromes\n",
      "D      H01469  Short bowel syndrome\n",
      "D      H01477  Congenital short bowel syndrome\n",
      "C    KB8A  Neonatal haematemesis or melaena due to swallowed maternal blood\n",
      "C    KB8B  Neonatal peritonitis\n",
      "C    KB8C  Noninfectious neonatal diarrhoea\n",
      "D      H01174  Congenital diarrhea\n",
      "C    KB8Y  Other specified digestive system disorders of fetus or newborn\n",
      "C    KB8Z  Digestive system disorders of fetus or newborn, unspecified\n",
      "B  Genitourinary system disorders specific to the perinatal or neonatal period\n",
      "C    KC00  Congenital hydrocele\n",
      "C    KC01  Congenital renal failure\n",
      "C    KC0Y  Other specified genitourinary system disorders specific to the perinatal or neonatal period\n",
      "C    KC0Z  Genitourinary system disorders specific to the perinatal or neonatal period, unspecified\n",
      "B  Disorders involving the integument of fetus or newborn\n",
      "C    KC20  Conditions involving the umbilical cord\n",
      "C    KC21  Inflammatory dermatoses of the newborn\n",
      "C    KC22  Neonatal disorders of subcutaneous fat\n",
      "C    KC23  Neonatal disorders of the oral mucosa\n",
      "C    KC24  Neonatal nutritional disorders affecting the skin\n",
      "C    Skin disorders associated with prematurity\n",
      "D      KC30  Skin fragility of prematurity\n",
      "D      KC31  Congenital erosive or vesicular dermatosis healing with reticulated supple scarring\n",
      "D      KC3Y  Other specified skin disorders associated with prematurity\n",
      "C    KC40  Miscellaneous skin disorders in the neonate\n",
      "C    KC41  Miscellaneous specified conditions of integument specific to fetus or newborn\n",
      "C    Iatrogenic injuries involving the skin of the neonate\n",
      "D      Postnatal iatrogenic skin injury\n",
      "E        KC50  Neonatal phototherapy burn\n",
      "E        KC5Y  Other specified postnatal iatrogenic skin injury\n",
      "E        KC5Z  Postnatal iatrogenic skin injury, unspecified\n",
      "D      KC7Y  Other specified iatrogenic injuries involving the skin of the neonate\n",
      "C    KC9Z  Disorders involving the integument of fetus or newborn, unspecified\n",
      "B  Disturbances of temperature regulation of newborn\n",
      "C    KD10  Environmental hyperthermia of newborn\n",
      "C    KD11  Fever of newborn\n",
      "C    KD12  Hypothermia of newborn\n",
      "C    KD1Y  Other specified disturbances of temperature regulation of newborn\n",
      "C    KD1Z  Disturbances of temperature regulation of newborn, unspecified\n",
      "B  Certain disorders originating in the perinatal period\n",
      "C    KD30  Birth depression\n",
      "C    KD31  Wide cranial sutures of newborn\n",
      "C    KD32  Feeding problems of newborn\n",
      "C    KD33  Jittery baby, not elsewhere classified\n",
      "C    KD34  Reactions or intoxications due to drugs administered to fetus or newborn\n",
      "C    KD35  Neonatal withdrawal syndrome from maternal use of drugs of addiction\n",
      "C    KD36  Withdrawal symptoms from therapeutic use of drugs in newborn\n",
      "C    KD37  Exposure to tobacco smoke in the perinatal period\n",
      "C    KD38  Meconium staining\n",
      "C    KD39  Complications of intrauterine procedures, not elsewhere classified\n",
      "C    KD3A  Termination of pregnancy, affecting surviving fetus or newborn\n",
      "C    KD3B  Fetal death, cause not specified\n",
      "C    KD3C  Vomiting in newborn\n",
      "C    KD3Y  Other specified disorders originating in the perinatal period\n",
      "B  KD5Z  Conditions originating in the perinatal or neonatal period, unspecified\n",
      "A20 Developmental anomalies\n",
      "B  Structural developmental anomalies primarily affecting one body system\n",
      "C    Structural developmental anomalies of the nervous system\n",
      "D      LA00  Anencephaly or similar anomalies\n",
      "E        H02120  Anencephaly\n",
      "D      LA01  Cephalocele\n",
      "D      LA02  Spina bifida\n",
      "E        H00262  Neural tube defects, folate-sensitive\n",
      "E        H02563  Neural tube defects\n",
      "D      LA03  Arnold-Chiari malformation type II\n",
      "E        H01561  Chiari malformation\n",
      "D      LA04  Congenital hydrocephalus\n",
      "E        H01677  Congenital hydrocephalus\n",
      "E        H02458  Hydrocephalus due to congenital stenosis of aqueduct of Sylvius\n",
      "D      LA05  Cerebral structural developmental anomalies\n",
      "E        H00269  Primary microcephaly\n",
      "E        H01833  Hemimegalencephaly\n",
      "E        H02446  Autosomal recessive macrocephaly/megalencephaly syndrome\n",
      "E        H00267  Holoprosencephaly\n",
      "E        H00263  Acrocallosal syndrome\n",
      "E        H01835  Neuronal migration disorder\n",
      "E        H00271  Polymicrogyria\n",
      "E        H01251  Focal cortical dysplasia of Taylor\n",
      "E        H01881  Complex cortical dysplasia with other brain malformations\n",
      "E        H00270  Periventricular nodular heterotopia\n",
      "E        H00839  Porencephaly\n",
      "E        H01160  Schizencephaly\n",
      "E        H01870  Microhydranencephaly\n",
      "E        H02501  Occipital cortical malformation\n",
      "D      LA06  Cerebellar structural developmental anomalies\n",
      "E        H01678  Dandy-Walker syndrome\n",
      "D      LA07  Structural developmental anomalies of the neurenteric canal, spinal cord or vertebral column\n",
      "E        H01675  Syringomyelia\n",
      "E        H01561  Chiari malformation\n",
      "E        H01893  Lateral meningocele syndrome\n",
      "D      LA0Y  Other specified structural developmental anomalies of the nervous system\n",
      "E        H02494  Alkuraya-Kucinskas syndrome\n",
      "D      LA0Z  Structural developmental anomalies of the nervous system, unspecified\n",
      "C    Structural developmental anomalies of the eye, eyelid or lacrimal apparatus\n",
      "D      LA10  Structural developmental anomalies of ocular globes\n",
      "E        H01027  Microphthalmia\n",
      "E        H02172  Nanophthalmos\n",
      "D      LA11  Structural developmental anomalies of the anterior segment of eye\n",
      "E        H01114  Ocular coloboma\n",
      "E        H01029  Cornea plana congenita\n",
      "E        H02104  Megalocornea\n",
      "E        H00620  Axenfeld-Rieger syndrome\n",
      "E        H01159  Anterior segment dysgenesis\n",
      "E        H00635  Aniridia\n",
      "E        H00961  Posterior polymorphous corneal dystrophy\n",
      "E        H01075  Peters anomaly\n",
      "D      LA12  Structural developmental anomalies of lens or zonula\n",
      "E        H00676  Congenital primary aphakia\n",
      "E        H00662  Ectopia lentis\n",
      "D      LA13  Structural developmental anomalies of the posterior segment of eye\n",
      "E        H02112  Persistent hyperplastic primary vitreous\n",
      "E        H00589  Familial exudative vitreoretinopathy\n",
      "E        H02475  Retinoschisis\n",
      "E        H02203  Optic nerve hypoplasia\n",
      "E        H02270  Cavitary optic disc anomalies\n",
      "E        H01256  Foveal hypoplasia\n",
      "E        H02231  Optic disc anomalies with retinal and/or macular dystrophy\n",
      "D      LA14  Structural developmental anomalies of eyelid, lacrimal apparatus or orbit\n",
      "E        H00677  Aplasia of lacrimal and salivary glands\n",
      "E        H02514  Lacrimal duct defect\n",
      "D      LA1Y  Other specified structural developmental anomalies of the eye, eyelid or lacrimal apparatus\n",
      "D      LA1Z  Structural developmental anomalies of the eye, eyelid or lacrimal apparatus, unspecified\n",
      "C    Structural developmental anomalies of the ear\n",
      "D      LA20  Structural anomaly of eustachian apparatus\n",
      "D      LA21  Minor anomalies of pinnae\n",
      "D      LA22  Structural developmental anomalies of ear causing hearing impairment\n",
      "E        H02115  Congenital aural atresia\n",
      "D      LA23  Otocephaly\n",
      "E        H02118  Agnathia-otocephaly complex\n",
      "D      LA24  Accessory auricle\n",
      "D      LA2Y  Other specified structural developmental anomalies of the ear\n",
      "D      LA2Z  Structural developmental anomalies of the ear, unspecified\n",
      "C    Structural developmental anomalies of the face, mouth or teeth\n",
      "D      LA30  Structural developmental anomalies of teeth and periodontal tissues\n",
      "E        H00625  Tooth agenesis\n",
      "E        H00652  Solitary median maxillary central incisor syndrome\n",
      "E        H00615  Amelogenesis imperfecta\n",
      "E        H00618  Amelogenesis imperfecta hypoplastic-hypomaturation with taurodontism\n",
      "E        H01015  Jalili syndrome\n",
      "E        H02348  Dentin dysplasia\n",
      "E        H00432  Hereditary dentine disorders\n",
      "D      LA31  Structural developmental anomalies of mouth or tongue\n",
      "D      Clefts of lip, alveolus or palate\n",
      "E        LA40  Cleft lip\n",
      "F          H00516  Cleft lip and/or cleft palate\n",
      "E        LA41  Cleft lip and alveolus\n",
      "F          H00516  Cleft lip and/or cleft palate\n",
      "E        LA42  Cleft palate\n",
      "F          H00516  Cleft lip and/or cleft palate\n",
      "F          H00909  Cleft palate with ankyloglossia\n",
      "E        LA4Y  Other specified clefts of lip, alveolus or palate\n",
      "E        LA4Z  Clefts of lip, alveolus or palate, unspecified\n",
      "D      LA50  Congenital velopharyngeal incompetence\n",
      "D      LA51  Facial clefts\n",
      "E        H02202  Oblique facial cleft\n",
      "D      LA52  Facial asymmetry\n",
      "D      LA53  Macrocheilia\n",
      "D      LA54  Microcheilia\n",
      "D      LA55  Compression facies\n",
      "D      LA56  Pierre Robin syndrome\n",
      "D      LA5Y  Other specified structural developmental anomalies of the face\n",
      "D      LA5Z  Structural developmental anomalies of the face, unspecified\n",
      "C    Structural developmental anomalies of the neck\n",
      "D      LA60  Webbed neck\n",
      "D      LA61  Congenital sternomastoid tumour\n",
      "D      LA62  Congenital torticollis\n",
      "D      LA6Y  Other specified structural developmental anomalies of the neck\n",
      "D      LA6Z  Structural developmental anomalies of the neck, unspecified\n",
      "C    Structural developmental anomalies of the respiratory system\n",
      "D      LA70  Structural developmental anomalies of the nose or cavum\n",
      "E        H01017  Choanal atresia and lymphedema\n",
      "D      LA71  Structural developmental anomalies of larynx\n",
      "D      LA72  Laryngotracheooesophageal cleft\n",
      "D      LA73  Structural developmental anomalies of trachea\n",
      "E        H02600  Congenital tracheal stenosis\n",
      "D      LA74  Structural developmental anomalies of bronchi\n",
      "D      LA75  Structural developmental anomalies of lungs\n",
      "E        H00564  Primary ciliary dyskinesia\n",
      "D      LA76  Structural developmental anomalies of pleura\n",
      "D      LA77  Congenital cyst of mediastinum\n",
      "D      LA7Y  Other specified structural developmental anomalies of the respiratory system\n",
      "D      LA7Z  Structural developmental anomalies of the respiratory system, unspecified\n",
      "C    Structural developmental anomalies of the circulatory system\n",
      "D      Structural developmental anomaly of heart or great vessels\n",
      "E        LA80  Anomalous position-orientation of heart\n",
      "E        LA81  Abnormal ventricular relationships\n",
      "E        LA82  Total mirror imagery\n",
      "E        LA83  Right isomerism\n",
      "E        LA84  Left isomerism\n",
      "F          H01764  Polysplenia syndrome\n",
      "E        LA85  Congenital anomaly of an atrioventricular or ventriculo-arterial connection\n",
      "F          H01786  Congenitally corrected transposition of the great arteries\n",
      "F          H00550  Complete transposition of the great arteries\n",
      "F          H00918  Double-outlet right ventricle\n",
      "F          H01736  Persistent truncus arteriosus\n",
      "E        LA86  Congenital anomaly of mediastinal vein\n",
      "F          H02605  Congenital pulmonary venous stenosis\n",
      "E        LA87  Congenital anomaly of an atrioventricular valve or atrioventricular septum\n",
      "F          H02230  X-linked cardiac valvular dysplasia\n",
      "F          H02602  Congenital tricuspid valve stenosis\n",
      "F          H01783  Ebstein anomaly\n",
      "F          H02603  Congenital mitral valve stenosis\n",
      "F          H00547  Atrioventricular septal defect\n",
      "E        LA88  Congenital anomaly of a ventricle or the ventricular septum\n",
      "F          H00549  Tetralogy of Fallot\n",
      "F          H01803  Pulmonary atresia with ventricular septal defect\n",
      "F          H01926  Ventricular septal defect\n",
      "E        LA89  Functionally univentricular heart\n",
      "F          H01787  Univentricular heart\n",
      "F          H01785  Tricuspid atresia\n",
      "F          H01272  Hypoplastic left heart syndrome\n",
      "F          H02375  Cardiac valvular defect, developmental\n",
      "E        LA8A  Congenital anomaly of a ventriculo-arterial valve or adjacent regions\n",
      "F          H01802  Pulmonary atresia with intact ventricular septum\n",
      "F          H00554  Aortic valve disease\n",
      "F          H00553  Congenital supravalvular aortic stenosis\n",
      "E        LA8B  Congenital anomaly of great arteries including arterial duct\n",
      "F          H01630  Patent ductus arteriosus\n",
      "F          H02601  Pulmonary arterial sling\n",
      "E        LA8C  Congenital anomaly of coronary artery\n",
      "E        LA8D  Congenital pericardial anomaly\n",
      "E        LA8E  Congenital anomaly of atrial septum\n",
      "F          H00546  Atrial septal defect\n",
      "E        LA8F  Congenital anomaly of right atrium\n",
      "E        LA8G  Congenital anomaly of left atrium\n",
      "E        LA8Y  Other specified structural developmental anomaly of heart or great vessels\n",
      "F          H00632  Heterotaxy\n",
      "F          H02199  Congenital heart defects, multiple type\n",
      "E        LA8Z  Structural developmental anomaly of heart or great vessels, unspecified\n",
      "D      LA90  Structural developmental anomalies of the peripheral vascular system\n",
      "E        H00533  Hereditary hemorrhagic telangiectasia\n",
      "E        H00531  Venous malformations\n",
      "E        H01849  Peripheral arteriovenous malformation\n",
      "E        H02043  Capillary malformation-arteriovenous malformation\n",
      "D      LA9Y  Other specified structural developmental anomalies of the circulatory system\n",
      "D      LA9Z  Structural developmental anomalies of the circulatory system, unspecified\n",
      "C    Structural developmental anomalies of the diaphragm, abdominal wall or umbilical cord\n",
      "D      LB00  Structural developmental anomalies of diaphragm\n",
      "E        H01241  Congenital diaphragmatic hernia\n",
      "D      LB01  Omphalocele\n",
      "D      LB02  Gastroschisis\n",
      "D      LB03  Structural developmental anomalies of umbilical cord\n",
      "D      LB0Y  Other specified structural developmental anomalies of the diaphragm, abdominal wall or umbilical cord\n",
      "D      LB0Z  Structural developmental anomalies of the diaphragm, abdominal wall or umbilical cord, unspecified\n",
      "C    Structural developmental anomalies of the digestive tract\n",
      "D      LB10  Structural developmental anomalies of salivary glands or ducts\n",
      "D      LB11  Congenital diverticulum of pharynx\n",
      "D      LB12  Structural developmental anomalies of oesophagus\n",
      "D      LB13  Structural developmental anomalies of stomach\n",
      "D      LB14  Structural developmental anomalies of duodenum\n",
      "D      LB15  Structural developmental anomalies of small intestine\n",
      "D      LB16  Structural developmental anomalies of large intestine\n",
      "E        H00910  Hirschsprung disease\n",
      "E        H01871  Isolated hypoganglionosis\n",
      "D      LB17  Structural developmental anomalies of anal canal\n",
      "E        H01858  Persistent cloaca\n",
      "E        H01856  Cloacal exstrophy\n",
      "D      LB18  Congenital anomalies of intestinal fixation\n",
      "D      LB1Y  Other specified structural developmental anomalies of the digestive tract\n",
      "E        H02331  Gastrointestinal defects and immunodeficiency syndrome\n",
      "D      LB1Z  Structural developmental anomalies of the digestive tract, unspecified\n",
      "C    Structural developmental anomalies of the liver, biliary tract, pancreas or spleen\n",
      "D      LB20  Structural developmental anomalies of gallbladder, bile ducts or liver\n",
      "E        H01855  Biliary atresia\n",
      "E        H00551  Alagille syndrome\n",
      "D      LB21  Structural developmental anomalies of pancreas\n",
      "E        H00861  Pancreatic agenesis\n",
      "D      LB22  Structural developmental anomalies of spleen\n",
      "E        H01435  Congenital asplenia\n",
      "D      LB2Y  Other specified structural developmental anomalies of the liver, biliary tract, pancreas or spleen\n",
      "D      LB2Z  Structural developmental anomalies of the liver, biliary tract, pancreas or spleen, unspecified\n",
      "C    Structural developmental anomalies of the urinary system\n",
      "D      LB30  Structural developmental anomalies of kidneys\n",
      "E        H01867  Congenital anomalies of kidney and urinary tract\n",
      "E        H00822  Renal hypodysplasia and aplasia\n",
      "E        H01728  Potter syndrome\n",
      "E        H00575  Renal tubular dysgenesis\n",
      "D      LB31  Structural developmental anomalies of urinary tract\n",
      "E        H01867  Congenital anomalies of kidney and urinary tract\n",
      "E        H02495  Congenital megabladder\n",
      "D      LB3Y  Other specified structural developmental anomalies of the urinary system\n",
      "D      LB3Z  Structural developmental anomalies of the urinary system, unspecified\n",
      "C    Structural developmental anomalies of the female genital system\n",
      "D      LB40  Structural developmental anomalies of vulva\n",
      "D      LB41  Structural developmental anomalies of clitoris\n",
      "D      LB42  Structural developmental anomalies of vagina\n",
      "D      LB43  Structural developmental anomalies of cervix uteri\n",
      "D      LB44  Structural developmental anomalies of uterus, except cervix\n",
      "E        H00600  Mullerian agenesis\n",
      "D      LB45  Structural developmental anomalies of ovaries, fallopian tubes or broad ligaments\n",
      "E        H00599  Ovarian dysgenesis\n",
      "D      LB4Y  Other specified structural developmental anomalies of the female genital system\n",
      "D      LB4Z  Structural developmental anomalies of the female genital system, unspecified\n",
      "C    Structural developmental anomalies of the male genital system\n",
      "D      LB50  Micropenis or penis agenesis\n",
      "D      LB51  Anorchia or microorchidia\n",
      "D      LB52  Cryptorchidism\n",
      "E        H02176  Cryptorchidism\n",
      "D      LB53  Hypospadias\n",
      "E        H02175  Hypospadias\n",
      "D      LB54  Congenital chordee\n",
      "D      LB55  Epispadias\n",
      "D      LB56  Bifid scrotum\n",
      "D      LB57  Agenesis of vas deferens\n",
      "E        H01033  Congenital bilateral absence of vas deferens\n",
      "D      LB58  Polyorchidism\n",
      "D      LB59  Hypoplasia of testis or scrotum\n",
      "D      LB5Y  Other specified structural developmental anomalies of the male genital system\n",
      "D      LB5Z  Structural developmental anomalies of the male genital system, unspecified\n",
      "C    Structural developmental anomalies of the breast\n",
      "D      LB60  Breast aplasia\n",
      "D      LB61  Absent nipple\n",
      "D      LB62  Supernumerary breasts\n",
      "D      LB63  Accessory nipple\n",
      "D      LB6Y  Other specified structural developmental anomalies of the breast\n",
      "D      LB6Z  Structural developmental anomalies of the breast, unspecified\n",
      "C    Structural developmental anomalies of the skeleton\n",
      "D      LB70  Structural developmental anomalies of cranium\n",
      "E        H02160  Craniosynostoses\n",
      "E        H01207  Trigonocephaly\n",
      "E        H00475  Enlarged parietal foramina/cranium bifidum\n",
      "E        H01105  Cranio-lenticulo-sutural dysplasia\n",
      "D      LB71  Structural developmental anomalies of facial bones\n",
      "D      LB72  Structural developmental anomalies of shoulder girdle\n",
      "D      LB73  Structural developmental anomalies of spine or bony thorax\n",
      "E        H01851  Congenital scoliosis associated with rib anomalies\n",
      "E        H00852  Klippel-Feil syndrome\n",
      "D      LB74  Structural developmental anomalies of pelvic girdle\n",
      "E        H01817  Beukes hip dysplasia\n",
      "D      LB75  Brachydactyly\n",
      "E        H00482  Brachydactyly\n",
      "D      LB76  Triphalangeal thumb\n",
      "D      LB77  Hyperphalangy\n",
      "D      LB78  Polydactyly\n",
      "E        H01226  Polysyndactyly\n",
      "E        H01852  Postaxial polydactyly\n",
      "E        H02332  Preaxial polydactyly\n",
      "D      LB79  Syndactyly\n",
      "E        H01095  Syndactyly\n",
      "E        H00459  Synpolydactyly\n",
      "E        H01854  Metacarpal 4-5 fusion\n",
      "D      Congenital deformities of fingers or toes\n",
      "E        LB80  Congenital deformities of fingers\n",
      "F          H01246  Isolated congenital nail clubbing\n",
      "E        LB81  Congenital deformities of toes\n",
      "E        LB8Z  Congenital deformities of fingers or toes, unspecified\n",
      "D      LB90  Joint formation defects\n",
      "E        H00484  Multiple synostosis syndrome\n",
      "E        H00851  Proximal symphalangism\n",
      "D      LB91  Congenital shoulder dislocation\n",
      "D      LB92  Congenital elbow dislocation\n",
      "D      LB93  Congenital knee dislocation\n",
      "D      LB94  Congenital patella dislocation\n",
      "D      LB95  Patella aplasia or hypoplasia\n",
      "D      LB96  Congenital bowing of long bones\n",
      "D      LB97  Limb overgrowth\n",
      "E        H02647  Macrodactyly\n",
      "D      LB98  Congenital deformities of feet\n",
      "E        H00903  Congenital clubfoot\n",
      "E        H00929  Congenital vertical talus\n",
      "D      LB99  Reduction defects of upper limb\n",
      "E        H00471  Split-hand/foot malformation\n",
      "D      LB9A  Reduction defects of lower limb\n",
      "E        H00471  Split-hand/foot malformation\n",
      "D      LB9B  Reduction defects of upper and lower limbs\n",
      "E        H00629  Acheiropodia\n",
      "E        H00636  Tetra-amelia syndrome\n",
      "D      LB9Y  Other specified structural developmental anomalies of the skeleton\n",
      "E        H00873  Cousin syndrome\n",
      "D      LB9Z  Structural developmental anomalies of the skeleton, unspecified\n",
      "E        H00762  Spondyloepiphyseal dysplasia with congenital joint dislocations\n",
      "C    Structural developmental anomalies of the skin\n",
      "D      Developmental hamartomata of the epidermis and epidermal appendages\n",
      "E        LC00  Keratinocytic epidermal hamartoma\n",
      "F          H02627  Epidermal nevus\n",
      "E        LC01  Pilosebaceous hamartoma\n",
      "E        LC02  Complex epidermal hamartoma\n",
      "E        LC0Y  Other specified developmental hamartomata of the epidermis and epidermal appendages\n",
      "D      Developmental anomalies of skin pigmentation\n",
      "E        LC10  Dermal melanocytosis\n",
      "E        LC1Y  Other specified developmental anomalies of skin pigmentation\n",
      "D      Hamartomata derived from dermal connective tissue\n",
      "E        LC20  Connective tissue hamartoma\n",
      "E        LC2Y  Other specified hamartomata derived from dermal connective tissue\n",
      "D      Developmental defects of hair or nails\n",
      "E        LC30  Developmental defects of hair or hair growth\n",
      "E        LC31  Developmental defects of the nail apparatus\n",
      "D      LC40  Dermoid cyst\n",
      "D      Developmental anomalies of cutaneous vasculature\n",
      "E        LC50  Developmental capillary vascular malformations of the skin\n",
      "E        LC51  Developmental venous malformations involving the skin\n",
      "F          H02044  Cutaneous and mucosal venous malformation\n",
      "E        LC52  Complex or combined developmental vascular malformations involving the skin\n",
      "E        LC5Y  Other specified developmental anomalies of cutaneous vasculature\n",
      "E        LC5Z  Developmental anomalies of cutaneous vasculature, unspecified\n",
      "D      Congenital anomalies of skin development\n",
      "E        LC60  Aplasia cutis congenita\n",
      "F          H01896  Aplasia cutis congenita\n",
      "D      LC7Y  Other specified structural developmental anomalies of the skin\n",
      "E        H02295  Adermatoglyphia\n",
      "D      LC7Z  Structural developmental anomalies of the skin, unspecified\n",
      "C    Structural developmental anomalies of the adrenal glands\n",
      "D      LC80  Congenital adrenal hypoplasia\n",
      "E        H01772  Adrenal hypoplasia, congenital\n",
      "D      LC8Y  Other specified structural developmental anomalies of the adrenal glands\n",
      "D      LC8Z  Structural developmental anomalies of the adrenal glands, unspecified\n",
      "C    LD0Y  Other specified structural developmental anomalies primarily affecting one body system\n",
      "C    LD0Z  Structural developmental anomalies primarily affecting one body system, unspecified\n",
      "B  Multiple developmental anomalies or syndromes\n",
      "C    LD20  Syndromes with central nervous system anomalies as a major feature\n",
      "D      H00530  Joubert syndrome and related disorders\n",
      "D      H00897  Pontocerebellar hypoplasia\n",
      "D      H01001  COACH syndrome\n",
      "D      H01811  Arima syndrome\n",
      "D      H02272  CAPOS syndrome\n",
      "D      H02431  Cerebellar hypoplasia, epilepsy, and global developmental delay\n",
      "D      H02464  Poretti-Boltshauser syndrome\n",
      "D      H00268  Lissencephaly\n",
      "D      H00792  Warburg micro syndrome\n",
      "D      H02117  Neu-Laxova syndrome\n",
      "D      H00616  Bowen-Conradi syndrome\n",
      "D      H00840  Pseudo-TORCH syndrome\n",
      "D      H00990  Microcephaly, Amish type\n",
      "D      H00991  Microcephalic osteodysplastic primordial dwarfism, type II (MOPD II)\n",
      "D      H00993  Microcephalic osteodysplastic primordial dwarfism, type I (MOPD I)\n",
      "D      H01872  Microcephaly-capillary malformation syndrome\n",
      "D      H01876  Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation\n",
      "D      H01921  MICPCH syndrome\n",
      "D      H02132  Microcephaly syndrome\n",
      "D      H02282  Spastic tetraplegia, thin corpus callosum, and progressive microcephaly\n",
      "D      H02461  Neurodevelopmental disorder with microcephaly\n",
      "D      H02492  Microcephaly, growth restriction, and increased sister chromatid exchange\n",
      "D      H00544  Septo-optic dysplasia\n",
      "D      H00816  Agenesis of the corpus callosum with peripheral neuropathy\n",
      "D      H01034  L1 syndrome\n",
      "D      H01035  Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia\n",
      "D      H01776  Aicardi syndrome\n",
      "D      H01789  You-Hoover-Fong syndrome\n",
      "D      H01919  Proud syndrome\n",
      "D      H01937  Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly\n",
      "D      H02366  Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome\n",
      "D      H02396  Corpus callosum agenesis with facial anomalies and cerebellar ataxia\n",
      "D      H02487  Diencephalic-mesencephalic junction dysplasia syndrome\n",
      "D      H02519  Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations\n",
      "D      H02606  Pachygyria, microcephaly, developmental delay, and dysmorphic facies, with or without seizures\n",
      "D      H02645  Cerebellar atrophy with seizures and variable developmental delay\n",
      "C    LD21  Syndromes with eye anomalies as a major feature\n",
      "D      H01904  Microphthalmia with linear skin defects syndrome\n",
      "D      H02134  Microphthalmia with limb anomalies\n",
      "D      H02170  Microphthalmia, syndromic\n",
      "D      H00673  Weill-Marchesani syndrome\n",
      "D      H00826  Blepharophimosis-ptosis-epicanthus inversus syndrome\n",
      "D      H01012  Oculo-auricular syndrome\n",
      "D      H02045  Norrie disease\n",
      "D      H02292  Retinal dystrophy, juvenile cataracts, and short stature syndrome\n",
      "D      H02422  Retinitis pigmentosa with skeletal anomalies\n",
      "D      H02445  Microcornea, myopic chorioretinal atrophy, and telecanthus\n",
      "C    LD22  Syndromes with dental anomalies as a major feature\n",
      "C    LD23  Syndromes with vascular anomalies as a major feature\n",
      "D      H00579  Hereditary angiopathy with nephropathy, aneurysms, and muscle cramps (HANAC)\n",
      "D      H01809  Sturge-Weber syndrome\n",
      "D      H02088  Primary intraosseous vascular malformation\n",
      "C    LD24  Syndromes with skeletal anomalies as a major feature\n",
      "D      H00520  Type II collagenopathies\n",
      "D      H00505  FGFR3-related short limb skeletal dysplasia\n",
      "D      H01749  Achondroplasia\n",
      "D      H02069  SADDAN\n",
      "D      H02068  Hypochondroplasia\n",
      "D      H01750  Thanatophoric dysplasia\n",
      "D      H00515  Atelosteogenesis type II\n",
      "D      H02063  Diastrophic dysplasia\n",
      "D      H00207  Rhizomelic chondrodysplasia punctata\n",
      "D      H00447  HEM skeletal dysplasia\n",
      "D      H00496  Congenital hemidysplasia with ichthyosiform nevus and limb defects (CHILD)\n",
      "D      H01194  X-linked chondrodysplasia punctata\n",
      "D      H00436  Osteopetrosis\n",
      "D      H00452  Buschke-Ollendorff syndrome\n",
      "D      H00434  Camurati-Engelmann disease\n",
      "D      H00444  Osteopathia striata with cranial sclerosis\n",
      "D      H00450  Worth type autosomal dominant osteosclerosis\n",
      "D      H00486  Sclerosteosis\n",
      "D      H00490  Diaphyseal dysplasia with anemia\n",
      "D      H00491  Craniometaphyseal dysplasia\n",
      "D      H00508  Blomstrand syndrome\n",
      "D      H00613  Infantile cortical hyperostosis\n",
      "D      H00968  Raine syndrome\n",
      "D      H01832  Lenz-Majewski syndrome\n",
      "D      H02631  Melorheostosis\n",
      "D      H00122  Multiple exostoses\n",
      "D      H00493  Heparan sulfate proteoglycan gene defects\n",
      "D      H00497  Cherubism\n",
      "D      H02127  Yunis-Varon syndrome\n",
      "D      H00443  Osteoglophonic dysplasia\n",
      "D      H00498  Gnathodiaphyseal dysplasia\n",
      "D      H00521  Cleidocranial dysplasia\n",
      "D      H01018  Metachondromatosis\n",
      "D      H02558  Craniotubular dysplasia, Ikegawa type\n",
      "D      H00445  Osteoarthritis with mild chondrodysplasia\n",
      "D      H00474  Schneckenbecken dysplasia\n",
      "D      H00483  Angel shaped phalangoepiphyseal dysplasia\n",
      "D      H00499  Spondylocarpotarsal synostosis syndrome\n",
      "D      H00519  Spondyloepiphyseal dysplasia congenita\n",
      "D      H00757  Dyggve-Melchior-Clausen disease\n",
      "D      H00758  Progressive pseudorheumatoid dysplasia\n",
      "D      H00760  Spondyloepiphyseal dysplasia tarda\n",
      "D      H00761  SEMD, Pakistani type\n",
      "D      H00765  Spondyloepiphyseal dysplasia, Kimberley type\n",
      "D      H00767  SEMD, Matrilin type\n",
      "D      H00777  SEMD, short limb-hand type\n",
      "D      H00863  Spondylo-megaepiphyseal-metaphyseal dysplasia\n",
      "D      H01494  SEMD with joint laxity type\n",
      "D      H01575  Roifman syndrome\n",
      "D      H01576  Spondyloenchondrodysplasia with immune dysregulation (SPENCDI)\n",
      "D      H01967  Anauxetic dysplasia\n",
      "D      H02070  Kniest dysplasia\n",
      "D      H02071  Czech dysplasia\n",
      "D      H02079  Oto-spondylo-megaepiphyseal dysplasia\n",
      "D      H02080  Fibrochondrogenesis\n",
      "D      H02155  Dyssegmental dysplasia\n",
      "D      H02183  Parastremmatic dwarfism\n",
      "D      H02184  Metatropic dysplasia\n",
      "D      H02186  Spondyloepiphyseal dysplasia, Maroteaux type\n",
      "D      H02187  Spondyloepimetaphyseal dysplasia\n",
      "D      H02462  Spondyloepiphyseal dysplasia\n",
      "D      H02497  Smith-McCort dysplasia\n",
      "D      H01821  Spondylometaphyseal dysplasia with cone-rod dystrophy\n",
      "D      H01825  Spondylometaphyseal dysplasia, Sedaghatian type\n",
      "D      H01830  Spondylometaphyseal dysplasia, Megarbane-Dagher-Melki type\n",
      "D      H02185  Spondylometaphyseal dysplasia\n",
      "D      H00678  Achondrogenesis type IA\n",
      "D      H02065  Achondrogenesis type IB\n",
      "D      H02066  Achondrogenesis type II\n",
      "D      H00522  Brachyolmia\n",
      "D      H01828  Opsismodysplasia\n",
      "D      H01844  Diaphanospondylodysostosis\n",
      "D      H00495  Eiken dysplasia\n",
      "D      H00477  Pseudoachondroplasia\n",
      "D      H00476  Multiple epiphyseal dysplasia\n",
      "D      H02436  Al-Gazali syndrome\n",
      "D      H00479  Metaphyseal dysplasias\n",
      "D      H00518  Metaphyseal dysplasia without hypotrichosis\n",
      "D      H00675  Acrocapitofemoral dysplasia\n",
      "D      H00900  Geleophysic dysplasia\n",
      "D      H02062  Familial digital arthropathy-brachydactyly\n",
      "D      H02228  Acromicric dysplasia\n",
      "D      H02229  Terminal osseous dysplasia\n",
      "D      H00466  Grebe dysplasia\n",
      "D      H00468  Acromesomelic dysplasia, Demirhan type\n",
      "D      H00470  Acromesomelic dysplasia, Maroteaux type\n",
      "D      H02543  Acromesomelic dysplasia\n",
      "D      H00485  Robinow syndrome\n",
      "D      H00492  SHOX-related short stature\n",
      "D      H02154  Omodysplasia\n",
      "D      H00511  Short rib-polydactyly syndrome\n",
      "D      H00751  Asphyxiating thoracic dystrophy\n",
      "D      H02157  Short-rib thoracic dysplasia\n",
      "D      H00462  Stuve-Wiedemann syndrome\n",
      "D      H02629  Bent bone dysplasia syndrome\n",
      "D      H00509  3M syndrome\n",
      "D      H00619  Kenny-Caffey syndrome\n",
      "D      H00622  Hypoparathyroidism-retardation-dysmorphism syndrome\n",
      "D      H00992  Seckel syndrome\n",
      "D      H02223  Osteocraniostenosis\n",
      "D      H00494  Desbuquois syndrome\n",
      "D      H01498  Multiple joint dislocations, short stature, craniofacial dysmorphism, and congenital heart defects\n",
      "D      H02048  Larsen syndrome\n",
      "D      H02064  Atelosteogenesis type I and III\n",
      "D      H02067  Boomerang dysplasia\n",
      "D      H00458  Syndromic craniosynostoses\n",
      "D      H01756  Pfeiffer syndrome\n",
      "D      H01754  Crouzon syndrome\n",
      "D      H01755  Apert syndrome\n",
      "D      H01008  C syndrome\n",
      "D      H01753  Antley-Bixler syndrome\n",
      "D      H01888  Carpenter syndrome\n",
      "D      H01988  Jackson-Weiss syndrome\n",
      "D      H01989  Beare-Stevenson syndrome\n",
      "D      H01990  Muenke syndrome\n",
      "D      H01991  Saethre-Chotzen syndrome\n",
      "D      H01992  Craniofrontonasal syndrome\n",
      "D      H01993  Baller-Gerold syndrome\n",
      "D      H02047  Bohring-Opitz syndrome\n",
      "D      H02254  Craniosynostosis and dental anomalies\n",
      "D      H02637  Brachycephaly, trichomegaly, and developmental delay\n",
      "D      H00517  Spondylocostal dysostosis\n",
      "D      H01843  Cerebrocostomandibular syndrome\n",
      "D      H00464  Nail-patella syndrome\n",
      "D      H00461  Ischiocoxopodopatellar syndrome\n",
      "D      H01889  Meier-Gorlin syndrome\n",
      "D      H00506  Osteogenesis imperfecta\n",
      "D      H00451  Osteoporosis-pseudoglioma syndrome\n",
      "D      H00514  Bruck syndrome\n",
      "D      H01496  Spondyloocular syndrome\n",
      "D      H01571  Singleton-Merten syndrome\n",
      "D      H01572  Cole-Carpenter syndrome\n",
      "D      H02395  Calvarial doughnut lesions with bone fragility\n",
      "D      H00969  Skeletal defects, genital hypoplasia, and mental retardation\n",
      "D      H02233  Alazami syndrome\n",
      "D      H02280  Complex lethal osteochondrodysplasia\n",
      "D      H02300  Steel syndrome\n",
      "D      H02306  Chondrodysplasia with joint dislocations, GPAPP type\n",
      "D      H02349  Odontochondrodysplasia\n",
      "D      H02415  Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome\n",
      "D      H02551  Skeletal dysplasia with joint laxity and advanced bone age\n",
      "C    LD25  Syndromes with face or limb anomalies as a major feature\n",
      "D      H00454  Oral-facial-digital syndrome\n",
      "D      H00456  Fronto-otopalatodigital syndromes\n",
      "D      H01816  Frank-ter Haar syndrome\n",
      "D      H02227  Frontometaphyseal dysplasia\n",
      "D      H01376  Acrofacial dysostosis\n",
      "D      H02158  Weyers acrofacial dysostosis\n",
      "D      H00528  Frontonasal dysplasia\n",
      "D      H00850  Frontorhiny\n",
      "D      H01884  Auriculocondylar syndrome\n",
      "D      H02210  Acromelic frontonasal dysostosis\n",
      "D      H02234  Hamamy syndrome\n",
      "D      H02640  Vertebral hypersegmentation and orofacial anomalies\n",
      "C    LD26  Syndromes with limb anomalies as a major feature\n",
      "D      H00467  Fibular hypoplasia and complex brachydactyly\n",
      "D      H00853  Cenani-Lenz syndactyly syndrome\n",
      "D      H00855  Triphalangeal thumb-polysyndactyly syndrome\n",
      "D      H00859  Guttmacher syndrome\n",
      "D      H00870  Brachydactyly-syndactyly syndrome\n",
      "D      H02161  Greig cephalopolysyndactyly syndrome\n",
      "D      H02333  Laurin-Sandrow syndrome\n",
      "D      H00778  Tarsal-carpal coalition syndrome\n",
      "D      H00986  Multiple pterygium syndrome\n",
      "D      H00935  Cold-induced sweating syndrome\n",
      "D      H01392  Arthrogryposis, mental retardation, and seizures\n",
      "D      H01886  Van den Ende-Gupta syndrome\n",
      "D      H02299  Arthrogryposis multiplex congenita\n",
      "D      H02358  Arthrogryposis multiplex congenita, neurogenic, with myelin defect\n",
      "D      H00811  Distal arthrogryposis\n",
      "D      H00865  Lethal congenital contractural syndrome\n",
      "D      H00872  Trismus-pseudocamptodactyly syndrome\n",
      "D      H01931  Lethal-type popliteal pterygium syndrome\n",
      "D      H02268  Wieacker-Wolff syndrome\n",
      "D      H00532  Parkes Weber syndrome\n",
      "D      H01788  Klippel-Trenaunay-Weber syndrome\n",
      "D      H01497  Temtamy preaxial brachydactyly syndrome\n",
      "D      H00846  Fuhrmann syndrome\n",
      "D      H00847  Al-Awadi/Raas-Rothschild syndrome\n",
      "C    LD27  Syndromes with skin or mucosal anomalies as a major feature\n",
      "D      H00651  Hypohidrotic ectodermal dysplasia\n",
      "D      H00645  Incontinentia pigmenti\n",
      "D      H01874  Cronkhite-Canada syndrome\n",
      "D      H02456  Ectodermal dysplasia\n",
      "D      H00648  Ectodermal dysplasia, Clouston type\n",
      "D      H00095  Ectodermal dysplasia and immunodeficiency\n",
      "D      H00204  Heimler syndrome\n",
      "D      H00449  Oculodentodigital dysplasia\n",
      "D      H00487  Tricho-dento-osseous syndrome\n",
      "D      H00503  Ellis-van Creveld syndrome\n",
      "D      H00529  Cranioectodermal dysplasia\n",
      "D      H00540  Osteoporosis, lymphedema, anhydrotic ectodermal dysplasia with immunodeficiency (OLEDAID)\n",
      "D      H00571  Johanson-Blizzard syndrome\n",
      "D      H00638  Ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome\n",
      "D      H00639  Ectodermal dysplasia, ectrodactyly, and macular dystrophy\n",
      "D      H00640  Limb-mammary syndrome\n",
      "D      H00641  ADULT syndrome\n",
      "D      H00642  Lacrimo-auriculo-dento-digital syndrome\n",
      "D      H00643  Tooth and nail syndrome\n",
      "D      H00646  Odontoonychodermal dysplasia\n",
      "D      H00647  Ectodermal dysplasia-syndactyly syndrome\n",
      "D      H00649  Ectodermal dysplasia, hair-nail type\n",
      "D      H00708  Naegeli-Franceschetti-Jadassohn syndrome\n",
      "D      H00752  Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome and Rapp-Hodgkin syndrome\n",
      "D      H00781  Schopf-Schulz-Passarge syndrome\n",
      "D      H00796  Dermatopathia pigmentosa reticularis\n",
      "D      H00857  Oligodontia-colorectal cancer syndrome\n",
      "D      H00922  Schinzel-Giedion midface retraction syndrome\n",
      "D      H00949  Focal dermal hypoplasia\n",
      "D      H00977  Trichorhinophalangeal syndrome\n",
      "D      H01271  Hypoparathyroidism with sensorineural deafness and renal dysplasia\n",
      "D      H01403  Coffin-Siris syndrome\n",
      "D      H01905  Trichomegaly\n",
      "D      H01966  Cartilage-hair hypoplasia\n",
      "D      H02058  Kohlschutter-Tonz syndrome\n",
      "D      H02081  Marshall syndrome\n",
      "D      H02083  Focal facial dermal dysplasia\n",
      "D      H02218  DOORS syndrome\n",
      "D      H02219  DDOD syndrome\n",
      "D      H02296  Basan syndrome\n",
      "D      H02303  Alopecia-mental retardation syndrome\n",
      "D      H02417  Gingival fibromatosis with hypertrichosis\n",
      "D      H02474  Blepharocheilodontic syndrome\n",
      "D      H01428  Xeroderma pigmentosum\n",
      "D      H00671  Netherton syndrome\n",
      "D      H00712  KID/HID syndrome\n",
      "D      H00739  Ichthyosis with hypotrichosis\n",
      "D      H00740  Ichthyosis follicularis, alopecia, and photophobia syndrome\n",
      "D      H00741  Ichthyosis prematurity syndrome\n",
      "D      H00799  CEDNIK syndrome\n",
      "D      H01934  Barber-Say syndrome\n",
      "D      H00818  Birt-Hogg-Dube syndrome\n",
      "D      H01986  Legius syndrome\n",
      "D      H02189  Neurofibromatosis-Noonan syndrome\n",
      "D      H01741  Autoinflammation lipodystrophy and dermatosis syndrome\n",
      "D      H00665  Mandibuloacral dysplasia\n",
      "D      H02236  Keppen-Lubinsky syndrome\n",
      "D      H00684  Pachyonychia congenita\n",
      "D      H00696  Haim-Munk syndrome\n",
      "D      H00785  Congenital hypotrichosis with juvenile macular dystrophy\n",
      "D      H00815  H syndrome\n",
      "D      H00883  Lipoid proteinosis\n",
      "D      H02486  HELIX syndrome\n",
      "C    LD28  Syndromes with connective tissue involvement as a major feature\n",
      "D      H00660  Congenital contractural arachnodactyly\n",
      "D      H00653  Marfan syndrome\n",
      "D      H00800  Loeys-Dietz syndrome\n",
      "D      H00659  Shprintzen-Goldberg syndrome\n",
      "D      H00661  MASS phenotype\n",
      "D      H01385  Rienhoff syndrome\n",
      "D      H00802  Ehlers-Danlos syndrome\n",
      "D      H01902  Brittle cornea syndrome\n",
      "D      H02239  Ehlers-Danlos syndrome, spondylodysplastic type\n",
      "D      H02240  Ehlers-Danlos syndrome periodontal type\n",
      "D      H02241  Ehlers-Danlos syndrome cardiac valvular type\n",
      "D      H02242  Ehlers-Danlos syndrome vascular type\n",
      "D      H02243  Ehlers-Danlos syndrome arthrochalasia type\n",
      "D      H02244  Ehlers-Danlos syndrome dermatosparaxis type\n",
      "D      H02245  Ehlers-Danlos syndrome kyphoscoliosis type\n",
      "D      H02246  Ehlers-Danlos syndrome musculocontractural type\n",
      "D      H02247  Ehlers-Danlos syndrome myopathic type\n",
      "D      H00904  Cutis laxa with severe pulmonary, gastrointestinal, and urinary abnormalities\n",
      "D      H00906  Macrocephaly, alopecia, cutis laxa, and scoliosis\n",
      "D      H01859  Occipital horn syndrome\n",
      "D      H00919  Arterial tortuosity syndrome\n",
      "D      H02224  Grange syndrome\n",
      "D      H02502  Joint laxity, short stature, and myopia\n",
      "C    LD29  Syndromes with obesity as a major feature\n",
      "D      H01915  Borjeson-Forssman-Lehmann syndrome\n",
      "D      H02195  MEHMO syndrome\n",
      "D      H02267  Wilson-Turner syndrome\n",
      "C    LD2A  Malformative disorders of sex development\n",
      "D      H00607  46,XY gonadal dysgenesis\n",
      "D      H00608  46,XY disorder of sex development due to testosterone secretion defect\n",
      "D      H02177  Androgen insensitivity syndrome\n",
      "D      H00442  Campomelic dysplasia\n",
      "D      H00598  46,XX testicular disorder of sex development\n",
      "D      H00609  Persistent Mullerian duct syndrome\n",
      "D      H02317  SERKAL syndrome\n",
      "D      H02318  Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal\n",
      "C    LD2B  Syndromes with premature ageing appearance as a major feature\n",
      "D      H00076  Cockayne syndrome\n",
      "D      H00558  Geroderma osteodysplasticum\n",
      "D      H00601  Hutchinson-Gilford progeria syndrome\n",
      "D      H01733  Werner syndrome\n",
      "D      H01734  Rothmund-Thomson syndrome\n",
      "D      H01883  Nestor-Guillermo progeria syndrome\n",
      "D      H02323  Ruijs-Aalfs syndrome\n",
      "D      H02480  Fontaine progeroid syndrome\n",
      "D      H02570  Cerebro-oculo-facio-skeletal syndrome\n",
      "C    LD2C  Overgrowth syndromes\n",
      "D      H00713  Beckwith-Wiedemann syndrome\n",
      "D      H00718  Sotos syndrome\n",
      "D      H00980  Nevo syndrome\n",
      "D      H01215  Simpson-Golabi-Behmel syndrome\n",
      "D      H01308  Macrocephaly macrosomia facial dysmorphism syndrome\n",
      "D      H01412  Perlman syndrome\n",
      "D      H01751  Weaver syndrome\n",
      "D      H01806  Tenorio syndrome\n",
      "D      H01834  Marshall-Smith syndrome\n",
      "D      H01885  Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome\n",
      "D      H01909  Hypoinsulinemic hypoglycemia with hemihypertrophy\n",
      "D      H01912  Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi\n",
      "D      H02119  Proteus syndrome\n",
      "D      H02153  Megalencephaly-capillary malformation syndrome\n",
      "D      H02294  Tatton-Brown-Rahman syndrome\n",
      "D      H02297  CLAPO syndrome\n",
      "D      H02298  Macrocephaly, dysmorphic facies, and psychomotor retardation\n",
      "D      H02347  Thauvin-Robinet-Faivre syndrome\n",
      "D      H02444  Luscan-Lumish syndrome\n",
      "D      H02477  Cohen-Gibson syndrome\n",
      "D      H02522  Imagawa-Matsumoto syndrome\n",
      "C    LD2D  Phakomatoses or hamartoneoplastic syndromes\n",
      "D      H00666  Peutz-Jeghers syndrome\n",
      "D      H01437  Neurofibromatosis type 1\n",
      "D      H01438  Neurofibromatosis type 2\n",
      "D      H00915  Tuberous sclerosis complex\n",
      "D      H00895  Basal cell nevus syndrome\n",
      "D      H00559  von Hippel-Lindau syndrome\n",
      "D      H01222  Cowden syndrome\n",
      "D      H02576  Familial cutaneous telangiectasia and cancer syndrome\n",
      "D      H02628  Schimmelpenning-Feuerstein-Mims syndrome\n",
      "C    LD2E  Syndromes with structural anomalies due to inborn errors of metabolism\n",
      "C    LD2F  Syndromes with multiple structural anomalies, without predominant body system involvement\n",
      "D      H00979  Sacral defect with anterior meningocele\n",
      "D      H02129  Prune belly syndrome\n",
      "D      H01195  VACTERL/VATER association\n",
      "D      H00261  Meckel syndrome\n",
      "D      H01738  Noonan syndrome\n",
      "D      H00610  Treacher Collins syndrome\n",
      "D      H01838  Mandibulofacial dysostosis with microcephaly\n",
      "D      H02126  Mandibulofacial dysostosis with alopecia\n",
      "D      H02211  Acrodysostosis\n",
      "D      H00433  Holt-Oram syndrome\n",
      "D      H00453  Branchio-oto-renal syndrome\n",
      "D      H00460  Hand-foot-genital syndrome\n",
      "D      H00463  Currarino syndrome\n",
      "D      H00500  Keutel syndrome\n",
      "D      H00502  Pallister-Hall syndrome\n",
      "D      H00504  Rubinstein-Taybi syndrome\n",
      "D      H00510  Feingold syndrome\n",
      "D      H00523  Noonan syndrome and related disorders\n",
      "D      H00555  Char syndrome\n",
      "D      H00556  CHARGE syndrome\n",
      "D      H00569  Aarskog-Scott syndrome\n",
      "D      H00570  Kabuki syndrome\n",
      "D      H00572  Roberts-SC phocomelia syndrome\n",
      "D      H00573  Townes-Brocks syndrome\n",
      "D      H00574  Coffin-Lowry syndrome\n",
      "D      H00583  Opitz-GBBB syndrome\n",
      "D      H00611  Popliteal pterygium syndrome (PPS)\n",
      "D      H00631  Cornelia de Lange syndrome\n",
      "D      H00634  Duane-radial ray syndrome\n",
      "D      H00637  Ulnar-mammary syndrome\n",
      "D      H00685  Bifid nose with or without anorectal and renal anomalies\n",
      "D      H00686  Manitoba oculotrichoanal syndrome\n",
      "D      H00709  Birk Barel mental retardation syndrome (BBMRS)\n",
      "D      H00711  Russell-Silver syndrome\n",
      "D      H00753  Urofacial syndrome\n",
      "D      H00756  Pitt-Hopkins syndrome\n",
      "D      H00797  Martsolf syndrome\n",
      "D      H00817  Branchiooculofacial syndrome\n",
      "D      H00868  Stapes ankylosis with broad thumb and toes\n",
      "D      H00886  Donnai-Barrow syndrome\n",
      "D      H00889  Lujan-Fryns syndrome\n",
      "D      H00894  FG syndrome\n",
      "D      H00907  Kleefstra syndrome\n",
      "D      H00908  Mowat-Wilson syndrome\n",
      "D      H00914  Warsaw breakage syndrome\n",
      "D      H00926  Growth retardation, developmental delay, coarse facies, and early death\n",
      "D      H00934  Caudal duplication anomaly\n",
      "D      H00936  Goldberg-Shprintzen megacolon syndrome\n",
      "D      H00943  TARP syndrome\n",
      "D      H00965  RAPADILINO syndrome\n",
      "D      H00972  Endocrine-cerebro-osteodysplasia syndrome\n",
      "D      H00987  Fetal akinesia deformation sequence\n",
      "D      H00997  CATSHL syndrome\n",
      "D      H01026  Renal coloboma syndrome\n",
      "D      H01030  Congenital arthrogryposis with anterior horn cell disease\n",
      "D      H01156  STAR syndrome\n",
      "D      H01220  Congenital cataracts, facial dysmorphism, and neuropathy\n",
      "D      H01265  Hydrolethalus syndrome\n",
      "D      H01289  Mulibrey nanism\n",
      "D      H01292  Nance-Horan syndrome\n",
      "D      H01370  SHORT syndrome\n",
      "D      H01393  Van Maldergem syndrome\n",
      "D      H01402  Nicolaides-Baraitser syndrome\n",
      "D      H01413  Adams-Oliver syndrome\n",
      "D      H01568  3C syndrome\n",
      "D      H01569  CHOPS syndrome\n",
      "D      H01573  Zimmermann-Laband syndrome\n",
      "D      H01745  Cardiofaciocutaneous syndrome\n",
      "D      H01747  Costello syndrome\n",
      "D      H01793  Young-Simpson syndrome\n",
      "D      H01794  Genitopatellar syndrome\n",
      "D      H01795  Blepharophimosis-mental retardation syndrome\n",
      "D      H01797  Webb-Dattani syndrome\n",
      "D      H01814  Stromme syndrome\n",
      "D      H01839  Burn-McKeown syndrome\n",
      "D      H01840  Moebius syndrome\n",
      "D      H01845  Catel-Manzke syndrome\n",
      "D      H01869  Megacystis microcolon intestinal hypoperistalsis syndrome\n",
      "D      H01878  Al-Raqad syndrome\n",
      "D      H01879  Wiedemann-Steiner syndrome\n",
      "D      H01887  3MC syndrome\n",
      "D      H01908  Carey-Fineman-Ziter syndrome\n",
      "D      H01917  CK syndrome\n",
      "D      H01923  Microcephaly, short stature, and impaired glucose metabolism\n",
      "D      H01927  Van der Woude syndrome\n",
      "D      H01930  Au-Kline syndrome\n",
      "D      H01932  Ablepharon-macrostomia syndrome\n",
      "D      H01984  Leopard syndrome\n",
      "D      H02023  Baraitser-Winter syndrome\n",
      "D      H02046  OFC syndrome\n",
      "D      H02072  Stickler syndrome\n",
      "D      H02074  Knobloch syndrome\n",
      "D      H02082  Floating-Harbor syndrome\n",
      "D      H02087  Vertebral, cardiac, renal, and limb defects syndrome\n",
      "D      H02102  Myhre syndrome\n",
      "D      H02180  McKusick-Kaufman syndrome\n",
      "D      H02190  CBL syndrome\n",
      "D      H02191  Noonan-like syndrome with loose anagen hair\n",
      "D      H02198  Pancreatic agenesis and congenital heart disease\n",
      "D      H02232  CAGSSS syndrome\n",
      "D      H02248  MEND syndrome\n",
      "D      H02249  Primrose syndrome\n",
      "D      H02253  Beaulieu-Boycott-Innes syndrome\n",
      "D      H02255  FDLAB syndrome\n",
      "D      H02260  Chondrodysplasia Chassaing-Lacombe type\n",
      "D      H02271  Cerebellofaciodental syndrome\n",
      "D      H02274  Cerebellar atrophy, visual impairment, and psychomotor retardation\n",
      "D      H02283  IVIC syndrome\n",
      "D      H02324  Sacral agenesis with vertebral anomalies\n",
      "D      H02327  KBG syndrome\n",
      "D      H02328  Sifrim-Hitz-Weiss syndrome\n",
      "D      H02334  Pierpont syndrome\n",
      "D      H02364  Heart and brain malformation syndrome\n",
      "D      H02368  Developmental delay with short stature, dysmorphic facial features, and sparse hair\n",
      "D      H02369  IMAGE-I syndrome\n",
      "D      H02370  FILS syndrome\n",
      "D      H02376  Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies\n",
      "D      H02381  Cleft palate, psychomotor retardation, and distinctive facial features\n",
      "D      H02382  Bainbridge-Ropers syndrome\n",
      "D      H02383  Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis\n",
      "D      H02391  Infantile-onset multisystem neurologic, endocrine, and pancreatic disease\n",
      "D      H02394  Cleft palate, cardiac defects, and mental retardation\n",
      "D      H02453  Congenital heart defects and ectodermal dysplasia\n",
      "D      H02454  Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder\n",
      "D      H02455  Congenital heart defects, hamartomas of tongue, and polysyndactyly\n",
      "D      H02478  CATIFA syndrome\n",
      "D      H02479  Nivelon-Nivelon-Mabille syndrome\n",
      "D      H02481  Syndromic disorder with short stature\n",
      "D      H02482  ROSAH syndrome\n",
      "D      H02483  Basel-Vanagaite-Smirin-Yosef syndrome\n",
      "D      H02493  Al Kaissi syndrome\n",
      "D      H02496  Cerebellar, ocular, craniofacial, and genital syndrome\n",
      "D      H02500  Congenital interstitial lung disease with nephrotic syndrome and epidermolysis bullosa\n",
      "D      H02503  Richieri-Costa-Pereira syndrome\n",
      "D      H02506  Cardioacrofacial dysplasia\n",
      "D      H02508  Agenesis of corpus callosum, cardiac, ocular, and genital syndrome\n",
      "D      H02533  Kaufman oculocerebrofacial syndrome\n",
      "D      H02581  Juberg-Hayward syndrome\n",
      "D      H02595  Oculoskeletodental syndrome\n",
      "D      H02607  Short stature and microcephaly with genital anomalies\n",
      "D      H02619  Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome\n",
      "D      H02625  Primordial dwarfism-immunodeficiency-lipodystrophy syndrome\n",
      "D      H02641  Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development\n",
      "D      H02650  Menke-Hennekam syndrome\n",
      "D      H01824  CODAS syndrome\n",
      "D      H01850  Hartsfield syndrome\n",
      "D      H01857  Filippi syndrome\n",
      "D      H02343  EVEN-plus syndrome\n",
      "D      H02465  Weiss-Kruszka syndrome\n",
      "D      H02547  BRENS syndrome\n",
      "D      H02548  CIMDAG syndrome\n",
      "D      H02549  Cerebellar ataxia, brain abnormalities, and cardiac conduction defects\n",
      "D      H02578  Short stature, microcephaly, and endocrine dysfunction\n",
      "D      H02638  Zaki syndrome\n",
      "D      H02639  Atelis syndrome\n",
      "C    LD2G  Conjoined twins\n",
      "C    LD2H  Syndromic genetic deafness\n",
      "D      H00687  Fraser syndrome\n",
      "D      H02356  PCWH syndrome\n",
      "D      H00779  Usher syndrome\n",
      "D      H00446  Craniofacial-deafness-hand syndrome\n",
      "D      H00581  Alport syndrome\n",
      "D      H00706  Bart-Pumphrey syndrome\n",
      "D      H00727  Athabascan brainstem dysgenesis syndrome\n",
      "D      H00803  Seizures-sensorineural deafness-ataxia-mental retardation-electrolyte imbalance (SESAME)\n",
      "D      H00823  ABCD syndrome\n",
      "D      H00946  Arts syndrome\n",
      "D      H01286  Microtia hearing impairment and cleft palate\n",
      "D      H01903  Brown-Vialetto-Van Laere syndrome\n",
      "D      H02095  Perrault syndrome\n",
      "D      H02135  Cone-rod dystrophy and hearing loss\n",
      "D      H02220  MEDNIK syndrome\n",
      "D      H02226  Cardiospondylocarpofacial syndrome\n",
      "D      H02286  Congenital deafness with inner ear agenesis, microtia, and microdontia\n",
      "D      H02287  Deafness, dystonia, and cerebral hypomyelination\n",
      "D      H02326  Keipert syndrome\n",
      "D      H02355  Deafness and myopia\n",
      "D      H02430  Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus\n",
      "D      H02435  Deafness-infertility syndrome\n",
      "D      H02634  Deafness, cataract, impaired intellectual development, and polyneuropathy\n",
      "C    LD2Y  Other specified multiple developmental anomalies or syndromes\n",
      "D      H00417  Alstrom syndrome\n",
      "D      H00418  Bardet-Biedl syndrome\n",
      "D      H01623  MDPL syndrome\n",
      "D      H02488  Cardiac-urogenital syndrome\n",
      "D      H02523  Genitourinary and/or brain malformation syndrome\n",
      "D      H02630  Chitayat syndrome\n",
      "C    LD2Z  Multiple developmental anomalies or syndromes, unspecified\n",
      "D      H00493  Heparan sulfate proteoglycan gene defects\n",
      "B  Chromosomal anomalies, excluding gene mutations\n",
      "C    LD40  Complete trisomies of the autosomes\n",
      "D      H01552  Down syndrome\n",
      "D      H01562  Patau syndrome\n",
      "D      H01564  Edwards syndrome\n",
      "C    LD41  Duplications of the autosomes\n",
      "D      H02604  Chromosome 1q21.1 duplication syndrome\n",
      "D      H01790  Emanuel syndrome\n",
      "C    LD42  Polyploidies\n",
      "C    LD43  Complete monosomies of the autosomes\n",
      "C    LD44  Deletions of the autosomes\n",
      "D      H01831  Ring chromosome 20 syndrome\n",
      "D      H01792  1p36 deletion syndrome\n",
      "D      H02471  Brain malformations with urinary tract defects\n",
      "D      H00561  Brachydactyly-mental retardation syndrome\n",
      "D      H02146  Glass syndrome\n",
      "D      H01773  4p deletion syndrome\n",
      "D      H01223  Mental retardation-stereotypic movements-epilepsy and/or cerebral malformations\n",
      "D      H00764  Chromosome 5p deletion syndrome\n",
      "D      H01439  Williams-Beuren syndrome\n",
      "D      H01800  Verheij syndrome\n",
      "D      H02103  DeSanto-Shinawi syndrome\n",
      "D      H02156  Lamb-Shaffer syndrome\n",
      "D      H01861  Chromosome 15q24 microdeletion syndrome\n",
      "D      H01877  Chromosome 15q13.3 microdeletion syndrome\n",
      "D      H02121  Koolen-De Vries syndrome\n",
      "D      H01791  Smith-Magenis syndrome\n",
      "D      H01004  Velocardiofacial syndrome\n",
      "D      H01524  DiGeorge syndrome\n",
      "D      H01525  22q11.2 deletion syndrome\n",
      "D      H01238  Phelan-McDermid syndrome\n",
      "C    LD45  Uniparental disomies\n",
      "D      H01801  Kagami-Ogata syndrome\n",
      "C    LD46  Imprinting errors\n",
      "C    LD47  Balanced rearrangements or structural rearrangements\n",
      "C    Sex chromosome anomalies\n",
      "D      LD50  Number anomalies of chromosome X\n",
      "D      LD51  Structural anomalies of chromosome X, excluding Turner syndrome\n",
      "E        H00552  Chromosome Xp21 deletion syndrome\n",
      "E        H00994  Familial skewed X-chromosome inactivation\n",
      "D      LD52  Number anomalies of chromosome Y\n",
      "D      LD53  Structural anomalies of chromosome Y\n",
      "D      LD54  Male with sex chromosome mosaicism\n",
      "D      LD55  Fragile X chromosome\n",
      "E        H00465  Fragile X syndrome\n",
      "E        H01731  Fragile X tremor/ataxia syndrome\n",
      "D      LD56  Chimaera 46, XX, 46, XY\n",
      "D      LD5Y  Other specified sex chromosome anomalies\n",
      "D      LD5Z  Sex chromosome anomalies, unspecified\n",
      "C    LD7Y  Other specified chromosomal anomalies, excluding gene mutations\n",
      "D      H01288  Mosaic variegated aneuploidy syndrome\n",
      "C    LD7Z  Chromosomal anomalies, excluding gene mutations, unspecified\n",
      "B  LD90  Conditions with disorders of intellectual development as a relevant clinical feature\n",
      "C    H01732  Angelman syndrome\n",
      "C    H00478  Prader-Willi syndrome\n",
      "C    H00440  Rett syndrome\n",
      "C    H00597  Snyder-Robinson syndrome\n",
      "C    H00769  Hyperekplexia\n",
      "C    H00940  Cohen syndrome\n",
      "C    H01752  ATR-X syndrome\n",
      "C    H01769  ZTTK syndrome\n",
      "C    H01913  Renpenning syndrome\n",
      "C    H01914  Christianson syndrome\n",
      "C    H01916  Stocco dos Santos X-linked mental retardation syndrome\n",
      "C    H01920  Partington syndrome\n",
      "C    H01922  Infantile hypotonia with psychomotor retardation and characteristic facies\n",
      "C    H02137  Laurence-Moon syndrome\n",
      "C    H02252  PEHO syndrome\n",
      "C    H02305  RERE-related neurodevelopmental syndrome\n",
      "C    H02325  Schaaf-Yang syndrome\n",
      "C    H02337  Skraban-Deardorff syndrome\n",
      "C    H02338  PEHO-like syndrome\n",
      "C    H02346  Intellectual developmental disorder with short stature\n",
      "C    H02353  Hyperekplexia and epilepsy\n",
      "C    H02363  Ververi-Brady syndrome\n",
      "C    H02365  Helsmoortel-van der Aa syndrome\n",
      "C    H02378  Hypotonia, ataxia, and delayed development syndrome\n",
      "C    H02397  Neurodevelopmental disorder with movement abnormalities or hypotonia\n",
      "C    H02437  Growth retardation, impaired intellectual development, hypotonia, and hepatopathy\n",
      "C    H02459  Syndromic neurodevelopmental disorder\n",
      "C    H02460  Neurodevelopmental disorder with dysmorphic facies and skeletal anomalies\n",
      "C    H02461  Neurodevelopmental disorder with microcephaly\n",
      "C    H02470  Neurodevelopmental disorder with structural brain abnormalities\n",
      "C    H02515  Li-Ghorbani-Weisz-Hubshman syndrome\n",
      "C    H02528  Hao-Fountain syndrome\n",
      "C    H02535  Neurodevelopmental disorder with dysmorphic facies\n",
      "C    H02560  White-Kernohan syndrome\n",
      "C    H02582  Mullegama-Klein-Martinez syndrome\n",
      "C    H02583  X-linked intellectual disability-hypotonic facies syndrome\n",
      "C    H02584  Ferguson-Bonni neurodevelopmental syndrome\n",
      "C    H02587  Luo-Schoch-Yamamoto syndrome\n",
      "C    H02611  Turnpenny-Fry syndrome\n",
      "C    H02612  Radio-Tartaglia syndrome\n",
      "C    H02613  Brunet-Wagner neurodevelopmental syndrome\n",
      "C    H02614  Snijders Blok-Campeau syndrome\n",
      "C    H02615  Parenti-Mignot neurodevelopmental syndrome\n",
      "C    H02616  Neurodevelopmental disorder with macrocephaly\n",
      "C    H02617  Bryant-Li-Bhoj neurodevelopmental syndrome\n",
      "C    H02618  Developmental delay with variable intellectual disability and dysmorphic facies\n",
      "C    H02622  Shukla-Vernon syndrome\n",
      "C    H02623  Kury-Isidor syndrome\n",
      "C    H02632  PP2A-related neurodevelopmental disorder\n",
      "C    H02633  Beck-Fahrner syndrome\n",
      "C    H02635  Poirier-Bienvenu neurodevelopmental syndrome\n",
      "C    H02651  Lessel-Kreienkamp syndrome\n",
      "B  LD9Y  Other specified developmental anomalies\n",
      "B  LD9Z  Developmental anomalies, unspecified\n",
      "A21 Symptoms, signs or clinical findings, not elsewhere classified\n",
      "B  Symptoms, signs or clinical findings of blood, blood-forming organs, or the immune system\n",
      "C    Symptoms of blood, blood-forming organs, or the immune system\n",
      "D      MA00  Symptom or complaint of the blood\n",
      "D      MA01  Enlarged lymph nodes\n",
      "D      MA0Y  Other specified symptoms of blood, blood-forming organs, or the immune system\n",
      "C    Clinical findings in blood, blood-forming organs, or the immune system\n",
      "D      MA10  Abnormal serum enzyme levels\n",
      "D      MA11  Clinical findings of hormones in blood, blood-forming organs, or the immune system\n",
      "D      MA12  Clinical findings of drugs, medicaments and biological substances in blood, blood-forming organs, or the immune system\n",
      "D      MA13  Clinical findings of substances chiefly nonmedicinal as to source in blood, blood-forming organs, or the immune system\n",
      "D      MA14  Immunological findings in blood, blood-forming organs, or the immune system\n",
      "D      MA15  Microbiological findings in blood, blood-forming organs, or the immune system\n",
      "D      MA16  Cytological findings in blood, blood-forming organs, or the immune system\n",
      "D      MA17  Histological findings in blood, blood-forming organs, or the immune system\n",
      "D      MA18  Certain clinical findings of blood chemistry\n",
      "D      MA19  Certain abnormalities of plasma proteins\n",
      "D      MA1A  Elevated erythrocyte sedimentation rate or abnormality of plasma viscosity\n",
      "D      MA1Y  Other specified clinical findings in blood, blood-forming organs, or the immune system\n",
      "C    MA3Y  Other specified symptoms, signs or clinical findings of blood, blood-forming organs, or the immune system\n",
      "B  Symptoms, signs or clinical findings of endocrine, nutritional or metabolic diseases\n",
      "C    Results of function studies of the endocrine, nutritional or metabolic diseases\n",
      "D      MA50  Abnormal results of thyroid function studies\n",
      "D      MA51  Abnormal results of other endocrine function studies\n",
      "C    MA6Y  Other specified symptoms, signs or clinical findings of endocrine, nutritional or metabolic diseases\n",
      "B  Symptoms, signs or clinical findings of speech or voice\n",
      "C    Symptoms or signs involving speech or voice\n",
      "D      MA80  Speech disturbances\n",
      "D      MA81  Speech dysfluency\n",
      "D      MA82  Voice disturbances\n",
      "D      MA8Y  Other specified symptoms or signs involving speech or voice\n",
      "C    MB0Y  Other specified symptoms, signs or clinical findings of speech or voice\n",
      "B  Mental or behavioural symptoms, signs or clinical findings\n",
      "C    MB20  Symptoms, signs or clinical findings involving consciousness\n",
      "C    MB21  Symptoms, signs or clinical findings involving cognition\n",
      "C    MB22  Symptoms or signs involving motivation or energy\n",
      "C    MB23  Symptoms or signs involving appearance or behaviour\n",
      "C    MB24  Symptoms or signs involving mood or affect\n",
      "C    MB25  Symptoms or signs involving form of thought\n",
      "C    MB26  Symptoms or signs involving content of thought\n",
      "C    MB27  Symptoms or signs involving perceptual disturbance\n",
      "C    MB28  Symptoms or signs related to personality features\n",
      "C    MB29  Symptoms or signs involving eating and related behaviour\n",
      "C    MB2A  Symptoms or signs involving elimination\n",
      "C    MB2Y  Other specified mental or behavioural symptoms, signs or clinical findings\n",
      "B  Symptoms, signs or clinical findings of the nervous system\n",
      "C    Symptoms or signs involving the nervous system\n",
      "D      MB40  Sensation disturbance\n",
      "D      MB41  Disturbances of smell and taste\n",
      "D      MB42  Phonophobia\n",
      "D      MB43  Dyssomnia\n",
      "D      MB44  Abnormalities of gait and mobility\n",
      "D      MB45  Lack of coordination\n",
      "D      MB46  Abnormal involuntary movements\n",
      "D      MB47  Abnormality of tonus and reflex\n",
      "E        H02388  Infantile-onset limb and orofacial dyskinesia\n",
      "E        H02389  Familial dyskinesia with facial myokymia\n",
      "D      MB48  Dizziness and giddiness\n",
      "D      MB49  Aura\n",
      "D      MB4A  Apraxia\n",
      "D      MB4B  Symbolic dysfunctions\n",
      "E        H01899  Dyslexia\n",
      "D      MB4C  Gerstmann syndrome\n",
      "D      MB4D  Headache, not elsewhere classified\n",
      "D      Paralytic symptoms\n",
      "E        MB50  Tetraplegia\n",
      "E        MB51  Diplegia of upper extremities\n",
      "E        MB52  Diplegia of lower extremities\n",
      "E        MB53  Hemiplegia\n",
      "F          H00998  Alternating hemiplegia of childhood\n",
      "E        MB54  Monoplegia of upper extremity\n",
      "E        MB55  Monoplegia of lower extremity\n",
      "E        MB56  Paraplegia\n",
      "E        MB57  Functional level of injury of spinal cord\n",
      "E        MB5Y  Other specified paralytic symptoms\n",
      "E        MB5Z  Paralytic symptoms, unspecified\n",
      "D      MB60  Sleeptalking\n",
      "D      MB6Y  Other specified symptoms or signs involving the nervous system\n",
      "C    Clinical findings in the nervous system\n",
      "D      MB70  Clinical findings in cerebrospinal fluid\n",
      "D      MB71  Clinical findings on diagnostic imaging of central nervous system\n",
      "D      MB72  Results of function studies of the nervous system\n",
      "D      MB7Y  Other specified clinical findings in the nervous system\n",
      "C    MB9Y  Other specified symptoms, signs or clinical findings of the nervous system\n",
      "B  Symptoms, signs or clinical findings of the visual system\n",
      "C    Symptoms or signs involving the visual system\n",
      "D      MC10  Eye appearance abnormal\n",
      "D      MC11  Eye sensation abnormal\n",
      "D      MC12  Chronic enlargement of lacrimal gland\n",
      "D      MC13  Epiphora\n",
      "D      MC14  Eye discharge\n",
      "D      MC15  Red eye\n",
      "D      MC16  Pallor conjunctiva\n",
      "D      MC17  Icteric sclera\n",
      "D      MC18  Ocular pain\n",
      "D      MC19  Quadrantanopia\n",
      "D      MC1A  Visual floaters\n",
      "D      MC1B  Symptom or complaint of the eyelid\n",
      "D      MC1C  Symptom or complaint of glasses\n",
      "D      MC1D  Symptom or complaint of contact lens\n",
      "D      MC1Y  Other specified symptoms or signs involving the visual system\n",
      "C    MC20  Clinical findings of the visual system\n",
      "C    MC21  Impairment of electrophysiological functions\n",
      "C    MC2Y  Other specified symptoms, signs or clinical findings of the visual system\n",
      "B  Symptoms, signs or clinical findings of ear or mastoid process\n",
      "C    Symptoms or signs involving the ear or mastoid process\n",
      "D      MC40  Plugged feeling ear\n",
      "D      MC41  Tinnitus\n",
      "D      MC4Y  Other specified symptoms or signs involving the ear or mastoid process\n",
      "C    MC6Y  Other specified symptoms, signs or clinical findings of ear or mastoid process\n",
      "B  Symptoms, signs or clinical findings of the circulatory system\n",
      "C    Symptoms or signs involving the circulatory system\n",
      "D      MC80  Abnormal blood-pressure reading, without diagnosis\n",
      "D      MC81  Abnormalities of heart beat\n",
      "D      MC82  Cardiac arrest\n",
      "D      MC83  Cardiac murmurs and other cardiac sounds\n",
      "D      MC84  Cardiovascular pain\n",
      "D      MC85  Gangrene\n",
      "D      MC86  Precordial pain\n",
      "D      MC87  Pressure or tightness of heart\n",
      "D      MC88  Prominent veins\n",
      "D      MC8Y  Other specified symptoms or signs involving the circulatory system\n",
      "C    MC90  Clinical findings on diagnostic imaging of heart or coronary circulation\n",
      "C    MC91  Results of function studies of the circulatory system\n",
      "C    MC9Y  Other specified symptoms, signs or clinical findings of the circulatory system\n",
      "B  Symptoms, signs or clinical findings of the respiratory system\n",
      "C    Symptoms or signs involving the respiratory system\n",
      "D      MD10  Abnormal sputum\n",
      "D      MD11  Abnormalities of breathing\n",
      "D      MD12  Cough\n",
      "D      Haemorrhage from respiratory passages\n",
      "E        MD20  Epistaxis\n",
      "E        MD21  Haemorrhage from throat\n",
      "E        MD22  Haemoptysis\n",
      "E        MD23  Haemorrhage from other sites in respiratory passages\n",
      "E        MD24  Acute idiopathic pulmonary haemorrhage in infants over 28 days of age\n",
      "E        MD2Z  Haemorrhage from respiratory passages, unspecified\n",
      "D      MD30  Pain in throat or chest\n",
      "D      MD31  Pleurisy\n",
      "D      MD32  Rales\n",
      "D      MD33  Respiratory arrest\n",
      "D      MD34  Symptom or complaint of the nose\n",
      "D      MD35  Symptom or complaint of the sinus\n",
      "D      MD36  Symptom or complaint of the throat\n",
      "D      MD3Y  Other specified symptoms or signs involving the respiratory system\n",
      "C    Clinical findings in the respiratory system\n",
      "D      MD40  Clinical findings in specimens from respiratory organs and thorax\n",
      "D      MD41  Clinical findings on diagnostic imaging of lung\n",
      "D      MD42  Results of function studies of the respiratory system\n",
      "D      MD4Y  Other specified clinical findings in the respiratory system\n",
      "C    MD6Y  Other specified symptoms, signs or clinical findings of the respiratory system\n",
      "B  Symptoms, signs or clinical findings of the digestive system or abdomen\n",
      "C    Symptoms or signs involving the digestive system or abdomen\n",
      "D      MD80  Symptoms or signs of the orofacial complex\n",
      "D      MD81  Abdominal or pelvic pain\n",
      "D      MD82  Intra-abdominal or pelvic swelling, mass or lump\n",
      "D      Symptoms related to the upper gastrointestinal tract\n",
      "E        MD90  Nausea or vomiting\n",
      "E        MD91  Belching\n",
      "E        MD92  Dyspepsia\n",
      "E        MD93  Dysphagia\n",
      "E        MD94  Halitosis\n",
      "E        MD95  Heartburn\n",
      "E        MD9Y  Other specified symptoms related to the upper gastrointestinal tract\n",
      "D      Symptoms related to the lower gastrointestinal tract or abdomen\n",
      "E        ME00  Abdominal compartment syndrome\n",
      "E        ME01  Abdominal distension\n",
      "E        ME02  Abdominal rigidity\n",
      "E        ME03  Abnormal bowel sounds\n",
      "E        ME04  Ascites\n",
      "E        ME05  Change in bowel habit\n",
      "E        ME06  Chronic enteritis of uncertain aetiology\n",
      "E        ME07  Faecal incontinence\n",
      "E        ME08  Flatulence and related conditions\n",
      "E        ME09  Rectal tenesmus\n",
      "E        ME0A  Visible peristalsis\n",
      "E        ME0B  Problems with defaecation, not otherwise specified\n",
      "E        ME0Y  Other specified symptoms related to the lower gastrointestinal tract or abdomen\n",
      "D      ME10  Abnormalities related to hepatobiliary system\n",
      "D      ME1Y  Other specified symptoms or signs involving the digestive system or abdomen\n",
      "C    Clinical findings in the digestive system\n",
      "D      ME20  Clinical findings in specimens from digestive organs or abdominal cavity\n",
      "D      ME21  Clinical findings on diagnostic imaging of liver or biliary tract\n",
      "D      ME22  Clinical findings on diagnostic imaging of digestive tract\n",
      "D      ME23  Results of function studies of the digestive system\n",
      "D      ME24  Clinical manifestations of the digestive system\n",
      "D      ME2Y  Other specified clinical findings in the digestive system\n",
      "C    ME4Y  Other specified symptoms, signs or clinical findings of the digestive system or abdomen\n",
      "B  Symptoms, signs or clinical findings involving the skin\n",
      "C    Symptoms or signs involving the skin\n",
      "D      ME60  Skin lesion of uncertain or unspecified nature\n",
      "D      ME61  Subcutaneous swelling, mass or lump of uncertain or unspecified nature\n",
      "D      ME62  Acute skin eruption of uncertain or unspecified nature\n",
      "D      ME63  Chronic skin disorder of uncertain or unspecified nature\n",
      "D      ME64  Non-specific cutaneous vascular signs\n",
      "D      ME65  Disturbances of skin sensation of unspecified aetiology\n",
      "D      ME66  Miscellaneous non-specific skin-related symptoms and signs\n",
      "D      ME67  Skin disorder of uncertain or unspecified nature\n",
      "D      ME6Y  Other specified symptoms or signs involving the skin\n",
      "B  Symptoms, signs or clinical findings of the musculoskeletal system\n",
      "C    Symptoms or signs of the musculoskeletal system\n",
      "D      ME80  Clicking hip\n",
      "D      ME81  Musculoskeletal chest pain\n",
      "D      ME82  Pain in joint\n",
      "D      ME83  Rheumatism, unspecified\n",
      "D      ME84  Spinal pain\n",
      "D      ME85  Stiffness of joint\n",
      "D      ME86  Symptom or complaint of a body part\n",
      "D      ME8Y  Other specified symptoms or signs of the musculoskeletal system\n",
      "C    Clinical findings in the musculoskeletal system\n",
      "D      ME90  Clinical findings on diagnostic imaging of skull and head\n",
      "D      ME91  Clinical findings on diagnostic imaging of limbs\n",
      "D      ME92  Clinical findings on diagnostic imaging of other parts of musculoskeletal system\n",
      "D      ME93  Biomechanical lesions, not elsewhere classified\n",
      "D      ME9Y  Other specified clinical findings in the musculoskeletal system\n",
      "C    MF1Y  Other specified symptoms, signs or clinical findings of the musculoskeletal system\n",
      "B  Symptoms, signs or clinical findings of the genitourinary system\n",
      "C    Symptoms, signs or clinical findings involving the female genital system\n",
      "D      MF30  Breast lump or mass female\n",
      "D      MF31  Breast or lactation symptom or complaint\n",
      "D      MF32  Menopausal symptom or complaint\n",
      "D      MF33  Premenstrual symptom or complaint\n",
      "D      MF34  Pregnancy symptom or complaint\n",
      "D      MF35  Postpartum symptom or complaint\n",
      "D      MF36  Other symptom or complaint of vagina\n",
      "D      MF37  Symptom or complaint of female nipple\n",
      "D      MF38  Symptom or complaint of female pelvis\n",
      "D      MF39  Symptom or complaint of the vulva\n",
      "D      MF3A  Vaginal discharge\n",
      "E        H01380  Bacterial vaginosis\n",
      "D      MF3Y  Other specified symptoms, signs or clinical findings involving the female genital system\n",
      "C    Symptoms, signs or clinical findings involving the male genital system\n",
      "D      MF40  Problems of male genital organs\n",
      "D      MF41  Symptom or complaint of male sexual function\n",
      "D      MF42  Retractile testis migrans\n",
      "D      MF4Y  Other specified symptoms, signs or clinical findings involving the male genital system\n",
      "C    Symptoms, signs or clinical findings involving the urinary system\n",
      "D      MF50  Abnormal micturition\n",
      "D      MF51  Anuria or oliguria\n",
      "D      MF52  Bladder pain\n",
      "D      MF53  Extrarenal uraemia\n",
      "D      MF54  Macroscopic changes of size of the kidney\n",
      "D      MF55  Polyuria\n",
      "D      MF56  Renal colic\n",
      "D      MF57  Symptom or complaint of bladder\n",
      "D      MF58  Urethral discharge\n",
      "D      MF59  Urinary symptom or complaint\n",
      "D      MF5Y  Other specified symptoms, signs or clinical findings involving the urinary system\n",
      "C    Clinical findings in specimens from female genital organs\n",
      "D      MF60  Abnormal level of enzymes in specimens from female genital organs\n",
      "D      MF61  Abnormal level of hormones in specimens from female genital organs\n",
      "D      MF62  Abnormal level of drugs, medicaments and biological substances in specimens from female genital organs\n",
      "D      MF63  Abnormal level of substances chiefly nonmedicinal as to source in specimens from female genital organs\n",
      "D      MF64  Abnormal immunological findings in specimens from female genital organs\n",
      "D      MF65  Abnormal microbiological findings in specimens from female genital organs\n",
      "D      MF66  Abnormal cytological findings in specimens from female genital organs\n",
      "D      MF67  Abnormal histological findings in specimens from female genital organs\n",
      "D      MF68  Abnormal chromosomal findings in specimens from female genital organs\n",
      "D      MF6Y  Other specified clinical findings in specimens from female genital organs\n",
      "D      MF6Z  Clinical findings in specimens from female genital organs, unspecified\n",
      "C    Clinical findings in specimens from male genital organs\n",
      "D      MF70  Abnormal level of enzymes in specimens from male genital organs\n",
      "D      MF71  Abnormal level of hormones in specimens from male genital organs\n",
      "D      MF72  Abnormal level of drugs, medicaments and biological substances in specimens from male genital organs\n",
      "D      MF73  Abnormal level of substances chiefly nonmedicinal as to source in specimens from male genital organs\n",
      "D      MF74  Abnormal immunological findings in specimens from male genital organs\n",
      "D      MF75  Abnormal microbiological findings in specimens from male genital organs\n",
      "D      MF76  Abnormal cytological findings in specimens from male genital organs\n",
      "D      MF77  Abnormal histological findings in specimens from male genital organs\n",
      "D      MF78  Abnormal chromosomal findings in specimens from male genital organs\n",
      "D      MF7Y  Other specified clinical findings in specimens from male genital organs\n",
      "D      MF7Z  Clinical findings in specimens from male genital organs, unspecified\n",
      "C    Clinical findings in specimens from the urinary system\n",
      "D      MF80  Diffuse mesangial sclerosis\n",
      "D      MF81  Fibronectin glomerulopathy\n",
      "E        H01260  Glomerulopathy with fibronectin deposits\n",
      "D      MF82  Lipoprotein glomerulopathy\n",
      "E        H00887  Lipoprotein glomerulopathy\n",
      "D      MF83  Diabetic glomerular changes\n",
      "D      MF84  Pauci-immune proliferative glomerulonephritis\n",
      "D      MF85  Anti-glomerular basement membrane antibody mediated disease\n",
      "E        H01721  Anti-glomerular basement membrane (GBM) disease\n",
      "D      MF8Y  Other specified clinical findings in specimens from the urinary system\n",
      "E        H00626  Focal segmental glomerulosclerosis\n",
      "E        H01581  IgA nephropathy\n",
      "E        H01726  Membranoproliferative glomerulonephritis\n",
      "E        H01767  Henoch-Schonlein purpura nephritis\n",
      "E        H02579  C3 glomerulopathy\n",
      "D      MF8Z  Clinical findings in specimens from the urinary system, unspecified\n",
      "C    Clinical findings on examination of urine, without diagnosis\n",
      "D      MF90  Acetonuria\n",
      "D      MF91  Bilirubinuria\n",
      "D      MF92  Chyluria\n",
      "D      MF93  Glycosuria\n",
      "D      MF94  Haemoglobinuria\n",
      "D      MF95  Myoglobinuria\n",
      "E        H01290  Acute recurrent myoglobinuria\n",
      "D      MF96  Proteinuria\n",
      "D      MF97  Pyuria\n",
      "D      MF98  Abnormal levels of serum electrolytes in the urine\n",
      "E        H02340  Absorptive hypercalciuria\n",
      "D      MF99  Elevated urine levels of drugs, medicaments and biological substances\n",
      "D      MF9A  Abnormal urine levels of substances chiefly nonmedicinal as to source\n",
      "D      MF9B  Abnormal findings on microbiological examination of urine\n",
      "D      MF9C  Abnormal findings on cytological and histological examination of urine\n",
      "D      MF9Y  Other specified clinical findings on examination of urine, without diagnosis\n",
      "C    MG00  Clinical findings on diagnostic imaging of breast\n",
      "C    MG01  Clinical findings on diagnostic imaging of urinary organs\n",
      "C    MG02  Results of kidney function studies\n",
      "C    MG0Y  Other specified symptoms, signs or clinical findings of the genitourinary system\n",
      "B  General symptoms, signs or clinical findings\n",
      "C    General symptoms\n",
      "D      MG20  Cachexia\n",
      "D      MG21  Chills\n",
      "D      MG22  Fatigue\n",
      "D      MG23  Fear of death or dying\n",
      "D      MG24  Fear of disease\n",
      "D      MG25  Feeling ill\n",
      "D      MG26  Fever of other or unknown origin\n",
      "D      MG27  Haemorrhage, not elsewhere classified\n",
      "D      MG28  Hypothermia, not associated with low environmental temperature\n",
      "D      MG29  Oedema\n",
      "D      MG2A  Ageing associated decline in intrinsic capacity\n",
      "D      Pain\n",
      "E        MG30  Chronic pain\n",
      "F          H01636  Fibromyalgia\n",
      "E        MG31  Acute pain\n",
      "E        MG3Z  Pain, unspecified\n",
      "D      MG40  Shock\n",
      "D      MG41  Sleep disturbance, not elsewhere classified\n",
      "D      MG42  Somnolence, not elsewhere classified\n",
      "D      MG43  Symptoms and signs concerning food and fluid intake\n",
      "D      MG44  Symptoms peculiar to infancy\n",
      "D      MG45  Syncope and collapse\n",
      "D      MG46  Systemic inflammatory response syndrome of noninfectious origin\n",
      "D      MG47  Toxicosis not further specified\n",
      "D      MG48  Unknown and unspecified causes of morbidity\n",
      "D      MG49  Hangover\n",
      "D      MG4A  Multi organ failure\n",
      "D      MG4Y  Other specified general symptoms\n",
      "C    Finding of microorganism resistant to antimicrobial drugs\n",
      "D      MG50  Finding of gram negative bacteria resistant to antimicrobial drugs\n",
      "E        H00309  Multidrug-resistant Acinetobacter infection\n",
      "E        H01422  Carbapenem-resistant bacterial infection\n",
      "E        H00313  Multidrug-resistant Pseudomonas aeruginosa infection\n",
      "D      MG51  Finding of gram positive bacteria resistant to antimicrobial drugs\n",
      "E        H00330  Methicillin-resistant Staphylococcal aureus (MRSA) infection\n",
      "E        H00331  Vancomycin-resistant Staphylococcal aureus (VRSA) infection\n",
      "E        H01423  Penicillin-resistant Streptococcus pneumoniae infection\n",
      "E        H00340  Vancomycin-resistant enterococci infection\n",
      "E        H01401  Methicillin-resistant Staphylococcus epidermidis (MRSE) infection\n",
      "D      MG52  Finding of bacteria, neither gram negative nor positive, resistant to antimicrobial drugs\n",
      "E        H01472  Multidrug-resistant tuberculosis\n",
      "D      MG53  Finding of virus resistant to antimicrobial drugs\n",
      "D      MG54  Finding of fungus resistant to antimicrobial drugs\n",
      "D      MG55  Finding of parasite resistant to antimicrobial drugs\n",
      "D      MG56  Finding of microorganism resistant to other multiple antimicrobial drugs\n",
      "D      MG5Y  Finding of other microorganism resistant to antimicrobial drugs\n",
      "D      MG5Z  Finding of microorganism resistant to antimicrobial drugs, unspecified\n",
      "C    Clinical findings in specimens from other specified organs, systems and tissues\n",
      "D      MG60  Abnormal level of enzymes in specimens from other organs, systems and tissues\n",
      "D      MG61  Abnormal level of hormones in specimens from other organs, systems and tissues\n",
      "D      MG62  Abnormal level of drugs, medicaments and biological substances in specimens from other organs, systems and tissues\n",
      "D      MG63  Abnormal level of substances chiefly nonmedicinal as to source in specimens from other organs, systems and tissues\n",
      "D      MG64  Abnormal immunological findings in specimens from other organs, systems and tissues\n",
      "D      MG65  Abnormal microbiological findings in specimens from other organs, systems and tissues\n",
      "D      MG66  Abnormal cytological findings in specimens from other organs, systems and tissues\n",
      "D      MG67  Abnormal histological findings in specimens from other organs, systems and tissues\n",
      "D      MG6Y  Other specified clinical findings in specimens from other specified organs, systems and tissues\n",
      "C    Abnormal results, not elsewhere classified\n",
      "D      MG70  Abnormal diagnostic imaging results not elsewhere classified\n",
      "D      MG71  Abnormal laboratory results, not elsewhere classified\n",
      "D      MG72  Abnormal results of function studies of other organs and systems\n",
      "D      MG7Y  Other specified abnormal results, not elsewhere classified\n",
      "D      MG7Z  Abnormal results, not elsewhere classified, unspecified\n",
      "C    MG9Y  Other specified general symptoms, signs or clinical findings\n",
      "B  Ill-defined and unknown causes of mortality\n",
      "C    MH10  Brain death\n",
      "C    MH11  Sudden infant death syndrome\n",
      "D      H02174  Sudden infant death with dysgenesis of the testes syndrome\n",
      "C    MH12  Other sudden death, cause unknown\n",
      "C    MH13  Unattended death\n",
      "C    MH14  Other ill-defined and unspecified causes of mortality\n",
      "C    MH15  Sudden unexpected death in epilepsy\n",
      "B  MH2Y  Other specified symptoms, signs or clinical findings, not elsewhere classified\n",
      "A22 Injury, poisoning or certain other consequences of external causes\n",
      "B  Injuries to the head\n",
      "C    NA00  Superficial injury of head\n",
      "C    NA01  Open wound of head\n",
      "C    NA02  Fracture of skull or facial bones\n",
      "C    NA03  Dislocation or strain or sprain of joints or ligaments of head\n",
      "C    NA04  Injury of cranial nerves\n",
      "C    NA05  Injury of blood vessels of head\n",
      "C    NA06  Injury of eye or orbit\n",
      "C    NA07  Intracranial injury\n",
      "C    NA08  Crushing injury of head\n",
      "C    NA09  Traumatic amputation of part of head\n",
      "C    NA0A  Certain specified injuries of head\n",
      "C    NA0B  Injury of the auricle\n",
      "C    NA0C  Injury of middle or inner ear\n",
      "C    NA0D  Injury of teeth or supporting structures\n",
      "C    NA0Z  Injuries to the head, unspecified\n",
      "B  Injuries to the neck\n",
      "C    NA20  Superficial injury of neck\n",
      "C    NA21  Open wound of neck\n",
      "C    NA22  Fracture of neck\n",
      "C    NA23  Dislocation or strain or sprain of joints or ligaments at neck level\n",
      "C    Injury of nerves or spinal cord at neck level\n",
      "D      Injury of spinal cord at neck level\n",
      "E        NA30  Concussion or oedema of cervical spinal cord\n",
      "E        NA31  Certain specified injuries of cervical spinal cord\n",
      "E        NA3Z  Injury of cervical spinal cord, unspecified\n",
      "D      Injury of nerves at neck level\n",
      "E        NA40  Injury of nerve root of cervical spine\n",
      "E        NA41  Injury of brachial plexus\n",
      "E        NA42  Injury of peripheral nerves of neck\n",
      "E        NA43  Injury of cervical sympathetic nerves\n",
      "E        NA44  Injury of phrenic nerve\n",
      "E        NA4Y  Injury of other specified nerves at neck level\n",
      "E        NA4Z  Injury of nerves at neck level, unspecified\n",
      "C    NA60  Injury of blood vessels at neck level\n",
      "C    NA61  Injury of muscle, fascia or tendon at neck level\n",
      "C    NA62  Crushing injury of neck\n",
      "C    NA63  Traumatic amputation at neck level\n",
      "C    NA64  Multiple injuries of neck\n",
      "C    NA6Y  Other specified injuries to the neck\n",
      "C    NA6Z  Injuries to the neck, unspecified\n",
      "B  Injuries to the thorax\n",
      "C    NA80  Superficial injury of thorax\n",
      "C    NA81  Open wound of thorax\n",
      "C    NA82  Fracture of rib, sternum or thoracic spine\n",
      "C    NA83  Dislocation or strain or sprain of joints or ligaments of thorax\n",
      "C    Injury of nerves or spinal cord at thorax level\n",
      "D      Injury of spinal cord at thorax level\n",
      "E        NA90  Concussion or oedema of thoracic spinal cord\n",
      "E        NA91  Certain specified injuries of thoracic spinal cord\n",
      "E        NA9Z  Injury of thoracic spinal cord, unspecified\n",
      "D      Injury of nerves at thorax level\n",
      "E        NB00  Injury of nerve root of thoracic spine\n",
      "E        NB01  Injury of peripheral nerves of thorax\n",
      "E        NB02  Injury of thoracic sympathetic nerves\n",
      "E        NB0Y  Injury of other specified nerves at thorax level\n",
      "D      NB2Y  Other specified injury of nerves or spinal cord at thorax level\n",
      "D      NB2Z  Injury of nerves or spinal cord at thorax level, unspecified\n",
      "C    NB30  Injury of blood vessels of thorax\n",
      "C    NB31  Injury of heart\n",
      "C    NB32  Injury of other or unspecified intrathoracic organs\n",
      "C    NB33  Crushing injury of thorax or traumatic amputation of part of thorax\n",
      "C    NB34  Injury of muscle, fascia or tendon at thorax level\n",
      "C    NB35  Multiple injuries of thorax\n",
      "C    NB3Y  Other specified injuries to the thorax\n",
      "C    NB3Z  Injuries to the thorax, unspecified\n",
      "B  Injuries to the abdomen, lower back, lumbar spine or pelvis\n",
      "C    NB50  Superficial injury of abdomen, lower back or pelvis\n",
      "C    NB51  Open wound of abdomen, lower back or pelvis\n",
      "C    NB52  Fracture of lumbar spine or pelvis\n",
      "C    NB53  Dislocation or strain or sprain of joints or ligaments of lumbar spine or pelvis\n",
      "C    Injury of nerves or lumbar spinal cord at abdomen, lower back or pelvis level\n",
      "D      Injury of spinal cord at abdomen, lower back or pelvis level\n",
      "E        NB60  Concussion or oedema of lumbar spinal cord\n",
      "E        NB61  Concussion or oedema of sacral spinal cord\n",
      "E        NB62  Certain specified injuries of lumbar spinal cord\n",
      "E        NB63  Certain specified injuries of sacral spinal cord\n",
      "E        NB6Z  Injury of spinal cord at abdomen, lower back or pelvis level, unspecified\n",
      "D      Injury of nerves at abdomen, lower back or pelvis level\n",
      "E        NB70  Injury of nerve root of lumbar spine\n",
      "E        NB71  Injury of nerve root of sacral spine\n",
      "E        NB72  Injury of cauda equina\n",
      "E        NB73  Injury of lumbosacral plexus\n",
      "E        NB74  Injury of lumbar, sacral or pelvic sympathetic nerves\n",
      "E        NB75  Injury of peripheral nerve of abdomen, lower back or pelvis\n",
      "E        NB7Y  Other specified injury of nerves at abdomen, lower back or pelvis level\n",
      "E        NB7Z  Injury of nerves at abdomen, lower back or pelvis level, unspecified\n",
      "C    NB90  Injury of blood vessels at abdomen, lower back or pelvis level\n",
      "C    NB91  Injury of intra-abdominal organs\n",
      "C    NB92  Injury of urinary or pelvic organs\n",
      "C    NB93  Crushing injury or traumatic amputation of part of abdomen, lower back or pelvis\n",
      "C    NB94  Injury of muscle, fascia or tendon of abdomen, lower back or pelvis\n",
      "C    NB95  Injury of intra-abdominal organ with pelvic organ\n",
      "C    NB96  Other multiple injuries of abdomen, lower back or pelvis\n",
      "C    NB97  Certain specified injuries of abdomen, lower back or pelvis\n",
      "C    NB98  Injury to female genital organ without further specification\n",
      "C    NB99  Injury to male genital organ without further specification\n",
      "C    NB9Y  Other specified injuries to the abdomen, lower back, lumbar spine or pelvis\n",
      "C    NB9Z  Injuries to the abdomen, lower back, lumbar spine or pelvis, unspecified\n",
      "B  Injuries to the shoulder or upper arm\n",
      "C    NC10  Superficial injury of shoulder or upper arm\n",
      "C    NC11  Open wound of shoulder or upper arm\n",
      "C    NC12  Fracture of shoulder or upper arm\n",
      "C    NC13  Dislocation or strain or sprain of joints or ligaments of shoulder girdle\n",
      "C    NC14  Injury of nerves at shoulder or upper arm level\n",
      "C    NC15  Injury of blood vessels at shoulder or upper arm level\n",
      "C    NC16  Injury of muscle, fascia, tendon or bursa at shoulder or upper arm level\n",
      "C    NC17  Crushing injury of shoulder or upper arm\n",
      "C    NC18  Traumatic amputation of shoulder or upper arm\n",
      "C    NC19  Multiple injuries of shoulder or upper arm\n",
      "C    NC1Y  Other specified injuries to the shoulder or upper arm\n",
      "C    NC1Z  Injuries to the shoulder or upper arm, unspecified\n",
      "B  Injuries to the elbow or forearm\n",
      "C    NC30  Superficial injury of forearm\n",
      "C    NC31  Open wound of forearm\n",
      "C    NC32  Fracture of forearm\n",
      "C    NC33  Dislocation or strain or sprain of joints or ligaments of elbow\n",
      "C    NC34  Injury of nerves at forearm level\n",
      "C    NC35  Injury of blood vessels at forearm level\n",
      "C    NC36  Injury of muscle, fascia, tendon or bursa at forearm level\n",
      "C    NC37  Crushing injury of forearm\n",
      "C    NC38  Traumatic amputation of forearm\n",
      "C    NC39  Multiple injuries of forearm\n",
      "C    NC3Y  Other specified injuries to the elbow or forearm\n",
      "C    NC3Z  Injuries to the elbow or forearm, unspecified\n",
      "B  Injuries to the wrist or hand\n",
      "C    NC50  Injury to fingernail\n",
      "C    NC51  Superficial injury of wrist or hand\n",
      "C    NC52  Open wound of wrist or hand\n",
      "C    NC53  Fracture at wrist or hand level\n",
      "C    NC54  Dislocation or strain or sprain of joints or ligaments at wrist or hand level\n",
      "C    NC55  Injury of nerves at wrist or hand level\n",
      "C    NC56  Injury of blood vessels at wrist or hand level\n",
      "C    NC57  Injury of muscle, fascia or tendon at wrist or hand level\n",
      "C    NC58  Crushing injury of wrist or hand\n",
      "C    NC59  Traumatic amputation of wrist or hand\n",
      "C    NC5A  Multiple injuries of wrist or hand\n",
      "C    NC5Y  Other specified injuries to the wrist or hand\n",
      "C    NC5Z  Injuries to the wrist or hand, unspecified\n",
      "B  Injuries to the hip or thigh\n",
      "C    NC70  Superficial injury of hip or thigh\n",
      "C    NC71  Open wound of hip or thigh\n",
      "C    NC72  Fracture of femur\n",
      "C    NC73  Dislocation or strain or sprain of joint or ligaments of hip\n",
      "C    NC74  Injury of nerves at hip or thigh level\n",
      "C    NC75  Injury of blood vessels at hip or thigh level\n",
      "C    NC76  Injury of muscle, fascia, tendon or bursa at hip or thigh level\n",
      "C    NC77  Crushing injury of hip or thigh\n",
      "C    NC78  Traumatic amputation of hip or thigh\n",
      "C    NC79  Multiple injuries of hip or thigh\n",
      "C    NC7Y  Other specified injuries to the hip or thigh\n",
      "C    NC7Z  Injuries to the hip or thigh, unspecified\n",
      "B  Injuries to the knee or lower leg\n",
      "C    NC90  Superficial injury of knee or lower leg\n",
      "C    NC91  Open wound of knee or lower leg\n",
      "C    NC92  Fracture of lower leg, including ankle\n",
      "C    NC93  Dislocation or strain or sprain of joints or ligaments of knee\n",
      "C    NC94  Injury of nerves at lower leg level\n",
      "C    NC95  Injury of blood vessels at lower leg level\n",
      "C    NC96  Injury of muscle, fascia, tendon or bursa at lower leg level\n",
      "C    NC97  Crushing injury of lower leg\n",
      "C    NC98  Traumatic amputation of lower leg\n",
      "C    NC99  Multiple injuries of lower leg\n",
      "C    NC9Y  Other specified injuries to the knee or lower leg\n",
      "C    NC9Z  Injuries to the knee or lower leg, unspecified\n",
      "B  Injuries to the ankle or foot\n",
      "C    ND10  Injury to toenail\n",
      "C    ND11  Superficial injury of ankle or foot\n",
      "C    ND12  Open wound of ankle or foot\n",
      "C    ND13  Fracture of foot, except ankle\n",
      "C    ND14  Dislocation or strain or sprain of joints or ligaments at ankle or foot level\n",
      "C    ND15  Injury of nerves at ankle or foot level\n",
      "C    ND16  Injury of blood vessels at ankle or foot level\n",
      "C    ND17  Injury of muscle, fascia or tendon at ankle or foot level\n",
      "C    ND18  Crushing injury of ankle or foot\n",
      "C    ND19  Traumatic amputation of ankle or foot\n",
      "C    ND1A  Multiple injuries of ankle or foot\n",
      "C    ND1Y  Other specified injuries to the ankle or foot\n",
      "C    ND1Z  Injuries to the ankle or foot, unspecified\n",
      "B  Injuries involving multiple body regions\n",
      "C    ND30  Superficial injuries involving multiple body regions\n",
      "C    ND31  Open wounds involving multiple body regions\n",
      "C    ND32  Fractures involving multiple body regions\n",
      "C    ND33  Dislocations, strains or sprains involving multiple body regions\n",
      "C    ND34  Crushing injuries involving multiple body regions\n",
      "C    ND35  Traumatic amputations involving multiple body regions\n",
      "C    ND36  Other injuries involving multiple body regions, not elsewhere classified\n",
      "C    ND37  Unspecified multiple injuries\n",
      "B  Injuries to unspecified part of trunk, limb or body region\n",
      "C    ND50  Fracture of spine, level unspecified\n",
      "C    ND51  Other injuries of spine or trunk, level unspecified\n",
      "C    ND52  Fracture of arm, level unspecified\n",
      "C    ND53  Other injuries of arm, level unspecified\n",
      "C    ND54  Fracture of leg, level unspecified\n",
      "C    ND55  Other injuries of leg, level unspecified\n",
      "C    ND56  Injury of unspecified body region\n",
      "C    ND57  Secondary effect of trauma\n",
      "C    ND5Y  Other specified injuries to unspecified part of trunk, limb or body region\n",
      "C    ND5Z  Injuries to unspecified part of trunk, limb or body region, unspecified\n",
      "B  Effects of foreign body entering through natural orifice\n",
      "C    ND70  Foreign body on external eye\n",
      "C    ND71  Foreign body in ear\n",
      "C    ND72  Foreign body in respiratory tract\n",
      "C    ND73  Foreign body in alimentary tract\n",
      "C    ND74  Foreign body in genitourinary tract\n",
      "C    ND7Z  Effects of foreign body entering through natural orifice, unspecified\n",
      "B  Burns\n",
      "C    Burns of external body surface, specified by site\n",
      "D      ND90  Burn of head or neck except face\n",
      "D      ND91  Burn of face except eye or ocular adnexa\n",
      "D      ND92  Burn of trunk except perineum or genitalia\n",
      "D      ND93  Burn of perineum or genitalia\n",
      "D      ND94  Burn of shoulder or arm, except wrist or hand\n",
      "D      ND95  Burn of wrist or hand\n",
      "D      ND96  Burn of hip or leg, except ankle or foot\n",
      "D      ND97  Burn of ankle or foot\n",
      "D      ND99  Acute skin injury due to skin contact with corrosive substance\n",
      "D      ND9Y  Burns of external body surface, other specified site\n",
      "D      ND9Z  Burns of external body surface, unspecified site\n",
      "C    Burns of eye or internal organs\n",
      "D      NE00  Burn of eye or ocular adnexa\n",
      "D      NE01  Burn of respiratory tract\n",
      "D      NE02  Burn of other internal organs\n",
      "D      NE0Z  Burns of unspecified internal organ\n",
      "C    Burns of multiple or unspecified body regions\n",
      "D      NE10  Burns of multiple body regions\n",
      "D      NE11  Burn of unspecified body region\n",
      "C    NE2Z  Burns, unspecified\n",
      "B  Frostbite\n",
      "C    NE40  Superficial frostbite\n",
      "C    NE41  Frostbite with tissue necrosis\n",
      "C    NE42  Frostbite involving multiple body regions\n",
      "C    NE4Z  Frostbite, unspecified\n",
      "B  Harmful effects of substances\n",
      "C    NE60  Harmful effects of drugs, medicaments or biological substances, not elsewhere classified\n",
      "C    NE61  Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified\n",
      "C    NE6Z  Harmful effects of unspecified substance\n",
      "B  Injury or harm arising from surgical or medical care, not elsewhere classified\n",
      "C    NE80  Injury or harm arising following infusion, transfusion or therapeutic injection, not elsewhere classified\n",
      "C    NE81  Injury or harm arising from a procedure, not elsewhere classified\n",
      "C    NE82  Dysfunction or complication of pacemaker, pacemaker lead or implantable cardioverter defibrillator, not elsewhere classified\n",
      "C    NE83  Injury or harm arising from other device, implant or graft, not elsewhere classified\n",
      "C    NE84  Failure or rejection of transplanted organs or tissues\n",
      "D      H00083  Allograft rejection\n",
      "C    NE85  Complications peculiar to reattachment or amputation\n",
      "C    NE86  Malignant hyperthermia due to anaesthesia\n",
      "C    NE87  Failed or difficult intubation\n",
      "C    NE88  Drug toxicity associated with harm in surgical or medical care, not elsewhere classified\n",
      "C    NE89  Awareness under general anaesthesia\n",
      "C    NE8Y  Other specified injury or harm arising from surgical or medical care, not elsewhere classified\n",
      "C    NE8Z  Injury or harm arising from surgical or medical care, not elsewhere classified, unspecified\n",
      "B  Other or unspecified effects of external causes\n",
      "C    NF00  Effects of radiation, not elsewhere classified\n",
      "C    NF01  Effects of heat\n",
      "C    NF02  Hypothermia\n",
      "C    NF03  Other effects of reduced temperature\n",
      "D      H01643  Chilblains\n",
      "C    NF04  Effects of air pressure or water pressure\n",
      "C    NF05  Asphyxiation\n",
      "C    NF06  Effects of strenuous physical exercise\n",
      "C    NF07  Effects of other deprivation\n",
      "C    NF08  Effects of certain specified external causes\n",
      "C    NF09  Adverse effects, not elsewhere classified\n",
      "C    NF0A  Certain early complications of trauma, not elsewhere classified\n",
      "C    NF0Y  Other specified effects of external causes\n",
      "C    NF0Z  Unspecified effects of external causes\n",
      "B  NF2Y  Other specified injury, poisoning or certain other consequences of external causes\n",
      "B  NF2Z  Unspecified injury, poisoning or certain other consequences of external causes\n",
      "A25 Codes for special purposes\n",
      "B  International provisional assignment of new diseases of uncertain aetiology and emergency use\n",
      "C    RA01  COVID-19\n",
      "D      H02398  COVID-19\n",
      "C    RA02  Post COVID-19 condition\n",
      "C    RA03  Multisystem inflammatory syndrome associated with COVID-19\n",
      "B  National provisional assignment of new diseases of uncertain aetiology\n",
      "!\n",
      "#\n",
      "#[ DISEASE | BRITE | KEGG2 | KEGG ]\n",
      "#Last updated: June 7, 2023\n",
      "#ICD-11 by World Health Organization\n",
      "#&raquo; Japanese version\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# From the results webpage of the KEGG Disease 'H01633' - High Blood Pressure\n",
    "# The Brite ID: Human diseases in ICD-11 classification [BR:br08403] was retrieved.\n",
    "\n",
    "print(k.get('br:br08403'))  \n",
    "\n",
    "# After we get the output, while in the Chrome Browser press Ctrl+F (to find), then type in 'hypertension'"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "814606f0",
   "metadata": {},
   "source": [
    "#### The manual search 'find' using the Browser's Find tool with term = 'Hypertension' was pasted here:"
   ]
  },
  {
   "cell_type": "raw",
   "id": "9c1bf26d",
   "metadata": {},
   "source": [
    "# The search result using chrome find was one-by-one pasted here:\n",
    "A11 Diseases of the circulatory system\n",
    "B  Hypertensive diseases\n",
    "C    BA00  Essential hypertension\n",
    "D      H01633  High blood pressure\n",
    "C    BA01  Hypertensive heart disease\n",
    "C    BA02  Hypertensive renal disease\n",
    "C    BA03  Hypertensive crisis\n",
    "C    BA04  Secondary hypertension\n",
    "D      H00603  Hypertension exacerbated in pregnancy\n",
    "\n",
    "B  Pulmonary heart disease or diseases of pulmonary circulation\n",
    "C    BB01  Pulmonary hypertension\n",
    "D      H01619  Primary pulmonary hypertension\n",
    "D      H01621  Pulmonary arterial hypertension\n",
    "D      H01622  Chronic thromboembolic pulmonary hypertension\n",
    "\n",
    "C    DB98  Vascular disorders of the liver\n",
    "D      H01686  Idiopathic portal hypertension\n",
    "\n",
    "B  Oedema, proteinuria, or hypertensive disorders in pregnancy, childbirth, or the puerperium\n",
    "C    JA20  Pre-existing hypertension complicating pregnancy, childbirth or the puerperium\n",
    "C    JA21  Pre-eclampsia superimposed on chronic hypertension\n",
    "C    JA22  Gestational oedema or proteinuria without hypertension\n",
    "C    JA23  Gestational hypertension\n",
    "\n",
    "B  Cardiovascular disorders present in the perinatal or neonatal period\n",
    "C    KB42  Persistent pulmonary hypertension of the newborn\n",
    "C    KB45  Neonatal hypertension"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d044092f",
   "metadata": {},
   "source": [
    " "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3e8e9f3c",
   "metadata": {},
   "source": [
    "# Part 2: Search Genes Associated with Hypertension"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a02bc74d",
   "metadata": {},
   "source": [
    "### ClinVar Database - Determine variants indentified from patients associated with disease Hypertension"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b3c69586",
   "metadata": {},
   "source": [
    "- As an alternative to searching via python, the web browser was used to retrieve the target information.\n",
    "- The series of steps performed was as follow:\n",
    " 1. Go to https://www.ncbi.nlm.nih.gov/clinvar/\n",
    " 2. Search the term 'Hypertension'\n",
    " 3. Download Tab-Delimited File by 'Relevance'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "e1c9f2c7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Headers Added\n",
      "Executing EntrezDirect\n"
     ]
    }
   ],
   "source": [
    "%%bash\n",
    "\n",
    "# This script is to use Unix EntrezDirect in searching through the Clinvar database\n",
    "# then xtract the data into a tab-delimited file\n",
    "\n",
    "# But first, Add headers to the output file\n",
    "echo -e 'Title\\tGene(s)\\tTrait_Name\\tAccession\\tChromosome\\tVariant_Type' > /mnt/c/Users/trini/Desktop/clinvar_result.txt\n",
    "\n",
    "echo 'Headers Added'\n",
    "\n",
    "# Execute EntrezDirect and append the output data\n",
    "echo 'Executing EntrezDirect'\n",
    "esearch -db clinvar -query 'Hypertension OR High blood pressure' |\\\n",
    "esummary |\\\n",
    "xtract -pattern DocumentSummary -sep \"|\" -element title symbol trait_name accession chr variant_type >> /mnt/c/Users/trini/Desktop/clinvar_result.txt\n",
    "\n",
    "echo 'Done'"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "939b26f5",
   "metadata": {},
   "source": [
    "#### Parse the Tab-Delimited File from EntrezDirect clinvar with only 'hypertension'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "80a8ecb6",
   "metadata": {},
   "outputs": [],
   "source": [
    "with open(\"/Users/trini/Desktop/clinvar_result.txt\") as file:\n",
    "    out = open(\"/Users/trini/Desktop/clinvar_hypertension.txt\",'w')\n",
    "    for line in file:\n",
    "        out.write(line)\n",
    "        break  # This way we can parse the header\n",
    "    for l in file:\n",
    "        if 'hypertension' in l:\n",
    "            out.write(l)\n",
    "    out.close()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e6682006",
   "metadata": {},
   "source": [
    "#### Analyze the hypertension clinvar search"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "30d78d58",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Title</th>\n",
       "      <th>Gene(s)</th>\n",
       "      <th>Trait_Name</th>\n",
       "      <th>Accession</th>\n",
       "      <th>Chromosome</th>\n",
       "      <th>Variant_Type</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NM_001753.5(CAV1):c.326T&gt;A (p.Ile109Asn)</td>\n",
       "      <td>CAV1</td>\n",
       "      <td>Pulmonary hypertension, primary, 3|Partial lip...</td>\n",
       "      <td>VCV002502255</td>\n",
       "      <td>7|7</td>\n",
       "      <td>single nucleotide variant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NM_001204.7(BMPR2):c.89A&gt;G (p.Gln30Arg)</td>\n",
       "      <td>BMPR2</td>\n",
       "      <td>Pulmonary hypertension, primary, 1</td>\n",
       "      <td>VCV002500767</td>\n",
       "      <td>2|2</td>\n",
       "      <td>single nucleotide variant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NM_002246.3(KCNK3):c.607G&gt;C (p.Gly203Arg)</td>\n",
       "      <td>KCNK3</td>\n",
       "      <td>Pulmonary hypertension, primary, 4</td>\n",
       "      <td>VCV002446440</td>\n",
       "      <td>2|2</td>\n",
       "      <td>single nucleotide variant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NM_001204.7(BMPR2):c.1250T&gt;G (p.Phe417Cys)</td>\n",
       "      <td>BMPR2</td>\n",
       "      <td>not provided|Pulmonary hypertension, primary, 1</td>\n",
       "      <td>VCV002443070</td>\n",
       "      <td>2|2</td>\n",
       "      <td>single nucleotide variant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NM_000921.5(PDE3A):c.507G&gt;T (p.Gly169=)</td>\n",
       "      <td>LOC124625920|PDE3A</td>\n",
       "      <td>Brachydactyly-arterial hypertension syndrome</td>\n",
       "      <td>VCV002434623</td>\n",
       "      <td>12|12</td>\n",
       "      <td>single nucleotide variant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NM_000921.5(PDE3A):c.1903G&gt;C (p.Asp635His)</td>\n",
       "      <td>PDE3A</td>\n",
       "      <td>Brachydactyly-arterial hypertension syndrome</td>\n",
       "      <td>VCV002434622</td>\n",
       "      <td>12|12</td>\n",
       "      <td>single nucleotide variant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>NM_001367549.1(ATP13A3):c.2009A&gt;G (p.Asp670Gly)</td>\n",
       "      <td>ATP13A3</td>\n",
       "      <td>Pulmonary hypertension, primary, autosomal rec...</td>\n",
       "      <td>VCV002431704</td>\n",
       "      <td>3|3</td>\n",
       "      <td>single nucleotide variant</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NC_000002.11:g.(?_203378422)_(203384944_?)del</td>\n",
       "      <td>BMPR2</td>\n",
       "      <td>Primary pulmonary hypertension</td>\n",
       "      <td>VCV002423974</td>\n",
       "      <td>2</td>\n",
       "      <td>Deletion</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NC_000002.11:g.(?_203378422)_(203379722_?)del</td>\n",
       "      <td>BMPR2</td>\n",
       "      <td>Primary pulmonary hypertension</td>\n",
       "      <td>VCV002423973</td>\n",
       "      <td>2</td>\n",
       "      <td>Deletion</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>NC_000002.11:g.(?_203332222)_(203332432_?)del</td>\n",
       "      <td>BMPR2</td>\n",
       "      <td>Primary pulmonary hypertension</td>\n",
       "      <td>VCV002423972</td>\n",
       "      <td>2</td>\n",
       "      <td>Deletion</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                             Title             Gene(s)  \\\n",
       "0         NM_001753.5(CAV1):c.326T>A (p.Ile109Asn)                CAV1   \n",
       "1          NM_001204.7(BMPR2):c.89A>G (p.Gln30Arg)               BMPR2   \n",
       "2        NM_002246.3(KCNK3):c.607G>C (p.Gly203Arg)               KCNK3   \n",
       "3       NM_001204.7(BMPR2):c.1250T>G (p.Phe417Cys)               BMPR2   \n",
       "4          NM_000921.5(PDE3A):c.507G>T (p.Gly169=)  LOC124625920|PDE3A   \n",
       "5       NM_000921.5(PDE3A):c.1903G>C (p.Asp635His)               PDE3A   \n",
       "6  NM_001367549.1(ATP13A3):c.2009A>G (p.Asp670Gly)             ATP13A3   \n",
       "7    NC_000002.11:g.(?_203378422)_(203384944_?)del               BMPR2   \n",
       "8    NC_000002.11:g.(?_203378422)_(203379722_?)del               BMPR2   \n",
       "9    NC_000002.11:g.(?_203332222)_(203332432_?)del               BMPR2   \n",
       "\n",
       "                                          Trait_Name     Accession Chromosome  \\\n",
       "0  Pulmonary hypertension, primary, 3|Partial lip...  VCV002502255        7|7   \n",
       "1                 Pulmonary hypertension, primary, 1  VCV002500767        2|2   \n",
       "2                 Pulmonary hypertension, primary, 4  VCV002446440        2|2   \n",
       "3    not provided|Pulmonary hypertension, primary, 1  VCV002443070        2|2   \n",
       "4       Brachydactyly-arterial hypertension syndrome  VCV002434623      12|12   \n",
       "5       Brachydactyly-arterial hypertension syndrome  VCV002434622      12|12   \n",
       "6  Pulmonary hypertension, primary, autosomal rec...  VCV002431704        3|3   \n",
       "7                     Primary pulmonary hypertension  VCV002423974          2   \n",
       "8                     Primary pulmonary hypertension  VCV002423973          2   \n",
       "9                     Primary pulmonary hypertension  VCV002423972          2   \n",
       "\n",
       "                Variant_Type  \n",
       "0  single nucleotide variant  \n",
       "1  single nucleotide variant  \n",
       "2  single nucleotide variant  \n",
       "3  single nucleotide variant  \n",
       "4  single nucleotide variant  \n",
       "5  single nucleotide variant  \n",
       "6  single nucleotide variant  \n",
       "7                   Deletion  \n",
       "8                   Deletion  \n",
       "9                   Deletion  "
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Note, the text file was opened in Excel and saved as .csv file\n",
    "import pandas as pd\n",
    "df = pd.read_csv(\"/Users/trini/Desktop/clinvar_hypertension.csv\")\n",
    "df.head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "99fd045b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['Title', 'Gene(s)', 'Trait_Name', 'Accession', 'Chromosome',\n",
       "       'Variant_Type'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.columns  # Get all the column headers names"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e7699f32",
   "metadata": {},
   "source": [
    "  "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "73f53d0b",
   "metadata": {},
   "source": [
    "##### - The output below are the number of genes in the clinvar results\n",
    "##### - There were 1499 genes from the clinVar search\n",
    "##### - Of the 1499 genes here, many are the same gene, but differ only by it's mutational_remarks"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "fbf09284",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Gene(s)</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>CAV1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>BMPR2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>KCNK3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>BMPR2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>LOC124625920|PDE3A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1494</th>\n",
       "      <td>BMPR2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1495</th>\n",
       "      <td>ACVRL1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1496</th>\n",
       "      <td>PTGIS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1497</th>\n",
       "      <td>SMAD9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1498</th>\n",
       "      <td>CPS1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1499 rows × 1 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                 Gene(s)\n",
       "0                   CAV1\n",
       "1                  BMPR2\n",
       "2                  KCNK3\n",
       "3                  BMPR2\n",
       "4     LOC124625920|PDE3A\n",
       "...                  ...\n",
       "1494               BMPR2\n",
       "1495              ACVRL1\n",
       "1496               PTGIS\n",
       "1497               SMAD9\n",
       "1498                CPS1\n",
       "\n",
       "[1499 rows x 1 columns]"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.get(['Gene(s)'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "1f80ea52",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "BMPR2                                                                                                                                                                                                                                                                                            868\n",
       "KCNK3                                                                                                                                                                                                                                                                                            142\n",
       "SARS2                                                                                                                                                                                                                                                                                             88\n",
       "SMAD9                                                                                                                                                                                                                                                                                             84\n",
       "TBX4                                                                                                                                                                                                                                                                                              73\n",
       "CAV1                                                                                                                                                                                                                                                                                              48\n",
       "BMPR1A                                                                                                                                                                                                                                                                                            39\n",
       "CPS1                                                                                                                                                                                                                                                                                              28\n",
       "AGT                                                                                                                                                                                                                                                                                               25\n",
       "ACVRL1                                                                                                                                                                                                                                                                                            16\n",
       "PDE3A                                                                                                                                                                                                                                                                                             13\n",
       "AGTR1                                                                                                                                                                                                                                                                                             11\n",
       "ATP13A3                                                                                                                                                                                                                                                                                            6\n",
       "GIMAP1-GIMAP5|GIMAP5                                                                                                                                                                                                                                                                               4\n",
       "ABCA3                                                                                                                                                                                                                                                                                              3\n",
       "ENG                                                                                                                                                                                                                                                                                                3\n",
       "EIF2AK4                                                                                                                                                                                                                                                                                            3\n",
       "NOS3                                                                                                                                                                                                                                                                                               3\n",
       "BMPR1B                                                                                                                                                                                                                                                                                             3\n",
       "ENG|LOC102723566                                                                                                                                                                                                                                                                                   3\n",
       "DGUOK                                                                                                                                                                                                                                                                                              3\n",
       "GDF2                                                                                                                                                                                                                                                                                               2\n",
       "HYDIN                                                                                                                                                                                                                                                                                              2\n",
       "PTGIS                                                                                                                                                                                                                                                                                              2\n",
       "LOC102723566|ENG                                                                                                                                                                                                                                                                                   1\n",
       "DIPK1A|RPL5                                                                                                                                                                                                                                                                                        1\n",
       "COL1A1                                                                                                                                                                                                                                                                                             1\n",
       "KCNA5                                                                                                                                                                                                                                                                                              1\n",
       "SNORD70B|NOP58|SNORD11|SNORD11B|SNORD70|BMPR2                                                                                                                                                                                                                                                      1\n",
       "PKD1                                                                                                                                                                                                                                                                                               1\n",
       "FOXF1                                                                                                                                                                                                                                                                                              1\n",
       "SMAD1|SMAD1-AS1                                                                                                                                                                                                                                                                                    1\n",
       "SCNN1B                                                                                                                                                                                                                                                                                             1\n",
       "DGUOK-AS1|DGUOK                                                                                                                                                                                                                                                                                    1\n",
       "UMOD                                                                                                                                                                                                                                                                                               1\n",
       "PHF6                                                                                                                                                                                                                                                                                               1\n",
       "BMPR2|NOP58                                                                                                                                                                                                                                                                                        1\n",
       "CYP3A5|ZSCAN25                                                                                                                                                                                                                                                                                     1\n",
       "LOC126805821|SARS1                                                                                                                                                                                                                                                                                 1\n",
       "SARS1                                                                                                                                                                                                                                                                                              1\n",
       "CARF|CTLA4|CYP20A1|BZW1|C2CD6|ABI2|ALS2|AOX1|BMPR2|CASP10|CASP8|CD28|CDK15|CFLAR|CLK1|FAM117B|FLACC1|FZD7|HYCC2|ICA1L|ICOS|KCTD18|MPP4|NBEAL1|NDUFB3|NIF3L1|NOP58|ORC2|PPIL3|RAPH1|SGO2|SPATS2L|STRADB|SUMO1|TMEM237|TRAK2|WDR12                                                                   1\n",
       "ABI2|BMPR2|CARF|CD28|CTLA4|CYP20A1|FAM117B|FZD7|ICA1L|ICOS|NBEAL1|NOP58|RAPH1|SUMO1|WDR12                                                                                                                                                                                                          1\n",
       "BMPR2|SUMO1|NOP58                                                                                                                                                                                                                                                                                  1\n",
       "CARF|FAM117B|ICA1L|BMPR2|NBEAL1|WDR12                                                                                                                                                                                                                                                              1\n",
       "CDK15|FZD7|NOP58|BMPR2|SUMO1|ALS2                                                                                                                                                                                                                                                                  1\n",
       "ABI2|ACADL|ADAM23|BMPR2|C2orf80|CARF|CCNYL1|CD28|CMKLR2|CPO|CPS1|CREB1|CRYGA|CRYGB|CRYGC|CRYGD|CTLA4|CYP20A1|DYTN|EEF1B2|FAM117B|FASTKD2|FZD5|ICA1L|ICOS|IDH1|INO80D|KANSL1L|KLF7|LANCL1|MAP2|MDH1B|METTL21A|MYL1|NBEAL1|NDUFS1|NRP2|PARD3B|PIKFYVE|PLEKHM3|PTH2R|RAPH1|RPE|UNC80|WDR12|ZDBF2      1\n",
       "SOX17                                                                                                                                                                                                                                                                                              1\n",
       "NOTCH3                                                                                                                                                                                                                                                                                             1\n",
       "TOPBP1                                                                                                                                                                                                                                                                                             1\n",
       "LOC124625920|PDE3A                                                                                                                                                                                                                                                                                 1\n",
       "MT-TI                                                                                                                                                                                                                                                                                              1\n",
       "Name: Gene(s), dtype: int64"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Get the list of genes with # of occurrence in the clinvar search\n",
    "df['Gene(s)'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c68bcc84",
   "metadata": {},
   "source": [
    "#### Export the Gene and its Counts in a text file"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "28274a25",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Then export it in a text file\n",
    "genes_count = df['Gene(s)'].value_counts()\n",
    "gene_out = open(\"/Users/trini/OneDrive/Documents/New York University/Guided Studies/ClinVarGenes.txt\", 'w')\n",
    "with gene_out as f:\n",
    "    df_string = genes_count.to_string()\n",
    "    f.write(df_string)\n",
    "gene_out.close()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "25580215",
   "metadata": {},
   "source": [
    "### As an easy way to fix the output file generated above.\n",
    "1. Open it in Excel > select delimiters as Tab and separated by space\n",
    "2. Create a head for first tab as 'gene(s)' then second tab as 'count'\n",
    "3. Save as text or csv"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "aa1fdeab",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Gene(s)</th>\n",
       "      <th>Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>BMPR2</td>\n",
       "      <td>868</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>KCNK3</td>\n",
       "      <td>142</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>SARS2</td>\n",
       "      <td>88</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>SMAD9</td>\n",
       "      <td>84</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>TBX4</td>\n",
       "      <td>73</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>CAV1</td>\n",
       "      <td>48</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>BMPR1A</td>\n",
       "      <td>39</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>CPS1</td>\n",
       "      <td>28</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>AGT</td>\n",
       "      <td>25</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>ACVRL1</td>\n",
       "      <td>16</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>PDE3A</td>\n",
       "      <td>13</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>AGTR1</td>\n",
       "      <td>11</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>ATP13A3</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>GIMAP1-GIMAP5|GIMAP5</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>ABCA3</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>ENG</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>EIF2AK4</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>NOS3</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>BMPR1B</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>ENG|LOC102723566</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>DGUOK</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>GDF2</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>HYDIN</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>PTGIS</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>LOC102723566|ENG</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>DIPK1A|RPL5</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>COL1A1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>KCNA5</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>SNORD70B|NOP58|SNORD11|SNORD11B|SNORD70|BMPR2</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>PKD1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>FOXF1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>SMAD1|SMAD1-AS1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>SCNN1B</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>DGUOK-AS1|DGUOK</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>UMOD</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>PHF6</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>BMPR2|NOP58</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>CYP3A5|ZSCAN25</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>LOC126805821|SARS1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>SARS1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>CARF|CTLA4|CYP20A1|BZW1|C2CD6|ABI2|ALS2|AOX1|B...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>ABI2|BMPR2|CARF|CD28|CTLA4|CYP20A1|FAM117B|FZD...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>BMPR2|SUMO1|NOP58</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>CARF|FAM117B|ICA1L|BMPR2|NBEAL1|WDR12</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>CDK15|FZD7|NOP58|BMPR2|SUMO1|ALS2</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>ABI2|ACADL|ADAM23|BMPR2|C2orf80|CARF|CCNYL1|CD...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>SOX17</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>NOTCH3</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>TOPBP1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>LOC124625920|PDE3A</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>MT-TI</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                              Gene(s)  Count\n",
       "0                                               BMPR2    868\n",
       "1                                               KCNK3    142\n",
       "2                                               SARS2     88\n",
       "3                                               SMAD9     84\n",
       "4                                                TBX4     73\n",
       "5                                                CAV1     48\n",
       "6                                              BMPR1A     39\n",
       "7                                                CPS1     28\n",
       "8                                                 AGT     25\n",
       "9                                              ACVRL1     16\n",
       "10                                              PDE3A     13\n",
       "11                                              AGTR1     11\n",
       "12                                            ATP13A3      6\n",
       "13                               GIMAP1-GIMAP5|GIMAP5      4\n",
       "14                                              ABCA3      3\n",
       "15                                                ENG      3\n",
       "16                                            EIF2AK4      3\n",
       "17                                               NOS3      3\n",
       "18                                             BMPR1B      3\n",
       "19                                   ENG|LOC102723566      3\n",
       "20                                              DGUOK      3\n",
       "21                                               GDF2      2\n",
       "22                                              HYDIN      2\n",
       "23                                              PTGIS      2\n",
       "24                                   LOC102723566|ENG      1\n",
       "25                                        DIPK1A|RPL5      1\n",
       "26                                             COL1A1      1\n",
       "27                                              KCNA5      1\n",
       "28      SNORD70B|NOP58|SNORD11|SNORD11B|SNORD70|BMPR2      1\n",
       "29                                               PKD1      1\n",
       "30                                              FOXF1      1\n",
       "31                                    SMAD1|SMAD1-AS1      1\n",
       "32                                             SCNN1B      1\n",
       "33                                    DGUOK-AS1|DGUOK      1\n",
       "34                                               UMOD      1\n",
       "35                                               PHF6      1\n",
       "36                                        BMPR2|NOP58      1\n",
       "37                                     CYP3A5|ZSCAN25      1\n",
       "38                                 LOC126805821|SARS1      1\n",
       "39                                              SARS1      1\n",
       "40  CARF|CTLA4|CYP20A1|BZW1|C2CD6|ABI2|ALS2|AOX1|B...      1\n",
       "41  ABI2|BMPR2|CARF|CD28|CTLA4|CYP20A1|FAM117B|FZD...      1\n",
       "42                                  BMPR2|SUMO1|NOP58      1\n",
       "43              CARF|FAM117B|ICA1L|BMPR2|NBEAL1|WDR12      1\n",
       "44                  CDK15|FZD7|NOP58|BMPR2|SUMO1|ALS2      1\n",
       "45  ABI2|ACADL|ADAM23|BMPR2|C2orf80|CARF|CCNYL1|CD...      1\n",
       "46                                              SOX17      1\n",
       "47                                             NOTCH3      1\n",
       "48                                             TOPBP1      1\n",
       "49                                 LOC124625920|PDE3A      1\n",
       "50                                              MT-TI      1"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_count = pd.read_csv(\"/Users/trini/OneDrive/Documents/New York University/Guided Studies/ClinVarGenes.csv\")\n",
    "df_count"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b6996d40",
   "metadata": {},
   "source": [
    "## Checkpoint_2: From this point, we now have genes and its counts from clinvar database associated only with 'Hypertension'"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c6b1d09d",
   "metadata": {},
   "source": [
    "### Now Let's begin searching through OMIM Database via Web-browser"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "32ff3614",
   "metadata": {},
   "source": [
    "1. Go to https://www.ncbi.nlm.nih.gov/omim/\n",
    "2. Search using the term \"Hypertension\" OR \"high blood pressure\"\n",
    "3. Download the output table"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "757441ce",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Extract the gene name from the 'Title' header\n",
    "omim_file = open(\"/Users/trini/Downloads/OMIM-Entry-Retrieval.txt\",'r')\n",
    "title_list = []\n",
    "for line in omim_file:\n",
    "    s = line.split('\\t')\n",
    "    title = s[1]\n",
    "    if ';' in title:\n",
    "        title_list.append(title)\n",
    "#print(title_list)\n",
    "output_file = open(\"/Users/trini/Downloads/OMIM_gene_list.txt\",'w')\n",
    "gene_list = []\n",
    "for gene in title_list:\n",
    "    s = gene.split(';')\n",
    "    gene_name = s[1].replace('\"','')\n",
    "    gene_name1 = gene_name.replace(' ','')\n",
    "    gene_list.append(gene_name1)\n",
    "    output_file.write(gene_name1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "c9e7d7b6",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['AAA1', 'AAS', 'AAT1', 'AAT11', 'AAT6', 'AAT7', 'AAT9', 'ABCA3', 'ABCC6', 'ABCC8', 'ABCC9', 'ABI2', 'ACDMPV', 'ACE', 'ACE2', 'ACH', 'ACO1', 'ACRDYS2', 'ACSM3', 'ACTN4', 'ACVRL1', 'AD2', 'ADA2', 'ADAMTS13', 'ADAMTS16', 'ADCAD1', 'ADCAD2', 'ADD1', 'ADD2', 'ADD3', 'ADM', 'ADORA2A', 'ADRB1', 'ADTKD1', 'ADTKD2', 'ADTKD5', 'AEACEI', 'AGK', 'AGS1', 'AGS7', 'AGS9', 'AGT', 'AGTR1', 'AHUS1', 'AHUS2', 'AHUS3', 'AHUS4', 'AHUS5', 'AHUS6', 'AIFBL1', 'AIMAH1', 'AIMAH2', 'AIP', 'AKT1', 'ALGS1', 'ALGS2', 'ALMS', 'ALOX5', 'AME', 'ANGPT1', 'ANIB1', 'ANIB10', 'ANIB11', 'ANIB12', 'ANIB3', 'ANIB4', 'ANIB5', 'ANIB6', 'ANIB7', 'ANIB8', 'ANIB9', 'ANKRD36', 'AOMS1', 'AOMS3', 'AOMS4', 'AOS1', 'AOS5', 'AOS6', 'AOVD2', 'APELA', 'APLAID', 'APLD', 'APOE', 'APOL1', 'AQP1', 'ARCL1A', 'ARHGAP42', 'ARHGEF1', 'ARHGEF12', 'ARMD1', 'ARVD11', 'ASD4', 'ASD9', 'ASIC2', 'ASL', 'ATFB10', 'ATFB13', 'ATFB14', 'ATFB6', 'ATORS', 'ATP13A3', 'ATP1A1', 'ATP1B1', 'ATP2A2', 'ATP2B3', 'ATS1', 'ATS2', 'ATS3', 'BAMLAZ', 'BARTS3', 'BBIS', 'BBS1', 'BBS2', 'BBS20', 'BBS4', 'BBS4', 'BCAHH', 'BDE1', 'BICC1', 'BILAPES', 'BIRC5', 'BLAUS', 'BMIQ14', 'BMIQ20', 'BMPR1A', 'BMPR2', 'BRDCS1', 'BRENS', 'BRGDA7', 'BRMUTD', 'BRS3', 'BSCL2', 'BSTVS', 'BWS', 'C3G3', 'C4AD', 'C4BD', 'C4ORF54', 'CACNA1D', 'CACNA1H', 'CADASIL1', 'CAFD1', 'CAKUT1', 'CALCRL', 'CAMK2N1', 'CAON2', 'CARASIL', 'CAST', 'CAT', 'CAV1', 'CBAS5', 'CBL', 'CBLN2', 'CC2D2A', 'CCHS3', 'CD36', 'CD46', 'CDAN1A', 'CDG1E', 'CDG1K', 'CDG2D', 'CDG2G', 'CDKN1A', 'CED2', 'CED4', 'CELA2A', 'CESD', 'CETP', 'CF', 'CFI', 'CFTR', 'CFZS1', 'CGL1', 'CGL2', 'CGL3', 'CGL4', 'CHC', 'CHDS8', 'CHGA', 'CHH', 'CIMAH', 'CLCN2', 'CLIFAHDD', 'CMA1', 'CMD1R', 'CMD1Y', 'CMD2C', 'CMD2D', 'CMH1', 'CMH15', 'CMH21', 'CMH26', 'CMH3', 'CMH4', 'CMH8', 'CMTC', 'CMYP17', 'CMYP3', 'CNC1', 'COACH1', 'COACH2', 'COL1A1', 'COL4A1', 'COL4A2', 'COMMD5', 'COMT', 'COPD', 'COQ10D2', 'COQ10D8', 'CORIN', 'CORTRD1', 'COX5A', 'COX8A', 'COXPD11', 'COXPD21', 'COXPD22', 'COXPD28', 'COXPD41', 'CPHD2', 'CPS1', 'CRELD1', 'CRH', 'CRMCC1', 'CRMCC2', 'CRSDA', 'CRTAP', 'CSA', 'CSB', 'CSTLO', 'CTH', 'CUL3', 'CUX1', 'CYBA', 'CYP11B1', 'CYP11B2', 'CYP17A1', 'CYP3A5', 'CYP4A11', 'CYSRD', 'DA5', 'DDAH1', 'DDS', 'DEDDFA', 'DGUOK', 'DHS1', 'DIH4', 'DKCA3', 'DKCX', 'DLL4', 'DM2', 'DMD', 'DRD1', 'DRD3', 'DRD5', 'DYNLT1', 'DYRK1B', 'DYX1', 'ECE1', 'ECYT1', 'ECYT2', 'ECYT3', 'EDMD3', 'EDN1', 'EDNRB', 'EDSCL1', 'EGLN1', 'EIF2AK4', 'ELN', 'EMILIN1', 'ENPP1', 'EPOR', 'ERAP1', 'ESR1', 'ESR2', 'ESRRG', 'F13A1', 'F2', 'FBL', 'FBN1', 'FCHL1', 'FDLAB', 'FFDD2', 'FGA', 'FGF10', 'FGF2', 'FGF8', 'FGLDS1', 'FGQTL2', 'FGQTL6', 'FHL1', 'FLHS', 'FLNA', 'FLT1', 'FMDA', 'FMDMF', 'FMO3', 'FN1', 'FPLD1', 'FPLD2', 'FPLD3', 'FPLD4', 'FPLD7', 'FPS', 'FRDA', 'FRTS5', 'FSGS1', 'FSGS10', 'FSGS2', 'FSGS4', 'FSGS5', 'FSTL3', 'FXTAS', 'G6PC3', 'GA3', 'GACI1', 'GACI2', 'GAMOS3', 'GAMOS8', 'GATA6', 'GBD2', 'GCCR', 'GCE1', 'GCG', 'GCGR', 'GCK', 'GD1', 'GD3C', 'GFND1', 'GFND2', 'GH1', 'GHR', 'GIMAP5', 'GJA4', 'GLA', 'GLC1A', 'GM1G2', 'GNA11', 'GNA12', 'GNA13', 'GNAQ', 'GNAS', 'GNB3', 'GP1BA', 'GPHYSD2', 'GPHYSD3', 'GPIBD1', 'GRK2', 'GRK4', 'GRNG', 'GSD1A', 'GSD1B', 'GSD1C', 'GSD3', 'GSD4', 'GTF2I', 'GTLMNS', 'GUCY1A3', 'GUCY1B2', 'GUCY1B3', 'GYS1', 'HAE4', 'HALD1', 'HALD2', 'HALD3', 'HALD4', 'HALP1', 'HBB', 'HCAD', 'HCIN', 'HCP', 'HD', 'HDCA', 'HDKR', 'HDLCQ1', 'HDLCQ7', 'HFE2A', 'HFTC1', 'HGPS', 'HHT1', 'HHT2', 'HHT5', 'HIES4B', 'HIF1A', 'HLA-B', 'HLA-DPB1', 'HLASA', 'HLTRS', 'HLTS', 'HMAG', 'HMNDYT1', 'HMOX1D', 'HNP1', 'HOMG2', 'HOMG3', 'HOS', 'HRAS', 'HRCDF', 'HSA', 'HSAN2A', 'HSAN3', 'HSAN9', 'HSD11B1', 'HSD11B2', 'HSD3B1', 'HSD3B2', 'HSPB7', 'HSS', 'HTNB', 'HTR2B', 'HTRA1', 'HUPRAS', 'HYT1', 'HYT2', 'HYT3', 'HYT4', 'HYT7', 'HYT8', 'IBGC1', 'ICH', 'ICPPS', 'IDMYS', 'IFAP1', 'IFIH1', 'IFNGR1', 'IFT172', 'IGAN1', 'IGAN2', 'IGAN3', 'IGF1', 'IGF2', 'IGS2', 'IKBKG', 'IL1A', 'ILD2', 'INS', 'INSR', 'IRS1', 'IRS2', 'ITGB3', 'ITGB7', 'JAK3', 'JBS', 'JBTS14', 'JDSCD', 'KCNE2', 'KCNJ5', 'KCNK3', 'KCNMB1', 'KCNN3', 'KCNN4', 'KDVS', 'KFS4', 'KL', 'KLHL3', 'KLK1', 'KMIN', 'KTLS', 'KYNU', 'L3MBTL4', 'LACHT', 'LATHOS', 'LCCS9', 'LCPD', 'LDLR', 'LEP', 'LEPD', 'LEPR', 'LIDLS1', 'LIDLS2', 'LIDLS3', 'LIPT1', 'LIPT1D', 'LMNA', 'LMNB2', 'LMPHM13', 'LMPHM5', 'LMPHM9', 'LPL', 'LPRD1', 'LQT13', 'LQT16', 'LRP1', 'LRP6', 'LSDMCA2', 'LSKB', 'LTBP4', 'LTL', 'LVNC8', 'MADB', 'MAHCC', 'MAHCJ', 'MBTPS2', 'MC1DN16', 'MC1DN22', 'MC1DN35', 'MC1DN37', 'MC1DN39', 'MC2R', 'MC4DN15', 'MC4DN20', 'MC4DN7', 'MC5DN1', 'MC5DN2', 'MCAHS4', 'MCTO', 'MDK', 'MDPS', 'MEL', 'MELAS', 'MEN2A', 'MEN4', 'MEX3C', 'MFLS', 'MFS', 'MIR155', 'MIR92A1', 'MKKS', 'MKKS', 'MMACHC', 'MMDS1', 'MMIHS2', 'MMIHS5', 'MMP2', 'MNKES', 'MNS', 'MOSPGF', 'MRSHSS', 'MRXSSB', 'MSMDS', 'MSPKA', 'MSX2', 'MTDPS3', 'MTHFR', 'MTPN', 'MTR', 'MTTI', 'MTTL1', 'MYH11', 'MYHRS', 'MYMY2', 'MYMY4', 'MYMY6', 'MYO18B', 'MYOC', 'MYOZ2', 'NBLST1', 'NCF1', 'NCPH1', 'NCPH2', 'NDH', 'NDUFA10', 'NEDD4', 'NEDD4L', 'NEDHLSS', 'NEDIM', 'NEDMCR', 'NEDSOA', 'NEDSSWI', 'NF1', 'NFAT5', 'NFKBIL1', 'NFU1', 'NGPS', 'NHEDC2', 'NISBD2', 'NOS2', 'NOS3', 'NOTCH1', 'NOTCH3', 'NPHP1', 'NPHP18', 'NPHP19', 'NPHP2', 'NPHPL1', 'NPHS1', 'NPHS2', 'NPHS7', 'NPPA', 'NPPB', 'NPR1', 'NPR2', 'NPR3', 'NPS', 'NR3C1', 'NR3C2', 'NSC', 'NSIAD', 'NSLL', 'OFD1', 'OGDNS', 'OGN', 'OI1', 'OI3', 'OPDG', 'ORTHYP1', 'P2RY12', 'PADMAL', 'PAPPAS', 'PAPRS', 'PASNA', 'PAX2', 'PCH17', 'PCOS1', 'PCWH', 'PD', 'PDA1', 'PDB6', 'PDE11A', 'PDE3A', 'PDE4D', 'PDE5A', 'PDE8B', 'PDIL', 'PEE1', 'PEE4', 'PEE5', 'PF4', 'PFBMFT1', 'PFBMFT3', 'PFBMFT7', 'PFBMFT8', 'PFIC4', 'PFIC8', 'PFIC9', 'PGF', 'PGL1', 'PGL3', 'PGL4', 'PGL5', 'PGL6', 'PHA1B1', 'PHA2A', 'PHA2B', 'PHA2C', 'PHA2D', 'PHA2E', 'PHN', 'PHP1A', 'PIEZO1', 'PIEZO2', 'PITA1', 'PITA4', 'PKD1', 'PKD1', 'PKD2', 'PKD2', 'PKD3', 'PKD4', 'PKD5', 'PKD6', 'PKD7', 'PKHD1', 'PLA2G1B', 'PLAT', 'PLCE1', 'PLIN1', 'POAG', 'POMC', 'POR', 'PPARA', 'PPARG', 'PPH1', 'PPH2', 'PPH3', 'PPH4', 'PPH5', 'PPM1F', 'PPNAD1', 'PPNAD2', 'PPNAD3', 'PPNAD4', 'PPP1R12A', 'PRCP', 'PRDM16', 'PRKG1', 'PRLHR', 'PROCHOB', 'PSC', 'PTGIR', 'PTGIS', 'PTORCH3', 'PTPN1', 'PTPRO', 'PVNH1', 'PVOD1', 'PVOD2', 'PWS', 'PXE', 'RALBP1', 'RAMP2', 'RAPGEF3', 'RCC', 'REN', 'RETN', 'RFH1', 'RGS2', 'RGS5', 'RHOA', 'RIFTD', 'RILDBC1', 'RNU4ATAC', 'RP93', 'RSTS1', 'RTS2', 'RVCLS', 'S100A1', 'SADDAN', 'SARS2', 'SATB2', 'SCARB1', 'SCKL10', 'SCN2B', 'SCN4', 'SCN5A', 'SCNN1A', 'SCNN1B', 'SCNN1D', 'SCNN1G', 'SCS', 'SDCCAG8', 'SDHB', 'SDHD', 'SDS2', 'SEDC', 'SEDCJD', 'SELE', 'SELP', 'SEMDHL', 'SENS', 'SERPINA1', 'SERPINA6', 'SERPINE1', 'SESAMES', 'SFD', 'SFTPB', 'SGBS1', 'SHFLD1', 'SHRF', 'SIHIWES', 'SIOD', 'SLC12A3', 'SLC25A24', 'SLC2A12', 'SLC2A4', 'SLC30A10', 'SLC39A12', 'SLC6A2', 'SLC6A4', 'SLC8A1', 'SLC9A1', 'SLOS', 'SLSN7', 'SMAD1', 'SMAD6', 'SMAD9', 'SMDCD', 'SMDMDM', 'SMDP1', 'SMDP3', 'SNDNS', 'SPS', 'SRS1', 'SRS3', 'SRTD1', 'SRTD5', 'SSFSC2', 'SSMS', 'STOX1', 'STWS1', 'STWS2', 'SUCNR1', 'T1D', 'T1D2', 'T2D', 'T2D1', 'TAC3', 'TAPVR1', 'TARPS', 'TBS1', 'TBX1', 'TBX4', 'TEBIVANED1', 'TGFB1', 'TGFB2', 'TH', 'THPH3', 'TINF2', 'TLR5', 'TMAU', 'TMEM150C', 'TMEM70', 'TNFRSF1B', 'TNFSF12', 'TNNI3K', 'TNNT2', 'TREX1', 'TRIM72', 'TRPC6', 'TRPM4', 'TS', 'TSC1', 'TTP', 'TTPP1', 'TTPP2', 'TULP3', 'UAQTL1', 'UCP1', 'UFS1', 'UMOD', 'USF1', 'UTP4', 'VAIHS', 'VARS2', 'VAV3', 'VCL', 'VEGFA', 'VEGFC', 'VHL', 'VHLS', 'VIP', 'VISS', 'VP', 'VSD1', 'VSD2', 'VSD3', 'VUR1', 'WBS', 'WNK1', 'WNK4', 'WPW', 'WT1', 'XAN1', 'XFEPS', 'XFS', 'XLHR', 'XMPMA', 'XPF', 'XPNPEP3', 'YVS', 'YY1AP1', 'ZFPM2', 'ZLS1', 'ZNF260', 'ZTTKS']\n"
     ]
    }
   ],
   "source": [
    "print(sorted(gene_list))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "44060cba",
   "metadata": {},
   "source": [
    "## Checkpoint_3: Successfully retrieved all genes linked to the term \"hypertension | Bloodpressure\" from OMIM Database"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8dde7838",
   "metadata": {},
   "source": [
    "# Overall at this point, all genes associated with disease hypertension was retrieved from bioinformatics tools such as the KEGG, ClinVar and OMIM databases"
   ]
  },
  {
   "cell_type": "raw",
   "id": "60bf136e",
   "metadata": {},
   "source": [
    "All genes associated with the term 'Hypertension' retrieved from KEGG Disease Database:\n",
    "- NR3C2, BMPR2, SMAD9, CAV1, KCNK3, ATP13A3, ACVRL1, EIF2AK4, CYP11B2, CYP11B1, HSD11B2, SCNN1B, and SCNN1G.\n",
    "\n",
    "The number of search occurrences of these genes from ClinVar searching with the term 'Hypertension'.\n",
    "NR3C2 = NaN\n",
    "BMPR2 = 868\n",
    "SMAD9 = 84\n",
    "CAV1 = 48\n",
    "KCNK3 = 142\n",
    "ATP13A3 = 6\n",
    "ACVRL1 = 16\n",
    "EIF2AK4 = 3\n",
    "CYP11B2 = NaN\n",
    "CYP11B1 = NaN\n",
    "HSD11B2 = NaN\n",
    "SCNN1B = 1\n",
    "SCNN1G = NaN\n",
    "\n",
    "OMIM gene_list above - refer back to OMIM section as it is too long to copy and paste here"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "eafbe84f",
   "metadata": {},
   "source": [
    "#### For the next step, only potential gene targets/biomarkers that were found in all 3 database tools (KEGG, ClinVar, and OMIM) would be analyzed.\n",
    "- NR3C2, BMPR2, SMAD9, CAV1, KCNK3, ATP13A3, ACVRL1, EIF2AK4, CYP11B2, CYP11B1, HSD11B2, SCNN1B, and SCNN1G\n",
    "#### In addition, potential gene targets found from literature reviews would also be included in the downstream analysis.\n",
    "- CYP11B1, CYP11B2, WNK1, WNK4, KLHL3, CUL3, SCNN1B, SCNN1G, CYP17A1, HSD11B2, NR3C2 and KCNJ5\n",
    "- AGT, DRD1, AGTR1, REN, ACE, SCNN1A, and SCNN1G"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "03dc864b",
   "metadata": {},
   "source": [
    "### Include only those potential gene targerts that have OMIM data results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "df0bd465",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['ACE', 'ACVRL1', 'AGT', 'AGTR1', 'ATP13A3', 'BMPR2', 'CAV1', 'CUL3', 'CYP11B1', 'CYP11B2', 'CYP17A1', 'DRD1', 'EIF2AK4', 'HSD11B2', 'KCNJ5', 'KCNK3', 'KLHL3', 'NR3C2', 'REN', 'SCNN1A', 'SCNN1B', 'SCNN1G', 'SMAD9', 'WNK1', 'WNK4']\n"
     ]
    }
   ],
   "source": [
    "# Merge all the lists of potential genes\n",
    "Kegg_ClinVar_OMIMList = ['NR3C2', 'BMPR2', 'SMAD9', 'CAV1', 'KCNK3', 'ATP13A3', 'ACVRL1', 'EIF2AK4', 'CYP11B2', 'CYP11B1', 'HSD11B2', 'SCNN1B', 'SCNN1G']\n",
    "Literature1 = ['CYP11B1', 'CYP11B2', 'WNK1', 'WNK4', 'KLHL3', 'CUL3', 'SCNN1B', 'SCNN1G', 'CYP17A1', 'HSD11B2', 'NR3C2', 'KCNJ5']\n",
    "Literature2 = ['AGT', 'DRD1', 'AGTR1', 'REN', 'ACE', 'SCNN1A', 'SCNN1G']\n",
    "genes = []\n",
    "for L1 in Kegg_ClinVar_OMIMList:\n",
    "    if L1 not in genes:\n",
    "        genes.append(L1)\n",
    "for L2 in Literature1:\n",
    "    if L2 not in genes:\n",
    "        genes.append(L2)\n",
    "for L3 in Literature2:\n",
    "    if L3 not in genes:\n",
    "        genes.append(L3)\n",
    "        \n",
    "#print(sorted(genes))\n",
    "\n",
    "# Include only those potential genes that were available in the OMIM database\n",
    "targets_biomarkers = []\n",
    "for markers in genes:\n",
    "    if markers in gene_list:\n",
    "        targets_biomarkers.append(markers)\n",
    "    else:\n",
    "        continue\n",
    "print(sorted(targets_biomarkers)) # Now we have gene_targets that have OMIM data, which would be important in ClinicalTrials.gov search"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fbf31734",
   "metadata": {},
   "source": [
    "# Part 3: Search these potential gene targets/biomarkers in ClinicalTrial.gov to obtain clinical trial information of antihypertensive drugs"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "db62466d",
   "metadata": {},
   "source": [
    "### Instructions:\n",
    "#### (1) Open ClinicalTrials.gov in Web browser\n",
    "#### (2) Search on the \"Condition or Disease\" entry with the term 'Hypertension'\n",
    "#### (3) On the results page, filter out the results by including the entry \"ACE\" on the 'Title/Acronym' entry cell\n",
    "#### (4) Download the results in table view as .csv (UTF-8 Comma delimited)\n",
    "#### (5) Remove lines that have no wanted 'term', 'Drugs' as its 'Interventions', and 'PHASE' of clinical trial processed below:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "id": "556a57d7",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Starting with ACE gene\n",
    "with open(\"/Users/trini/Downloads/ClinicalTrial_ACE.txt\") as ACE:\n",
    "    out = open(\"/Users/trini/Downloads/ClinicalTrial_ACE_Drug.txt\",'w')\n",
    "    for line in ACE:\n",
    "        out.write(line)\n",
    "        break  # This way we can parse the header\n",
    "    for l in ACE:\n",
    "        if 'ACE' in l:\n",
    "            if 'DRUG' in l:\n",
    "                if 'PHASE' in l:\n",
    "                    out.write(l)\n",
    "    out.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "id": "73d7824f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Other Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00185120</td>\n",
       "      <td>Treatment of High Blood Pressure Using Olmesar...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT00185120</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Hypertension</td>\n",
       "      <td>DRUG: Olmesartan medoxomil|DRUG: Hydroclorothi...</td>\n",
       "      <td>Change in systolic blood pressure from the sta...</td>\n",
       "      <td>Change in diastolic blood pressure from the st...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Daiichi Sankyo, Inc.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>866-447</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT02995954</td>\n",
       "      <td>Fixed vs Free Dose of ACEi/CCB Combination The...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT02995954</td>\n",
       "      <td>FixFree</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Hypertension</td>\n",
       "      <td>DRUG: Perindopril/Amlodipine</td>\n",
       "      <td>systolic Blood pressure control, reduction in ...</td>\n",
       "      <td>blood pressure control, percentage of patients...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Guido Iaccarino</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>iacca001</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT00221845</td>\n",
       "      <td>Effect of Strict Blood Pressure Control and AC...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT00221845</td>\n",
       "      <td>ESCAPE</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Children|Chronic Renal Failure|Hypertension|Ac...</td>\n",
       "      <td>DRUG: ACE Inhibition|DRUG: Intensified Blood P...</td>\n",
       "      <td>Time interval to renal 'loss' as defined by an...</td>\n",
       "      <td>Effect of treatment on urinary protein excreti...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Heidelberg University</td>\n",
       "      <td>European Commission|Boehringer Ingelheim|Baxte...</td>\n",
       "      <td>CHILD, ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>QLRT-2001-00908</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT00126516</td>\n",
       "      <td>Angiotensin II Receptor Blockers (ARB) and ACE...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT00126516</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Brain Infarction|Hypertension</td>\n",
       "      <td>DRUG: Angiotensin II Receptor Antagonists|DRUG...</td>\n",
       "      <td>Fatal and nonfatal stroke, two years|Progressi...</td>\n",
       "      <td>Fatal and nonfatal acute coronary syndrome, tw...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Nara Medical University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>03-Ken-52</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT00985322</td>\n",
       "      <td>Angiotensin-converting-enzyme (ACE) Inhibitors...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT00985322</td>\n",
       "      <td>ARCADIA</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Left Ventricular Hypertrophy|Hypertension</td>\n",
       "      <td>DRUG: ACE inhibitor Ramipril|DRUG: non-RAS inh...</td>\n",
       "      <td>The main outcome variable will be a combined e...</td>\n",
       "      <td>Single components of combined endpoint,myocard...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Mario Negri Institute for Pharmacological Rese...</td>\n",
       "      <td>Agenzia Italiana del Farmaco</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>ARCADIA|2008-003529-17</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NCT02807987</td>\n",
       "      <td>Study of CS-3150 in Combination With ARB or AC...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT02807987</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Hypertension With Moderate Renal Impairment</td>\n",
       "      <td>DRUG: CS-3150</td>\n",
       "      <td>Change from baseline in sitting systolic and d...</td>\n",
       "      <td>Time course of systolic and diastolic blood pr...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Daiichi Sankyo Co., Ltd.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>CS3150-A-J305</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>NCT00980187</td>\n",
       "      <td>A Comparison of Indapamide SR 1.5 mg With HCTZ...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT00980187</td>\n",
       "      <td>AISHA</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Hypertension|Type 2 Diabetes Mellitus</td>\n",
       "      <td>DRUG: Hydrochlorothiazide|DRUG: Indapamide</td>\n",
       "      <td>Better metabolic effects of indapamide SR 1.5 ...</td>\n",
       "      <td>Better antihypertensive effects of indapamide ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>LaborMed Pharma S.A.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>RO-SCL-IQ v 1.0/04.07</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NCT00666848</td>\n",
       "      <td>Effect of Sitagliptin and an ACE Inhibitor on ...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT00666848</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>YES</td>\n",
       "      <td>Metabolic Syndrome|Hypertension</td>\n",
       "      <td>DRUG: Placebo|DRUG: Enalapril 5mg|DRUG: Enalap...</td>\n",
       "      <td>Change in MAP During Placebo, The change in me...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Vanderbilt University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>70977</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NCT00939588</td>\n",
       "      <td>Compare the Effect of Aliskiren Plus Valsartan...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT00939588</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Hypertension</td>\n",
       "      <td>DRUG: Aliskiren/ Valsartan|DRUG: Telmisartan/ ...</td>\n",
       "      <td>Compare the effects of aliskiren + valsartan v...</td>\n",
       "      <td>Compare the effects of aliskiren + valsartan v...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Novartis Pharmaceuticals</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>CSPV100A2225</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>NCT00051389</td>\n",
       "      <td>ACE Inhibition and Novel Cardiovascular Risk F...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT00051389</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Cardiovascular Diseases|Heart Diseases|Hyperte...</td>\n",
       "      <td>DRUG: Fosinopril</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>National Heart, Lung, and Blood Institute (NHLBI)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>155|R01HL068901</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>NCT01195662</td>\n",
       "      <td>A Study of BMS-512148 (Dapagliflozin) in Patie...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT01195662</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>YES</td>\n",
       "      <td>Type 2 Diabetes</td>\n",
       "      <td>DRUG: Dapagliflozin|DRUG: Placebo matching Dap...</td>\n",
       "      <td>Adjusted Mean Change From Baseline in Seated S...</td>\n",
       "      <td>Adjusted Mean Change From Baseline in 24-hour ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>AstraZeneca</td>\n",
       "      <td>Bristol-Myers Squibb</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>MB102-077 ST|2010-019798-13</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>NCT00157729</td>\n",
       "      <td>MATCHED (MC-1 and ACE Therapeutic Combination ...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT00157729</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Diabetes Mellitus Type 2|Hypertension|Metaboli...</td>\n",
       "      <td>DRUG: pyridoxal-5'-phosphate with and without ...</td>\n",
       "      <td>Effects on blood pressure:|Determine the effic...</td>\n",
       "      <td>To compare the effects of the different treatm...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Medicure</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>MC6021-CL-04001</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>NCT03295734</td>\n",
       "      <td>ACES - ACE Inhibitors Combined With Exercise f...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT03295734</td>\n",
       "      <td>ACES</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>NO</td>\n",
       "      <td>Hypertension|Aging|Sedentary Lifestyle</td>\n",
       "      <td>BEHAVIORAL: Aerobic exercise|DRUG: Perindopril...</td>\n",
       "      <td>Gait speed, Self-paced gait speed over 4m dist...</td>\n",
       "      <td>Six minute walk test, maximal distance covered...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>University of Alabama at Birmingham</td>\n",
       "      <td>University of Colorado, Denver|Translational R...</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     NCT Number                                        Study Title  \\\n",
       "0   NCT00185120  Treatment of High Blood Pressure Using Olmesar...   \n",
       "1   NCT02995954  Fixed vs Free Dose of ACEi/CCB Combination The...   \n",
       "2   NCT00221845  Effect of Strict Blood Pressure Control and AC...   \n",
       "3   NCT00126516  Angiotensin II Receptor Blockers (ARB) and ACE...   \n",
       "4   NCT00985322  Angiotensin-converting-enzyme (ACE) Inhibitors...   \n",
       "5   NCT02807987  Study of CS-3150 in Combination With ARB or AC...   \n",
       "6   NCT00980187  A Comparison of Indapamide SR 1.5 mg With HCTZ...   \n",
       "7   NCT00666848  Effect of Sitagliptin and an ACE Inhibitor on ...   \n",
       "8   NCT00939588  Compare the Effect of Aliskiren Plus Valsartan...   \n",
       "9   NCT00051389  ACE Inhibition and Novel Cardiovascular Risk F...   \n",
       "10  NCT01195662  A Study of BMS-512148 (Dapagliflozin) in Patie...   \n",
       "11  NCT00157729  MATCHED (MC-1 and ACE Therapeutic Combination ...   \n",
       "12  NCT03295734  ACES - ACE Inhibitors Combined With Exercise f...   \n",
       "\n",
       "                                            Study URL  Acronym Study Status  \\\n",
       "0   https://beta.clinicaltrials.gov/study/NCT00185120      NaN    COMPLETED   \n",
       "1   https://beta.clinicaltrials.gov/study/NCT02995954  FixFree    COMPLETED   \n",
       "2   https://beta.clinicaltrials.gov/study/NCT00221845   ESCAPE    COMPLETED   \n",
       "3   https://beta.clinicaltrials.gov/study/NCT00126516      NaN    COMPLETED   \n",
       "4   https://beta.clinicaltrials.gov/study/NCT00985322  ARCADIA    COMPLETED   \n",
       "5   https://beta.clinicaltrials.gov/study/NCT02807987      NaN    COMPLETED   \n",
       "6   https://beta.clinicaltrials.gov/study/NCT00980187    AISHA    COMPLETED   \n",
       "7   https://beta.clinicaltrials.gov/study/NCT00666848      NaN    COMPLETED   \n",
       "8   https://beta.clinicaltrials.gov/study/NCT00939588      NaN    COMPLETED   \n",
       "9   https://beta.clinicaltrials.gov/study/NCT00051389      NaN    COMPLETED   \n",
       "10  https://beta.clinicaltrials.gov/study/NCT01195662      NaN    COMPLETED   \n",
       "11  https://beta.clinicaltrials.gov/study/NCT00157729      NaN    COMPLETED   \n",
       "12  https://beta.clinicaltrials.gov/study/NCT03295734     ACES   RECRUITING   \n",
       "\n",
       "   Study Results                                         Conditions  \\\n",
       "0             NO                                       Hypertension   \n",
       "1             NO                                       Hypertension   \n",
       "2             NO  Children|Chronic Renal Failure|Hypertension|Ac...   \n",
       "3             NO                      Brain Infarction|Hypertension   \n",
       "4             NO          Left Ventricular Hypertrophy|Hypertension   \n",
       "5             NO        Hypertension With Moderate Renal Impairment   \n",
       "6             NO              Hypertension|Type 2 Diabetes Mellitus   \n",
       "7            YES                    Metabolic Syndrome|Hypertension   \n",
       "8             NO                                       Hypertension   \n",
       "9             NO  Cardiovascular Diseases|Heart Diseases|Hyperte...   \n",
       "10           YES                                    Type 2 Diabetes   \n",
       "11            NO  Diabetes Mellitus Type 2|Hypertension|Metaboli...   \n",
       "12            NO             Hypertension|Aging|Sedentary Lifestyle   \n",
       "\n",
       "                                        Interventions  \\\n",
       "0   DRUG: Olmesartan medoxomil|DRUG: Hydroclorothi...   \n",
       "1                        DRUG: Perindopril/Amlodipine   \n",
       "2   DRUG: ACE Inhibition|DRUG: Intensified Blood P...   \n",
       "3   DRUG: Angiotensin II Receptor Antagonists|DRUG...   \n",
       "4   DRUG: ACE inhibitor Ramipril|DRUG: non-RAS inh...   \n",
       "5                                       DRUG: CS-3150   \n",
       "6          DRUG: Hydrochlorothiazide|DRUG: Indapamide   \n",
       "7   DRUG: Placebo|DRUG: Enalapril 5mg|DRUG: Enalap...   \n",
       "8   DRUG: Aliskiren/ Valsartan|DRUG: Telmisartan/ ...   \n",
       "9                                    DRUG: Fosinopril   \n",
       "10  DRUG: Dapagliflozin|DRUG: Placebo matching Dap...   \n",
       "11  DRUG: pyridoxal-5'-phosphate with and without ...   \n",
       "12  BEHAVIORAL: Aerobic exercise|DRUG: Perindopril...   \n",
       "\n",
       "                             Primary Outcome Measures  \\\n",
       "0   Change in systolic blood pressure from the sta...   \n",
       "1   systolic Blood pressure control, reduction in ...   \n",
       "2   Time interval to renal 'loss' as defined by an...   \n",
       "3   Fatal and nonfatal stroke, two years|Progressi...   \n",
       "4   The main outcome variable will be a combined e...   \n",
       "5   Change from baseline in sitting systolic and d...   \n",
       "6   Better metabolic effects of indapamide SR 1.5 ...   \n",
       "7   Change in MAP During Placebo, The change in me...   \n",
       "8   Compare the effects of aliskiren + valsartan v...   \n",
       "9                                                 NaN   \n",
       "10  Adjusted Mean Change From Baseline in Seated S...   \n",
       "11  Effects on blood pressure:|Determine the effic...   \n",
       "12  Gait speed, Self-paced gait speed over 4m dist...   \n",
       "\n",
       "                           Secondary Outcome Measures  Other Outcome Measures  \\\n",
       "0   Change in diastolic blood pressure from the st...                     NaN   \n",
       "1   blood pressure control, percentage of patients...                     NaN   \n",
       "2   Effect of treatment on urinary protein excreti...                     NaN   \n",
       "3   Fatal and nonfatal acute coronary syndrome, tw...                     NaN   \n",
       "4   Single components of combined endpoint,myocard...                     NaN   \n",
       "5   Time course of systolic and diastolic blood pr...                     NaN   \n",
       "6   Better antihypertensive effects of indapamide ...                     NaN   \n",
       "7                                                 NaN                     NaN   \n",
       "8   Compare the effects of aliskiren + valsartan v...                     NaN   \n",
       "9                                                 NaN                     NaN   \n",
       "10  Adjusted Mean Change From Baseline in 24-hour ...                     NaN   \n",
       "11  To compare the effects of the different treatm...                     NaN   \n",
       "12  Six minute walk test, maximal distance covered...                     NaN   \n",
       "\n",
       "                                              Sponsor  \\\n",
       "0                                Daiichi Sankyo, Inc.   \n",
       "1                                     Guido Iaccarino   \n",
       "2                               Heidelberg University   \n",
       "3                             Nara Medical University   \n",
       "4   Mario Negri Institute for Pharmacological Rese...   \n",
       "5                            Daiichi Sankyo Co., Ltd.   \n",
       "6                                LaborMed Pharma S.A.   \n",
       "7                               Vanderbilt University   \n",
       "8                            Novartis Pharmaceuticals   \n",
       "9   National Heart, Lung, and Blood Institute (NHLBI)   \n",
       "10                                        AstraZeneca   \n",
       "11                                           Medicure   \n",
       "12                University of Alabama at Birmingham   \n",
       "\n",
       "                                        Collaborators                 Age  \\\n",
       "0                                                 NaN  ADULT, OLDER_ADULT   \n",
       "1                                                 NaN  ADULT, OLDER_ADULT   \n",
       "2   European Commission|Boehringer Ingelheim|Baxte...        CHILD, ADULT   \n",
       "3                                                 NaN         OLDER_ADULT   \n",
       "4                        Agenzia Italiana del Farmaco  ADULT, OLDER_ADULT   \n",
       "5                                                 NaN  ADULT, OLDER_ADULT   \n",
       "6                                                 NaN  ADULT, OLDER_ADULT   \n",
       "7                                                 NaN  ADULT, OLDER_ADULT   \n",
       "8                                                 NaN  ADULT, OLDER_ADULT   \n",
       "9                                                 NaN  ADULT, OLDER_ADULT   \n",
       "10                               Bristol-Myers Squibb  ADULT, OLDER_ADULT   \n",
       "11                                                NaN  ADULT, OLDER_ADULT   \n",
       "12  University of Colorado, Denver|Translational R...  ADULT, OLDER_ADULT   \n",
       "\n",
       "    Phases      Study Type                    Other IDs  Study Documents  \n",
       "0   PHASE4  INTERVENTIONAL                      866-447              NaN  \n",
       "1   PHASE4  INTERVENTIONAL                     iacca001              NaN  \n",
       "2   PHASE3  INTERVENTIONAL              QLRT-2001-00908              NaN  \n",
       "3   PHASE4  INTERVENTIONAL                    03-Ken-52              NaN  \n",
       "4   PHASE3  INTERVENTIONAL       ARCADIA|2008-003529-17              NaN  \n",
       "5   PHASE3  INTERVENTIONAL                CS3150-A-J305              NaN  \n",
       "6   PHASE4  INTERVENTIONAL        RO-SCL-IQ v 1.0/04.07              NaN  \n",
       "7   PHASE4  INTERVENTIONAL                        70977              NaN  \n",
       "8   PHASE2  INTERVENTIONAL                 CSPV100A2225              NaN  \n",
       "9   PHASE2  INTERVENTIONAL              155|R01HL068901              NaN  \n",
       "10  PHASE3  INTERVENTIONAL  MB102-077 ST|2010-019798-13              NaN  \n",
       "11  PHASE2  INTERVENTIONAL              MC6021-CL-04001              NaN  \n",
       "12  PHASE2  INTERVENTIONAL                          NaN              NaN  "
      ]
     },
     "execution_count": 55,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Open the ACE gene search results in ClinicalTrial.gov\n",
    "# Note, the text file was opened in Excel and saved as .csv file\n",
    "import pandas as pd\n",
    "df_ACE = pd.read_csv(\"/Users/trini/Downloads/ClinicalTrial_ACE_Drug.csv\")\n",
    "df_ACE"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "03d62707",
   "metadata": {},
   "source": [
    "### Repeat the procedure for the remaining gene_targets"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "id": "af2a9d86",
   "metadata": {},
   "outputs": [],
   "source": [
    "# For AGTR1\n",
    "with open(\"/Users/trini/Downloads/ClinicalTrial_AGTR1.txt\") as AGTR1:\n",
    "    out = open(\"/Users/trini/Downloads/ClinicalTrial_AGTR1_Drug.txt\",'w')\n",
    "    for line in AGTR1:\n",
    "        out.write(line)\n",
    "        break  # This way we can parse the header\n",
    "    for l in AGTR1:\n",
    "        if 'Angiotensin' in l:\n",
    "            if 'DRUG' in l:\n",
    "                if 'PHASE' in l:\n",
    "                    out.write(l)\n",
    "    out.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "id": "a189bcd9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Other Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02513979</td>\n",
       "      <td>Postoperative Pain and Angiotensin II Receptor...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT02513979</td>\n",
       "      <td>PP&amp;ARA</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>NO</td>\n",
       "      <td>Hypertension</td>\n",
       "      <td>DRUG: Angiotensin type II receptor antagonists</td>\n",
       "      <td>Acute pain after cough, Intensity of pain afte...</td>\n",
       "      <td>Acute pain at rest, Intensity of pain at rest ...</td>\n",
       "      <td>Patient satisfaction, Patient satisfaction mea...</td>\n",
       "      <td>University of Athens</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>AHSTSA-102</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT00529750</td>\n",
       "      <td>Effect of the Angiotensin II Receptor Antagoni...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT00529750</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Hypertension</td>\n",
       "      <td>DRUG: IRBESARTAN|DRUG: Atenolol</td>\n",
       "      <td>Endothelial function in vivo qualification: br...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Sanofi</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>L_8261</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT00126516</td>\n",
       "      <td>Angiotensin II Receptor Blockers (ARB) and ACE...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT00126516</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Brain Infarction|Hypertension</td>\n",
       "      <td>DRUG: Angiotensin II Receptor Antagonists|DRUG...</td>\n",
       "      <td>Fatal and nonfatal stroke, two years|Progressi...</td>\n",
       "      <td>Fatal and nonfatal acute coronary syndrome, tw...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Nara Medical University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>03-Ken-52</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT03733145</td>\n",
       "      <td>Angiotensin II in General Anesthesia</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT03733145</td>\n",
       "      <td>NaN</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>NO</td>\n",
       "      <td>Hypertension</td>\n",
       "      <td>DRUG: Angiotensin II</td>\n",
       "      <td>Mean dose required to increase the SBP, The me...</td>\n",
       "      <td>Mean value of Bradykinin, Mean values of Brady...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Wake Forest University Health Sciences</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE1</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>IRB00054661</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT01502787</td>\n",
       "      <td>Comparison of Nebivolol and Metoprolol With Ex...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT01502787</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>YES</td>\n",
       "      <td>Hypertension</td>\n",
       "      <td>DRUG: Metoprolol succinate|DRUG: Nebivolol|PRO...</td>\n",
       "      <td>Forearm Blood Flow, 12 weeks after each specif...</td>\n",
       "      <td>Blood Pressure During Exercise, 12 weeks|Blood...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>University of Texas Southwestern Medical Center</td>\n",
       "      <td>Forest Laboratories</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>STU 062011-072</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NCT01684748</td>\n",
       "      <td>Angiotensin II Blockade and Inflammation in Ob...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT01684748</td>\n",
       "      <td>ARB</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>YES</td>\n",
       "      <td>Overweight|Obese|Prehypertension|Hypertension</td>\n",
       "      <td>DRUG: Olmesartan medoxomil</td>\n",
       "      <td>Insulin Sensitivity by Intravenous Glucose Tol...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Collagen Gene Expression in Skeletal Muscle (C...</td>\n",
       "      <td>Virginia Polytechnic Institute and State Unive...</td>\n",
       "      <td>National Heart, Lung, and Blood Institute (NHLBI)</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>arbfat</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>NCT04753112</td>\n",
       "      <td>Treatment of PH With Angiotensin II Receptor B...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT04753112</td>\n",
       "      <td>ARNIMEMS-HFpEF</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Pulmonary Hypertension</td>\n",
       "      <td>DRUG: Sacubitril / Valsartan Oral Tablet [Entr...</td>\n",
       "      <td>Change in mPAP With Sacubitril/Valsartan compa...</td>\n",
       "      <td>Mean Change in mPAP, Mean Change in mPAP on Sa...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Germans Trias i Pujol Hospital</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>ICOR-2020-03-PA-ARNIMEMS</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NCT02175355</td>\n",
       "      <td>Efficacy and Safety of the Angiotensin II Rece...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT02175355</td>\n",
       "      <td>ARAMIS</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Hypertension</td>\n",
       "      <td>DRUG: Low dose of MicardisÂ®|DRUG: Medium dose...</td>\n",
       "      <td>Change from baseline in seated systolic blood ...</td>\n",
       "      <td>Percentage of patients achieving a target fall...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Boehringer Ingelheim</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>502.254</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NCT00237588</td>\n",
       "      <td>Glucose Optimisation With Angiotensin II Antag...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT00237588</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Hypertension</td>\n",
       "      <td>DRUG: Amlodipine 10 mg or Losartan 100 mg + Am...</td>\n",
       "      <td>Insulin sensitivity assessed with hyperinsulin...</td>\n",
       "      <td>Fasting serum glucose|Fasting serum insulin|HO...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Ullevaal University Hospital</td>\n",
       "      <td>Merck Sharp &amp; Dohme LLC</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>308-1</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>NCT01011660</td>\n",
       "      <td>Effects of Angiotensin II Receptor Blocker Com...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT01011660</td>\n",
       "      <td>CHIEF</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>NO</td>\n",
       "      <td>Essential Hypertension</td>\n",
       "      <td>DRUG: Amlodipine, Telmisartan, Amiloride Compo...</td>\n",
       "      <td>The primary study outcomes are composite of no...</td>\n",
       "      <td>All cardiovascular eventsï¼›all-cause death, h...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Chinese Academy of Medical Sciences, Fuwai Hos...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: FAC...</td>\n",
       "      <td>115</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>NCT01292694</td>\n",
       "      <td>Contribution of Angiotensin II to Supine Hyper...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT01292694</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Hypertension|Pure Autonomic Failure|Multiple S...</td>\n",
       "      <td>DRUG: Losartan|DRUG: Captopril|DRUG: Placebo</td>\n",
       "      <td>Changes in plasma renin activity and subsequen...</td>\n",
       "      <td>Changes in blood pressure, Changes in supine b...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Vanderbilt University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE1</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>101618</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>NCT03482440</td>\n",
       "      <td>Angiotensin II and Chronic Inflammation in Per...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT03482440</td>\n",
       "      <td>NaN</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>NO</td>\n",
       "      <td>Preeclampsia</td>\n",
       "      <td>DRUG: Salsalate Oral Tablet|DRUG: Placebo Oral...</td>\n",
       "      <td>change in endothelial function following salsa...</td>\n",
       "      <td>change in inflammatory response to ang II comp...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>University of Iowa</td>\n",
       "      <td>Penn State University</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>EARLY_PHASE1</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>HL138133</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>NCT02796170</td>\n",
       "      <td>Inhibition of Urinary Angiotensinogen and the ...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT02796170</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>YES</td>\n",
       "      <td>Type 2 Diabetes|Hypertension</td>\n",
       "      <td>DRUG: Dapagliflozin|DRUG: Placebo</td>\n",
       "      <td>Change in Blood Pressure From Baseline to 6 We...</td>\n",
       "      <td>Change in Urinary AGT Levels From Baseline to ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tulane University School of Medicine</td>\n",
       "      <td>AstraZeneca</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>812701</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>NCT00144144</td>\n",
       "      <td>A Study on Ca Blocker Versus AII Antagonists i...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT00144144</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>NO</td>\n",
       "      <td>Hypertension|Diabetes Mellitus, Type 2</td>\n",
       "      <td>DRUG: Angiotensin II receptor antagonists, Cal...</td>\n",
       "      <td>Changes in blood pressure level at home after ...</td>\n",
       "      <td>Changes in blood pressure levels measured on a...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Advanced-J</td>\n",
       "      <td>Japan Heart Foundation</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>ADVANCED-J01|UMIN-C000000017</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     NCT Number                                        Study Title  \\\n",
       "0   NCT02513979  Postoperative Pain and Angiotensin II Receptor...   \n",
       "1   NCT00529750  Effect of the Angiotensin II Receptor Antagoni...   \n",
       "2   NCT00126516  Angiotensin II Receptor Blockers (ARB) and ACE...   \n",
       "3   NCT03733145               Angiotensin II in General Anesthesia   \n",
       "4   NCT01502787  Comparison of Nebivolol and Metoprolol With Ex...   \n",
       "5   NCT01684748  Angiotensin II Blockade and Inflammation in Ob...   \n",
       "6   NCT04753112  Treatment of PH With Angiotensin II Receptor B...   \n",
       "7   NCT02175355  Efficacy and Safety of the Angiotensin II Rece...   \n",
       "8   NCT00237588  Glucose Optimisation With Angiotensin II Antag...   \n",
       "9   NCT01011660  Effects of Angiotensin II Receptor Blocker Com...   \n",
       "10  NCT01292694  Contribution of Angiotensin II to Supine Hyper...   \n",
       "11  NCT03482440  Angiotensin II and Chronic Inflammation in Per...   \n",
       "12  NCT02796170  Inhibition of Urinary Angiotensinogen and the ...   \n",
       "13  NCT00144144  A Study on Ca Blocker Versus AII Antagonists i...   \n",
       "\n",
       "                                            Study URL         Acronym  \\\n",
       "0   https://beta.clinicaltrials.gov/study/NCT02513979          PP&ARA   \n",
       "1   https://beta.clinicaltrials.gov/study/NCT00529750             NaN   \n",
       "2   https://beta.clinicaltrials.gov/study/NCT00126516             NaN   \n",
       "3   https://beta.clinicaltrials.gov/study/NCT03733145             NaN   \n",
       "4   https://beta.clinicaltrials.gov/study/NCT01502787             NaN   \n",
       "5   https://beta.clinicaltrials.gov/study/NCT01684748             ARB   \n",
       "6   https://beta.clinicaltrials.gov/study/NCT04753112  ARNIMEMS-HFpEF   \n",
       "7   https://beta.clinicaltrials.gov/study/NCT02175355          ARAMIS   \n",
       "8   https://beta.clinicaltrials.gov/study/NCT00237588             NaN   \n",
       "9   https://beta.clinicaltrials.gov/study/NCT01011660           CHIEF   \n",
       "10  https://beta.clinicaltrials.gov/study/NCT01292694             NaN   \n",
       "11  https://beta.clinicaltrials.gov/study/NCT03482440             NaN   \n",
       "12  https://beta.clinicaltrials.gov/study/NCT02796170             NaN   \n",
       "13  https://beta.clinicaltrials.gov/study/NCT00144144             NaN   \n",
       "\n",
       "   Study Status Study Results  \\\n",
       "0       UNKNOWN            NO   \n",
       "1     COMPLETED            NO   \n",
       "2     COMPLETED            NO   \n",
       "3    RECRUITING            NO   \n",
       "4     COMPLETED           YES   \n",
       "5     COMPLETED           YES   \n",
       "6     COMPLETED            NO   \n",
       "7     COMPLETED            NO   \n",
       "8     COMPLETED            NO   \n",
       "9       UNKNOWN            NO   \n",
       "10   TERMINATED            NO   \n",
       "11   RECRUITING            NO   \n",
       "12    COMPLETED           YES   \n",
       "13      UNKNOWN            NO   \n",
       "\n",
       "                                           Conditions  \\\n",
       "0                                        Hypertension   \n",
       "1                                        Hypertension   \n",
       "2                       Brain Infarction|Hypertension   \n",
       "3                                        Hypertension   \n",
       "4                                        Hypertension   \n",
       "5       Overweight|Obese|Prehypertension|Hypertension   \n",
       "6                              Pulmonary Hypertension   \n",
       "7                                        Hypertension   \n",
       "8                                        Hypertension   \n",
       "9                              Essential Hypertension   \n",
       "10  Hypertension|Pure Autonomic Failure|Multiple S...   \n",
       "11                                       Preeclampsia   \n",
       "12                       Type 2 Diabetes|Hypertension   \n",
       "13             Hypertension|Diabetes Mellitus, Type 2   \n",
       "\n",
       "                                        Interventions  \\\n",
       "0      DRUG: Angiotensin type II receptor antagonists   \n",
       "1                     DRUG: IRBESARTAN|DRUG: Atenolol   \n",
       "2   DRUG: Angiotensin II Receptor Antagonists|DRUG...   \n",
       "3                                DRUG: Angiotensin II   \n",
       "4   DRUG: Metoprolol succinate|DRUG: Nebivolol|PRO...   \n",
       "5                          DRUG: Olmesartan medoxomil   \n",
       "6   DRUG: Sacubitril / Valsartan Oral Tablet [Entr...   \n",
       "7   DRUG: Low dose of MicardisÂ®|DRUG: Medium dose...   \n",
       "8   DRUG: Amlodipine 10 mg or Losartan 100 mg + Am...   \n",
       "9   DRUG: Amlodipine, Telmisartan, Amiloride Compo...   \n",
       "10       DRUG: Losartan|DRUG: Captopril|DRUG: Placebo   \n",
       "11  DRUG: Salsalate Oral Tablet|DRUG: Placebo Oral...   \n",
       "12                  DRUG: Dapagliflozin|DRUG: Placebo   \n",
       "13  DRUG: Angiotensin II receptor antagonists, Cal...   \n",
       "\n",
       "                             Primary Outcome Measures  \\\n",
       "0   Acute pain after cough, Intensity of pain afte...   \n",
       "1   Endothelial function in vivo qualification: br...   \n",
       "2   Fatal and nonfatal stroke, two years|Progressi...   \n",
       "3   Mean dose required to increase the SBP, The me...   \n",
       "4   Forearm Blood Flow, 12 weeks after each specif...   \n",
       "5   Insulin Sensitivity by Intravenous Glucose Tol...   \n",
       "6   Change in mPAP With Sacubitril/Valsartan compa...   \n",
       "7   Change from baseline in seated systolic blood ...   \n",
       "8   Insulin sensitivity assessed with hyperinsulin...   \n",
       "9   The primary study outcomes are composite of no...   \n",
       "10  Changes in plasma renin activity and subsequen...   \n",
       "11  change in endothelial function following salsa...   \n",
       "12  Change in Blood Pressure From Baseline to 6 We...   \n",
       "13  Changes in blood pressure level at home after ...   \n",
       "\n",
       "                           Secondary Outcome Measures  \\\n",
       "0   Acute pain at rest, Intensity of pain at rest ...   \n",
       "1                                                 NaN   \n",
       "2   Fatal and nonfatal acute coronary syndrome, tw...   \n",
       "3   Mean value of Bradykinin, Mean values of Brady...   \n",
       "4   Blood Pressure During Exercise, 12 weeks|Blood...   \n",
       "5                                                 NaN   \n",
       "6   Mean Change in mPAP, Mean Change in mPAP on Sa...   \n",
       "7   Percentage of patients achieving a target fall...   \n",
       "8   Fasting serum glucose|Fasting serum insulin|HO...   \n",
       "9   All cardiovascular eventsï¼›all-cause death, h...   \n",
       "10  Changes in blood pressure, Changes in supine b...   \n",
       "11  change in inflammatory response to ang II comp...   \n",
       "12  Change in Urinary AGT Levels From Baseline to ...   \n",
       "13  Changes in blood pressure levels measured on a...   \n",
       "\n",
       "                               Other Outcome Measures  \\\n",
       "0   Patient satisfaction, Patient satisfaction mea...   \n",
       "1                                                 NaN   \n",
       "2                                                 NaN   \n",
       "3                                                 NaN   \n",
       "4                                                 NaN   \n",
       "5   Collagen Gene Expression in Skeletal Muscle (C...   \n",
       "6                                                 NaN   \n",
       "7                                                 NaN   \n",
       "8                                                 NaN   \n",
       "9                                                 NaN   \n",
       "10                                                NaN   \n",
       "11                                                NaN   \n",
       "12                                                NaN   \n",
       "13                                                NaN   \n",
       "\n",
       "                                              Sponsor  \\\n",
       "0                                University of Athens   \n",
       "1                                              Sanofi   \n",
       "2                             Nara Medical University   \n",
       "3              Wake Forest University Health Sciences   \n",
       "4     University of Texas Southwestern Medical Center   \n",
       "5   Virginia Polytechnic Institute and State Unive...   \n",
       "6                      Germans Trias i Pujol Hospital   \n",
       "7                                Boehringer Ingelheim   \n",
       "8                        Ullevaal University Hospital   \n",
       "9   Chinese Academy of Medical Sciences, Fuwai Hos...   \n",
       "10                              Vanderbilt University   \n",
       "11                                 University of Iowa   \n",
       "12               Tulane University School of Medicine   \n",
       "13                                         Advanced-J   \n",
       "\n",
       "                                        Collaborators                 Age  \\\n",
       "0                                                 NaN  ADULT, OLDER_ADULT   \n",
       "1                                                 NaN  ADULT, OLDER_ADULT   \n",
       "2                                                 NaN         OLDER_ADULT   \n",
       "3                                                 NaN  ADULT, OLDER_ADULT   \n",
       "4                                 Forest Laboratories  ADULT, OLDER_ADULT   \n",
       "5   National Heart, Lung, and Blood Institute (NHLBI)  ADULT, OLDER_ADULT   \n",
       "6                                                 NaN  ADULT, OLDER_ADULT   \n",
       "7                                                 NaN  ADULT, OLDER_ADULT   \n",
       "8                             Merck Sharp & Dohme LLC  ADULT, OLDER_ADULT   \n",
       "9                                                 NaN  ADULT, OLDER_ADULT   \n",
       "10                                                NaN  ADULT, OLDER_ADULT   \n",
       "11                              Penn State University  ADULT, OLDER_ADULT   \n",
       "12                                        AstraZeneca  ADULT, OLDER_ADULT   \n",
       "13                             Japan Heart Foundation  ADULT, OLDER_ADULT   \n",
       "\n",
       "          Phases      Study Type  \\\n",
       "0         PHASE4  INTERVENTIONAL   \n",
       "1         PHASE4  INTERVENTIONAL   \n",
       "2         PHASE4  INTERVENTIONAL   \n",
       "3         PHASE1  INTERVENTIONAL   \n",
       "4         PHASE4  INTERVENTIONAL   \n",
       "5         PHASE4  INTERVENTIONAL   \n",
       "6         PHASE3  INTERVENTIONAL   \n",
       "7         PHASE3  INTERVENTIONAL   \n",
       "8         PHASE4  INTERVENTIONAL   \n",
       "9         PHASE4  INTERVENTIONAL   \n",
       "10        PHASE1  INTERVENTIONAL   \n",
       "11  EARLY_PHASE1  INTERVENTIONAL   \n",
       "12        PHASE4  INTERVENTIONAL   \n",
       "13        PHASE4  INTERVENTIONAL   \n",
       "\n",
       "                                         Study Design  \\\n",
       "0   Allocation: NON_RANDOMIZED|Intervention Model:...   \n",
       "1   Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "2   Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "3   Allocation: NON_RANDOMIZED|Intervention Model:...   \n",
       "4   Allocation: RANDOMIZED|Intervention Model: CRO...   \n",
       "5   Allocation: RANDOMIZED|Intervention Model: CRO...   \n",
       "6   Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
       "7   Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "8   Allocation: RANDOMIZED|Intervention Model: CRO...   \n",
       "9   Allocation: RANDOMIZED|Intervention Model: FAC...   \n",
       "10  Allocation: RANDOMIZED|Intervention Model: CRO...   \n",
       "11  Allocation: RANDOMIZED|Intervention Model: CRO...   \n",
       "12  Allocation: RANDOMIZED|Intervention Model: CRO...   \n",
       "13  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "\n",
       "                       Other IDs                               Study Documents  \n",
       "0                     AHSTSA-102                                           NaN  \n",
       "1                         L_8261                                           NaN  \n",
       "2                      03-Ken-52                                           NaN  \n",
       "3                    IRB00054661                                           NaN  \n",
       "4                 STU 062011-072  Study Protocol and Statistical Analysis Plan  \n",
       "5                         arbfat                                           NaN  \n",
       "6       ICOR-2020-03-PA-ARNIMEMS                                           NaN  \n",
       "7                        502.254                                           NaN  \n",
       "8                          308-1                                           NaN  \n",
       "9                            115                                           NaN  \n",
       "10                        101618                                           NaN  \n",
       "11                      HL138133                                           NaN  \n",
       "12                        812701  Study Protocol and Statistical Analysis Plan  \n",
       "13  ADVANCED-J01|UMIN-C000000017                                           NaN  "
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "df_AGTR1 = pd.read_csv(\"/Users/trini/Downloads/ClinicalTrial_AGTR1_Drug.csv\")\n",
    "df_AGTR1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "id": "20c4d07b",
   "metadata": {},
   "outputs": [],
   "source": [
    "# For ATP13A3, causes Pulmonary Hypertension Primary 5 (PPH5)\n",
    "# For POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 3; (KCNK3) - causes PPH4 OMIM: 615344\n",
    "# For SMAD FAMILY MEMBER 9; (SMAD9) - causes PPH2 OMIM: 615342\n",
    "\n",
    "with open(\"/Users/trini/Downloads/ClinicalTrial_ATP13A3.txt\", encoding='utf-8') as PPH5:\n",
    "    out = open(\"/Users/trini/Downloads/ClinicalTrial_ATP13A3_Drug.txt\",'w', encoding='utf-8')\n",
    "    for line in PPH5:\n",
    "        out.write(line)\n",
    "        break  # This way we can parse the header\n",
    "    for l in PPH5:  # Filter only those with lines that have the disease term, Drug, and Phase trial\n",
    "        if 'Pulmonary' in l:\n",
    "            if 'DRUG' in l:\n",
    "                if 'PHASE' in l:\n",
    "                    out.write(l)\n",
    "    out.close()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "720b8246",
   "metadata": {},
   "source": [
    "#### Note: The reason why these 3 genes were combined here was because all 3 of them causes Primary Pulmonary Hypertension in general. Only differs by which mutated gene caused the disease to occur"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "id": "c1c4e055",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Other Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00595049</td>\n",
       "      <td>Pulmonary Artery Remodelling With Bosentan</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT00595049</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Hypertension, Pulmonary</td>\n",
       "      <td>DRUG: bosentan</td>\n",
       "      <td>Change from baseline (BL) to 6 mths in the IVU...</td>\n",
       "      <td>Change from BL to 6 mths in each of the IVUS d...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Actelion</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>AC-052-416</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03431649</td>\n",
       "      <td>Efficacy of Beraprost in Lowering Pulmonary Ar...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT03431649</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Pediatric Pulmonary Hypertension</td>\n",
       "      <td>DRUG: Beraprost Sodium|DRUG: Sildenafil Citrate</td>\n",
       "      <td>Efficacy of Beraprost, Sildenafil and comparis...</td>\n",
       "      <td>Emergent Adverse Events, adverse event reporte...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Dr. Soetomo General Hospital</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>TAshirley</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT01027949</td>\n",
       "      <td>An Open-Label Extension Trial of UT-15C Sustai...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT01027949</td>\n",
       "      <td>FREEDOM-EXT</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>YES</td>\n",
       "      <td>Pulmonary Arterial Hypertension</td>\n",
       "      <td>DRUG: Oral Treprostinil</td>\n",
       "      <td>Change in Exercise Capacity at Month 12, Asses...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>United Therapeutics</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>TDE-PH-304</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT00086463</td>\n",
       "      <td>Trial of Iloprost Inhaled Solution as Add-On T...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT00086463</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Pulmonary Arterial Hypertension|Ayerza Syndrom...</td>\n",
       "      <td>DRUG: Iloprost or placebo</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Actelion</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: SIN...</td>\n",
       "      <td>STEP STUDY|STEP|Pulmonary Hypertension|Pulmona...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT00617305</td>\n",
       "      <td>Study of Add-on Ambrisentan Therapy to Backgro...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT00617305</td>\n",
       "      <td>ATHENA-1</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>YES</td>\n",
       "      <td>Pulmonary Arterial Hypertension</td>\n",
       "      <td>DRUG: Ambrisentan|DRUG: Placebo|DRUG: Sildenaf...</td>\n",
       "      <td>Change From Baseline in Pulmonary Vascular Res...</td>\n",
       "      <td>Change From Baseline in Mean Pulmonary Artery ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Gilead Sciences</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>GS-US-300-0117</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>306</th>\n",
       "      <td>NCT00477269</td>\n",
       "      <td>Safety and Efficacy of Imatinib Mesylate in Pa...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT00477269</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>YES</td>\n",
       "      <td>Pulmonary Arterial Hypertension</td>\n",
       "      <td>DRUG: Imatinib mesylate|DRUG: Placebo</td>\n",
       "      <td>Number of Patients With Adverse Events (AEs), ...</td>\n",
       "      <td>Number of Patients With Pulmonary Hypertension...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Novartis Pharmaceuticals</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2|PHASE3</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>CSTI571E2203|2005-005569-12</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>307</th>\n",
       "      <td>NCT00159913</td>\n",
       "      <td>A Randomized, Double-Blind, Placebo-Controlled...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT00159913</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>YES</td>\n",
       "      <td>Pulmonary Arterial Hypertension, Children</td>\n",
       "      <td>DRUG: Sildenafil citrate|DRUG: Sildenafil citr...</td>\n",
       "      <td>Percent Change From Baseline in Peak Volume of...</td>\n",
       "      <td>Change From Baseline to Week 16 in Mean Pulmon...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pfizer's Upjohn has merged with Mylan to form ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>A1481131</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>308</th>\n",
       "      <td>NCT01469169</td>\n",
       "      <td>Inhaled Iloprost (Ventavis): Efficacy, Safety,...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT01469169</td>\n",
       "      <td>IBUKI</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Hypertension, Pulmonary</td>\n",
       "      <td>DRUG: Iloprost (Ventavis inhaled, BAYQ6256)</td>\n",
       "      <td>Change in Pulmonary vascular resistance (PVR) ...</td>\n",
       "      <td>Change of Pulmonary vascular resistance index ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Bayer</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>15503</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>309</th>\n",
       "      <td>NCT00625469</td>\n",
       "      <td>Pulmonary Arterial Hypertension Secondary to I...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT00625469</td>\n",
       "      <td>NaN</td>\n",
       "      <td>WITHDRAWN</td>\n",
       "      <td>NO</td>\n",
       "      <td>Pulmonary Arterial Hypertension|Idiopathic Pul...</td>\n",
       "      <td>DRUG: bosentan</td>\n",
       "      <td>6 minute walk distance, ATS Guideline 6MW dist...</td>\n",
       "      <td>right heart catheterization hemodynamics, pulm...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Rajan Saggar</td>\n",
       "      <td>Actelion</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>IPF/PAH</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>310</th>\n",
       "      <td>NCT02562235</td>\n",
       "      <td>Riociguat in Children With Pulmonary Arterial ...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT02562235</td>\n",
       "      <td>PATENT-CHILD</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>YES</td>\n",
       "      <td>Hypertension, Pulmonary</td>\n",
       "      <td>DRUG: Riociguat (Adempas, BAY63-2521)</td>\n",
       "      <td>Number of Participants With Any Treatment-emer...</td>\n",
       "      <td>Change in 6-minute Walking Distance From Basel...</td>\n",
       "      <td>Taste and Texture (Questions 1 to 4) of the Or...</td>\n",
       "      <td>Bayer</td>\n",
       "      <td>Merck Sharp &amp; Dohme LLC</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>15681|2014-003952-29</td>\n",
       "      <td>Study Protocol|Statistical Analysis Plan</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>311 rows × 19 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      NCT Number                                        Study Title  \\\n",
       "0    NCT00595049         Pulmonary Artery Remodelling With Bosentan   \n",
       "1    NCT03431649  Efficacy of Beraprost in Lowering Pulmonary Ar...   \n",
       "2    NCT01027949  An Open-Label Extension Trial of UT-15C Sustai...   \n",
       "3    NCT00086463  Trial of Iloprost Inhaled Solution as Add-On T...   \n",
       "4    NCT00617305  Study of Add-on Ambrisentan Therapy to Backgro...   \n",
       "..           ...                                                ...   \n",
       "306  NCT00477269  Safety and Efficacy of Imatinib Mesylate in Pa...   \n",
       "307  NCT00159913  A Randomized, Double-Blind, Placebo-Controlled...   \n",
       "308  NCT01469169  Inhaled Iloprost (Ventavis): Efficacy, Safety,...   \n",
       "309  NCT00625469  Pulmonary Arterial Hypertension Secondary to I...   \n",
       "310  NCT02562235  Riociguat in Children With Pulmonary Arterial ...   \n",
       "\n",
       "                                             Study URL       Acronym  \\\n",
       "0    https://beta.clinicaltrials.gov/study/NCT00595049           NaN   \n",
       "1    https://beta.clinicaltrials.gov/study/NCT03431649           NaN   \n",
       "2    https://beta.clinicaltrials.gov/study/NCT01027949   FREEDOM-EXT   \n",
       "3    https://beta.clinicaltrials.gov/study/NCT00086463           NaN   \n",
       "4    https://beta.clinicaltrials.gov/study/NCT00617305      ATHENA-1   \n",
       "..                                                 ...           ...   \n",
       "306  https://beta.clinicaltrials.gov/study/NCT00477269           NaN   \n",
       "307  https://beta.clinicaltrials.gov/study/NCT00159913           NaN   \n",
       "308  https://beta.clinicaltrials.gov/study/NCT01469169         IBUKI   \n",
       "309  https://beta.clinicaltrials.gov/study/NCT00625469           NaN   \n",
       "310  https://beta.clinicaltrials.gov/study/NCT02562235  PATENT-CHILD   \n",
       "\n",
       "              Study Status Study Results  \\\n",
       "0                COMPLETED            NO   \n",
       "1                COMPLETED            NO   \n",
       "2                COMPLETED           YES   \n",
       "3                COMPLETED            NO   \n",
       "4                COMPLETED           YES   \n",
       "..                     ...           ...   \n",
       "306              COMPLETED           YES   \n",
       "307              COMPLETED           YES   \n",
       "308              COMPLETED            NO   \n",
       "309              WITHDRAWN            NO   \n",
       "310  ACTIVE_NOT_RECRUITING           YES   \n",
       "\n",
       "                                            Conditions  \\\n",
       "0                              Hypertension, Pulmonary   \n",
       "1                     Pediatric Pulmonary Hypertension   \n",
       "2                      Pulmonary Arterial Hypertension   \n",
       "3    Pulmonary Arterial Hypertension|Ayerza Syndrom...   \n",
       "4                      Pulmonary Arterial Hypertension   \n",
       "..                                                 ...   \n",
       "306                    Pulmonary Arterial Hypertension   \n",
       "307          Pulmonary Arterial Hypertension, Children   \n",
       "308                            Hypertension, Pulmonary   \n",
       "309  Pulmonary Arterial Hypertension|Idiopathic Pul...   \n",
       "310                            Hypertension, Pulmonary   \n",
       "\n",
       "                                         Interventions  \\\n",
       "0                                       DRUG: bosentan   \n",
       "1      DRUG: Beraprost Sodium|DRUG: Sildenafil Citrate   \n",
       "2                              DRUG: Oral Treprostinil   \n",
       "3                            DRUG: Iloprost or placebo   \n",
       "4    DRUG: Ambrisentan|DRUG: Placebo|DRUG: Sildenaf...   \n",
       "..                                                 ...   \n",
       "306              DRUG: Imatinib mesylate|DRUG: Placebo   \n",
       "307  DRUG: Sildenafil citrate|DRUG: Sildenafil citr...   \n",
       "308        DRUG: Iloprost (Ventavis inhaled, BAYQ6256)   \n",
       "309                                     DRUG: bosentan   \n",
       "310              DRUG: Riociguat (Adempas, BAY63-2521)   \n",
       "\n",
       "                              Primary Outcome Measures  \\\n",
       "0    Change from baseline (BL) to 6 mths in the IVU...   \n",
       "1    Efficacy of Beraprost, Sildenafil and comparis...   \n",
       "2    Change in Exercise Capacity at Month 12, Asses...   \n",
       "3                                                  NaN   \n",
       "4    Change From Baseline in Pulmonary Vascular Res...   \n",
       "..                                                 ...   \n",
       "306  Number of Patients With Adverse Events (AEs), ...   \n",
       "307  Percent Change From Baseline in Peak Volume of...   \n",
       "308  Change in Pulmonary vascular resistance (PVR) ...   \n",
       "309  6 minute walk distance, ATS Guideline 6MW dist...   \n",
       "310  Number of Participants With Any Treatment-emer...   \n",
       "\n",
       "                            Secondary Outcome Measures  \\\n",
       "0    Change from BL to 6 mths in each of the IVUS d...   \n",
       "1    Emergent Adverse Events, adverse event reporte...   \n",
       "2                                                  NaN   \n",
       "3                                                  NaN   \n",
       "4    Change From Baseline in Mean Pulmonary Artery ...   \n",
       "..                                                 ...   \n",
       "306  Number of Patients With Pulmonary Hypertension...   \n",
       "307  Change From Baseline to Week 16 in Mean Pulmon...   \n",
       "308  Change of Pulmonary vascular resistance index ...   \n",
       "309  right heart catheterization hemodynamics, pulm...   \n",
       "310  Change in 6-minute Walking Distance From Basel...   \n",
       "\n",
       "                                Other Outcome Measures  \\\n",
       "0                                                  NaN   \n",
       "1                                                  NaN   \n",
       "2                                                  NaN   \n",
       "3                                                  NaN   \n",
       "4                                                  NaN   \n",
       "..                                                 ...   \n",
       "306                                                NaN   \n",
       "307                                                NaN   \n",
       "308                                                NaN   \n",
       "309                                                NaN   \n",
       "310  Taste and Texture (Questions 1 to 4) of the Or...   \n",
       "\n",
       "                                               Sponsor  \\\n",
       "0                                             Actelion   \n",
       "1                         Dr. Soetomo General Hospital   \n",
       "2                                  United Therapeutics   \n",
       "3                                             Actelion   \n",
       "4                                      Gilead Sciences   \n",
       "..                                                 ...   \n",
       "306                           Novartis Pharmaceuticals   \n",
       "307  Pfizer's Upjohn has merged with Mylan to form ...   \n",
       "308                                              Bayer   \n",
       "309                                       Rajan Saggar   \n",
       "310                                              Bayer   \n",
       "\n",
       "               Collaborators                        Age         Phases  \\\n",
       "0                        NaN         ADULT, OLDER_ADULT         PHASE4   \n",
       "1                        NaN                      CHILD         PHASE4   \n",
       "2                        NaN  CHILD, ADULT, OLDER_ADULT         PHASE3   \n",
       "3                        NaN  CHILD, ADULT, OLDER_ADULT         PHASE2   \n",
       "4                        NaN  CHILD, ADULT, OLDER_ADULT         PHASE4   \n",
       "..                       ...                        ...            ...   \n",
       "306                      NaN         ADULT, OLDER_ADULT  PHASE2|PHASE3   \n",
       "307                      NaN                      CHILD         PHASE3   \n",
       "308                      NaN         ADULT, OLDER_ADULT         PHASE3   \n",
       "309                 Actelion  CHILD, ADULT, OLDER_ADULT         PHASE4   \n",
       "310  Merck Sharp & Dohme LLC                      CHILD         PHASE3   \n",
       "\n",
       "         Study Type                                       Study Design  \\\n",
       "0    INTERVENTIONAL  Allocation: NON_RANDOMIZED|Intervention Model:...   \n",
       "1    INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "2    INTERVENTIONAL  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
       "3    INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: SIN...   \n",
       "4    INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "..              ...                                                ...   \n",
       "306  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "307  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "308  INTERVENTIONAL  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
       "309  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "310  INTERVENTIONAL  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
       "\n",
       "                                             Other IDs  \\\n",
       "0                                           AC-052-416   \n",
       "1                                            TAshirley   \n",
       "2                                           TDE-PH-304   \n",
       "3    STEP STUDY|STEP|Pulmonary Hypertension|Pulmona...   \n",
       "4                                       GS-US-300-0117   \n",
       "..                                                 ...   \n",
       "306                        CSTI571E2203|2005-005569-12   \n",
       "307                                           A1481131   \n",
       "308                                              15503   \n",
       "309                                            IPF/PAH   \n",
       "310                               15681|2014-003952-29   \n",
       "\n",
       "                              Study Documents  \n",
       "0                                         NaN  \n",
       "1                                         NaN  \n",
       "2    Study Protocol|Statistical Analysis Plan  \n",
       "3                                         NaN  \n",
       "4                                         NaN  \n",
       "..                                        ...  \n",
       "306                                       NaN  \n",
       "307                                       NaN  \n",
       "308                                       NaN  \n",
       "309                                       NaN  \n",
       "310  Study Protocol|Statistical Analysis Plan  \n",
       "\n",
       "[311 rows x 19 columns]"
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "df_ATP13A3 = pd.read_csv(\"/Users/trini/Downloads/ClinicalTrial_ATP13A3_Drug.csv\")\n",
    "df_ATP13A3"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "id": "899e332e",
   "metadata": {},
   "outputs": [],
   "source": [
    "# For BMPR2 (DO NOT OVERWRITE THIS RUN)\n",
    "with open(\"/Users/trini/Downloads/ClinicalTrial_BMPR2.txt\", encoding='utf-8') as BMPR2:\n",
    "    out = open(\"/Users/trini/Downloads/ClinicalTrial_BMPR2_Drug.txt\",'w', encoding='utf-8')\n",
    "    for line in BMPR2:\n",
    "        out.write(line)\n",
    "        break  # This way we can parse the header\n",
    "    for l in BMPR2:  # Filter only those with lines that have the disease term, Drug, and Phase trial\n",
    "        if 'DRUG' in l:\n",
    "            out.write(l)\n",
    "    out.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "id": "131e7697",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Other Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00896389</td>\n",
       "      <td>Salt Loading and Thiazide Intervention Study</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT00896389</td>\n",
       "      <td>SALTI</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>YES</td>\n",
       "      <td>Hypertension</td>\n",
       "      <td>PROCEDURE: Salt loading|DRUG: Hydrochlorothiaz...</td>\n",
       "      <td>Blood Pressure Change During Salt Loading, Sys...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                   Study Title  \\\n",
       "0  NCT00896389  Salt Loading and Thiazide Intervention Study   \n",
       "\n",
       "                                           Study URL Acronym Study Status  \\\n",
       "0  https://beta.clinicaltrials.gov/study/NCT00896389   SALTI    COMPLETED   \n",
       "\n",
       "  Study Results    Conditions  \\\n",
       "0           YES  Hypertension   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  PROCEDURE: Salt loading|DRUG: Hydrochlorothiaz...   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Blood Pressure Change During Salt Loading, Sys...   \n",
       "\n",
       "   Secondary Outcome Measures  Other Outcome Measures  Sponsor  Collaborators  \\\n",
       "0                         NaN                     NaN      NaN            NaN   \n",
       "\n",
       "   Age  Phases  Study Type  Study Design  Other IDs  Study Documents  \n",
       "0  NaN  PHASE4         NaN           NaN        NaN              NaN  "
      ]
     },
     "execution_count": 67,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "df_BMPR2 = pd.read_csv(\"/Users/trini/Downloads/ClinicalTrial_BMPR2_Drug.csv\")\n",
    "df_BMPR2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "id": "fce65765",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Other Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT01426529</td>\n",
       "      <td>Caveolin-1 and Vascular Dysfunction</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT01426529</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ACTIVE_NOT_RECRUITING</td>\n",
       "      <td>NO</td>\n",
       "      <td>Hypertension|Insulin Resistance</td>\n",
       "      <td>DRUG: Para-aminohippuric Acid|DRUG: Angiotensi...</td>\n",
       "      <td>Genetic Variation at the Caveolin-1 Locus, We ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Brigham and Women's Hospital</td>\n",
       "      <td>National Heart, Lung, and Blood Institute (NHL...</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE1</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>2010P002187|1R01HL104032-01</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                          Study Title  \\\n",
       "0  NCT01426529  Caveolin-1 and Vascular Dysfunction   \n",
       "\n",
       "                                           Study URL  Acronym  \\\n",
       "0  https://beta.clinicaltrials.gov/study/NCT01426529      NaN   \n",
       "\n",
       "            Study Status Study Results                       Conditions  \\\n",
       "0  ACTIVE_NOT_RECRUITING            NO  Hypertension|Insulin Resistance   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  DRUG: Para-aminohippuric Acid|DRUG: Angiotensi...   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Genetic Variation at the Caveolin-1 Locus, We ...   \n",
       "\n",
       "   Secondary Outcome Measures  Other Outcome Measures  \\\n",
       "0                         NaN                     NaN   \n",
       "\n",
       "                        Sponsor  \\\n",
       "0  Brigham and Women's Hospital   \n",
       "\n",
       "                                       Collaborators                 Age  \\\n",
       "0  National Heart, Lung, and Blood Institute (NHL...  ADULT, OLDER_ADULT   \n",
       "\n",
       "   Phases      Study Type                                       Study Design  \\\n",
       "0  PHASE1  INTERVENTIONAL  Allocation: NON_RANDOMIZED|Intervention Model:...   \n",
       "\n",
       "                     Other IDs  Study Documents  \n",
       "0  2010P002187|1R01HL104032-01              NaN  "
      ]
     },
     "execution_count": 68,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# For CAV1, causes PULMONARY HYPERTENSION, PRIMARY, 3; PPH3 (Data obtained from OMIM)\n",
    "import pandas as pd\n",
    "df_CAV1 = pd.read_csv(\"/Users/trini/Downloads/ClinicalTrial_CAV1.csv\")\n",
    "df_CAV1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "id": "56b78ed1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Other Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00732771</td>\n",
       "      <td>Proof-of-concept for the Aldosterone Synthase ...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT00732771</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Primary Hyperaldosteronism</td>\n",
       "      <td>DRUG: LCI699</td>\n",
       "      <td>Systolic blood pressure over a 7-week forced t...</td>\n",
       "      <td>Plasma and urine hormone levels and electrolyt...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Novartis</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>CLCI699A2206</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT00732771  Proof-of-concept for the Aldosterone Synthase ...   \n",
       "\n",
       "                                           Study URL  Acronym Study Status  \\\n",
       "0  https://beta.clinicaltrials.gov/study/NCT00732771      NaN    COMPLETED   \n",
       "\n",
       "  Study Results                  Conditions Interventions  \\\n",
       "0            NO  Primary Hyperaldosteronism  DRUG: LCI699   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Systolic blood pressure over a 7-week forced t...   \n",
       "\n",
       "                          Secondary Outcome Measures  Other Outcome Measures  \\\n",
       "0  Plasma and urine hormone levels and electrolyt...                     NaN   \n",
       "\n",
       "    Sponsor  Collaborators                 Age  Phases      Study Type  \\\n",
       "0  Novartis            NaN  ADULT, OLDER_ADULT  PHASE2  INTERVENTIONAL   \n",
       "\n",
       "                                        Study Design     Other IDs  \\\n",
       "0  Allocation: NON_RANDOMIZED|Intervention Model:...  CLCI699A2206   \n",
       "\n",
       "   Study Documents  \n",
       "0              NaN  "
      ]
     },
     "execution_count": 72,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# For CYP11B2 \n",
    "df_CYP11B2  = pd.read_csv(\"/Users/trini/Downloads/ClinicalTrial_CYP11B2.csv\")\n",
    "df_CYP11B2 "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 74,
   "id": "9b19ab60",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Other Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00592150</td>\n",
       "      <td>Effect of Gene Variants on Dopamine Receptor N...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT00592150</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>NO</td>\n",
       "      <td>Hypertension</td>\n",
       "      <td>DRUG: fenoldopam|DRUG: Placebo</td>\n",
       "      <td>Urine sodium excretion, 7 days</td>\n",
       "      <td>gene dose effect of GPK-4 on fenoldopam induce...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>University of Virginia</td>\n",
       "      <td>National Institutes of Health (NIH)</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE1</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>13072</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT00592150  Effect of Gene Variants on Dopamine Receptor N...   \n",
       "\n",
       "                                           Study URL  Acronym Study Status  \\\n",
       "0  https://beta.clinicaltrials.gov/study/NCT00592150      NaN      UNKNOWN   \n",
       "\n",
       "  Study Results    Conditions                   Interventions  \\\n",
       "0            NO  Hypertension  DRUG: fenoldopam|DRUG: Placebo   \n",
       "\n",
       "         Primary Outcome Measures  \\\n",
       "0  Urine sodium excretion, 7 days   \n",
       "\n",
       "                          Secondary Outcome Measures  Other Outcome Measures  \\\n",
       "0  gene dose effect of GPK-4 on fenoldopam induce...                     NaN   \n",
       "\n",
       "                  Sponsor                        Collaborators  \\\n",
       "0  University of Virginia  National Institutes of Health (NIH)   \n",
       "\n",
       "                  Age  Phases      Study Type  \\\n",
       "0  ADULT, OLDER_ADULT  PHASE1  INTERVENTIONAL   \n",
       "\n",
       "                                        Study Design  Other IDs  \\\n",
       "0  Allocation: RANDOMIZED|Intervention Model: CRO...      13072   \n",
       "\n",
       "   Study Documents  \n",
       "0              NaN  "
      ]
     },
     "execution_count": 74,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# For DRD1\n",
    "df_DRD1  = pd.read_csv(\"/Users/trini/Downloads/ClinicalTrial_DRD1.csv\")\n",
    "df_DRD1 "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "id": "4a5b1fea",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Other Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT03414918</td>\n",
       "      <td>Macrolides for KCNJ5 - Mutated Aldosterone-Pro...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT03414918</td>\n",
       "      <td>MAPA</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>NO</td>\n",
       "      <td>Hyperaldosteronism</td>\n",
       "      <td>DRUG: Clarithromycin</td>\n",
       "      <td>Study 1: Change in Relative Aldosterone Secret...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>University Hospital Padova</td>\n",
       "      <td>DMG Paris Descartes</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>4283/AO/17</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT03414918  Macrolides for KCNJ5 - Mutated Aldosterone-Pro...   \n",
       "\n",
       "                                           Study URL Acronym Study Status  \\\n",
       "0  https://beta.clinicaltrials.gov/study/NCT03414918    MAPA      UNKNOWN   \n",
       "\n",
       "  Study Results          Conditions         Interventions  \\\n",
       "0            NO  Hyperaldosteronism  DRUG: Clarithromycin   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Study 1: Change in Relative Aldosterone Secret...   \n",
       "\n",
       "   Secondary Outcome Measures  Other Outcome Measures  \\\n",
       "0                         NaN                     NaN   \n",
       "\n",
       "                      Sponsor        Collaborators                 Age  \\\n",
       "0  University Hospital Padova  DMG Paris Descartes  ADULT, OLDER_ADULT   \n",
       "\n",
       "   Phases      Study Type                                       Study Design  \\\n",
       "0     NaN  INTERVENTIONAL  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
       "\n",
       "    Other IDs  Study Documents  \n",
       "0  4283/AO/17              NaN  "
      ]
     },
     "execution_count": 77,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# For KCNJ5\n",
    "df_KCNJ5  = pd.read_csv(\"/Users/trini/Downloads/ClinicalTrial_KCNJ5.csv\")\n",
    "df_KCNJ5 "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "id": "802dbbdb",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Other Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT03476616</td>\n",
       "      <td>Antihypertensive Pharmacological Therapy With ...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT03476616</td>\n",
       "      <td>HEVRO</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>NO</td>\n",
       "      <td>Hypertension|Obesity</td>\n",
       "      <td>DRUG: Eplerenone (-based therapy) arm|DRUG: Va...</td>\n",
       "      <td>Difference in change of ABPM from baseline, in...</td>\n",
       "      <td>Difference in change of office BP from baselin...</td>\n",
       "      <td>Difference in frequency of controlled hyperten...</td>\n",
       "      <td>Hippocration General Hospital</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT04746495</td>\n",
       "      <td>Effect of Eplerenone on Novel Biomarkers of Mi...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT04746495</td>\n",
       "      <td>ENOVA</td>\n",
       "      <td>WITHDRAWN</td>\n",
       "      <td>NO</td>\n",
       "      <td>Hypertension</td>\n",
       "      <td>DRUG: Placebo|DRUG: Eplerenone 50mg</td>\n",
       "      <td>Reverse transcriptase quantitative polymerase ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>University of Michigan</td>\n",
       "      <td>National Heart, Lung, and Blood Institute (NHLBI)</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: CRO...</td>\n",
       "      <td>HUM00170418|1K23HL128909-01A1</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT05593055</td>\n",
       "      <td>Mineralocorticoid Receptor, Coronary Microvasc...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT05593055</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>NO</td>\n",
       "      <td>Hypertension|Left Ventricular Hypertrophy</td>\n",
       "      <td>DRUG: Eplerenone|DRUG: Chlorthalidone|DRUG: Po...</td>\n",
       "      <td>Change in myocardial flow reserve, Change in m...</td>\n",
       "      <td>Change in myocardial external efficiency, Chan...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Brigham and Women's Hospital</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2022P002126</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT04519164</td>\n",
       "      <td>Aldosterone, the Mineralocorticoid Receptor, a...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT04519164</td>\n",
       "      <td>NaN</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>NO</td>\n",
       "      <td>Metabolic Syndrome|Hypertension|Overweight and...</td>\n",
       "      <td>DRUG: Eplerenone|DRUG: Chlorthalidone with pot...</td>\n",
       "      <td>Change in stress myocardial perfusion reserve ...</td>\n",
       "      <td>Change in extracellular volume fraction on car...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Brigham and Women's Hospital</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2020P002311</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT04968184</td>\n",
       "      <td>Efficacy and Safety of KBP-5074 in Uncontrolle...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT04968184</td>\n",
       "      <td>Clarion-CKD</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>NO</td>\n",
       "      <td>Chronic Kidney Diseases</td>\n",
       "      <td>DRUG: Placebo|DRUG: KBP-5074</td>\n",
       "      <td>Change in seated trough cuff SBP from baseline...</td>\n",
       "      <td>Change in seated trough cuff SBP from baseline...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>KBP Biosciences</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>KBP5074-3-001</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NCT05814770</td>\n",
       "      <td>Comparing the Efficacy and Safety of Finerenon...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT05814770</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>NO</td>\n",
       "      <td>Primary Aldosteronism|Hypertension</td>\n",
       "      <td>DRUG: Finerenone|DRUG: Spironolactone</td>\n",
       "      <td>Hypertension remission rate., The proportion o...</td>\n",
       "      <td>The change of systolic and diastolic BP from t...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The Affiliated Nanjing Drum Tower Hospital of ...</td>\n",
       "      <td>National Key Research and Development Program ...</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>PA2023</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT03476616  Antihypertensive Pharmacological Therapy With ...   \n",
       "1  NCT04746495  Effect of Eplerenone on Novel Biomarkers of Mi...   \n",
       "2  NCT05593055  Mineralocorticoid Receptor, Coronary Microvasc...   \n",
       "3  NCT04519164  Aldosterone, the Mineralocorticoid Receptor, a...   \n",
       "4  NCT04968184  Efficacy and Safety of KBP-5074 in Uncontrolle...   \n",
       "5  NCT05814770  Comparing the Efficacy and Safety of Finerenon...   \n",
       "\n",
       "                                           Study URL      Acronym  \\\n",
       "0  https://beta.clinicaltrials.gov/study/NCT03476616        HEVRO   \n",
       "1  https://beta.clinicaltrials.gov/study/NCT04746495        ENOVA   \n",
       "2  https://beta.clinicaltrials.gov/study/NCT05593055          NaN   \n",
       "3  https://beta.clinicaltrials.gov/study/NCT04519164          NaN   \n",
       "4  https://beta.clinicaltrials.gov/study/NCT04968184  Clarion-CKD   \n",
       "5  https://beta.clinicaltrials.gov/study/NCT05814770          NaN   \n",
       "\n",
       "         Study Status Study Results  \\\n",
       "0             UNKNOWN            NO   \n",
       "1           WITHDRAWN            NO   \n",
       "2  NOT_YET_RECRUITING            NO   \n",
       "3          RECRUITING            NO   \n",
       "4          RECRUITING            NO   \n",
       "5  NOT_YET_RECRUITING            NO   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0                               Hypertension|Obesity   \n",
       "1                                       Hypertension   \n",
       "2          Hypertension|Left Ventricular Hypertrophy   \n",
       "3  Metabolic Syndrome|Hypertension|Overweight and...   \n",
       "4                            Chronic Kidney Diseases   \n",
       "5                 Primary Aldosteronism|Hypertension   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0  DRUG: Eplerenone (-based therapy) arm|DRUG: Va...   \n",
       "1                DRUG: Placebo|DRUG: Eplerenone 50mg   \n",
       "2  DRUG: Eplerenone|DRUG: Chlorthalidone|DRUG: Po...   \n",
       "3  DRUG: Eplerenone|DRUG: Chlorthalidone with pot...   \n",
       "4                       DRUG: Placebo|DRUG: KBP-5074   \n",
       "5              DRUG: Finerenone|DRUG: Spironolactone   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Difference in change of ABPM from baseline, in...   \n",
       "1  Reverse transcriptase quantitative polymerase ...   \n",
       "2  Change in myocardial flow reserve, Change in m...   \n",
       "3  Change in stress myocardial perfusion reserve ...   \n",
       "4  Change in seated trough cuff SBP from baseline...   \n",
       "5  Hypertension remission rate., The proportion o...   \n",
       "\n",
       "                          Secondary Outcome Measures  \\\n",
       "0  Difference in change of office BP from baselin...   \n",
       "1                                                NaN   \n",
       "2  Change in myocardial external efficiency, Chan...   \n",
       "3  Change in extracellular volume fraction on car...   \n",
       "4  Change in seated trough cuff SBP from baseline...   \n",
       "5  The change of systolic and diastolic BP from t...   \n",
       "\n",
       "                              Other Outcome Measures  \\\n",
       "0  Difference in frequency of controlled hyperten...   \n",
       "1                                                NaN   \n",
       "2                                                NaN   \n",
       "3                                                NaN   \n",
       "4                                                NaN   \n",
       "5                                                NaN   \n",
       "\n",
       "                                             Sponsor  \\\n",
       "0                      Hippocration General Hospital   \n",
       "1                             University of Michigan   \n",
       "2                       Brigham and Women's Hospital   \n",
       "3                       Brigham and Women's Hospital   \n",
       "4                                    KBP Biosciences   \n",
       "5  The Affiliated Nanjing Drum Tower Hospital of ...   \n",
       "\n",
       "                                       Collaborators                 Age  \\\n",
       "0                                                NaN  ADULT, OLDER_ADULT   \n",
       "1  National Heart, Lung, and Blood Institute (NHLBI)  ADULT, OLDER_ADULT   \n",
       "2                                                NaN  ADULT, OLDER_ADULT   \n",
       "3                                                NaN  ADULT, OLDER_ADULT   \n",
       "4                                                NaN  ADULT, OLDER_ADULT   \n",
       "5  National Key Research and Development Program ...  ADULT, OLDER_ADULT   \n",
       "\n",
       "   Phases      Study Type                                       Study Design  \\\n",
       "0  PHASE4  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "1  PHASE4  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: CRO...   \n",
       "2  PHASE4  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "3  PHASE4  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "4  PHASE3  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "5  PHASE4  INTERVENTIONAL  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "\n",
       "                       Other IDs  Study Documents  \n",
       "0                            NaN              NaN  \n",
       "1  HUM00170418|1K23HL128909-01A1              NaN  \n",
       "2                    2022P002126              NaN  \n",
       "3                    2020P002311              NaN  \n",
       "4                  KBP5074-3-001              NaN  \n",
       "5                         PA2023              NaN  "
      ]
     },
     "execution_count": 78,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# For NR3C2 - causes HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH SEVERE EXACERBATION IN PREGNANCY OMIM: 605115\n",
    "df_NR3C2  = pd.read_csv(\"/Users/trini/Downloads/ClinicalTrial_NR3C2.csv\")\n",
    "df_NR3C2 "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "id": "132d25f8",
   "metadata": {},
   "outputs": [],
   "source": [
    "# For REN\n",
    "with open(\"/Users/trini/Downloads/ClinicalTrial_REN.txt\", encoding='utf-8') as REN:\n",
    "    out = open(\"/Users/trini/Downloads/ClinicalTrial_REN_Drug.txt\",'w', encoding='utf-8')\n",
    "    for line in REN:\n",
    "        out.write(line)\n",
    "        break  # This way we can parse the header\n",
    "    for l in REN:\n",
    "        if 'Ren' in l:\n",
    "            if 'DRUG' in l:\n",
    "                if 'PHASE' in l:\n",
    "                    out.write(l)\n",
    "    out.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 82,
   "id": "6d4a1cf3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Other Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT01901549</td>\n",
       "      <td>Renal Denervation in Patients After Acute Coro...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT01901549</td>\n",
       "      <td>ACSRD</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>NO</td>\n",
       "      <td>Acute Coronary Syndrome|Arterial Hypertension</td>\n",
       "      <td>PROCEDURE: Renal denervation|DRUG: Metoprolol|...</td>\n",
       "      <td>cardiovascular death, 1 year|myocardium infarc...</td>\n",
       "      <td>blood pressure changes, 1 year|CCS and NYHA, 1...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Meshalkin Research Institute of Pathology of C...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>AMIRD</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT01663805</td>\n",
       "      <td>Effects of the Use of \"de Novo\" Everolimus in ...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT01663805</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>NO</td>\n",
       "      <td>Delayed Function of Renal Transplant</td>\n",
       "      <td>DRUG: Everolimus</td>\n",
       "      <td>Molecular profile of cytokines, To characteriz...</td>\n",
       "      <td>Pattern of cytokines with DGF, cold ischemia t...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>MARIO ABBUD FILHO</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>CRAD001ABR21T</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT05222191</td>\n",
       "      <td>Spironolactone in CKD Enabled by Chlorthalidon...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT05222191</td>\n",
       "      <td>SPICE PILOT</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>NO</td>\n",
       "      <td>Renal Insufficiency|Chronic Hypertension</td>\n",
       "      <td>DRUG: Spironolactone|DRUG: Chlorthalidone|DRUG...</td>\n",
       "      <td>Change in Systolic Automated Office Blood Pres...</td>\n",
       "      <td>Change in logarithmically transformed albumin/...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Indiana Institute for Medical Research</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>12672</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT01095939</td>\n",
       "      <td>Post-preeclampsia Renal Project: Study of Neph...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT01095939</td>\n",
       "      <td>RPPEC</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Renal Alteration</td>\n",
       "      <td>DRUG: Placebo|DRUG: Benazepril hydrochloride</td>\n",
       "      <td>microalbuminuria excretion rate (spot or 24h),...</td>\n",
       "      <td>Filtration fraction %, Baseline; 1 week + 24 w...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>University Hospital, Geneva</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>09-136</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT04971720</td>\n",
       "      <td>PRECISION-BP: Precision Chronopharamacotherapy...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT04971720</td>\n",
       "      <td>PRECISION-BP</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>NO</td>\n",
       "      <td>Obesity|Cardiovascular Diseases|Hypertension|N...</td>\n",
       "      <td>DRUG: Sacubitril-Valsartan 49 Mg-51 Mg Oral Ta...</td>\n",
       "      <td>Change in mean nocturnal systolic blood pressu...</td>\n",
       "      <td>Change in percent nocturnal dipping blood pres...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>University of Alabama at Birmingham</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE2|PHASE3</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: FAC...</td>\n",
       "      <td>IRB-300007789</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>NCT01519635</td>\n",
       "      <td>Effect of Aliskiren and Hydrochlorothiazide on...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT01519635</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>YES</td>\n",
       "      <td>Hypertension</td>\n",
       "      <td>DRUG: Aliskiren|DRUG: Hydrochlorothiazide</td>\n",
       "      <td>Renal Oxygenation Changes After Chronic Treatm...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Centre Hospitalier Universitaire Vaudois</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2011DR3137</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>NCT04078711</td>\n",
       "      <td>Chinese Medicine Treat for Hypertensive Renal ...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT04078711</td>\n",
       "      <td>CHAIR</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>NO</td>\n",
       "      <td>Hypertension|Renal Injury</td>\n",
       "      <td>DRUG: Losartan 100Mg Tab|DRUG: Qianyangyuyin 2...</td>\n",
       "      <td>albumin-to-creatinine ratio(UACR), UACR tested...</td>\n",
       "      <td>Ambulatory blood pressure level, ABPM was meas...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Jiangsu Province Hospital of Traditional Chine...</td>\n",
       "      <td>Ministry of Science and Technology of the Peop...</td>\n",
       "      <td>ADULT</td>\n",
       "      <td>PHASE2|PHASE3</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>2019NL-086-02</td>\n",
       "      <td>Study Protocol and Statistical Analysis Plan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>NCT01184599</td>\n",
       "      <td>A Prospective Study of the Kidney Protective E...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT01184599</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>NO</td>\n",
       "      <td>Glomerulonephritis, IGA|Hypertension</td>\n",
       "      <td>DRUG: aliskiren</td>\n",
       "      <td>Renal function (Creatinine clearance), One yea...</td>\n",
       "      <td>Urinary angiotensinogen, One year (every 6 mon...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Kagawa University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>OCGH-746</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>78</th>\n",
       "      <td>NCT01840540</td>\n",
       "      <td>MSC for Occlusive Disease of the Kidney</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT01840540</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NO</td>\n",
       "      <td>Atherosclerotic Renal Artery Stenosis|Ischemic...</td>\n",
       "      <td>DRUG: Arterial infusion of autologous mesenchy...</td>\n",
       "      <td>Renal blood flow and function in the treated k...</td>\n",
       "      <td>Level of kidney function., Level of kidney fun...</td>\n",
       "      <td>Blood pressure levels., Blood pressure will be...</td>\n",
       "      <td>Mayo Clinic</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE1</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>12-009298</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>79</th>\n",
       "      <td>NCT05687669</td>\n",
       "      <td>Comparison Between the Use of Phentolamine Ver...</td>\n",
       "      <td>https://beta.clinicaltrials.gov/study/NCT05687669</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>NO</td>\n",
       "      <td>Pre-Eclampsia; Complicating Pregnancy|Pre-ecla...</td>\n",
       "      <td>DRUG: Glyceryl trinitrate vs phentolamine for ...</td>\n",
       "      <td>kidney function tests, creatinine in micromole...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Assiut University</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHILD, ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>obstetric Renal prophylaxis</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>80 rows × 19 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     NCT Number                                        Study Title  \\\n",
       "0   NCT01901549  Renal Denervation in Patients After Acute Coro...   \n",
       "1   NCT01663805  Effects of the Use of \"de Novo\" Everolimus in ...   \n",
       "2   NCT05222191  Spironolactone in CKD Enabled by Chlorthalidon...   \n",
       "3   NCT01095939  Post-preeclampsia Renal Project: Study of Neph...   \n",
       "4   NCT04971720  PRECISION-BP: Precision Chronopharamacotherapy...   \n",
       "..          ...                                                ...   \n",
       "75  NCT01519635  Effect of Aliskiren and Hydrochlorothiazide on...   \n",
       "76  NCT04078711  Chinese Medicine Treat for Hypertensive Renal ...   \n",
       "77  NCT01184599  A Prospective Study of the Kidney Protective E...   \n",
       "78  NCT01840540            MSC for Occlusive Disease of the Kidney   \n",
       "79  NCT05687669  Comparison Between the Use of Phentolamine Ver...   \n",
       "\n",
       "                                            Study URL       Acronym  \\\n",
       "0   https://beta.clinicaltrials.gov/study/NCT01901549         ACSRD   \n",
       "1   https://beta.clinicaltrials.gov/study/NCT01663805           NaN   \n",
       "2   https://beta.clinicaltrials.gov/study/NCT05222191   SPICE PILOT   \n",
       "3   https://beta.clinicaltrials.gov/study/NCT01095939         RPPEC   \n",
       "4   https://beta.clinicaltrials.gov/study/NCT04971720  PRECISION-BP   \n",
       "..                                                ...           ...   \n",
       "75  https://beta.clinicaltrials.gov/study/NCT01519635           NaN   \n",
       "76  https://beta.clinicaltrials.gov/study/NCT04078711         CHAIR   \n",
       "77  https://beta.clinicaltrials.gov/study/NCT01184599           NaN   \n",
       "78  https://beta.clinicaltrials.gov/study/NCT01840540           NaN   \n",
       "79  https://beta.clinicaltrials.gov/study/NCT05687669           NaN   \n",
       "\n",
       "          Study Status Study Results  \\\n",
       "0              UNKNOWN            NO   \n",
       "1              UNKNOWN            NO   \n",
       "2           RECRUITING            NO   \n",
       "3            COMPLETED            NO   \n",
       "4           RECRUITING            NO   \n",
       "..                 ...           ...   \n",
       "75           COMPLETED           YES   \n",
       "76             UNKNOWN            NO   \n",
       "77             UNKNOWN            NO   \n",
       "78           COMPLETED            NO   \n",
       "79  NOT_YET_RECRUITING            NO   \n",
       "\n",
       "                                           Conditions  \\\n",
       "0       Acute Coronary Syndrome|Arterial Hypertension   \n",
       "1                Delayed Function of Renal Transplant   \n",
       "2            Renal Insufficiency|Chronic Hypertension   \n",
       "3                                    Renal Alteration   \n",
       "4   Obesity|Cardiovascular Diseases|Hypertension|N...   \n",
       "..                                                ...   \n",
       "75                                       Hypertension   \n",
       "76                          Hypertension|Renal Injury   \n",
       "77               Glomerulonephritis, IGA|Hypertension   \n",
       "78  Atherosclerotic Renal Artery Stenosis|Ischemic...   \n",
       "79  Pre-Eclampsia; Complicating Pregnancy|Pre-ecla...   \n",
       "\n",
       "                                        Interventions  \\\n",
       "0   PROCEDURE: Renal denervation|DRUG: Metoprolol|...   \n",
       "1                                    DRUG: Everolimus   \n",
       "2   DRUG: Spironolactone|DRUG: Chlorthalidone|DRUG...   \n",
       "3        DRUG: Placebo|DRUG: Benazepril hydrochloride   \n",
       "4   DRUG: Sacubitril-Valsartan 49 Mg-51 Mg Oral Ta...   \n",
       "..                                                ...   \n",
       "75          DRUG: Aliskiren|DRUG: Hydrochlorothiazide   \n",
       "76  DRUG: Losartan 100Mg Tab|DRUG: Qianyangyuyin 2...   \n",
       "77                                    DRUG: aliskiren   \n",
       "78  DRUG: Arterial infusion of autologous mesenchy...   \n",
       "79  DRUG: Glyceryl trinitrate vs phentolamine for ...   \n",
       "\n",
       "                             Primary Outcome Measures  \\\n",
       "0   cardiovascular death, 1 year|myocardium infarc...   \n",
       "1   Molecular profile of cytokines, To characteriz...   \n",
       "2   Change in Systolic Automated Office Blood Pres...   \n",
       "3   microalbuminuria excretion rate (spot or 24h),...   \n",
       "4   Change in mean nocturnal systolic blood pressu...   \n",
       "..                                                ...   \n",
       "75  Renal Oxygenation Changes After Chronic Treatm...   \n",
       "76  albumin-to-creatinine ratio(UACR), UACR tested...   \n",
       "77  Renal function (Creatinine clearance), One yea...   \n",
       "78  Renal blood flow and function in the treated k...   \n",
       "79  kidney function tests, creatinine in micromole...   \n",
       "\n",
       "                           Secondary Outcome Measures  \\\n",
       "0   blood pressure changes, 1 year|CCS and NYHA, 1...   \n",
       "1   Pattern of cytokines with DGF, cold ischemia t...   \n",
       "2   Change in logarithmically transformed albumin/...   \n",
       "3   Filtration fraction %, Baseline; 1 week + 24 w...   \n",
       "4   Change in percent nocturnal dipping blood pres...   \n",
       "..                                                ...   \n",
       "75                                                NaN   \n",
       "76  Ambulatory blood pressure level, ABPM was meas...   \n",
       "77  Urinary angiotensinogen, One year (every 6 mon...   \n",
       "78  Level of kidney function., Level of kidney fun...   \n",
       "79                                                NaN   \n",
       "\n",
       "                               Other Outcome Measures  \\\n",
       "0                                                 NaN   \n",
       "1                                                 NaN   \n",
       "2                                                 NaN   \n",
       "3                                                 NaN   \n",
       "4                                                 NaN   \n",
       "..                                                ...   \n",
       "75                                                NaN   \n",
       "76                                                NaN   \n",
       "77                                                NaN   \n",
       "78  Blood pressure levels., Blood pressure will be...   \n",
       "79                                                NaN   \n",
       "\n",
       "                                              Sponsor  \\\n",
       "0   Meshalkin Research Institute of Pathology of C...   \n",
       "1                                   MARIO ABBUD FILHO   \n",
       "2              Indiana Institute for Medical Research   \n",
       "3                         University Hospital, Geneva   \n",
       "4                 University of Alabama at Birmingham   \n",
       "..                                                ...   \n",
       "75           Centre Hospitalier Universitaire Vaudois   \n",
       "76  Jiangsu Province Hospital of Traditional Chine...   \n",
       "77                                  Kagawa University   \n",
       "78                                        Mayo Clinic   \n",
       "79                                  Assiut University   \n",
       "\n",
       "                                        Collaborators  \\\n",
       "0                                                 NaN   \n",
       "1                                                 NaN   \n",
       "2                                                 NaN   \n",
       "3                                                 NaN   \n",
       "4                                                 NaN   \n",
       "..                                                ...   \n",
       "75                                                NaN   \n",
       "76  Ministry of Science and Technology of the Peop...   \n",
       "77                                                NaN   \n",
       "78                                                NaN   \n",
       "79                                                NaN   \n",
       "\n",
       "                          Age         Phases      Study Type  \\\n",
       "0          ADULT, OLDER_ADULT         PHASE2  INTERVENTIONAL   \n",
       "1          ADULT, OLDER_ADULT         PHASE4  INTERVENTIONAL   \n",
       "2          ADULT, OLDER_ADULT         PHASE2  INTERVENTIONAL   \n",
       "3          ADULT, OLDER_ADULT         PHASE3  INTERVENTIONAL   \n",
       "4          ADULT, OLDER_ADULT  PHASE2|PHASE3  INTERVENTIONAL   \n",
       "..                        ...            ...             ...   \n",
       "75         ADULT, OLDER_ADULT         PHASE4  INTERVENTIONAL   \n",
       "76                      ADULT  PHASE2|PHASE3  INTERVENTIONAL   \n",
       "77  CHILD, ADULT, OLDER_ADULT         PHASE4  INTERVENTIONAL   \n",
       "78         ADULT, OLDER_ADULT         PHASE1  INTERVENTIONAL   \n",
       "79  CHILD, ADULT, OLDER_ADULT         PHASE4  INTERVENTIONAL   \n",
       "\n",
       "                                         Study Design  \\\n",
       "0   Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "1   Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "2   Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "3   Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "4   Allocation: RANDOMIZED|Intervention Model: FAC...   \n",
       "..                                                ...   \n",
       "75  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "76  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "77  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
       "78  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
       "79  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "\n",
       "                      Other IDs                               Study Documents  \n",
       "0                         AMIRD                                           NaN  \n",
       "1                 CRAD001ABR21T                                           NaN  \n",
       "2                         12672                                           NaN  \n",
       "3                        09-136                                           NaN  \n",
       "4                 IRB-300007789                                           NaN  \n",
       "..                          ...                                           ...  \n",
       "75                   2011DR3137                                           NaN  \n",
       "76                2019NL-086-02  Study Protocol and Statistical Analysis Plan  \n",
       "77                     OCGH-746                                           NaN  \n",
       "78                    12-009298                                           NaN  \n",
       "79  obstetric Renal prophylaxis                                           NaN  \n",
       "\n",
       "[80 rows x 19 columns]"
      ]
     },
     "execution_count": 82,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_REN  = pd.read_csv(\"/Users/trini/Downloads/ClinicalTrial_REN_Drug.csv\")\n",
    "df_REN "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5aa6f14f",
   "metadata": {},
   "source": [
    "- No results found for (activin A receptor-like type 1) ACVRL1\n",
    "- No results found for Angiotensinogen (AGT)\n",
    "- No results found for CULLIN 3 (CUL3)\n",
    "- No results found for CYTOCHROME P450, SUBFAMILY XIB, POLYPEPTIDE 1 (CYP11B1)\n",
    "     - causes Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency OMIM: 202010; and\n",
    "     - causes Aldosteronism, glucocorticoid-remediable OMIM: 103900\n",
    "- No results found for CYTOCHROME P450, FAMILY 17, SUBFAMILY A, POLYPEPTIDE 1 (CYP17A1)\n",
    "     - causes 17,20-lyase deficiency, isolated OMIM: 202110\n",
    "- No results found for EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 4 (EIF2AK4) - causes Pulmonary venoocclusive disease 2 OMIM: 234810\n",
    "- No results found for 11-BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II (HSD11B2) - No Drug, only Dietary in ClinicalTrial.gov\n",
    "     - causes Apparent mineralocorticoid excess OMIM: 218030\n",
    "- No results found for POTASSIUM CHANNEL, SUBFAMILY K, MEMBER 3; (KCNK3) - causes PPH4 OMIM: 615344\n",
    "- No results found for SODIUM CHANNEL, EPITHELIAL 1, ALPHA SUBUNIT; (SCNN1A) - causes Liddle Syndrome 1 OMIM: 177200\n",
    "- No results found for SODIUM CHANNEL, EPITHELIAL 1, BETA SUBUNIT; (SCNN1B) - causes Liddle Syndrome 1 OMIM: 177200\n",
    "- No results found for SODIUM CHANNEL, EPITHELIAL 1, GAMMA SUBUNIT; (SCNN1G) - causes Liddle Syndrome 2 OMIM: 618114\n",
    "- No results found for PROTEIN KINASE, LYSINE-DEFICIENT 1; (WNK1)\n",
    "- No results found for PROTEIN KINASE, LYSINE-DEFICIENT 4; (WNK4)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e30d7bf9",
   "metadata": {},
   "source": [
    "# END OF PROGRESS 2\n",
    "- Summary: ClinicalTrial.gov data was retrieved for genes: ACE, AGTR1, ATP13A3, BMPR2, CAV1, CYP11B2, DRD1, KCNJ5, NR3C2, REN\n",
    "    while other potential genes did not have any clinicaltrial information in the database.\n",
    "- Progress 3 expectation: Populate .csv table of all required fields in the project prompt. Add more info in introduction/literature. Genes that do no have clinicaltrial information will just have empty cells."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "04a1ed3d",
   "metadata": {},
   "source": [
    "# Part 3: Populate .csv table with data obtained from Part 1 and 2"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fed30b7c",
   "metadata": {},
   "source": [
    "### The drug_class data of each ClinicalTrial.gov drugs was retreived by searching via Web browser of Kegg Drugs https://www.kegg.jp/kegg/drug/\n",
    "#### Drugs that had no return results from Kegg Drug Database will be labeled \"NaN\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "013019c4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Gene</th>\n",
       "      <th>Mutation_Remark</th>\n",
       "      <th>System/Pathway_info</th>\n",
       "      <th>Drug_Name_and_Combination</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Primary Phenotype Measures</th>\n",
       "      <th>Primary/Secondary_Hypertension</th>\n",
       "      <th>Drug_Class</th>\n",
       "      <th>Source</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>ACE</td>\n",
       "      <td>homozygous or compound heterozygous mutation i...</td>\n",
       "      <td>Renin-angiotensin system</td>\n",
       "      <td>DRUG: Olmesartan medoxomil+ Hydrochlorothiazid...</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>Change in systolic blood pressure from the sta...</td>\n",
       "      <td>Hypertension, Primary</td>\n",
       "      <td>Renin-angiotensin system inhibitor</td>\n",
       "      <td>NCT00185120</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>ACE</td>\n",
       "      <td>homozygous or compound heterozygous mutation i...</td>\n",
       "      <td>Renin-angiotensin system</td>\n",
       "      <td>DRUG: Perindopril+Amlodipine</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>systolic Blood pressure control, reduction in ...</td>\n",
       "      <td>Hypertension, Primary</td>\n",
       "      <td>Renin-angiotensin system inhibitor</td>\n",
       "      <td>NCT02995954</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>ACE</td>\n",
       "      <td>homozygous or compound heterozygous mutation i...</td>\n",
       "      <td>Renin-angiotensin system</td>\n",
       "      <td>DRUG: Ramipril</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>Time interval to renal 'loss' as defined by an...</td>\n",
       "      <td>Children|Chronic Renal Failure|Hypertension|Ac...</td>\n",
       "      <td>Antihypertensive, Angiotensin-converting enzym...</td>\n",
       "      <td>NCT00221845</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>ACE</td>\n",
       "      <td>homozygous or compound heterozygous mutation i...</td>\n",
       "      <td>Renin-angiotensin system</td>\n",
       "      <td>DRUG: losartan|DRUG: ramipril</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>Fatal and nonfatal stroke, two years|Progressi...</td>\n",
       "      <td>Brain Infarction|Hypertension</td>\n",
       "      <td>Antihypertensive, Angiotensin II receptor anta...</td>\n",
       "      <td>NCT00126516</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>ACE</td>\n",
       "      <td>homozygous or compound heterozygous mutation i...</td>\n",
       "      <td>Renin-angiotensin system</td>\n",
       "      <td>DRUG: Ramipril</td>\n",
       "      <td>PHASE3</td>\n",
       "      <td>The main outcome variable will be a combined e...</td>\n",
       "      <td>Left Ventricular Hypertrophy|Hypertension</td>\n",
       "      <td>Antihypertensive, Angiotensin-converting enzym...</td>\n",
       "      <td>NCT00985322</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>439</th>\n",
       "      <td>SCNN1B</td>\n",
       "      <td>heterozygous mutation in the SCNN1B gene (6007...</td>\n",
       "      <td>Aldosterone-regulated sodium reabsorption</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Liddle Syndrome 1</td>\n",
       "      <td>Secondary hypertension</td>\n",
       "      <td>NaN</td>\n",
       "      <td>OMIM: 177200</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>440</th>\n",
       "      <td>SCNN1G</td>\n",
       "      <td>heterozygous mutation in the SCNN1G gene (6007...</td>\n",
       "      <td>Aldosterone-regulated sodium reabsorption</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Liddle Syndrome 2</td>\n",
       "      <td>Secondary hypertension</td>\n",
       "      <td>NaN</td>\n",
       "      <td>OMIM: 618114</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>441</th>\n",
       "      <td>WNK1</td>\n",
       "      <td>autosomal recessive</td>\n",
       "      <td>\\tAldosterone-regulated sodium reabsorption</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Neuropathy, hereditary sensory and autonomic, ...</td>\n",
       "      <td>Secondary hypertension</td>\n",
       "      <td>NaN</td>\n",
       "      <td>OMIM: 201300</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>442</th>\n",
       "      <td>WNK4</td>\n",
       "      <td>autosomal recessive</td>\n",
       "      <td>\\tAldosterone-regulated sodium reabsorption</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pseudohypoaldosteronism, type IIB</td>\n",
       "      <td>Secondary hypertension</td>\n",
       "      <td>NaN</td>\n",
       "      <td>OMIM: 614491</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>443</th>\n",
       "      <td>SMAD9</td>\n",
       "      <td>heterozygous truncating mutation in the SMAD9 ...</td>\n",
       "      <td>TGF-beta signaling pathway</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Primary Pulmonary Hypertension 2</td>\n",
       "      <td>Primary Pulmonary Hypertension</td>\n",
       "      <td>NaN</td>\n",
       "      <td>OMIM: 615342</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>444 rows × 9 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       Gene                                    Mutation_Remark  \\\n",
       "0       ACE  homozygous or compound heterozygous mutation i...   \n",
       "1       ACE  homozygous or compound heterozygous mutation i...   \n",
       "2       ACE  homozygous or compound heterozygous mutation i...   \n",
       "3       ACE  homozygous or compound heterozygous mutation i...   \n",
       "4       ACE  homozygous or compound heterozygous mutation i...   \n",
       "..      ...                                                ...   \n",
       "439  SCNN1B  heterozygous mutation in the SCNN1B gene (6007...   \n",
       "440  SCNN1G  heterozygous mutation in the SCNN1G gene (6007...   \n",
       "441    WNK1                                autosomal recessive   \n",
       "442    WNK4                                autosomal recessive   \n",
       "443   SMAD9  heterozygous truncating mutation in the SMAD9 ...   \n",
       "\n",
       "                             System/Pathway_info  \\\n",
       "0                       Renin-angiotensin system   \n",
       "1                       Renin-angiotensin system   \n",
       "2                       Renin-angiotensin system   \n",
       "3                       Renin-angiotensin system   \n",
       "4                       Renin-angiotensin system   \n",
       "..                                           ...   \n",
       "439    Aldosterone-regulated sodium reabsorption   \n",
       "440    Aldosterone-regulated sodium reabsorption   \n",
       "441  \\tAldosterone-regulated sodium reabsorption   \n",
       "442  \\tAldosterone-regulated sodium reabsorption   \n",
       "443                   TGF-beta signaling pathway   \n",
       "\n",
       "                             Drug_Name_and_Combination  Phases  \\\n",
       "0    DRUG: Olmesartan medoxomil+ Hydrochlorothiazid...  PHASE4   \n",
       "1                         DRUG: Perindopril+Amlodipine  PHASE4   \n",
       "2                                       DRUG: Ramipril  PHASE3   \n",
       "3                        DRUG: losartan|DRUG: ramipril  PHASE4   \n",
       "4                                       DRUG: Ramipril  PHASE3   \n",
       "..                                                 ...     ...   \n",
       "439                                                NaN     NaN   \n",
       "440                                                NaN     NaN   \n",
       "441                                                NaN     NaN   \n",
       "442                                                NaN     NaN   \n",
       "443                                                NaN     NaN   \n",
       "\n",
       "                            Primary Phenotype Measures  \\\n",
       "0    Change in systolic blood pressure from the sta...   \n",
       "1    systolic Blood pressure control, reduction in ...   \n",
       "2    Time interval to renal 'loss' as defined by an...   \n",
       "3    Fatal and nonfatal stroke, two years|Progressi...   \n",
       "4    The main outcome variable will be a combined e...   \n",
       "..                                                 ...   \n",
       "439                                  Liddle Syndrome 1   \n",
       "440                                  Liddle Syndrome 2   \n",
       "441  Neuropathy, hereditary sensory and autonomic, ...   \n",
       "442                  Pseudohypoaldosteronism, type IIB   \n",
       "443                   Primary Pulmonary Hypertension 2   \n",
       "\n",
       "                        Primary/Secondary_Hypertension  \\\n",
       "0                                Hypertension, Primary   \n",
       "1                                Hypertension, Primary   \n",
       "2    Children|Chronic Renal Failure|Hypertension|Ac...   \n",
       "3                        Brain Infarction|Hypertension   \n",
       "4            Left Ventricular Hypertrophy|Hypertension   \n",
       "..                                                 ...   \n",
       "439                             Secondary hypertension   \n",
       "440                             Secondary hypertension   \n",
       "441                             Secondary hypertension   \n",
       "442                             Secondary hypertension   \n",
       "443                     Primary Pulmonary Hypertension   \n",
       "\n",
       "                                            Drug_Class        Source  \n",
       "0                   Renin-angiotensin system inhibitor   NCT00185120  \n",
       "1                   Renin-angiotensin system inhibitor   NCT02995954  \n",
       "2    Antihypertensive, Angiotensin-converting enzym...   NCT00221845  \n",
       "3    Antihypertensive, Angiotensin II receptor anta...   NCT00126516  \n",
       "4    Antihypertensive, Angiotensin-converting enzym...   NCT00985322  \n",
       "..                                                 ...           ...  \n",
       "439                                                NaN  OMIM: 177200  \n",
       "440                                                NaN  OMIM: 618114  \n",
       "441                                                NaN  OMIM: 201300  \n",
       "442                                                NaN  OMIM: 614491  \n",
       "443                                                NaN  OMIM: 615342  \n",
       "\n",
       "[444 rows x 9 columns]"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Open the populated .csv table named \"Progress 3 Data Sheet\"\n",
    "\n",
    "Progress_data_table = pd.read_csv(\"/Users/trini/OneDrive/Documents/New York University/Guided Studies/Progress 3 Data Sheet.csv\")\n",
    "Progress_data_table\n",
    "\n",
    "# NOTICE: The cell_location column was empty. Still deciding if I will be including this in my final report\n",
    "# If decided not to included, this column will be deleted"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0eba300b",
   "metadata": {},
   "source": [
    "# END OF PROGRESS 3\n",
    "### Final report adjustments: Finally complete and reorganize the introductions section and close out the project report with conclusions and future remarks."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "1ab59aea",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
